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ABSTRACT
Radio-labelled forms of ribonuclease, lysozyme and insulin 
were shown to be ingested by 17.5-day rat yolk sacs almost exclusively 
by adsorptive pinocytosis and were rapidly degraded by the tissue to the 
level of free amino acids. The rates of pinocytosis were shown to decrease 
markedly on treating these proteins with alkaline formaldehyde but not 
other denaturing reagents. Aggregates of radio-labelled lysozyme were 
ingested more slowly than the monomeric protein. Formaldehyde-denatured 
bovine serum albumin and ribonuclease were shown to adsorb to differing 
regions of the pinocytosing plasma membrane? such binding is discussed 
in terms of basic and hydrophobic regions on these protein molecules.
Radio-labelled bovine serum albumin was shown to be digested 
exclusively intralysosomally. The effects on this process of chloroquine, 
ammonium- and substituted ammonium ions were investigated; each was 
shown to inhibit both intralysosomal proteolysis and the rate of 
pinosome formation. In contrast a number of proteinase inhibitors 
(leupeptin, chymostatin, antipain, bestatin, elastatinal and pepstatin) 
were without effect on pinosome formation but several markedly inhibited 
intralysosomal digestion.
When radio-labelled forms of a number of proteins (formaldehyde- 
-denatured albumin, rat immunoglobulin G, ribonuclease and lysozyme) and 
peptides (insulin, calcitonin, insulin B-chain and glucagon) were 
exposed to yolk-sac tissue, each showed a characteristic "lag-period" 
before digestion products appeared in the incubation medium. The durations 
of such lag-periods were shown to correlate well with the susceptibility 
of individual substrates to degradation by both disrupted rat-liver 
tritosomes and cell-free homogenates of yolk sacs. An attempt was made
Ill
to relate the effects of inhibitors of lysosomal proteolysis on exogenous 
protein breakdown to their effects on the breakdown of endogenous [3H]- 
leucine-labelled yolk-sac proteins to discover whether both groups 
of proteins are degraded intralysosomally. (This study was made in 
collaboration with S. Knowles and P.J. Ballard, CSIRO, Adelaide.)
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VABBREVIATIONS
Abbreviations in this thesis comply with the policy of the 
Biochemical Journal (1978) but in addition, the following are also used
E l ............ Endocytic Index.
C l ............ Catabolic Index.
Y.S............. yolk sac.
r.p.m. . . . . . revolutions per minute.
125I-PVP . . . . 125I-labelled poly(vinylpyrrolidone).
db-cAMP . . . . dibutyryl cyclic AMP.
CHAPTER ONE
GENERAL INTRODUCTION
11.1 Preface
The ability of certain cells to ingest molecules, colloidal 
substances (0.2-20nm dia.) and particles of bacterial size (0.20ym 
dia.) that are unable to penetrate cytomembranes by diffusion or active 
transport is now well recognised and has been the subject of numerous 
reviews, most of which have appeared during the last decade (Mudd et al., 
1934; Schechtman, 1956; Holter, 1959; Ryser, 1968; Jacques, 1969;
Stockem & Wohlfarth-gotterman, 1969; North, 1970; Ryser 1970; Gordon,
1973; Chapman-Andresen, 1973; Simpson & Spicer, 1973; Allison & Davies.
1974; Stossel, 1974; Jacques, 1975; Stossel & Cohn, 1976; Chapman- 
-Andresen, 1977; Stossel, 1977; Silverstein et al., 1977). The ingestion 
process (endocytosis) involves microscopic movements in the plasma membrane, 
the extracellular substrate being taken into the cell by either membrane 
invagination or evagination to encage the prey. In both cases membrane 
fusion occurs at the lips of the newly formed plasma membrane cavity to 
form free, membrane-limited vesicles within the cytoplasm of the cell.
■Since these vesicles usually fuse with lysosomes, a much reviewed organelle 
(see de Duve, 1959; Weissman, 1965; de Duve & Wattiaux, 1966; CIBA 
Foundation Symposium, 1963; Lysosomes in Biology and Pathology, 1969a,b, 
1973, 1975, 1976; Holtzman, 1976; Dean & Barrett, 1976, see also Tissue 
Proteinases, 1977; Proteinases in Mammalian Cells and Tissue, 1977), 
¿igestible prey, e.g. serum proteins or peptides, can be catabolized 
following uptake via this route. Cell-proteins, however, are probably 
also digested by other routes (see Schimke & Doyle, 1970; Goldberg &
Dice, 1974; Goldberg & St. John, 1976; Ballard, 1977 for reviews on 
this subject, see also Turk & Marks, 1977) but it is emerging that 
lysosomes might also be involved in the digestion of substrate captured by
2autophagy. This thesis reports investigations of aspects of endocytosis 
in relation to the catabolism of proteins and peptides in the 17.5-day 
rat visceral yolk sac and (in collaboration with S. Knowles & F.J.
Ballard, CSIRO, Division of Human Nutrition, Adelaide, Australia) 
the possible role of lysosomes in cell-protein catabolism. Before 
proceeding to these, however, it is appropriate to describe some of 
those studies which have contributed to the formulation of the current 
concepts of endocytosis and lysosomal proteolysis and to describe the 
structure and activities of the rat yolk sac that are relevant to its 
endocytic activity.
1,2 The concepts of endocytosis and intralysosomal proteolysis.
Uptake of erythrocytes, bacteria and non-living particles by 
leucocytes was observed with the light microscope by several workers 
including Metchnikoff (1883), who in 1892 used the term 'phagocytosis' 
to describe the process. The possibility of endocytosis at a sub- 
-microscopic level was envisaged by Meltzer (1904) in his hypothesis of 
fluid uptake and passage through cells ("photocytosis") as an explanation 
of oedema in mammalian tissues; a phenomenon that was later demonstrated 
by electron microscopy (Palade, 1953). The physiological importance of 
the uptake of dissolved macromolecules was first appreciated by Lewis 
(1931) who suggested that: "By pinocytosis the cells are able to take 
in substances which cannot diffuse into them or be taken up by ordinary 
phagocytosis." However, uptake of soluble proteins by non-phagocytic 
cells in multicellular organisms was still questioned by Schechtman 
(1956): "... until we have definite evidence that such elements as 
hepatic cells, lymphocytes, heart myocardial cells, renal tubule epithelium, 
and ovarian eggs of birds carry on some form of pinocytosis, we can hardly
3accord this process a role of general significance in macromolecular 
uptake". Nevertheless, the universality of pinocytosis became immediately 
apparent following electron microscopic observations made by Palade 
(1 9 5 3, 1956) and Bennett (1956). In 1958, Holter and Holtzer, introduced 
the technique of following pinocytosis with fluorescein-labelled proteins 
and observed under the light microscope the ingestion of such proteins 
by cells in a wide variety of mammalian tissues. Straus (1961) made 
similar observations with the foreign enzyme horseradish peroxidase.
Straus (1962), using histochemical methods, later observed that the 
peroxidase initially appeared in small phagosomes [a term coined by 
Straus (1959) to describe the vesicles which contained the endocytosed 
material] but later became concentrated in large phagosomes. Electron 
microscopic evidence using the electron opaque proteins ferritin (Caufield, 
1963) and haemoglobin (Miller, 1960) gave similar results. Using 
histochemical methods, Straus (1964) elegantly demonstrated the fusion 
of peroxidase containing phagosomes with lysosomes [a particle discovered 
by de Duve (see de Duve, 1969) and now known to contain many hydrolytic 
enzymes). Straus called the resultant particle a phagolysosome. In the 
meantime, work on leucocytes (Cohn & Hirsch, 1960a_,b; Hirsch & Cohn, I960; 
Zucker-Franklin & Hirsch, 1964) and later on macrophages (Cohn & Wiener, 
1963a,b) identified the process whereby lysosomes merge with endocytic 
vacuoles and supply them with digestive enzymes. These observations gave 
a basis to the long inferred belief that endocytosed substrates are 
digested after being absorbed into the cell, an assumption that was made 
much earlier by Lewis (1931) to explain the disappearance of pinocytic 
vesicles that occurred after he had observed them travel toward the 
nucleus by time-lapse photography.
Straus (1964) announced his evidence for phagosome-lysosome
4fusion, at about the same time that Mego & McQueen (1965a) demonstrated 
the digestion of I-labelled albumin within particulate cell 
fractions isolated frcm the livers of adult mice that had been previously 
injected (i.v.) with the radiolabelled protein. Shortly afterwards 
(1965b) they indicated the digestive particles to be lysosomes,a point 
which Mego et al. (1967) established. The trichloroacetic acid-soluble 
digestion product released from the particulate fraction was found to 
be I13^1iodo-L-tyrosine (Mego et al., 1967). Radioiodinated L-tyrosine 
was also identified as the label appearing in the culture medium of 
mouse macrophages (Ehrenreich & Cohn, 1967, 1968; Unanue & Askonas, 1968) 
and sarcoma S180 cells (Gabathuler & Ryser, 1969) when radio-iodinated 
protein was digested after endocytosis. In vitro, lysosomal enzymes were 
shown to digest proteins to amino acids and oligopeptides, mainly dipeptides 
(Coffey & de Duve, 1968) and, in intact lysosomes, the lysosomal membrane 
was found to be permeable to amino acids and oligopeptides less than 
200-240 molecular weight (Ehrenreich & Cohn, 1969; Lloyd, 1971).
1.3 The role of lysosomes in cell-protein catabolism.
The role of lysosomes in the catabolism of endocytosed proteins 
is now well established but the role of lysosomes in cell-protein turnover 
is not clear. Nevertheless several authors have postulated such a role 
(Gordon, 1973; Wibo & Poole, 1974; Dean, 1975a,b; Segal, 1976, Lloyd, 
1976; Ballard, 1977) and Dean (1978) has even provided a hypothetical 
mechanism that would permit the selective catabolism of certain soluble 
cell-proteins by the invagination of the lysosomal membrane, a process 
that resembles pinocytosis. Such invaginations have been observed in 
mouse peritoneal macrophages treated with chloroquine (Fedorko et al.,
1968a). Additional evidence for a lysosomal role in cell-protein 
breakdown [in addition to inhibition of lysosomal activity by weak
5bases (see Chapter 5) and microbial proteinase inhibitors (see Chapter 
6)] is as follows.
Stimulation of autophagy in rat liver can be achieved by the 
administration of glucagon. In such conditions electron micrographs of 
hepatocytes showed (de Duve & Wattiaux, 1966) autophagic vacuoles fusing 
with lysosomes. Neely et al. (1974) showed that in liver perfusion studies 
increased numbers of autophagosome-like bodies were found in hepatocytes 
and increased rates of protein breakdown were observed in isolated lysosomes. 
A demonstration of a rapid increase in the number of autophagosomes 
and of secondary lysosomes in cells exposed to an acute nutritional step- 
-down (Mitchener e£ al., 1976) supports a lysosomal role in cell-proteolysis 
under conditions of accelerated catabolism. Amenta et al. (1977) showed 
that, when added to rat embryo fibroblasts in culture, microtubular 
poisons, which disorganise the vacuolar apparatus (Hoffstein et al., 1977) 
are inhibitors of the enhanced protein degradation induced by a nutritional 
step-down. Knowles £ Ballard (1976) observed that the degradation of 
normal proteins in Reuber H35 hepatoma cells is between 28-44% inhibited 
by optimal concentrations of insulin, puromycin, cycloheximide, fetal 
calf serum, NH^Cl, leupeptin, antipain and 7-amino-l-chloro-3-tosylamido- 
heptan-2-one. Combinations of the inhibitors present at optimal 
concentrations did not have additive effects also the inhibitors had no 
effect on the digestion of canavanine containing (i.e. short-lived) 
proteins. To explain their results it was proposed that the inhibitors 
completely inactivate a proteolytic pathway. The inactive pathway in cells 
incubated in the presence of insulin or serum became activated on 
nutritional step-down caused by the removal of these substances from the 
culture medium; suggesting that it may be an autophago-lysosomal pathway 
that is responsible for the digestion of long-lived proteins. An alternative
6pathway, possibly not involving lysosomes, was suggested for the short 
lived proteins. Amenta et al. (1977) made similar proposals of a dual 
pathway in cell protein catabolism. More recently. Ward et al.(1977) 
provided evidence for the uptake of intracellular proteins by lysosomes 
during insulin and amino acid deprivation. Other factors involved in 
the regulation of cell-protein catabolism have been reviewed by Schimke 
& Doyle (1970), Goldberg & Dice (1974), Goldberg & St. John (1976) 
and Ballard (1977)j only the last reviewer discusses a dual pathway 
of cell-protein catabolism.
For a further clarification of the role of lysosomes in cell- 
-protein breakdown there is a need for specific inhibition of lysosomal 
function and an understanding of the inhibition process. Experiments 
aimed at answering questions in this area form the subject matter of 
the latter half of this thesis.
1.4 Morphology of endocytosis and the origin of intracellular vacuoles.
Hie simplest classification of endocytosis is a morphological 
one (see Allison & Davies, 1974) on the basis of the size of vesicle 
formed, its fate and its contents. Phagocytosis results in the entrapment 
of either solid or semi-solid particles within a vacuole formed by 
evaginations of the surface membrane that flow over the particle and 
fuse. The phagosome membrane adheres closely to the edocytosed particle 
so that the latter determines the size (usually about lym dia. or 
larger) and shape of the membrane-limited vacuole. Such vacuoles usually 
fuse with lysosomes.
Pinocytosis, by a process of membrane invagination and fusion 
results in the entrapment of fluid within a pinosome (pinocytic vesicle 
or phagosome). Micropinocytosis (observable by electronmicroscopy) and
7macropinocytosis (observable by phase-contrast microscopy) have been 
described and result in the formation of micropinosomes (70-110nm dia.) 
and macropinosomes (0.2-lum dia.). A specialized vesicle, called a 
coated micropinocytic vesicle has also been described, it is formed 
from dense caveolae (Fawcett, 1965) that further invaginate to develop 
into mature vesicles containing a condensed layer of glycocalyx. Roth 
& Porter (1964) suggested the glycocalyx may play an important role in 
the selective uptake of intact molecules. The detailed morphology of 
the coated micropinocytic vesicle is discussed by Ockiford (1976).
Micropinocytosis can take at least two main forms. One,called 
diacytosis#is classically seen in capillaries (Bruns & Palade, 1968).
It is principally associated with the passage of fluid, in vesicles with 
a smooth inner surface, through cells by a process of endocytosis and 
exocytosis. The second form of pinocytosis is one in which the vesicles, 
often with an inner coat of mucopolysaccharide (Bennett, 1963), are 
delivered to and fuse with lysosomes where the endocytosed material is 
usually either digested or stored depending upon its susceptibility to 
attack by the lysosomal hydrolases. Coated micropinocytic vesicles can 
either release their contents at an opposing cell surface (Moxon et al., 
1976) or empty their contents into lysosomes (Anderson et al., 1976, 1977). 
The contents of pinocytic vesicles have also been observed to be discharged 
into the cytoplasm by either vesicle rupture or dissolution (Wohlfarth- 
-Bottermann, I960; Casely-Smith, 1965; Florey, 1967; Bessis & Breton- 
-Gorius, 1957, 1959). However, this process appears to be a rare event.
In the absence of results that can be more confidently interpreted, it 
must be assumed not to be a process involved in normal cell physiology but 
to be the result of either some micropathological event or an artifact 
arising from the preparation of cells and tissues for ultrastruetural
8examination.
Not all cell vacuoles/vesicles arise from the plasma membrane. 
Primary lysosomes belong to a postulated GERL complex; Golgi-associated 
endoplasmic reticulum and lysosomes (NoviJtoff et al., 1971). Secretory 
vacuoles also arise fromthe Golgi apparatus. Fusion may occur between 
secretory vacuoles and primary lysosomes (Farquhar, 1969), a process 
called crinophagy. More frequently however, exocytic discharge of the 
exportable contents of the secretory vacuole occurs by its fusion with 
the plasma membrane; the membrane may later be retrieved by an endocytic 
mechanism. It is important to note that the contents of primary lysosomes, 
in some cell types, might also be discharged by exocytosis. This was 
proposed by Hickman & Neufeld (1972) as an explanation of the ability 
of normal fibroblasts to correct the lysosomal enzyme deficiency of 
mutant (I-cell) fibroblasts during co-cultivation. An alternative 
hypothesis (Lloyd, 1978) suggests that it is secondary lysosomes that 
discharge their contents extracellularly as a consequence of a postulated 
membrane recycling process. Neither hypothesis is supported by much 
experimental evidence. However, lysosomal enzymes are known to be released 
by several cell types under a variety of conditions (see Dean & Barrett, 
1976) and often such release is associated with endocytic uptake of 
particulate materials (for a discussion of this subject see Ericsson 
et al., 1975).
Autophagic vacuoles may arise from the surrounding of cellular 
elements by a pair of smooth endoplasmic reticulum membranes, that fuse 
to form a double-membrane bounded vacuole. A second possible mechanism of 
formation is by invagination of the lysosomal membrane in a process that 
resembles pinocytosis; again a double membrane bounded vacuole is produced. 
Crinophagy is also a variant of autophagy but results in the formation of
9a single membrane-bounded vacuole.
1.5 Mechanisms of endocytosis.
It is clear that endocytosis results in the internalization 
of membrane from the surface of the endocytosing cell. In the studies 
that follow, reference is often made to "the internalizing plasma-membrane" 
or "the plasma membrane from which pinosomes are formed", but it is not 
known, however, whether the membrane of the endocytic vesicle is a 
representative or a selected sample of the plasma membrane. Phagocytic 
membrane appears to be representative of the plasma membrane (see Silverstein 
et al., 1977) but the evidence that follows suggests pinocytic membrane is 
selected.
Anti-immunoglobulin binding-sites on B-lymphocytes are pinocytosed 
in the presence of anti-immunoglobulins but without perceptibly altering the 
binding of antibodies to other plasma-membrane components e.g. histocompar­
ability antigens (Taylor et al., 1971). Similarly, Schneider et al. (1976) 
showed that specific anti-fibroblast plasma membrane antibodies were 
not interiorized but the same cells pinocytosed non-specific antibodies. 
After an examination of the lipid and protein components of isolated 
kidney brush border membranes and isolated pinocytic vesicles from the 
same tissue. Bode et al. (1976) discovered differences that led them to 
suggest that: "pinocytic vesicles are not derived from the brush border 
microvillous membrane but are independent entities that are newly synthe­
sized during the pinocytic process".
The biochemical mechanisms underlying endocytic processes are 
poorly understood. Evidence is discussed by Allison & Davies (1974) for 
the proposal that formation of micropinocytic vesicles does not require 
metabolic energy and is unaffected by cytochalasin B, whereas the formation
10
of larger vacuoles in macropinocytosis and phagocytosis requires metabolic 
energy and is inhibited by cytochalasin B. Similar biochemical means were 
used to determine whether more than one endocytic mechanism underlies the 
formation of pinocytic vesicles (Gabathuler & Ryser, 1975). Cytochalasin B 
is a fungal product that is thought to inhibit both microfilament function 
(Wessels et al., 1971) and hexose tmasport in a number of phagocytes 
(Zigmond & Hirsch, 1972; Kletzien et al., 1972). However, its mode of 
action as an inhibitor of endocytosis appears to be the breakdown of 
microfilaments (Stossel, 1977). The observed inhibitions, by cytochalasin 
B, gave stimulus to the idea that contractile proteins (of the actin and 
myosin types) are involved in the formation of some endocytic vesicles.
A hypothetical mechanism of how this might occur has been forwarded by 
Stossel (1977), who also reviews the evidence for the involvement of both 
contractile proteins and high energy compounds in endocytic uptake. Silver- 
stein et al. (1977) also review these two aspects of endocytosis.
Whatever the mechanism underlying endocytic vesicle formation, 
pinocytosis is often am ongoing process that comes under some form of 
regulation e.g. in macrophages (Steinman & Cohn, 1972) and fibroblasts 
(Wenfeld et al., 1975). In certain cell types pinocytosis can be induced 
e.g. macrophages pinocytose several times more actively when obtained 
from inflammatory exudates (Edelson et al_., 1975) , cell-lines pinocytose 
2-4 times faster on their becoming confluent (Steinman et al., 1974;
Kaplan, 1976), synchronized hepatoma cells can interiorize horseradish 
peroxidase most actively in the Gl phase of the cell-cycle (Quintart et al., 
1976) and partial hepatectomy induced an increased pinocytic activity 
in rat hepatocytes (Mori & Novikoff, 1977). The underlying regulatory 
mechanisms involved in these processes are, as yet, unknown.
11
Central to the problem of the control of protein turnover is 
the ability of some peptide hormones and proteins to modify the rate of 
pinosome formation, an ability which may well regulate a protein's own 
turnover. Thus stimululation of pinocytosis occurs in certain cell 
types: e.g. concanavalin A in mouse macrophages (Edelson & Cohn, 1974), 
maternal yolk-sac proteins in oocytes (Roth et al., 1976), a platelet- 
-factor in arterial smooth-muscle cells (Davies & Ross, unpublished results), 
insulin in adipose cells (Barnette & Ball, 1959) and Hela cells (Paul & 
Person, cited in Becker & Ashwood-Smith, 1973) and thyroxin in epithelial 
cells of the thyroid (Wollman, 1969).
1.6 Adsorptive endocytosis.
A central feature of pinocytosis that similarly affects the 
rate of pinocytic ingestion in all cells, independently of the precise 
mechanism of pinosome formation or the way the process is controlled, is 
the extent to which a substrate is concentrated by binding to the surface 
of the membrane from which pinosomes are formed.
The adsorption of proteins (and other molecules) to the cell- 
-surface prior to internalization was postulated by Bennett (1956) and 
confirmed in the amoeba by both morphological (Brandt, 1958) and biochemical 
(Schumaker, 1958) techniques. Chapman-Andresen & Holter (1955) had 
shown previously that serum albumin is ingested by the amoeba at a greater 
rate than glucose even when serum albumin was present with the latter.
Since the rate of glucose uptake represents the maximum rate of fluid 
uptake, Holter (1959) concluded that the albumin must be concentrated by 
adsorption to the internalizing surface membrane and that: "surface 
adsorption is the dominant factor in pinocytosis, and that the uptake of 
fluid may, at least in certain cases, play a secondary role".
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The method described above by Chapman-Andresen and Holter is still 
of great value in determining the extent to which proteins (and other 
substrates) bind to the membrane from which pinosomes are formed (see e.g. 
Williams et al., 1975b; Moore et al., 1977) and has been employed in the 
work reported in this thesis specifically for this purpose.
A theoretical treatment of the adsorption of substrate to membranes 
was left to Jacques (1975) who proposed that pinocytosis may take either 
one of three forms: uptake in the fluid phase only (substrate does not 
bind to the membrane), uptake in the adsorptive phase only (fluid being 
expelled from the forming pinocytic vesicle) and uptake in a combination 
of these two forms. In principle, negative adsorption is also possible 
where the substrate may be repelled from the external surface of the 
forming pinosome. An important feature of adsorptive pinocytosis is 
that, in theory at least, it can be selective. Those substrates that 
bind most extensively to the membrane that forms the pinosome will be 
ingested most rapidly. The occurrence of adsorption also permits 
competition between similar substrates for binding-sites. Fluid pinocytosis, 
however, can exhibit neither selection nor competitive uptake.
1 . 7  Morphology of the rat yolk-sac and its vacuolar system.
Prenatal transfer of passive immunity from a mother to her 
young is an important process in certain mammals but the placental tissues 
that immunoglobulins must penetrate to reach the embryo probably vary 
between species. In the rat it has been suggested that the visceral yolk 
sac may be involved in this process. This has helped to stimulate 
investigation of its morphological and ultrastructural features.
Development of the extra embryonic membranes of the rat occurs
during the 23-day gestational period but is virtually complete by day 17 
(Anderson, 1959; Sorkin & Padykula, 1964) the morphology then remains
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essentially unchanged until term. A cross sectional drawing of placental
tissue in am 18-day pregnant rat uterine horn, cut through a single
conceptus, is shown in Fig. 1.1. The visceral yolk-sac membrane at its
apex is smooth and lies closely adjacent to the epithelial cells of the
uterus, but basally and laterally the yolk sac is thrown into folds or
villi. Microscopic observations of the villous and non-villous regions
(see Fig. 1.2) show it to include two basement membranes sandwiched
between three cellular layers. Flattened mesothelial cells lie subjacent
to a thick serosal basement membrane and face the amniotic cavity. On
the opposite side of this membrane lie scattered mesenchymal cells and
fetal, sinusoidal capillaries. Occasionally capillaries are found within
villi where folding is extensive. Superior to these is the visceral 
4  • '*basement membrane |o. which a*« attached the pinocytically active columnar 
epithelial cells that face the uterine cavity.
Histological and electron microscopic studies have shown the 
columnar epithelial cells of the yolk sac to be coated in a microvillous 
brush border and to be engaged in micropinocytosis (Sorkin & Padykula,
1964; Padykula et al., 1966; Lambson, 1966; Jollie & Triche, 1971;
Seibel, 1974).
These cells have prominent basally-located nuclei. The apical 
plasma-membrane is evaginated into microvilli between which the membrane 
is often invaginated, forming caveolae. The latter seem to give rise 
to relatively electron-lucent micropinocytic vesicles. These apical 
structures each carry a fuzzy coat (glycocalyx) on their exoplasmic surface. 
Immediately inferior to the microvilli, in the same region as the electron- 
-lucent vesicles, occur inherently electron-dense microvesicles and 
canaliculi; both seem not to be connected with the free, apical surface
Figure 1.1 Cross-sectional drawing of the extraembryonic tissues 
in an 18-day pregnant rat uterine horn cut through a single conceptus.
(Richardson, 1963)
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Figure 1.2 Drawing of sections through the villous and the
non-villous regions of the rat visceral yolk-sac membrane.
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Figure 1.3 Drawing of a typical columnar vitelline epithelial 
cell from the rat visceral yolk-sac membrane.
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of the cell. It is not certain whether the micropinocytic vesicles 
empty into the electron-dense system or whether they condense and reduce 
into elements of the system. Membrane profiles, apparently transitional 
between micropinocytic vesicles and the electron dense system, were 
observed indicating the latter of the above alternatives might occur.
The contents of pinocytic vesicles eventually become contained 
within larger vacuoles (phagosomes) that soon acquire lysosomal enzymes 
thus are converted into phagolysosomes of remarkable heterogeneity with 
regard to their size and electron density (Goetze et al., 1976).
1.8 Uptake, storage and digestion of exogenous materials by the rat 
yolk sac.
The ingestion and storage of exogenous materials such as vital
dyes by the yolk-sac epithelium has been known for many years (Goldman,
1909). It has been shown that the lysosomes are the storage sites of
accumulated materials such as ferritin (Lambson, 1966), Triton WR-1339
(Schultz et al., 1966) and Trypan Blue (Lloyd e^ t al_., 1968) . Roberts et
al. (1976) showed storage of sucrose, dextran, poly(vinylpyrrolidone), and
Triton WR-1339 within large supranuclear vacuoles, inferred to be lysosomes.
Earlier, Beck et al.(1970) observed maternally administered horseradish
peroxidase to accumulate in vacuoles that also stained for acid phosphatase.
Moreover, the possible digestion of peroxidase was suggested by the
observed loss of peroxidase activity on incubation of such tissue
without its recovery in the incubation medium. Conclusive evidence of
the ability of yolk-sac lysosomes to digest pinocytosed protein (acid- 
125-denatured I-labelled bovine serum albumin) was first provided by
Williams et^  al_. (1971). Kinetic evidence that the isolated 17.5-day rat
125yolk sac could accumulate (indigestible) I-labelled poly(vinylpyrrolidone)
125and (digestible) acid-denatured I-labelled bovine serum albumin was 
given by Lloyd _et al. (1972) who used a technique that was developed to
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enable quantitative kinetic experiments to be performed on endocytosis and
lysosome function (see Williams et al., 1975a,b). The kinetics of
endocytosis in this system have since been examined by Roberts et al.
14 125(1977) using indigestible substrates ([ c]sucrose, I-labelled
198poly(vinylpyrrolidone) and colloidal [ Au]gold) and by Moore et al. (1977) 
using digestible protein substrates (differently denatured preparations of 
*^I-labelled bovine serum albumin and ^^I-labelled orosomucoid) .
CHAPTER TWO
125SELECTIVE PINOCYTOSIS OF I-LABELLED
PROTEINS BY RAT YOLK SACS
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2.1 INTRODUCTION
Proteins are cleared from the mammalian circulation at widely 
differing rates and those factors that affect the rate of clearance 
have been reviewed by Bocci (1970). A continuing flow of more recent 
publications (see e.g. Ashwell & Morrel, 1974a,b; Rogers & Komf eld,
1971; Kitani & Taplin, 1972. 1974; Buys et al., 1973, 1975; Normann,
1973, 1974£,b; Dice & Goldberg, 1976; Moore et al., 1974, 1977; Stahl 
et al., 1976ji,b; Jose & Hickman, 1977; Furbish et al., 1978; Kooistra 
et al., 1978) indicates the area is still one of active research. 
Endocytosis is probably responsible for the in vivo clearance of 
proteins (Gordon, 1973) and this process has been studied more closely 
in suitable culture systems using either an intact tissue (see e.g. 
Williams et al., 1975a,b; Moore et al., 1974, 1977; Jirmanova et al.,
1977) or isolated mammalian cells (see e.g. Kalderon & Wittner, 1971; 
Gabathuler & Ryser, 1975; Ryser, 1970; Wiesman, 1974; Hickman et al.,
1974; Stein et al., 1976; Pratten et al., 1977; Nilsson & Berg, 1977; 
Tolleshaug et al., 1977; Munthe-Kaas, 1977; Ullrich et al., 1978; 
von Figura et al., 1978).
Of particular physiological interest, and possible pathological 
importance, are the demonstrations by Hickman et al. (1974) and Wiesman 
(1974) that lysosomal enzymes are selectively endocytosed by fibroblasts 
in culture but that lysosomal enzymes from patients with mucolipidoses 
types II and III are not (for review see Neufeld et al., 1977). Goldstein 
and co-workers (for reviews see Goldstein & Brown, 1976, 1977 and Brown 
& Goldstein, 1976) have shown that plasma low density lipoprotein is 
ingested by normal human fibroblasts iri vitro by adsorptive endocytosis 
but that fibroblasts from homozygous hypercholesterolaemia patients 
appear to lack the necessary surface receptors, have a defective uptake of 
low density lipoprotein and consequently show impaired regulation of
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cholesterol synthesis.
In general, the underlying mechanismsby which endocytic cells 
display sufficient specificity to account for the observed differences 
in uptake rate are poorly understood. A single exception exists as a 
result of detailed studies by Ashwell & Morell (for reviews see 
Ashwell & Morell, 1974a,b) who demonstrated conclusively that the rates 
of clearance of a number of human serum glycoproteins, from the 
circulation of the rat, are increased dramatically following removal of 
terminal sialic acid residues from the carbohydrate moiety of these 
glycoproteins. Removal of sialic acid exposes the penultimate galactose 
residues that participate in the selective binding of the desialylated 
glycoprotein to the receptor sites on the plasma membrane of hepatocytes. 
The mechanism of pinocytic recognition of certain lysosomal enzymes 
(Stahl et al., 1976a,b) is now also becoming clear and involves the 
participation of phosphohexosyl (seemingly phosphomannosyl) residues 
in the recognition site of the lysosomal enzyme (Kaplan et al., 1977a,b; 
Sando & Neufeld, 1977). other pinocytic recognition systems, that 
are less well characterized, include the recognition of agalacto- 
-glycoproteins in mammalian livers (Stockert et al., 1976) and avian livers 
(Lunney & Ashwell, 1976) and a system for the clearance of mannosyl- 
terminal glycoproteins (Winkel hake & Nicolson, 1976; Baynes & Wold,
1976). A rapid clearance of semi-synthetic D-glucosyl-protein has been 
reported and it seems to be mediated by binding to the same hepatic 
receptors that bind D-galactosy1-glycoproteins such as asialo^orosomucoid 
(Stowell et al., 19771. Dice & Goldberg (1976) have found that those rat- 
-serum proteins with acidic isoelectric points are cleared from the 
circulation more rapidly than those with a basic isoelectric point 
and that those proteins cleared rapidly are more readily degraded by
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both neutral and acid endoproteinases. Moreover, the half-lives 
of intracellular proteins also correlate with these two characteristics.
The factors which determine the rate of catabolism of intracellular 
proteins are currently under active investigation (Dice et al., 1973;
Dice & Goldberg, 1975a,b; Goldberg et al., 1976; Dean, 1975a; Schimke 
& Bradley, 1975; Momany & Larabee, 1976; Segal et al., 1974, 1976;. Segal, 1976; 
Paskin & Meyer, 1977, 1978) and it has been suggested by Lloyd (1976) 
that the lysosomal system could be responsible for the selective 
degradation of cytoplasmic proteins if such proteins adsorb differentially 
to the cytoplasmic surface of the lysosomal membrane and subsequently 
enter lysosomes by budding of lysosomal membrane into the lysosomal 
interior, a process closely resembling pinocytosis.
Moore et al. (1974, 1977) have shown that treatment of
125I-labelled bovine serum albumin with increasingly severe denaturing 
conditions, which induce a decrease in the a-helical content of the 
protein (as judged by optical rotatory dispersion), leads to a 
corresponding increase in the rate of uptake of this protein by the 
17.5-day rat visceral yolk sac in culture. It was concluded that 
the elevated rate of clearance resulted from increased adsorption of these 
protein preparations to the plasma membrane. Exposure of chemical 
groupings, perhaps hydrophobic in nature, that are normally masked in 
the native conformation of the protein, is a possible explanation 
(Lloyd, 1976). However, for a number of reasons discussed below, it is 
not easy to identify those structural features of bovine serum albumin 
that are responsible for its increased rate of uptake.
Bovine serum albumin is a large single chain protein with 
microheterogenic forms. One cause of the heterogeneity is oxidation of 
the single, free sulphydryl group (Noel & Him ter, 1972). Oxidation
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of bovine serum albumin has been shown to decrease its half-life in the 
circulation of the rat (Bocci, 1969). Pairing of disulphide bonds also 
accounts for heterogeneity (Sogami et al., 1969) and sulphydryl-disulphide 
exchange reactions, leading to a shuffling of disulphide bonds within the 
molecule, are enhanced under denaturing conditions (Foster, 1960).
Two distinct conformers of bovine serum albumin are known
(Pederson & Foster, 1969; Foster, 1960) and transition from the compact
(N) form to the expanded (F) form is associated with the exposure of
hydrophobic surfaces. Buys (1973) has shown that denaturation of bovine
serum albumin using alkaline formaldehyde results in a molecule with a
larger Stokes radius (and a reduced half-life in the circulation of the
rat) but it is not known whether this transition is of the type discussed
by Pederson . &' Foster (1969) and Foster (1960). Wallevik & Mouridsen
a!I>U*ia
(1968) were able to separate human serum/into fractions (by ammonium 
sulphate precipitation) that show differences in the proportion of the 
N form to the F form at pH values between 4.5 and 3.7, but which show 
identical rates of clearance from the circulation of human subjects. 
However, it is not known if the albumin preparations have different 
proportions of the N form to the F form at physiological pH. In 
addition to the structural differences between individual albumin molecules 
within a single preparation, and which affect the physical behaviour of 
the preparation as a whole (Foster, 1960) albumin also binds many 
substances including: hormones, bile acids, vitamins, anions, neuro­
transmitters, metal ions, dyes, drugs, antibiotics and, more importantly, 
fatty acids (Spector, 1975). Complete removal of fatty acids is very 
difficult, but Goodman (1957) has reduced fatty acid contamination 
to a vanishingly small level using 5% acetic acid in iso-octane (a 
treatment that is, however, also likely to denature the albumin) and
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Verbruggen et al. (1968) have shown that removal of lipids from bovine 
serum albumin, by four consecutive extractions with carbon tetrachloride, 
changes the conformation of the albumin molecule.
Because of these factors, and because bovine serum albumin may
not behave as a representative protein substrate in the rat visceral
125yolk-sac system, three less complex I-labelled proteins: bovine 
insulin, hen egg-white lysozyme and bovine pancreatic ribonucléase A 
were studied in the same system. These proteins were chosen both because 
they are of lower molecular weight than albumin and because their 
structures and properties are well documented. The effects of treatment 
of these proteins with alkaline-formaldehyde (and other potential 
denaturing conditions) on their rates of endocytic capture were examined 
to discover whether, like albumin, their rates of uptake could be 
increased. It was hoped that a correlation would appear between the rates 
of ingestion of these protein molecules and some structural feature(s) 
thus permitting identification of the characteristic of a protein 
molecule that most strongly influences its ability to adsorb to the 
pinocytosing plasma membrane of the epithelial cells of 17.5-day rat 
visceral yolk sac.
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2.2 METHODS
2.2.1 Methods for the culture of rat visceral yolk sac and the assay 
of yolk-sac tissue and culture medium.
(1) The culture technique. The method of Williams et al. (1975a,b) 
was used to determine the rate of pinocytic capture of substrates by 
the 17.5-day rat visceral yolk sac in culture. Wistar rats, from an 
inbred colony, were mated overnight; if a sperm plug was detected below 
the grid-cage the next morning, pregnancy was timed from midnight of the 
night of mating. After 17.5 days the rats were killed by cervical 
dislocation and the intact uterus immediately removed and placed in warm 
(37°C) culture medium [medium 199 (preparation TC20, containing penicillin, 
200 units/ml and streptomycin, 100 ug/ml) supplemented with 10% (v/v) calf 
serum (preparation CS07); both products of Wellcome Reagents Limited, 
Beckenham, England]. The intact feto-placental units were removed from 
the uterus and each yolk sac dissected free from the placenta and fetus, 
then placed in fresh warm culture medium. The remaining amniotic tissue was 
removed and the yolk-sacs gently rinsed to remove any debris and blood.
Each yolk sac was placed in a separate sterile 50ml Erlenmeyer 
flask containing 9.0ml of gassed medium (8.0ml medium 199 and 1.0ml 
calf serum) under an atmosphere of 95% 02 and 5% C02. This medium had been 
sealed in each flask with a sterile silicone-rubber bung and maintained at 
37 ± 0.3°C for at least 15min prior to the introduction of the yolk sac.
Each yolk sac was preincubated (15-20min) in a reciprocating water bath 
set with a stroke length of 3.4cm and stroke frequency of 100 ± 5 strokes 
per min, before 1.0ml of medium 199 containing dissolved substrate was 
added to each flask. The flasks were then re-gassed, re-stoppered and 
incubation continued for either 3h or 6-7h (according to the rate of
substrate depletion).
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Yolk sacs taken from the flasks at regular intervals over the
3h or 6-7h period were each washed three times to remove extracellular
substrate, by agitating for 2min in 1% (w/v) aq. NaCl (approx. 30ml)
at 4°C, then placed in a 5ml graduated flask and either assayed immediately
for protein content and radioactivity (see below) or stored at -20°c
until assayed. When protein substrates were used, incubation of the
culture medium was continued after removal of the yolk sac. (This
procedure was adopted to standardize any possible effects from de-
-iodination or hydrolysis of the substrate by enzymes present in the
culture medium during the incubation period.) A control flask, containing
both medium and labelled protein but no yolk sac, was also incubated in
the same manner in each experiment and the amount of low molecular weight
radioactive material present at the end of the incubation period
determined. At the end of an experiment all media were either assayed
for radioactivity immediately or deep frozen at -20°C until assayed.
125Control experiments using I-labelled poly(vinylpyrrolidone)
125I I-PVPj as substrate at a concentration of 2 or 5yg/ml of culture 
medium were performed at regular intervals throughout this study.
(2) The assay methods for yolk sacs and culture media when using the 
125non-digestible I-labelled poly(vinylpyrrolidone) as substrate. The 
yolk sacs, each contained in a 5.0ml graduated flask, were dissolved in 
5.0ml of lM-NaOH by warming at 37°c for lh. Duplicate samples (1.0ml) 
of each yolk-sac solution were pipetted into 3ml disposable tubes (LP3, 
Luckhams Ltd., Burgess Hill, Sussex) and assayed for radioactivity in a 
5142 Selektronic gamma spectrometer (Packard Instrument Ltd., Caversham, 
Berks.) using a standard counting geometry. The protein content of each 
yolk sac was determined by the method of Lowry et al. (1951), using bovine
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serum albumin (Sigma, London) as the reference protein. Duplicate 0.1ml 
samples of yolk-sac solution were used for this purpose. (Yolk sacs from 
17.5-day pregnant rats usually contained 4-7mg bovine serum albumin 
equivalents of protein . )
Duplicate samples (1.0ml) of medium were pipetted into 3ml 
disposable tubes, then assayed for radioactivity. The means of each 
pair of values (yolk-sac protein,. radioactivity in the medium and in 
the yolk-sac solution) were used in subsequent calculations.
(3) The assay methods for yolk sacs and culture media when using
125digestible substrates ( I-labelled proteins). Duplicate samples 
(1.0ml) of culture medium were first assayed, as in (2) above, for 
radioactivity ('total radioactivity') then the protein was precipitated 
with trichloroacetic acid and the radioactivity in the supernatant 
('acid-soluble radioactivity') also assayed. For bovine serum albumin 
full precipitation was achieved by simply adding trichloroacetic acid 
(0.5ml, 20% w/v)^ but with bovine insulin, hen egg-white lysozyme and 
bovine pancreatic ribonuclease complete precipitation of protein required 
the addition of phosphotungstic acid solution* (0.5ml) before addition 
of the trichloroacetic acid as above. After thorough mixing, the tubes 
were immediately centrifuged at 2000g for 20min (MSE Mistral 4L) and the 
clear supernatant carefully decanted into another 3ml disposable tube 
and counted ('acid-soluble radioactivity'). The observed count was 
corrected for the change in counting geometry and for loss of acid- 
-soluble radioactivity through occlusion within the precipitated protein, 
to give the count that would have been given if the entire acid-soluble
*[Prepared by dissolving 10.Og sodium tungstate, 25.2g Na HPO , 9 0g
2 4 ’ ’
NaCl and l.Og phenol in 875ml of distilled water then adding 125ml of 
1M-HC1.]
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radioactivity had been assayed in a volume of 1.0ml. This was done 
by multiplying the observed count by an empirical correction factor, which 
differed according to the precipitation method used (see Appendix I for 
details).
The radioactivity and protein content of each yolk-sac solution 
was determined as in (2) above.
2.2.2 Calculation and expression of the pinocytic uptake data.
In quantitative studies of the pinocytic uptake of substrates 
it is desirable to express the rate of uptake in a form that permits 
the reproducibility of the results between experiments to be readily 
assessed. Even when uptake occurs at a constant rate, the factors whose 
effects must be eliminated are: the variable quantity of tissue in 
individual yolk sacs, the effect of isotopic decay on the specific 
radioactivity of the substrate and day to day variation in the sensitivity 
of the gamma spectrometer. For this reason the rate of uptake is 
expressed in the form described by Williams et al. (1975a) i.e. the 
volume of culture medium whose contained substrate has been captured 
by unit quantity of the yolk-sac tissue in unit time. This quantity, 
termed the Endocytic Index, and whose units are yl/h per mg of yolk-sac 
protein, is obtained from the gradient of the regression line fitted to 
a plot of uptake (in vl/mg yolk-sac protein) against incubation time (h).
The calculations of uptake (see Appendix II) and the linear 
regression analysis were made with an ICL 4130 computer. The associated 
Correlation Coefficient gives a crude index of the scatter of the points 
about the regression line, but is insensitive to slight curvature in a 
plot, hence each plot was inspected visually for linearity.
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2.2.3 Preparation of protein substrates for pinocytosis experiments.
125(1) Preparation of I-labelled proteins. The method used for the 
radio-iodination of protein substrates was one adapted from the method of 
Bocci (1969), which itself is based on the original method of Hunter & 
Greenwood (1962). Usually lOmg quantities of protein were radio-iodinated, 
but when a different quantity was required, the quantities stated below 
were altered proportionately.
Bovine serum albumin (Koch-Light; preparation 0142t, purity 99%),
bovine insulin (Sigma, London; approx. 25 IU per mg), bovine pancreatic
ribonuclease A (Sigma preparations Type XA purchased as a solution and
Type XlA purchased as a lyophilized powder) or hen egg-white lysozyme
(Sigma, Grade I), were dissolved in 4.25ml of 0.05M-Na HPO -KH PO. buffer,— 2 4 2 4
pH 8.0, in a 25ml disposable glass bottle. The solution was stirred in
125an ice bath and Na I (lmCi, approx. 0.25ml) added. After stirring for 
2min, chloramine-T (2mg in 2.5ml distilled water) was added and the solution 
stirred at 0°C for a further 8min. (Bocci has shown that for bovine serum 
albumin, the degree of labelling reached a maximum level at 8min and that 
further, unnecessary exposure of the protein to oxidising properties of 
chloramine-T caused the half-life of the protein in the blood stream to 
decrease.) At 8min, the excess chloramine-T was destroyed by the addition 
of sodium metabisulphite (2mg in 2.5ml of distilled water) and solid KI 
(approximately 20mg) was added to aid the displacement of unreacted in 
subsequent dialysis. A 50jj1 sample of the undialysed reaction mixture 
(total volume 9ml) was taken to determine its content of acid-soluble 
radioactivity, hence the labelling efficiency. The remainder of the final 
reaction mixture was dialysed at 4°C for 48-72h against 5 or 6 changes of 
1% (w/v) aq. NaCl (52,). The non-diffusible material was stored at -20°C.
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Occasionally, when a large percentage of the radioactivity in the 
dialysis residue remained acid-soluble, the preparation was passed through 
a small column (10cm x 1.1cm) of Sephadex G-25, with 1% (w/v) aq. NaCl as 
elutant, to remove the low molecular weight radioactive material.
The labelling efficiencies of bovine serum albumin, insulin, 
ribonuclease (XA and XlA) and lysozyme were 60, 85, 5 and 5% repsectively. 
As lmCi of radio-iodide was used for each lOmg of protein, the specific 
activities of the radio-labelled proteins were 60, 85, 5 and 5pCi per 
mg protein. It was calculated that the number of molecules of protein 
containing one atom of radio-iodide were: bovine serum albumin, 300 - 500; 
insulin, 2 800 - 4 400; ribonuclease, 20 000 - 31 000 and lysozyme 19 500 - 
30 000 molecules.
125(2) Treatment of I-labelled proteins with acetic acid. A small volume
125(2 - 3ml) of the I-labelled protein solution was titrated to pH 2.5 
with glacial acetic acid using a glass microelectrode. The acidified 
solution was kept at 37°C for 2h before being dialysed as described in (1) 
above.
125(3) Treatment of I-labelled proteins with 4M-urea. A small volume
125(2 - 3ml) of the I-labelled protein solution was mixed with an equal 
volume of aq. 8M-urea which had been adjusted to pH 5.0 with lM-HCl. The 
resulting solution was kept at 22-25°C for 24h after which it was dialysed 
as described in (1) above.
125(4) Treatment of I-labelled proteins with formaldehyde. A solution of
10% (w/v) formaldehyde was made up in 0.5M-NaHCO^ buffer, pH 10, and an
125equal volume added to a portion of the I-labelled protein solution.
The resultant 5% (w/v) formaldehyde solution was kept at 22-25°C for 72h 
before being dialysed as described in (1) above. A further portion of
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the I-labelled protein solution was treated with bicarbonate buffer 
alone.
After treatment with either formaldehyde (pH 10) or bicarbonate
buffer (pH 10) alone, the lysozyme preparations were found to be
heterogenous as judged by their elution patterns on Sephadex G-75. Each
new species produced after treatment with either formaldehyde or alkali
was isolated by Sephadex G-75 chromatography as described in Section
1252.2.5 but using 1% (w/v) aq. NaCl as eluant. The I-labelled protein 
contained in the pooled fractions of each peak was used separately as 
substrate.
(5) Assay of protein substrate concentration. In the above preparative
procedures some of the protein substrate was incompletely transferred in
certain manipulations (e.g. dialysis). It was therefore necessary to
measure the protein content of each final preparation before its use in
experiments. A spectrophotometric method was used as this caused minimal
loss of material. (The possible effects of the various treatments on the
optical properties of the proteins were ignored). The extinction, at 
125280nm, of each I-labelled protein preparation was compared with 
extinction values measured using native protein solutions of known concentra­
tion in the 0 to lmg range. The native proteins were dissolved in 1.0%
(w/v) aq. NaCl that was adjusted to pH 5.6 with dilute HCl to give the
125same pH as observed in the dialysis of the I-labelled protein
125preparations. [For native insulin and a portion of each I-labelled 
insulin preparation, the solution was adjusted to pH 3.7 with a known 
quantity of 0.5M-HC1 as insulin is not very soluble in the pH range 4 - 8].
125
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2.2.4 Release of radioactivity on re-incubating yolk sacs that had
125previously ingested I-labelled proteins in vitro.
The method used to calculate the Endocytic Index of a non-digestible
substrate (see Section 2.2.2) assumed that the rate of release of substrate
back into the culture medium from the yolk-sac tissue is negligible.
Similarly, for digestible substrates, the method assumes that only acid-
-soluble digestion products are returned to the culture medium. Williams
125et al. (1975a) and Roberts et al.(1977) have shown that for I-labelled
poly(vinylpyrrolidone) the first of these assumptions is correct. To show
that the second of these assumptions was correct for each protein, it was
necessary to determine the rate of release of radioactivity from yolk sacs
125that had ingested the I-labelled protein vitro and to establish 
the nature of the products released into the medium.
(1) Method of determining the rate of release of radioactivity from
125yolk sacs containing I-labelled proteins. Three 17.5-day yolk sacs
were incubated together for 2h, essentially as described in Section
2.2.1 above, but in the presence of substrate(5pg/ml of medium). They
were then washed three times for 2min in 10ml of fresh, gassed culture
125medium, initially containing no I-labelled protein, at 37®C under the 
usual incubation conditions. (This washing procedure was found to be 
optimal, further washing resulted in excessive loss of tissue-associated 
radioactivity through substrate degradation, without significant desorption 
of substrate associated with extracellular surfaces.)
The washed yolk sacs were then incubated in 10.0ml of fresh, 
initially substrate-free culture medium for a further 2h period under the 
same conditions as described above. Samples (1.0ml) of medium were removed 
at lOmin intervals throughout the 2h incubation period and replaced by an
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equal volume of warm, substrate-free, gassed culture medium to maintain 
the volume at 10.0ml. The flasks were re-gassed after each sampling.
At the end of the incubation period the yolk sacs were quickly rinsed in 
cold (4°C) aq. NaCl (1%, w/v) for 10s to remove culture medium, then 
dissolved in 20.0ml of aq. lM-NaOH at 31 °C and the contained protein and 
radioactivity assayed as described in Section 2.2.1. Each of the 1.0ml 
samples of culture medium taken throughout the re-incubation period, 
together with 3 x 1.0ml samples taken at the end of the Initial 
incubation were assayed for total- and acid-soluble radioactivity as 
described in Section 2.2.1.
(2) Expression of the release of radioactivity from yolk sacs containing 
125I-labelled proteins. The quantities of total- and acid-soluble radio­
activity released by the yolk sacs over the 2h re-incubation period were 
calculated according to the formula described by Williams et al. (1971)s
T„ * 10Ci(i*n) + I£ i n*1’Ci <2'1)
where T is the radioactivity (c.p.m.) released up to the time of the n
n**1 sampling, and the radioactivity (c.p.'m., corrected for background) 
per ml of culture medium of the i^1 sample.
To facilitate comparison between this data and that obtained 
in the pinocytosis experiments it was considered desirable to express the 
radioactivity released in the same units as those used for uptake (i.e. 
yl/mg yolk-sac protein). This can be achieved using the equation:
T ’ - T /P.M (2.2)n n
where T 1 is the radioactivity (yl/mg yolk-sac protein) released up to
the time of the n^1 sampling, T is as described for equation 2.1, P isn
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the total protein content of the yolk sacs (mg) and M is the acid-
-insoluble radioactivity (c.p.m., corrected for background and initial acid-
125-soluble material) in lyl of the culture medium containing the I-labelled 
protein at a concentration of 5ug/ml of medium. The sum of tne radioactivity 
remaining in the tissue at the end of the incubation period and the total 
radioactivity released by the yolk sacs at the end of the incubation period 
gave the radioactivity in the yolk-sac tissue at the time of transfer to 
the re-incubation medium. This value enables the total radioactivity 
released by the yolk sacs at the end of the incubation period to be 
expressed as a percentage of that associated with the yolk sac at the 
start of the re-incubation.
125(3) Examination of the hydrolysis products derived from I-labelled
125proteins. The procedure for the re-incubation of I-labelled protein
loaded yolk sacs, as described in (1) above, was used but no medium samples
were taken during the 2h re-incubation period. Portions of the culture
medium, taken from the end of the incubation and re-incubation period
were centrifuged at 4°C (MSE Mistral 4L) at 500g for lOmin to remove
cellular debris. Each was then examined by gel-chromatography on Sephadex
G-25 (Pharmacia, Uppsala, Sweden) and the pooled fractions containing
low molecular weight digestion products were concentrated by lyophilization
and further examined by eluting from a copper-complex of Sephadex G-25, which
. . 125separates radioactive dipeptides containing [ I]iodo-L-tyrosine from 
125the [ I]iodo-L-tyrosine (Fazakerley & Best, 1965).
Sephadex G-25 chromatography. Centrifuged culture medium (5.0ml) was
applied to a Sephadex G-25 (fine) column (35cm x 1.7cm) that had been
previously equilibrated with a solution suitable for the elution of a
125particular protein substrate. For I-labelled insulin 0.05M-sodium
acetate (pH 6.5) containing 0.1% (w/v) sodium azide was suitable but
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125this solution was unsuitable for I-labelled lysozyme, which was found
to adsorb strongly to the gel. This could be prevented by addition of 1%
125(w/v) NaCl (as described by Hampe, 1972). However, I-labelled 
ribonuclease was found to bind to the gel' when using the acetate solution 
even in the presence of 1% (w/v) NaCl, but almost 100% recoveries were 
achieved using 0.2M-NaH2PO^, pH 6.5, containing 0.1% (w/v) sodium azide.
After the 5.0ml sample had run into the gel it was further washed 
in using 2 x 1ml portions of the appropriate eluent before the column 
was eluted at 4°C at a flow rate of 24ml/h, collecting fractions (2ml) in 
glass test tubes. The fractions were decanted into 3ml disposable tubes 
and assayed for radioactivity as described in Section 2.2.1 above.
Chromatography on the copper-complex of Sephadex G-25. Sephadex G-25
(16g) was hydrated in distilled water and the 'fines’ decanted off. The
swollen gel suspension (125ml) was mixed with 0.16M-CuSC>4 (28ml) for
15min before lM-NaOH (30ml) was added to precipitate the copper within the
gel matrix. After a further 15min stirring, the gel was washed four times
with 1 vol. of 0.5M-sodium borate, pH 11, and then packed into a column
(30 cm x 1.7cm) which was equilibrated with the borax buffer at 4°C. The
sample to be examined (2.0 - 3,0ml) was applied to the column, washed in
with 2 x 1ml portions of borax buffer, then eluted with the same buffer
at a flow rate of 24ml/h, and 2ml fractions collected. After 20 - 30
fractions had been collected, elution was continued with 0.4M-HC1, which
solubilized the copper hydroxide in the gel matrix thus releasing the 
125chelated [ I]iodo-L-tyrosine. The fractions were assayed for radioactivity 
as described above.
Calculation of recovery values. The radioactivity recovered from a column 
after each chromatographic procedure was determined according to the
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equation:
R = (ZB . G/A)100 (2.3)n
where R is the percentage recovery, G is an empirical correction factor
(which corrects both for the loss of radioactivity on decanting the
fractions from the glass collection tubes into the 3ml disposable plastic
tubes and for the difference in counting geometry). G effectively
converts the observed count in 1.6ml of solution to the number of counts
that would have been observed if the entire fraction had been assayed in
a volume of 1.0ml). B is the radioactivity contained in the n01 samplen
(c.p.m., corrected for background) and A is the total radioactivity applied 
to the column (c.p.m., corrected for background).
1252.2.5 Analysis of I-labelled protein substrates by Sephadex G-75 
chromatography♦
The possible presence of protein aggregates in both untreated
labe lied protein preparations and those ^ ’’i-labelled protein preparations
which showed a modified rate of pinocytic uptake after treatments as
described in Section 2.2.3 was investigated by chromatography on Sephadex
G-75 (particle size 40-120y).
125The I-labelled proteins (5-25yg) were analysed on a Sephadex
G-75 column (80cm x 1.7cm) essentially as described for the gel-filtration
studies in Section 2.1.4 (3). The column was eluted with an appropriate
125salt solution at 24ml/h and 4ml fractions collected. For I-labelled 
125insulin and I-labelled ribonuclease, 0.2M-NaH PO , pH 6.5, containing
a  4
0.1% (w/v) sodium azide was a satisfactory eluent and gave high recovery 
125values but for I-labelled lysozyme, 0.05M-sodium acetate, (pH 6.5) 
containing 1% (w/v) NaCl and 0.1% (w/v) sodium azide was required to 
achieve high recoveries.
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2.3 RESULTS
2.3.1 Uptake by the 17.5-day rat yolk sac in vitro.
Uptake data from a typical control experiment are shown
graphically in Fig. 2.1 and the results of 29 such experiments are
125summarized in Table 2.1. The uptake of I-labelled poly(vinylpyrrolidone) 
125[ I-PVP], a non-digestible substrate, is linear over the 6-7h 
incubation period (linearity has been shown to extend to 15h by Williams^ K . E .  - unpublished results, but 6-7h was used routinely for convenience). 
Little inter-experimental variation and no systematic drift in the 
individual values of Endocytic Indices (mean value 1.75 ± 0.33) were 
observed over the period of study (Table 2.1). This demonstrated the 
high degree of reproducibility of the pinocytic activity of the in vitro 
system.
A typical experiment in which yolk sacs were incubated in the
125presence of formaldehyde-denatured I-labelled bovine serum albumin,
a digestible substrate, gave the results shown in Fig. 2.2. Both the
quantity of tissue-associated radioactivity and the quantity of acid-soluble
radioactivity returned to the medium at different times up to 6h are
shown. Overall uptake is calculated by summing these values at each
time point. The quantities of tissue-associated radioactivity became
constant within 2h so that the rate of release of acid-soluble radioactivity
into the incubation medium became constant, and equal to the Endocytic
Index in the period beyond 2h.
Results of equivalent experiments in which yolk sacs were
125incubated in the presence of I-labelled insulin, lysozyme or 
ribonuclease (Type XA), eached stored at -20°C or further treated with 
either: acetic acid (pH2.5), 4M-urea, formaldehyde (pH 10) or bicarbonate
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buffer (pH 10), can be seen in Tables 2.2a,b & c. The results of similar
experiments with lyophilized ribonuclease (Type XIA) which had either been
stored at -20°C or further treated with either: acetic acid (pH 2.5),
4M-urea or formaldehyde (pH 10) are shown in Tables 2.2d. The same Table
125also shows results of experiments with formaldehyde-denatured I-labelled
bovine serum albumin. The above results are summarized in Table 2.3. For
comparison the results obtained by Moore et al. (1977) for differently 
125treated I-labelled bovine serum albumin preparations are also shown.
In the present investigation, as in those of Williams et al.
(1975b) and Moore at al.(1974, 1977) the Endocytic Index of each
^'’i-labelled protein substrate is markedly higher than that of "^I-PVP.
125In contrast to I-labelled bovine serum albumin the treatment of
125I-labelled insulin, 125l-labelled lysozyme and ^25I-labelled ribonuclease
with either acetic acid (pH 2.5) or 4M-urea, results in little or no
change in the Endocytic Index of these protein substrates. Where the
students t-test of significance could be applied, no significant differences
were found at the 0.05 level. Treatment with formaldehyde (pH 10) however,
modified substantially the rate of uptake of each protein, but, unlike 
"I 25I-labelled bovine serum albumin (where there is a 10-20 fold increase
in the Endocytic Index after treatment with formaldehyde) these lower
molecular weight proteins show a marked decrease in their rates of uptake. 
125Except for I-labelled lysozyme, treatment of the radiolabelled proteins
with bicarbonate buffer (pH 10) alone produces little or no change in the
observed rate of uptake, suggesting that the modified rate of uptake
results from a reaction in the presence of formaldehyde rather than mere
125exposure to an alkaline solution alone. Unlike the I-labelled forms of
125insulin and ribonuclease, I-labelled lysozyme showed markedly reduce^
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rates of uptaJce on treatment with alkali. Table 2.2d shows that, after 
radio-iodination, a second Sigma preparation of ribonuclease was 
endocytosed at a lower rate than that shown in Table 2.2c. This second 
preparation differed from the first only in that it had been lyophilized 
prior to radio-iodination. Its rate of uptake was not modified by 
treatment with either acetic acid (pH 2.5) , 4M-urea (pH 5.0) or formalde­
hyde (pH 10) .
Because a 3h incubation period was used (except for the 
125formaldehyde-denatured I-labelled bovine serum albumin), it was not 
always possible to determine the steady-state quantity of radioactivity 
associated with the tissue as accurately as would have been possible in 
experiments of longer duration. However, Fig. 2.3 shows the levels of 
tissue-associated radioactivity over the 3h incubation period for each 
substrate. In general, the quantity of tissue-associated radioactivity 
increased rapidly during the first 30min, but then became virtually 
constant after 2-2.5h; this pattern is particularly pronounced for insulin. 
Untreated, acetic acid- and urea-treated preparationsof
125I-labelled insulin all showed the quantity of tissue-associated
radioactivity to be lower than that of the corresponding treated prepara-
^ 125, , , ,, , 125txons of either I-labelled ribonuclease or I-labelled lysozyme
(Fig. 2.3). Since^for all three proteins, the corresponding preparations
have similar Endocytic Indices (see Table 2.3)’, this indicates that the
125yolk sac catabolises the I-labelled insulin preparations more rapidly
than those of the other two proteins.
The widely different Endocytic Indices observed between the 
125non-digestible substrate, I-PVP (1.75yl/h per mg yolk-sac protein)
125and the formaldehyde-denatured I-labelled proteins (45-90yl/h per mg 
yolk-sac protein) and untreated, acetic acid- or urea-treated preparations
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125of I-labelled insulin, lysozyme and nbonuclease (120-150yl/h per 
mg yolk-sac protein) may arise either from a modification of the rate 
of pinosome formation, in response to the presence of the different 
substrates, or from the substrates adsorbing differentially to binding
sites on the pinocytosing plasma membrane. The results of experiments
127 127 127with i-iodinated insulin, i-iodinated lysozyme and I-iodinated
ribonucléase, as potential modifiers (Table 2.4a), and likewise the
127corresponding formaldehyde-treated I-xodinated proteins (Table 2.4b),
show that there is no significant modification of the rate of pinocytic 
125capture of the I-PVP. This indicates that the higher Endocytic Indices 
observed for the protein substrates result from their adsorbing to the 
pinocytosing plasma membrane. Moreover, the lowered rates of uptake of 
the formaldehyde-treated proteins arise from a lower degree of adsorption
-frO*H
to the pinocytosing plasma membrane rather than/their inhibiting pinosome 
formation by cytotoxic or other effects.
2.3.2 Release of radioactivity from yolk-sac tissue and analysis of the
125hydrolysis products of I-labelled protein substrates.
The patterns of release of total- and acid-soluble radioactivity
125from yolk sacs, that had previously ingested one of the I-labelled 
protein preparations,into incubation medium containing no substrate are 
shown in Figs. 2.4a,b,c, & d. To facilitate comparison with pmocytosis 
experiments, release of radioactivity is expressed in the same units as 
uptake (i.e. yl/h per mg yolk-sac protein). The results for each substrate 
used (formaldehyde-denatured 125l-labelled bovine serum albumin, 125l- 
-labelled insulin, "^I-labelled lysozyme and ^25I-labelled ribonucléase) 
are similar. A large proportion of the tissue-associated radioactivity 
was released but only a small part was in the form of acid-insoluble
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material. It is not clear from these experiments whether the released
acid-insoluble radioactivity represents exocytosis of previously
pinocytosed substrate or whether it arises from desorption of substrate
from surface membranes of the tissue or leakage from dead or dying cells.
Whatever the cause, the results indicate that following pinocytosis of 
125any of the above I-labelled protein, at least 90-95% of the radioactivity 
released is acid-soluble.
125When yolk sacs, incubated for 2h in the presence of I-labelled
protein substrates, were subsequently washed at 4°C (as described for the
pinocytosis experiments) rather than 37°C (as employed in the release
experiments) the radioactivity remaining associated with the yolk-sac
tissue was very much greater. The mean values for tissue-associated
radioactivity, expressed as yl/h per mg yolk-sac protein following washing
at 4°C (and 37°C) were: 60 (28), 52 (18), 106 (30), 86 (44) for the
125formaldehyde-denatured I-labelled bovine serum albumin and the untreated 
■1-^I-labelled proteins:insulin, lysozyme and ribonuclease respectively. 
Continued rapid hydrolysis of ingested protein substrate would be expected 
during the 37°C wash but not during the 4°C wash. Thus tissue washed at 
4°C would be expected to retain virtually all its radioactivity. However, 
desorption would be expected to occur at both temperatures. The above 
observation therefore suggests the true proportion of acid-soluble 
radioactivity released from the yolk sacs is markedly greater than indicated 
by the data in Figs. 2.4 a,b,c, & d alone. In addition, the release of 
acid-insoluble radioactivity is complete within 20min for each substrate 
used, but acid-soluble radioactivity continues to be released after this 
time. This is more easily explained by the desorption of the acid- 
-insoluble radioactivity from surface membranes and the release of acid-
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-soluble radioactivity from an intracellular site, probably lysosomal.
The radioactive species present in the incubation media were
examined by gel-filtration on Sephadex G-25. Figs. 2.5 a,b, & c show the
elution patterns of intact substrates (125I-labelled insulin, lysozyme
and ribonuclease), incubation media in which yolk sacs had been incubated 
. 125for 2h in the presence of a I-labelled protein and incubation media
in which yolk sacs, previously loaded with a l25I-labelled protein, had
been incubated for 2h in the absence of substrate. In each case incubation
with a yolk sac caused a new peak of radioactivity to appear. This peak
125eluted after the free [ I]iodide peak and in the same position as
125
[ I]iodo-L-tyrosine i.e. a little later than glycyl-[125rjiodo-L-tyrosine.
The pooled fractions of these peaks (A, B, c, D, E and F) were further
examined using a copper-complex of Sephadex G-25, which resolved each into
two peaks. Fig. 2.6 shows a typical elution profile using the low molecular
weight material which appeared when yolk sacs were incubated with 125I-
-labelled insulin (pooled fractions of peak A, Fig. 2.5a). Approximately
10% of the radioactivity is not retained by the copper-complex, and
corresponds to oligopeptides containing [125i]iodo-L-tyrosine.
A summary of the results obtained for the pooled fractions of peaks A,
B, C, D, E and F of Figs. 2.4 a, b & c is given in Table 2.5 together with
results obtained with the markers ( I]iodo-L-tyrosine and glycyl-[125i]-
lodo—L—tyrosine• Similar results, obtained by Williams et al.(1971)
. 125when using acid denatured I-labelled bovine serum albumin are also 
presented for comparison. The close similarity in the proportions of 
radioactive oligopeptide and radioactive amino acid (in the low molecular 
weight material obtained when a I-labelled protein substrate was 
incubated with yolk sacs and when yolk sacs previously loaded with
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I-labelled protein substrate were incubated in the absence of substrate)
suggests that, for all these substrates, the low molecular weight material
125obtained during the incubation of yolk sacs with I-labelled protein 
results from intracellular digestion.
125
1252.3.3 Analysis of I—labelled protein substrates by Sephadex G-75 
chromatography.
125Each of the untreated I-labelled proteins and each of those
125I-labelled protein preparations that showed a modified rate of 
uptake by yolk sacs were analysed on Sephadex g -75 as described in 
Section 2.2.5.
Untreated and formaldehyde-treated 125l-labelled insulin
preparations each eluted as single components. Similar observations were 
. , 125made with untreated I-labelled ribonucléase (Types XA & XlA) and
125formaldehyde-treated I-labelled ribonucléase (Type XA). The resolving 
power of the Sephadex G-75 column was tested with a mixture of unlabelled 
ribonucléase aggregates, dimer and monomer prepared by lyophilization 
of ribonucléase from 50% acetic acid (Crestfield et al., 1962). Recoveries 
of the insulin and ribonucléase preparations were greater than 95%.
Unlike the insulin and ribonucléase elution profiles, those of 
untreated, formaldehyde-treated and alkali-treated 125I-labelled lysozyme 
were complex, see Fig. 2.7. The untreated 125l-labelled lysozyme 
preparation contained a major component, which co-eluted with unlabelled
monomeric lysozyme, and a minor component of lysozyme aggregates a 
little later than bovine serum albumin (approx, molecular weight 60 000, 
possibly tetrameric lysozyme). Treatment of I-labelled lysozyme with 
formaldehyde (pH 10) or bicarbonate (pH 10) increased the proportion of 
lysozyme aggregates. In addition, the formaldehyde-treatment produced a
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new component which eluted in a similar position to a—chymotrypsin 
(molecular weight 24 000) which probably represents dimeric lysozyme 
rather than lysozyme in which disulphide bonds had been reduced, a species 
which elutes in a similar position from Bio-gels (Acharya & Taniuchi, 
1976) but is severely retarded on Sephadex g-75 (see Fig 2.7) with poor 
recovery (16.5%). Following the formaldehyde-treatment of 125I-labelled 
lysozyme no monomeric lysozyme remained.
The monomers, dimers and aggregates of l25l-labelled lysozyme 
do not appear to be an equilibrium mixture as each gives a single peak 
of radioactivity in their respective positions on re-running on Sephadex 
G-75. Each species was found to be stable for at least one week when 
stored at -20°C also when incubated under the usual culture conditions 
(see Section 2.2.1).
1252.3.4 Uptake of the various I-labelled lysozyme species isolated 
by Sephadex g-75 chromatography.
125
Five of the i-labelled lysozyme species (see Fig. 2.7, 
peaks I-V) produced by treatment of a single 125I-labelled lysozyme 
preparation with either formaldehyde (pH 10) or bicarbonate (pH 10) were 
separated on Sephadex G-.75 as described in Section 2.2.3(4) but in the 
absence of NaN3> Each lysozyme species was incubated with 17.5-day 
rat yolk sacs and its rate of uptake determined. The results are shown 
in Table 2.6. The Endocytic Index of the untreated 125I-labelled lysozyme 
monomer (species I, 136.0 ± 6.8yl/h per mg yolk-sac protein) was similar to 
that reported earlier for the untreated 125l-lysozyme preparation (129.9 ± 
16.6, see Table 2.2b). The formaldehyde-induced dimer of 125I-labelled 
lysozyme (species III) and the I-labelled lysozyme monomer (species V) 
remaining after treatment with bicarbonate (pH 10) each have either lower
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or unchanged rates of uptake. The aggregated species of I-labelled
lysozyme (II and IV) induced by either formaldehyde (pH 10) or bicarbonate
(pH 10) have markedly lower rates of uptake compared to the other three 
125species of i-labelled lysozume (I, III and V). These results suggest
125that the decreased Endocytic Index observed for I-labelled lysozyme
following formaldehyde (pH 10) treatment is caused by the presence of 
125I-labelled lysozyme aggregates. The accumulation of the various
125I-labelled lysozyme species by the yolk-sac tissue is shown in Fig. 2.3. 
In general, the features shown here are similar to those described for 
Fig. 2.3. Also, in general, the higher the degree of aggregation the 
lower is the observed level of tissue-associated radioactivity.
Table 
rat yo
1252.1 Endocytosis of I-labelled poly(vinylpyrrolidone) by 17.5-day
lk sacs incubated in medium 199 containing 10% (v/v) of icalf serum.
A *
Experiments were performed/in Section 2.2.1; yolk sacs were 
cultured with 125I-PVP, at the concentrations indicated, for up to 6-7h. 
Values of Endocytic Indices more than 2 standard deviations away from the 
mean value were not included unless the associated correlation coefficient 
was greater than 0.95.
Expt.
No.
125I-PVP
concentration
(yg/ml)
Endocytic
Index
(yl/h per mg
yolk-sac
protein)
Correlation
Coefficient
Intercept 
on ordinate 
(yl/mg yolk- 
-sac protein)
No. of yolk 
sacs per 
experiment
1 5 1.604 0.977 +0.494 12
2 5 1.632 0.889 +0.570 12
3 5 2.149 0.983 +1.476 11
4 5 2.605 0.965 +0.388 12
5 5 1.848 0.934 +0.889 11
6 5 2.364 0.949 +0.883 12
7 5 2.278 0.998 +1.321 11
8 5 1.920 0.994 +1.227 12
9 5 1.696 0.988 +0.762 14
10 5 1.500 0.982 +0.700 13
11 2 2.220 0.987 -0.173 6
12 2 1.784 0.983 +0.624 7
13 2 2.042 0.985 +0.747 10
14 2 1.840 0.960 +0.595 11
15 2 1.078 0.977 +0.718 10
16 2 1.738 0.978 +1.988 9
17 2 1.678 0.978 +1.323 8
18 2 1.825 0.932 +0.293 10
19 2 1.629 0.971 +0.522 10
20 2 1.707 0.988 +0.006 10
21 2 1.462 0.985 . +2.061 9
22 2 1.374 0.957 +1.346 10
23 2 1.322 0.958 +1.760 10
24 2 1.440 0.978 +1.972 10
25 2 1.535 0.991 +0.869 10
26 2 1.608 0.978 +0.614 10
27 2 1.532 0.983 +1.063 10
28 2 1.868 0.978 -0.088 10
29 2 1.586 0.974 +0.867 10
MEAN ± S.D. 1.75 ± 0.33
Tab'll 2.2a Endocytosis of I-labelled insulin preparations by 17.5-day 
rat yolk sacs incubated in medium 199 containing 10% (v/v) of calf serum. 
125I-Labelled insulin was prepared as described in Section 2.2.3 
and uptake experiments were performed as described in Section 2.2.1 using 
l^5I-labelled insulin at a concentration of 1 yg/ml; the duration of each 
experiment was 3 h. The results are also summarized in Table 2.3.
125
125I-Insulin
preparation
Expt.
No.
% acid- Endocytic 
-solubles in Index 
preparation (yl/h per
mg yolk sac 
protein)
Correlation
Coefficient
No. of yolk 
sacs per 
experiment
1 2.1 120.8 0.918 10
2 2.1 147.6 0.988 10
Frozen 3 2.1 130.1 0.944 9
(-20°C.) 4 1.6 190.0 0.978 5
5 1.7 157.7 0.857 8
6 2.1 155.7 0.960 10
MEAN ± S,,D. 150.3 + 24.3
1 1.3 154.2 0.940 10
Acetic acid 2 2.7 168.2 0.914 9
(pH 2.5) 3 1.7 152.4 0.873 10
4 1.2 148.0 0.938 8
MEAN ± S. D. 155.7 ± 8.7
1 1.5 172.0 0.929 8
2 1.2 123.2 0.926 8
4M-Urea 3 1.6 148.3 0.962 10
(pH 5) 4 2.3 145.4 0.915 8
5 1.7 142.8 0.928 8
MEAN ± S• D. 147.3 ± 15.8
Formaldehyde 
(pH 10)
1
2
3
4
0.6
1.8
3.1
3.1
62.9
42.9 
30.6 
42.8
0.985
0.986
0.874
0.983
10
10
10
10
MEAN ± S.D. : * 44.8 ± 13.4
1 0.4 139.5 0.985 10
Bicarbonate
buffer 2 0.4 115.9 0.967 10
(pH 10) 3 0.4 116.5 0.960 8
MEAN ± S.D. ; — 129.3 ±13.5
Table 2.2b Endocytosis of I-labelled lysozyme preparations by 17.5-day 
rat yolk sacs incubated in medium 199 containing 10% (v/v) of calf serum. 
125I-Labelled lysozyme was prepared as described in Section 2.2.3 
and uptake experiments were performed as described in Section 2.2.1 using 
lz5I-labelled lysozyme at a concentration of 2.5 yg/ml; the duration of 
each experiment was 3 h. These results are also summarized in Table 2.3.
125
125t tI-Lysozyme> Expt. % acid- Endocytic Correlation No. of yolk
préparation No. -solubles in Index coefficient sacs per
preparation (yl/h per 
mg yolk sac 
protein)
experiment
1 6.3 166.8 0.975 6
2 6.3 121.9 0.966 6
Frozen 3 7.1 111.1 0.952 9
(-20°C) 4 8.1 146.6 0.978 10
5 10.1 129.3 0.980 7
6 8.2 104.0 0.974 10
MEAN ± S.D. 129.9 ± 16.6
1 7.1 136.3 0.967 10
Acetic acid 
(pH 2.5) 2 10.0 136.3 0.978 7
3 7.1 129.6 0.980 10
MEAN ± S.D. :- 134.2 ± 3.9
4M-Urea 1 4.8 130.0 0.995 8
(pH 5) 2 7.2 136.0 0.965 7
MEAN : — 133.0
1 2.2 103.6 0.993 9
Formaldéhyde 
(pH 10) 2 2.0 78.2 0.978 8
3 2.5 80.0 0.957 9
MEAN ± S.D. î— 87.3 ± 12.4
1 1.15 86.7 0.985 8
Bicarbonate
buffer 2 9.2 60.3 0.955 10
(pH 10) 3 9.2 82.8 0.950 10
MEAN ± S.D. :— 76.6 ± 14.3
Table 2.2c Endocytosis of I-labelled ribonuclease preparations by
17.5-day rat yolk sacs incubated in medium 199 containing 10% (v/v) of 
calf serum.
125
125I-Labelled ribonuclease was prepared as described in Section
2.2.3 and uptake experiments performed as described in Section 2.2.1 
using 125I-labelled ribonuclease at a concentration of 1 pg/ml, the 
duration of each experiment was 3 h. These results are also summarized 
in Table 2.3.
125I-Ribo- Expt. % acid- Endocytic Correlation No. of yolk
nuclease No. -solubles in Index Coefficient sacs per
préparation preparation (yil/h per experiment
mg yolk-sac
protein)
1 27.0 120.1 0.970 10
2 2.2 144.6 0.862 6
3 2.2 135.3 0.954 6
Frozen
(-20°C) 4 2.2 206.1 0.993 6
5 2.2 201.7 0.963 6
6 2.9 167.3 0.991 7
7 3.0 100.7 0.948 10
8 3.1 97.5 0.972 10
MEAN ± S.D. :- 146.6 ± 42.0
Acetic acid 1 11.1 140.5 0.994 9
(pH 2.5) 2 1.5 100.5 0.978 10
MEAN : - 120.5
4M-Urea 1 î.i 139.3 0.996 7
(pH5)
1 7.8 60.8 0.988 10
Formaldéhyde 2 7.8 67.2 0.907 9
(pH 10) 3 9.6 53.3 0.939 10
4 3.0 49.3 0.976 7
MEAN ± S.D. :- 57.6 ± 7.8
Bicarbonate 1 9.1 117.3 0.981 10
buffer 2 9.1 134.4 0.945 7
(pH 10) 3 9.4 112.3 0.980 8
MEAN ± S.D. :- 121.1 ± 11.8
125formaldehyde-denatured I-labelled bovine serum albumin preparations by
17.5-day rat yolk sacs incubated in medium 199 containing 10% (v/v) of 
calf serum.
125Table 2.2d Endocytosis of lyophilized I-labelled ribonucléase and
125Lyophilized I-labelled ribonucléase and formaldehyde- 
-denatured 12^I-labelled bovine serum albundn were prepared as described 
in Section 2.1.3 and the experiments were^formed as described in Section 
2.2.1. Ribonucléase preparations were cultured at 1 yg/ml, the albumin 
preparation at 0.6 yg/ml. The durations of the experiments were 3 h and 
6 h for ribonucléase and albumin respectively. The results are also 
summarized in Table 2.3.
125I-Labelled Expt. % acid- Endocytic Correlation No. of yolk
protein No. -solubles in Index Coefficient sacs per
preparation preparation (yl/h per 
mg yolk-sac 
protein)
experiment
Lyophilized
ribonucléase
1 5.5 73.1
69.4
0.967
0.965
10
8(Frozen, -20°C) 2 5*5MEAN 71.2
Lyophilized 1 2.8 58.8 0.947 10
ribonucléase. 
Acetic acid 
treated (pH 2.5)
2 2.8 69.1 0.953 10
MEAN 63.4
Lyophilized 1 2.7 56.9 0.984 9ribonucléase.
4M-Urea 2 2.7 79.1 0.959 9
treated MEAN s - 68.0
Lyophilized 
ribonucléase. 1 0.8 56.5 0.992 10
Formaldehyde 
treated (pH 10)
2 0.8 52.7 0.945 10
MEAN • _ 54.5
Bovine serum 1 0 .0 71.1 0.925 11
albumin.
Formaldehyde 2 0 .0 68.1 0.970 11
treated (pH 10) 3 1.7 65.8 0.985 10
4 1.5 80.3 0.986 9
MEAN ± S.D. :- 71.3 ± 6.4
Table 2.3 Summary of Endocytic Indices for I-labelled protein preparations incubated with 17.5-day 
rat yolk sacs.
125I-Labelled protein preparations were treated as indicated (see Section 2.2.3) and incubated with
17.5-day rat yolk sacs as described in Section 2.2.1. The data show the mean Endocytic Index (yl/h per mg 
yolk-sac protein) for each preparation, and its standard deviation; the number of individual experiments 
is shown in parentheses. Results of individual experiments are shown in Table 2.2a,b,c & d. Also shown* 
are the results of similar experiments using bovine serum albumin preparations (from Moore et al., 1977).
125
Frozen (-20 C)
125Treatment of I-labelled protein preparations
pH 2.5 Acetic Acid 4M-Urea pH 10 Formaldehyde pH 10 Bicarbonate
Insulin
Lysozyme
Ribonucléase 
(Type XA)
Lyophilized 
ribonucléase 
(Type XlA)
Bovine serum 
albumin
150.3 ± 24.3 (6)
129.9 ± 16.6 (6) 
146.6 ± 42.0 (8)
71.2 (2)
8.9 ± 2.0 (5)*
155.7 ± 8.7 (4) 
134.2 ± 3.9 (3)
120.5 (2)
63.4 (2)
14.5 ± 3.1 (4)*
147.3 ± 15.8 (5)
133.0 (2)
139.3 (1)
6 8 .0  ( 2)
73.3 ± 6.7 (2)*
44.8 ± 13.4 (4)
87.3 ± 12.4 (3)
57.6 ± 7.8 (4)
54.5 (2)
65.0 ± 11.0 (4)*
71.3 ± 6.4 (4)
123.9 ± 13.5 (3)
76.6 ± 14.3 (3) 
121.1 ± 11.8 (3)
N.D.
8.1* (1)
Table 2.4a Endocytosis of I-labelled poly(vinylpyrrolidone) by 17.5-day125
127rat yolk sacs incubated in the presence of I-iodinated protein 
preparations in medium 199 containing 10% (v/v) of calf serum.
125The uptake of I-PVP at 2 yg/ml was determined as described in 
Section 2.2.1. The proteins were iodinated ostensibly by the same procedure 
as for radiolabelling with l25I-iodide (see Section 2.2.3).
127I-Protein Expt. Endocytic Correlation Intercept No. of yolk
preparation No. Index Coefficient on ordinate sacs per
(yl/h per experiment
mg yolk-sac
protein)
1 1.609 0.977 + 0.614 10
(Matched 2 1.532 0.983 + 1.060 10controls)
3 1.868 0.978 - 0.090 10
MEAN ± S.D. 1.670 ± 0.176
1 1.237 0.974 + 1.021 10
I-Insulin 2 1.691 0.960 + 0.284 8(1 yg/mi)
3 1.936 0.960 + 0.090 9
MEAN ± S.D. :- 1.621 ± 0.355
1 1.375 0.978 + 0.583 9
I-Lysozyme 2 1.986 0.943 + 0.229 10(2.5 yg/ml)
3 1.351 0.965 + 0.370 10
MEAN ± S.D. 1.580 ± 0.351
127I-Ribo- 1 1.373 0.978 + 0.422 10
nuclease 2 1.729 0.953 + 0.057 10
(1 yg/ml) . 3 .... 1.433 ....0.958 + 0.332 10
MEAN ± S.D. 1.511 ± 0.191
Table 2.4b Endocytosis of I-labelled poly(vinylpyrrolidone) by125
17.5-day rat yolk sacs incubated in medium 199 containing 10% (v/v)
127of calf serum in the presence of formaldehyde treated I-iodinated 
protein preparations.
125The uptake of I-PVP at 2 Vg/ml was determined as described 
in Section 2.2.1. The proteins were iodinated ostensibly by the same 
procedure as for radiolabelling with 12^I-iodide and treated with 
formaldehyde as described for the i2^I-protein preparation in Section 
2.2.3.
1 77x I-Protein Expt. 
preparation No.
Endocytic 
Index 
(VIA per 
mg yolk-sac 
protein)
Correlation
Coefficient
Intercept 
on ordinate
No. of yolk 
sacs per 
experiment
1 1.322 0.953 + 1.062 10
(Matched 2 1.586 0.963 + 0.305 10controls)
3 1.148 0.963 + 1.734 10
MEAN ± S.D. :- 1.352 ± 0.220
pH 10 1 1.744 0.960 + 0.671 10
Formaldehyde 2 1.360 0.926 + 0.984 10treated
127I-insulin 3 1.734 0.950 + 0.661 9
(1 yg/ml)
MEAN ± S.D. :- 1.613 ± 0.219
pH 10 1 1.882 0.918 + 0.466 10
Formaldehyde 2 1.648 0.994 + 0.542 9treated
l27I-lysozyme 3 2.404 0.887 + 0.340 10
(2.5 yg/ml)
MEAN ± S.D. !- 1.978 ± 0.387
pH 10 1 1.475 0.974 + 1.132 9
Formaldehyde 2 1.376 0.928 + 0.643 9treated
l27I-ribo- 3 1.649 0.968 + 0.280 10
nuclease
(1 na/ml) MEAN ± S.D. :- 1.500 ± 0.138
Table 2.5 Chromatography of the low molecular weight hydrolysis products 
125of I-labelled proteins on the copper complex of Sephadex G-25.
After concentration by freeze-drying, the pooled fractions 
(A,B,C,D,E and F) from Fig. 2.3 a,b & c, were further analysed on a copper- 
-complex of Sephadex G-25 as described in Section 2.2.4(3). [i25I]Xodo- 
-1-tyrosine and glycyl-[125I]iodo-L-tyrosine were used as markers. Values 
obtained by Williams et al. (1971) for 125I-labelled bovine serum albumin 
are also shown*. The distribution of the recovered radioactivity between the 
alkaline fractions and the acid fractions is given as a percentage. Total 
recovery of radioactivity is given as a percentage.
Low molecular weight 
hydrolysis products
i
Elution with 
borax buffer 
pH 11.0
Elution with 
0.4M-HC1
Recovery of 
applied label
*2^I-Iodo-L-tyrosine 2.5 97.5 102.0
125I-Glycyliodo-L-tyrosine 88.4 11.6 88.0
125I-Insulin peak A 11.6 88.4 93.0
125I-Insulin peak B 11.4 88.6 92.0
125I-Lysozyme peak C 8.6 91.4 98.6
125I-Lysozyme peak D 14.4 85.6 98.2
125I-Ribonuclease
peak E 11.9 88.1 93.5
125I-Ribonuclease
peak F 11.6 88.4 107.0
125I-Bovine serum
albumin 14* 86.0* 98.4*
Table 2.6 Endocytosis of the various I-labelled lysozyme species by
17.5-day rat yolk sacs incubated in medium 199 containing 10% (v/v) of 
calf serum.
. . 125
Five species of I-labelled lysozyme were prepared as described
in Section 2.23 (4) (see also Fig. 2.8) and uptake experiments were performed 
as described in Section 2.2.1. I-Labelled lysozyme species were present 
at a concentration of 1 yg/ml; the duration of each experiment was 3 h.
125I-Labelied Expt 
lysozyme No. 
species
;. % acid- 
-solubles in 
preparation
Endocytic Correlation 
Index Coefficient 
(pl/h per 
mg yolk-sac 
protein)
No. of yolk 
sacs per 
experiment
I
Untreated
monomer
1
2
3
4
7.1
7.1
7.0
7.1
140.3 
129.5 
130.9
143.3
0.989
0.996
0.989
0.995
8
8
9
7
MEAN ± S.D. s- 136.0 + 6.8
II
Formaldehyde
induced
aggregates
1
2
3
0.9
0.6
0.7
63.3
58.2
53.5
0.994
0.889
0.943
9
10
10
MEAN ± S.D. •  _  • 58.3 ± 4.9
Formaldehyde
induced
dimer
1
2
3
0.5
0.7
0.6
109.3
142.4 
123.1
0.939
0.900
0.953
10
10
10
MEAN ± S.D. 124.9 ± 16.6
IV
Bicarbonate
induced
aggregates
1
2
3
6.0
5.6
5.7
34.7
26.2
33.4
0.953
0.944
0.978
10
10
6
MEAN ± S.D. 32.3 ± 5.7
V
Bicarbonate
treated
monomer
1
2
3
3.9
3.0
3.1
114.5
128.1
113.0
0.989
0.932
0.922
10
8
10
MEAN ± S.D. 118.5 ± 8.3
Figure 2.1 Uptake of I -labelled poly(vinylpyrrolidone) by 17.5-day 
rat yolk sacs in culture.
Points are derived from data on single yolk sacs each taken from one 
animal and incubated separately in medium 199 + 10% (v/v) calf serum, 
as described in Section 2.2.1, with [l25I]-PVP (2 yg/ml of culture 
medium). Uptake is expressed as the number of microlitres of culture 
medium whose contained t^2^I]-PVP has been ingested by unit quantity 
of tissue in a given time. The rate of uptake or "Endocytic Index" 
in the representative experiment shown above is 1.61 yl/h per mg 
yolk-sac protein and the Correlation Coefficient of the regression line 
is 0.978.
125Figure 2.2 Uptake and digestion of formaldehyde-denatured I-labelled 
bovine serum albumin by 17.5-day rat yolk sacs in culture.
Data at each time interval are derived from two yolk sacs each
r r r e lL i  “ i r v 1*9 1 lm (v/vi 2f a i i  s e r u a «  m2~l' io™al4ehyae-denatur.a 12=1-labelled bovine serum albumin
(0.6 ug/ml of culture medium). Uptake (. ) is the sum of the tissue- 
- associated radioactivity (o) and the acid-soluble radioactivity 
released into the culture medium (o ). The rate of uptake or »EL>cytic
Index is 65.8 ul/h per nig yolk-sac protein and the correlation Coemcient of the regression line is 0.985. ucmuent.
100
A. Bovine insulin
(1 yg/ml of culture 
medium)
B .
C.
Hen egg-white 
lysozyme 
(2.5 yg/ml of 
culture medium)
Bovine pancreatic 
ribonucléase A.
(1 yg/ml of 
culture medium)
Incubation time (h)
Figure 2.3 Tissue levels of the various preparative of 125r.l »H», i-,, 
proteins accumulated by  17.5-day rat yolk sers in cu l t u r e .
Each point represents the mean amount of tissue-associated radioactivity
t ? lncubated »“ *> 125I-labelled proteins in mediuS 199 + 10% (v/v) calf serum, as described in Section 2 2 i a
fell within *20% of the mean value). ' <Indlvldual »«!«•«
Each preparation was either untreated ( . ), or treated with either,
acetrc acid. pH 2.5 (o), 4M-urea, pH 5.0 (□), formaldehyde pH 1 0  or bicarbonate, pH 10 ( a ).~ wmainenyoe, pH 10 (a);
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Figure 2.4a Release of tissue-associated radioactivity from yolk sacs 
previously loaded with formaldehyde-denatured 125I-labelled bovine serum
albumin.
Each point represents the mean quantity of radioactivity released by a given 
time in three separate experiments and the corresponding standard deviation 
(vertical bar). In each experiment three yolk sacs from one animal were 
incubated together in the presence of formaldehyde-denatured 125I-labelled 
bovine serum albumin (5 yg/ml) and the release of total-(• ) and acid soluble 
(o ) radioactivity monitored after the transfer of the yolk sacs to fresh 
culture medium as described in Section 2.2.4. The difference between 
corresponding values of the total- and the acid-soluble radioactivity gives 
the acid-insoluble radioactivity released into the medium (X ). At the 
end of the re-incubation period 76.8% of the radioactivity associated with 
the yolk sac at the start of re-incubation had been released.
20
Incubation time (h)
Figure 2.4b Release of tissue-associated radioactivity from yolk sacs 
previously loaded with 125I-labelled insulin.
Each point represents the mean quantity of radioactivity released bv a 
given time in three separate experiments and the corresponding standard 
deviation (vertical bar). In each experiment three yolk sacs from one 
animal were incubated together in the presence of l2SI-labelled in«,Un 
(5 yg/ml) and the release of total- (» ) and acid-soluble (o) radioactivity 
monitored after the transfer of the yolk sacs to fresh culturé medium as 
described in Section 2.2.4. The difference between corresponding values 
of the total- and the acid-soluble radioactivity gives the quantity of 
acid-insoluble radioactivity released into the medium (x ). At the end 
of the incubation period 75.0% of the radioactivity associated with the 
yolk sac at the start of the re-incubation had been released
30 r
•H>•H•PO
fdo•H
(dp
<D
(d•HO0
CO
CO
<d1(D3
COCO•H•p
ipo
d) W id 0) I—IQJPi
c•H<u+Jopft
0id(01a;iHO>i
(7>
6
20
10
S'--- x--- x--- x---■**,
X--- x
Incubation time (h)
Figure 2.4c Release of tissue-associated radioactivity from yolk sacs
125previously loaded with I-labelled lysozyme.
Each point represents the mean quantity of radioactivity released by a 
given time in three separate experiments and the corresponding standard 
deviation (vertical bar). In each experiment three yolk sacs from one 
animal were incubated together in the presence of 1 “ I-labelled lysozyme 
(5 yg/ml) and the release of total- ( • ) and acid-soluble (o ) radioactivity 
monitored after the transfer of the yolk sacs to fresh culture medium as 
described in Section 2.2.4. The difference between corresponding values 
of the total- and the acid-soluble radioactivity gives the acid-insoluble 
radioactivity released into the medium (x ). At the end of the incubation 
period 99.5% of the radioactivity associated with the yolk sac at the 
start of re-incubation had been released.
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Figure 2.4d Release of tissue-associated radioactivity from yolk sacs
125previously loaded with I-labelled nbonuClease A .
Each point represents the mean quantity of radioactivity released by a 
given time in three separate experiments and the corresponding standard 
deviation (vertical bar). In each experiment three yolk sacs from one 
animal were incubated together in the presence of 125I-labelled ribonuclease 
(5 yg/mlj and the release of total- ( • ) and acid-soluble (o ) radioactivity 
monitored after the transfer of the yolk sacs to fresh culture medium as 
described in the Section 2.2.4. The difference between corresponding 
values of the total- and the acid-soluble radioactivity gives the acid- 
-insoluble radioactivity released into the medium (x ). At the end of 
the incubation period 67.0% of the radioactivity associated with the 
yolk sac at the start of re-incubation had been released.
Elution volume (ml)
125Figure 2.5a Sephadex G-25 chromatography of i-labelled insulin hydrolysis 
products.
Upper, ^^I-labelled insulin alone; middle, ^^i-labelled insulin after 
incubation with yolk sacs; lower, radioactivity released on re-incubating 
yolk sacs previously loaded with *25I-labelled insulin. Experiments were 
performed as described in Section 2.2.4. Recovery of radioactivity applied 
to the column was in each case 79%, 89%, 98%, respectively. The horizontal 
bars give the elution positions of [125I]-iodide, glycyl-[*25I]iodo-L-tyrosine 
and [*25I]iodo-L-tyrosine. The pooled fractions of peaks A and B were further 
analysed on a copper-complex of Sephadex G-25.
5Figure 2.5b Sephadex G-25 chromatography of 125l-labelled lysozyme
hydrolysis products»
125
uPP.?j> I~.1i ,el1fd alone; middle. 125I-labelled lysozyme afterincubation with yolk sacs; lower, radioactivifv j y . 6 arter
yolk sacs previously loaded with 125I-lahen h i  se on re-incubating
L  described in Section o o  a D 1 labelled lysozyme. Experiments wereas described m  Section 2.2.4. Recovery of radioactivity applied to the
column was m  each case 97%, 80%, 96%, respectively. The horizontal bars 
analysed on a copper-complex of Sephadex G-25. further
125Figure 2.5c Sephadex G-25 chromatography of I-ribonuclease hydrolysis 
products.
2§j££'. I-labelled rjbojiuclease alone,- middle, 125I-labelled ribonucléase 
after incubation withyolk sacs, lower, rSIS^tivity released from yolklacs 
previously loaded with l25I-labelled ribonucléase. Experiments were as 
described m  Section 2.2.4. Recovery of radioactivity applied to the column 
was in each case, 104 108, 103, respectively. The Lrllontal b a S g“ e 2 *
elution positions of r125I]iodide, glycyl- f ^ IJiodo-L-tyrosine and r?25TiÏÏL 
-L-tyrosine. The pooled fractions of peaks E and F were further analysed 
on a copper-complex of Sephadex G-25. y
12
I
Elution volume (ml)
125Figure 2.6 Chromatography of the low molecular weight I-labelled insulin 
hydrolysis products on a copper-complex of Sephadex G-25.
The pooled and lyophilized fractions of peak A, Fig. 2.5a, were analysed on 
a copper-complex of Sephadex G-25 as described in Section 2.2.4(3). This 
procedure separates amino acids (acid peak) from dipeptide and oligopeptides 
(alkaline peak) as described by Fazakerley and Best (1965). The quantities 
of the recovered radioactivity present in the alkaline and acid peaks shown 
here is 11.6% to 88.4%. Recovery of the applied radioactivity was 93%.
The pH of the effluent was measured using indicator paper. Results for 
similar experiments with the pooled and lyophilized fractions of peaks B,
C, D, E and F of Figs 2.5a,b & £, are summarized in Table 2.5 together 
with those for the radioactive markers glycyl-[125I]iodo-L-tyrosine 
and [125I]iodo-L-tyrosine.
Figure 2.7 Sephadex G-75 chromatography of____ I-labelled
lysozyme preparations.
, 125Upper untreated I-labelled lysozyme
125Middle formaldehyde (pH 10)treated I-labelled lysozyme
12^Lover bicarbonate (pH 10)treated I-labelled lysozyme.
125In each case 5-25 U;9 of a I-labelled lysozyme preparation m  
10 mg unlabelled lysozyme (internal marker) was analysed 
as described in Section 2.2.5. Radioactivity (• ) and extinction 
at 280 nm (□ ) of the eluate was monitored. The horizontal 
bars give the positions of marker substances. Reduced lysozyme 
was prepared as described by White (1967). Recovery of radio­
activity was 98%, 84% and 92% for upper, middle and lower 
respectively. l25I-labelled lysozyme species (peaks I-V) 
were prepared and their rates of uptake by the 17.5-day rat 
yolk sac determined (see Section 2.3.4).
125
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125 -3I-Activity (cpm per 1 ml of fraction, x^ -0 )
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125Figure 2.8 Tissue levels of the various preparations of I-labelled 
lysozyme accumulated by 17.5-day rat yolk sacs in culture.
Each point represents the mean amount of tissue-associated radioactivity, 
and the vertical bar its standard deviation, for 4-8 yolk sacs incubated 
separately with a 125I-labelled lysozyme preparation (1 yg/ml) in medium 
199 + 10% (v/v) calf serum as described in Section 2.2.1.
125The I-labelled lysozyme preparations were: I, untreated-monomer (•); 
II, formaldehyde treated-aggregates (a ) ; III formaldehyde treated-dimer 
(A ); IV, alkaline treated-aggregates ( ■ ); V, alkaline treated-monomer 
( o ) .
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2.4 DISCUSSION
Many quantitative studies of the uptake of proteins by
mammalian cells, either in vivo or in vitro, neglect the fact that,
following endocytosis, proteins may be digested extremely rapidly
and low molecular weight digestion products released back into the
extracellular fluid. Consequently,the rate of uptake of different 
125I-labelled proteins, by the 17.5-day rat yolk sac incubated in 
vitro, was monitored by measuring both the amount of the protein 
label accumulated within the yolk-sac tissue and the amount of 
acid-soluble digestion products released back into the incubation 
medium over a given incubation period, then summing the two to give 
the amount of substrate that would have accumulated in the tissue if 
proteolysis had not occurred.
Calculation of the rate of uptake (Endocytic Index) of a
protein substrate by the yolk-sac tissue in the above manner assumes:
1) that the observed proteolysis occurs exclusively intracellularly
and 2) that once a protein is endocytosed it is not subsequently
released back into the incubation medium, except as trichloroacetic
acid-soluble (low molecular weight) digestion products. There is now
conclusive evidence (see Chapters 4 & 7) that a number of protein
substrates are digested solely at an intracellular site when they are
incubated with yolk sacs, as suggested by Moore et al. (1977).
125The elution profiles of both the I-labelled protein digestion 
products found in the incubation medium and the radioactivity released
TOCon re-incubating yolk sacs previously loaded with the I-labelled
proteins each show (Figs. : 2.5a,b & c; 2.6 and Table 2.5) the bulk of
the radioactive digestion products released by the yolk sacs to be 
125[ I]iodo-L-tyrosine with only a small amount (approx. 10%, see Table 2.5)
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125of oligopeptides containing an [ I]iodo-L-tyrosyl residue. Williams
et al. (1971, 1975b) obtained similar results with 17.5-day rat yolk
sacs that had been previously loaded (either in vivo or in vitro)
125with denatured I-labelled bovine serum albumin. These observations
are consistent with the known permeability properties of lysosomal
membranes (see Reijngoud & Tager, 1977) and suggest a lysosomal site
125of hydrolysis of each I-labelled protein studied in this chapter.
Moreover, in addition to these findings^by studying the
nature of the radioactivity released on reincubating yolk sacs previously
125loaded in vitro with one of the I-labelled proteins (formaldehyde-
denatured bovine serum albumin, insulin, lysozyme or ribonuclease)
it was shown that essentially only acid-soluble radioactivity was returned
to the medium (Figs. 2.4a,b,c & d). This indicates that the second of the
above assumptions is substantially true for the yolk-sac system for
all the above proteins, although Ibbotson (1978) found that this assumption 
125does not hold for I-labelled rat IgG preparations.
. 125Steady-state tissue-levels were observed for I-labelled
albumin, insulin, lysozyme and ribonuclease (see Figs. 2.2 & 2.3).
These occur when the tissue degrades the exogenous protein at a rate
equal to that of its capture (Williams et al., 1975b). Pinocytic
ingestion is thus the rate-limiting step and a possible control point
in the overall process of ingestion and catabolism.
125The rates of pinocytic ingestion of I-labelled insulin,
lysozyme and ribonuclease by the 17.5-day rat yolk sac are very rapid
125(Table 2.3) compared to that of I-labelled poly(vinylpyrrolidone)
125[ I-PVPl. The high Endocytic Indices observed for these proteins
(130-150yl/h per mg yolk-sac protein) are approximately twice as large 
as the highest values previously reported for formaldehyde-treated
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I-labelled bovine serum albumin by Moore et al. (1977; see also Table
2.3) and 14-17 times greater than that reported by the same authors for
125the equivalent, untreated I-labelled bovine serum albumin. This 
demonstrates that the yolk-sac tissue has a very efficient system 
for the clearance of some proteins from its extracellular environment.
A number of explanations are possible for the widely different
values of Endocytic Index observed for the various protein substrates
(see Table 2.3). As described by Jacques (1975), the pinocytosis
of a solute may occur in either of the adsorptive phase or the fluid
phase or both (see Section 1.6). The upper limit to the rate of capture
of fluid by the 17.5-day rat yolk sac (when incubated in medium 199
plus 10% (v/v) calf serum] can be no greater than the rate of uptake of 
125I-PVP (1.75 ± 0.33pl/h per mg yolk-sac protein, over this period
of study), since this substrate probably enters the yolk-sac epithelial
cells only in the fluid phase (Roberts et al., 1977; Ibbotson, 1978).
Thus, a substrate with an Endocytic Index of lOOpl/h per mg yolk-sac
protein either enters 98% via the adsorptive route (due to its affinity
for the pinocytosing plasma membrane) or enters via the fluid phase but
pinocytosis is stimulated 50-fold^or both processes contribute. That
no increase in the rate of accumulation of I-PVP occurs when yolk
sacs are incubated with either untreated- or formaldehyde-treated 
127I-iodinated analogues of each protein (Tables 2.4a & b) suggests 
that tracer quantities of these proteins do not modify the rate of 
pinosome formation. Thus the radiolabelled proteins studied here must 
enter almost entirely by the adsorptive route; the wide variation in 
the Endocytic Indices observed for the various proteins result from 
differential adsorption to the external surface of the internalizing 
plasma membrane. Modification of the adsorptive process should therefore 
regulate the rate of pinocytic capture of extracellular proteins and
125
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their subsequent catabolism.
It has already been shewn that denaturation of serum albumin 
increases this proteins rate of capture by rat liver in vivo (Kitani 
& Taplin, 1971, 1974; Buys et al., 1973, 1975; Moore et al., 197/) 
and by 17.5-day rat yolk sacs in vitro (Moore et al., 1977). Buys 
and co-workers offered the explanation that formaldehyde-treatment of 
bovine serum albumin might result in either the 'unmasking' of recognition 
sites already existing within the protein molecule or the synthesis of 
new recognition sites, through chemical modification of functional 
groups at the surface of the molecule, to give a species that is more 
rapidly cleared from the rat blood stream. Lloyd (1976) preferred the 
first of these possibilities, and further suggested that the exposed 
recognition site is probably hydrophobic in character. Evidence that 
formaldehyde treatment does not always lead to an increase in the number 
of recognition sites on proteins (c.f. desialylation of glycoproteins) is
shown here by the decreased rate of uptake by the rat yolk sac of
125I-labelled insulin, lysozyme and ribonuclease following their 
formaldehyde treatment (Table 2.3). Here, the recognition sites, which 
already exist at the surface of these substrates, become modified so as 
to reduce their degree of adsorption to the pinocytosing plasma membrane.
We can still only guess at the factors responsible for the 
modified Endocytic Indices: conformational changes within the protein 
molecule, chemical modification of the recognition site(s) or the 
formation of protein aggregates, in which recognition sites become 
sheltered within the interfacial region between monomers, are all 
possible explanations. Clearly, the latter effect might explain the 
lower Endocytic Indices of lysozyme#following its treatment with either 
alkaline formaldehyde or alkali alonefsince lysozyme aggregates are
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formed in each of these processes (Fig. 2.7). [The properties of the
lysozyme aggregates produced in the presence of alkaline formaldehyde
must differ from those of aggregates produced in the presence of alkali
alone, since Galenbeck et al. (1977) showed that, during treatment
14with alkaline-formaldehyde, [ C]formaldehyde bound irreversibly to the
lysozyme molecule. However, the chemical modifications that result from
the binding of formaldehyde do not appear to appreciably modify the
Endocytic Index of lysozyme aggregates (except possibly to enhance the. rate of
uptake rather than decrease it; see Table 2.6). Moreover, lysozyme
dimers, which are presumed to bind formaldehyde (Galenbeck et al., 1977)
show an Endocytic Index similar to that of untreated lysozyme monomers.]
125The decreased values of the Endocytic Index of both I-labelled 
insulin and ribonucléase, that accompany treatment with formaldehyde, 
could result from the formation of protein aggregates but this suggestion 
was excluded by gel-filtration studies. Chemical modifications or changes 
in the conformation of these macromolecules must therefore be considered. 
Formaldehyde reacts with proteins in many different ways (e.g. see 
Means & Feeney, 1968; Meyers & Hardman, 1971; Bizzini Reynaud,
1974 & Feeney et al., 1975). Chemical modification of ribonucléase
with formaldehyde has been reported by Galenbeck et al. (1977) but it is 
not known if insulin is similarly modified, although this is most likely 
(see Section 7.4). Likewise, the conformational states of both formaldehyde- 
-treated ribonucléase and insulin have not been established. The inactiva­
tion of ribonucléase by formaldehyde has been reported by Zittle (1948), 
but this may result from chemical modification of the amino group essential 
for its enzymic activity (Means & Feeney, 1968). A strong indication 
that the conformation alone of the ribonucléase molecule might be important 
in determining the rate of clearance of this protein by the rat yolk sac
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is given here by the markedly decreased rate of uptake of the lyophilized 
ribonuclease preparation compared to that of the ribonuclease preparation, 
isolated from bovine pancreas by the same method, but never lyophilized 
(Table 2.3). Both of these preparations were shown to be free of 
aggregates.
The observed decrease in the rate of uptake of the 125I-labelled
125lysozyme aggregates compared to the I-labelled lysozyme monomers contrasts
with much of the literature on endocytosis which suggests that, in general,
the effect of the formation of protein aggregates is to cause a more
rapid rate of capture of a protein by endocytic cells. Thus Bocci, (1970)
and Kitani & Taplin (1972, 1974) have shown that serum albumin aggregates
are cleared from the rat blood stream more rapidly than albumin monomers.
Sherman et al. (1974) suggested that the formation of fibrinogen aggregates
following treatment of fibrinogen with high doses of chloramine-T is
responsible for its more rapid clearance when radioiodinated using
this method. Kooistra et al. (1978) indicated that the in vivo rates
125of uptake into rat-liver both of I-labelled ribonuclease and of
125I-labelled lysozyme were more rapid following chemical modification 
of these proteins with dimethylsuberidimate which produces protein dimers 
and higher polymers. Gabathuler & Byser (1975) demonstrated that 
sarcoma S180 cells in culture endocytose ferritin more rapidly when it is 
presented to cells as ferritin aggregates. The actively phagocytic reticulo­
endothelial system is responsible for the clearance of each of these 
protein aggregates from the blood stream and the enhanced endocytosis of 
ferritin aggregates is caused by an enhanced phagocytic uptake into the 
sarcoma S180 cells. The behaviour of endocytic cells in respect of 
their ability to ingest protein aggregates might depend on the relative 
contributions made to the endocytic process by both phagocytic and
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pinocytic mechanisms of uptake (see Section 8.3). Morphological and 
biochemical evidence (Jollies Triche, 1971; Goetze et al., 1976) show, 
however, that the rat yolk sac is not capable of phagocytosis^endocytic 
uptake being by micropinocytosis alone.
CHAPTER THREE
CHARACTERISTICS OF THE ADSORPTIVE 
PINOCYTOSIS OF FORMALDEHYDE- 
-DENATURED BOVINE SERUM ALBUMIN
AND RIBONUCLEASE BY RAT YOLK SACS
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3.1 INTRODUCTION
A number of studies have been published on the rates of uptake of 
different proteins and, in some, attempts have been made at correlating the 
observed rates of uptake with certain characteristic properties of the 
proteins. Thus, Ryser (1970) found that, cultured sarcoma S180 cells 
endocytosed proteins with an isoelectric point above pH 7 (basic proteins) 
more rapidly than those with an isoelectric point below pH 7 (acidic 
proteins). However, Dice & Goldberg (1976) discovered that, i£ vivo, 
the more acidic of the rat-serum proteins turnover more rapidly than the 
neutral or basic ones. It is not clear, however, in these studies whether 
pinocytosis is the rate-limiting step in the turnover of the serum proteins, 
although this has previously been considered to be so (Mego & McQueen,
1965a, Kirsch et al., 1972). Dice & Goldberg (1976) have suggested that 
limited proteolysis or the denaturation of serum proteins prior to 
pinocytosis may limit the rate of serum protein turnover. Alternatively, 
the more acidic serum proteins, which are known to be more resistant to 
degradation by endoproteinases (Dice & Goldberg, 1976) might resist 
lysosomal proteolysis and be released to re-enter the circulation (Gordon 
& Jacques, 1966; Jacques, 1974; Wild, 1973).
125The relative rates of uptake of the I-labelled basic proteins:
lysozyme and ribonuclease (see Chapter 2 of this thesis) and those of 
125the i-labelled acidic proteins: bovine serum albumin and human oroso-
mucoid (Moore et al., 1977) in the 17.5-day rat yolk sac in culture are
in keeping with the suggestion of Ryser (1970) that basic proteins are
endocytosed more rapidly than acidic ones. However, the rapid endocytic
125uptake, by the 17.5-day rat yolk sac, of I-labelled insulin and of
125formaldehyde-denatured I-labelled bovine serum albumin (see Table 
2.3) neither of which possess basic characteristics, suggests a factor
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other than net charge might govern their rate of endocytosis. Lloyd
125(1976) has suggested that for the formaldehyde-denatured I-labelled
bovine serum albumin, hydrophobicity might be such a factor. This might
125also be true for the I-labelled insulin since some 60% of the monomeric
form of insulin is hydrophobic in character (Chothia & Janin, 1975).
125Because their charge properties are different, I-labelled
125ribonuclease and formaldehyde-denatured I-labelled bovine serum 
albumin may bind to different parts of the plasma membrane that subsequently 
become pinocytically internalized. This possibility was examined in the 
section of work that follows.
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3.2 METHODS
3.2.1 Method for the rapid determination of quantitative uptake data.
In order to more rapidly assess the effect of compounds on both
125the endocytosis and the degradation of I-labelled proteins, the 
experimental procedure described in Section 2.2.1 was modified. The 
modified procedure also permits the use of smaller numbers of yolk sacs 
and smaller quantities of culture medium, substrate and effector compounds 
thus saving on animal and material costs.
(1) Rapid method to determine the rate of uptake and degradation of a 
125I-labelled protein by the 17.5»day rat yolk sac in serum-free medium 199. 
Yolk sacs, dissected fremi 17.5-day pregnant rats were placed in 50ml 
Erlenmeyer flasks containing serum-free medium 199 then sealed with a 
silicone-rubber stopper and incubated at 37°C as described previously 
(see Section 2.2.1). Either 1 yolk sac was incubated in 19ml of medium 
199 or 3 yolk sacs were incubated in 30ml. The experiments were either 
of 3-4h or less than lh in duration, respectively. When experiments of 
3-4h duration were performed, uptake of substrate commenced on addition of 
the substrate dissolved in medium 199 (1.0ml), but for experiments of less 
than lh duration, substrate was contained within the 30ml of medium so that 
addition of thè yolk sacs initiated uptake. At regular intervals aliquots 
of the medium (0.5ml, in the 3-4h experiments and 1.0ml in the shorter 
experiments) were removed, the flasks re-gassed and re-sealed and incubation 
continued. Incubation was terminated by the removal of yolk sacs from 
the incubation medium and a final sample of medium was then taken for 
analysis.
After removal from the incubation medium the yolk sacs were 
immediately washed in cold aq. N a d  (1% w/v, 4°c) to remove extracellular
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substrate, and assayed for radioactivity and protein content as described
in Section 2.2.1. Medium samples were assayed for both total- and
acid-soluble radioactivity as described before [Section 2.2.1 (1)]. when
0.5ml samples were taken, 0.5ml of aqueous calf serum (20%, v/v) was added
before assaying, both to standardize the counting volume to 1.0ml and
125to aid the precipitation of the i-labelled protein substrate. With 
1.0ml samples, this was achieved by the addition of 0.1ml of calf 
serum after assaying for total radioactivity. The acid-soluble radioactivity 
present in the incubation medium at the start of the uptake experiment 
was determined by assaying medium containing substrate but no yolk sac.
When effector compounds were studied the effector was added to 
the medium before introducing the yolk sacs.
<2> Expression_gf_data on uptake and degradation of 125x-labelled proteins. 
Uptake (and degradation) data can be expressed conveniently in two ways. 
Firstly, as the volume of culture medium whose contained substrate has been 
captured by unit quantity of yolk-sac tissue (units: moles of substrate/mg 
yolk-sac protein or g of substrate/mg yolk-sac protein). The second 
expression is obtained from the first by multiplying the uptake value 
(Ul/mg yolk-sac protein) by the mean quantity of substrate (in moles or g) 
contained in lyl of culture medium over the interval of the experiment. 
Expressing the data in either of these ways has the merit of enabling a 
ready comparison to be made of the results from different experiments (for 
a list of the merits of the first form of esqpression see Section 2.2 2)
The volume, V, given by the first expression is equivalent to 
the Endocytic Index (El) and can be calculated by the following equation:
y + t
v = EI = - t (3 u
M' x P x t ' *1}
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where Y is the total radioactivity in the whole yolk-sac tissue (c.p.m., 
corrected for background), T is the total quantity of acid-soluble 
radioactivity released by the yolk-sac tissue throughout the incubation 
period of a given yolk sac (c.p.m., corrected for background), and M' 
is the mean concentration of radiolabelled substrate (c.p.m. per pi of 
culture medium, corrected for background) present in the medium over the 
particular incubation period, t, measured in hours. P is the protein 
content of the yolk-sac tissue (mg), t is calculated from equation 3.2 , 
where T is simply the value of at the end of the incubation period 
of a given yolk sac:
T = v. n i Ci(i=n) +
zi=(n-l)
i=o C.i (3.2)
where Tr is the acid-soluble radioactivity (c.p.m.) released up to the 
time of the n ^  sampling, v is the volume of the culture medium (ml) just 
prior to the removal of the 1th sample [v replaces the volume factor, 1 0, 
in equation 2.1, Section 2.2.4(2)] and accounts for the decrease in the 
volume of the culture medium over the period of incubation. is the 
acid-soluble radioactivity per ml of culture medium in the i^ 1 sample 
(c.p.m., corrected for background and initial acid-soluble radioactivity).
The mean concentration of radiolabelled substrate over a 
particular incubation period (M' in equation 3.1) is calculated according 
to equation 3.3.
M' = (M + Mi - C± - 2F) 0.5 X 10_3 (3 .3,
where Mq is the total radioactivity (c.p.m., corrected for background) per 
ml of culture medium at the start of the incubation period, is the total 
radioactivity per ml of culture medium of the i ^  sample (c.p.m., corrected 
for background) and is the same as in equation 3.2. F, a correction
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factor, is the acid-soluble radioactivity per ml of culture medium at 
the beginning of the incubation period (c.p.m., corrected for background), 
it is calculated as described in equation A.3 in Appendix II.
Analysis of a plot of the acid-soluble radioactivity released 
by the yolk-sac tissue (according to equation 3.5) against time enables 
the proteolytic activity of the yolk sac to be measured. In some 
experiments the rate of degradation of radiolabelled substrate (yl/h per 
mg yolk-sac protein) was calculated from the slope of the linear part 
of the plot, using the expression:
Tn' = Tn/M'* P (3.5)
Here T ' is the acid-soluble radioactivity released by the yolk sac up
thto the time of the n sampling (units: yl per mg yolk-sac protein).
X , M' and P are as defined previously, n
To express the data as the quantity of substrate captured 
or released by unit quantity of yolk-sac tissue, uptake and degradation 
data (expressed in yl/mg yolk-sac protein) were multipled by C, the 
quantity of substrate contained in lyl of medium at the start of the 
experiment, according to equations 3.6 and 3.7.
Q = El x i
P
ii T ' X C n
(3.6)
(3.7)
where Q is the quantity of substrate captured by the yolk sac per hour
of incubation per mg of yolk-sac protein, is the quantity of substrate
thdegraded and released up to the time of the n sampling. For the 
purpose of calculating the substrate concentration in moles/yl, the
molecular weights of the bovine serum albumin and ribonucléase were taken 
to be 68 000 and 13 700, respectively (Weber and Osborn 1969).
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3.1.2 Preparation of protein substrates and potential protein and peptide 
competitors.
125Formaldehyde-denatured I-labelled bovine serum albumin and
125I-labelled bovine pancreatic ribonucléase A were prepared as described 
previously (Section 2.2.3, using Sigma ribonucléase A type XIA). 
Non-radioactive formaldehyde-denatured bovine serum albumin was prepared 
ostensibly by the same method as described for the radiolabelled analogue 
[see Section 2.2.3(4)]. Non-radioactive pancreatic ribonucléase A was 
Sigma preparation Type 1-A. Other potential competitor proteins and 
peptides were: tyrosyl-glycyl-glycine, bovine insulin and hen egg-white 
lysozyme (all from Sigma), bovine calcitonin (Calbiochem, San Diego, 
California) and bovine serum albumin (Koch-Light, preparation 0142t; 
purity 99%).
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3.3 RESULTS
1253.3.1 Endocytosis of formaldehyde-denatured I-labelled bovine serum 
125albumin and I-labelled ribonucléase by the 17.5-day rat yolk sac 
incubated in serum-free medium 199.
(1) Effect of substrate concentration on the Endocytic Index. The values
125of the Endocytic Index for both formaldehyde-denatured I-labelled
125bovine serum albumin and I-labelled ribonuclease, in the presence of 
increasing concentrations of the non-radioactive substrate, 
were determined by the rapid method described in Section 3.2.1. The 
results of individual experiments are shown in Tables 3.1 and 3.2 and are 
summarised in Figs. 3.1 and 3.2. With both substrates a decrease in 
Endocytic Index was observed with increasing substrate concentration; the 
Index was most sensitive to changes of substrate concentration at the 
tracer concentrations normally used in pinocytosis experiments (viz. approx, 
lyg/ml of medium). This effect was more pronounced for ribonuclease. 
Although the Endocytic Index of both protein substrates was substantially 
decreased in the presence of the corresponding unlabelled substrate
I5C(200yg/ml) it still remained far greater than that of I-labelled 
poly(vinylpyrrolidone) a marker of the rate of fluid uptake.
(2) Kinetic analysis of the uptake data. A decrease in the Endocytic 
Index of a substrate with increasing concentration does not mean that less 
substrate is captured by the yolk sac, but merely that a smaller proportion 
of the substrate present in the extracellular fluid is captured. Indeed, 
expression of the uptake of substrate as j> moles/h per mg yolk-sac protein 
shows that the yolk sac captures more substrate at higher substrate 
concentrations. This is shown in Tables 3.1 and 3.2 (see also the insert
to Figs 3.3 and 3.4).
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As stated by Jacques (1975), the rate at which a solute enters a 
cell by endocytosis is given by the sum of two terms, the first 
representing uptake in the liquid phase, the second uptake by adsorption 
on the pinocytosing plasma membrane. Thus, assuming an Instantaneous 
and continuous adsorption equilibrium between substrate and binding sites:
Q Fc + SRcK+c (3.8)
where Q is the rate of uptake of solute, c its concentration in the 
external liquid, K the dissociation constant of the substrate-surface
V
complex, and R the maximum amount of substrate than can be adsorbed 
per unit area of cell-surface. F and S are the rates of endocytic 
internalization of external liquid and of cell-surface, respectively. 
Given simple (Michaelis-Menten type) kinetic data, all the terms given 
in equation (3.8) are potentially variable. For any given substrate 
which adsorbs to a single class of receptor, R and K will be constant. 
For substrates with an Endocytic Index very much greater than the rate 
of fluid capture the term Fc in equation (3.8) becomes negligible 
so that the rate of uptake of a solute via the adsorptive phase, q, 
becomes:
q SRcK+c (3.9)
Taking reciprocals of these quantities an equation analogous to the 
Lineweaver-Burk equation, used in enzyme kinetics, is obtained:
1 = _K_ 1
q ~ SRc SR (3.10)
Multiplication of each side by SRq gives equation 3.11 and re-arrangement 
and replacement of q/c by El (Williams et al., 1975b) gives equation
3.12.
58
SR = a K + q (3.11)
q = -K.EI + SR (3.12)
Equation 3.11 (and 3.12) is equivalent to the Hoftsee equation 
used in enzyme kinetics. Like the Lineweaver-Burk equation, the Hoftsee 
equation gives a plot (here, q against El) which, given simple kinetic data, 
is linear and the slope of the line is equal to -K and the intercept on the 
ordinate axis is equal to SR. The kinetic data obtained in this chapter 
are more suited to analysis by Hoftsee plot than by the Lineweaver-Burk 
plot, which would display a cramped distribution of points along its 
abscissa, enabling only poor interpretation of the data. Also, because 
the slope of the line in the Hoftsee plot is equal to -K (the dissociation 
constant of the substrate-cell-surface complex) one can see how K changes 
when complex kinetic data are plotted.
The effect of the substrate concentration on the rates of 
capture of formaldehyde-denatured bovine serum albumin and of ribonuciease 
are shown in Figs. 3.3 & 3.4 (inserts) respectively; hyperbolic plots 
were obtained for each substrate. The corresponding Hoftsee plots (Figs.
3.3 & 3.4) each gave non-linear plots, indicating that the kinetic data 
are not simple but complex. As the substrate concentration increases 
(Endocytic Index decreases) the gradient (negative) of the line increases 
so that K increases. The Hoftsee plots for both substrates therefore show 
negative co-operativity, which is defined by an increase in the value of 
K (i.e. a decrease of the "average affinity" of the substrate for the cell 
surface) with an increase of substrate concentration (Lewitzi & Koshland, 
1970). In addition the data for both substrates show that K changes 
continuously over the range of substrate concentrations used; a feature,
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which indicates that multiple forms of interactions occur between the 
substrates and the cell-surface.
(3) Effect of exogenous proteins and peptides on the Endocytic Indices
125 125of formaldehyde-denatured I-labelled bovine serum/and I-labelled
ribonucléase. The decreasing Endocytic Indices observed above with
increasing substrate concentration can be accounted for by the competition
between each unlabelled protein substrate and its radioactive I-labelled
analogue both of which are captured adsorptively by the yolk-sac epithelial
cells. The degree of specificity of each binding to the plasma membrane
was tested by adding various proteins or peptides to the incubation
medium before measuring uptake. The potential competitors were added at
a concentration 100pg/ml of medium since additions of each non-radioactive
substrate at this concentration had been shown to substantially inhibit
125uptake of its corresponding i-labelled analogue.
As shown in Figs. 3.5 & 3.6 (see Tables 3.3 and 3.4 for results
of individual experiments) a number of the potential competitors are
125able to inhibit the uptake of both formaldehyde-denatured I-labelled
125bovine serum albumin and I-labelled ribonucléase. This demonstrates
that the binding process is not very specific. The tripeptide tyrosyl-
-glycyl-glycine had no measurable effect on the uptake of either of the
protein substrates. Bovine serum albumin was similarly without measurable
effect. Insulin, calcitonin and formaldehyde-denatured bovine serum
albumin each inhibited the uptake of 125l-labelled formaldehyde-denatured
bovine serum albumin whereas the two basic proteins, ribonucléase and
125
lysozyme, did not. with I-iabeiled ribonucléase as substrate, substantial
inhibition was observed with lysozyme, insulin, calcitonin and (non- 
-radioactive) ribonucléase.
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3-3-2 E^ c* Qg_exogenous proteins and peptides on the fluid-phase 
uptake in 17.5-day rat yolk sacs incubated in serum-free medium 199.
. . . 125The inhibition of I-labelled protein uptake by exogenously 
added proteins can be readily explained by competition for binding- 
-sites which are subsequently internalized during the process of pinosome 
formation. An alternative ejqplanation is that exogenous proteins modify 
the rate of pinosome formation. The latter explanation was tested by 
measuring the Endocytic Index of i-labelled poly(vinylpyrrolidone)
in the presence of the various proteins and peptides used above (at a 
concentration of 100yg/ml of medium). Table 3.5 shows that only calcitonin 
and insulin substantially modified the rate of pinosome formation 
(approx, a 50% decrease). The lower rate of pinosome formation alone is 
sufficient to account for the inhibition of 125I-labelled ribonuclease 
uptake by insulin and, similarly, the inhibition of formaldehyde-denatured 
125I-labelled bovine serum albumin uptake by calcitonin.
3.3.3 Effect of exogenous proteins and peptides on the proteolysis of
125ingested formaldehyde-denatured I-labelled bovine serum albumin and 125
125I-labelled ribonuclease by 17.5-day rat yolk sacs.
Lloyd (1976) concluded that the rate-determining step in the 
proteolysis of exogenous proteins by the rat yolk sac lies entirely in 
the uptake phase and that the proteolytic capacity of lysosomes apparently 
far exceeds demand. In agreement with this notion, a steady-state level 
of tissue-associated substrate has been observed for all protein substrates 
described in Chapter 2 (see Section 2.3.1). The precise value of the 
steady-state level is, however, dependent on the ease with which the 
proteolytic system can digest a particular protein and return the digestion 
products to the medium. As described in Section 2.3.1 the steady-state
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tissue-level observed for the more easily degradable I-insulin is
125less than that of i-labelled ribonuclease, although both substrates
have approximately the same Endocytic Index. An indication of the ease
with which the yolk sac can digest a substrate and return its digestion
products to the incubation medium following its capture by endocytosis
is obtained from the ratio of tissue-associated radioactivity (during the
steady-state period) to the Endocytic Index. The ratio is termed here
the "Catabolic Index"; its units are hours.
Table 3.6 shows how the Catabolic Index differs for a number
of different protein substrates (majority of data taken from Chapter 2;
that on 1 2 5I-labelled orosomucoid and bovine serum albumin from Moore et
al. 1977)• Plots of tissue-associated radioactivity against Endocytic
125Index for both formaldehyde-denatured I-labelled bovine serum albumin
12^i-labelled ribonuclease, in the presence of either non-radioactive
substrate at different concentrations or of a number of other exogenous
proteins and peptides, are shown in Figs. 3.7 & 3.8. In each case all
the data fall on a straight line which passes through the origin. The
slope of each line was 0.477 and 0.425h for the albumin and ribonuclease
substrates respectively. This suggests that, following pinocytosis, the
125digestion of both of the I-labelled substrates is affected neither 
by the presence of increasing quantities of the substrate itself nor 
by the presence of substantial amounts of different exogenous proteins. 
This conclusion is supported by the finding that the observed lag-period 
(i e. the period before radioactive digestion products are released 
from the yolk sac into the incubation medium) is also unchanged either 
on increasing the substrate concentration or by the presence of high 
concentrations of other exogenous proteins (see Tables 3.1, 3.2 and
125
3.4) .
Table 3.1 Endocytosis of formaldehyde-denatured I-labelled bovine serum 
albumin by 17.5-day rat yolk sacs incubated in serum-free medium ; effect 
of increasing concentrations of non-radioactive formaldehyde-denatured bovine 
serum albumin.
125The uptake of formaldehyde-denatured I-labelled bovine serum albumin 
( 1 yg/ml of medium) in the presence of increasing concentrations of non- 
-radioactive formaldehyde-denatured bovine serum albumin was determined as 
described in Section 3.2.1'. , The total rate of uptake (ymoles/h per mg 
yolk-sac protein) was calculated by multiplying the Endocytic Index (yl/h 
per mg yolk-sac protein) by the total initial substrate concentration 
[pmoles of substrate (radioactive plus non-radioactive) per yl of culture
medium] .
125
Concentration of Endocytic Tissue- Total rate Duration of
non-radioactive Expt. Index -associated of uptake the lag
HCHO-denatured N O . (yl/h per mg radioactivity (pmoles/h period
bovine serum yolk-sac (yl/mg yolk- per mg yolk- (min)
albumin (yg/ml) protein) -sac protein) -sac protein)
1 258.9 114.4 3.8 20.9
2 337.5 152.3 5.0 18.3
0 3 276.5 138.9 4.1 23.0
4 262.1 132.5 3.9 27.0
5 276.5 142.6 4.0 23.6MEAN ± S.D. :- 282.3 ± 31.8 136.2 ± 14.1 4.2 ± 0.5 22.7 + 3.4
1 183.9 81.3 29.7 18.8
10 2 199.1 81.9 32.2 19.3
3 189.4 78.7 30.6 16.7MEAN ± S.D. • 190.8 ± 7.7 80.6 ± 1.7 30.8 ± 1.26 18.2 ± 1.4
i 138.1 57.9 58.4 19.2
30 2 173.3 73.3 79.0 22.9
3 166.6 73.7 75.9 19.1MEAN ± S.D. :- 159.3 ±18.7 68.3 ± 9.0 71.7 ± 11.1 20.4 + 2 .2
1 112.9 51.4 92.2 2 1 .8
50 2 117.2 54.8 87.8 24.2
3 125.7 57.8 94.3 2 1 .6m e a n  ± S.D. :- 118.6 ± 6.5 54.7 ± 3.2 91.4 ± 3.3 22.5 + 1.4
1 1 2 1 .6 55.2 180.6 22.3
100 2 136.7 64.2 195.3 2 0 .6
3 99.7 44.3 148.1 19.7MEAN ± S.D. :- 119.3 ± 18.6 54.7 ± 9.9 174.6 ± 24.1 20.9 + 1.3
—
1 74.9 35.2 2 2 1 .1 2 2 .2
200 2 90.3 43.9 266.9 19.5
3 106.9 51.3 315.9 19.5MEAN ± S.D. • *"* 90.7 ± 14.5 43.5 ± 8 . 1 267.9 ± 47.4 20.4 + 1 .6
I-labelled ribonucléase by 17.5-day rat yolkTable 3.2 Endocytosis of
sacs incubated in serum-free medium : effect of increasing concentration of
non-radioactive ribonucléase.
125The uptake of I-labelled ribonucléase (1 yg/ml of medium) in the 
presence of increasing concentrations of non-radioactive ribonucléase was 
determined as described in Section 3.2*1*. The total rate of uptake was 
calculated as described in the legend to Table 3.1.
Concentration of Endocytic Tissue- Total rate Duration of
non-radioactive Expt. Index -associated of uptake the lag
ribonucléase No. (yl/h per mg radioactivity (pmoles/h period
(yg/ml) yolk-sac (yl/mg yolk- per mg yolk- (min)
protein) -sac protein) -sac protein)
1 721.3 312.4 50.8 19.5
0 2 562.6 262.5 41.0 2 1 .0
3 606.1 266.3 44.1 21.9
4 661.1 254.0 48.2 2 1 .1
MEAN± S.D. 637.7 ± 68.7 273.8 ± 26.3 46.0 ± 4.3 20.9 ± 1.0
1 310.0 125.3 249.4 20.9
10 2 288.5 1 0 0 .6 231.5 2 0 .2
3 282.9 116.2 227.1 19.6
293.8 ± 14.3 116.7 ± 8.4 236.3 ± 11.5 20.2 ± 0.7
1 157.7 69.1 356.8 16.6
30 2 164.0 6 6 .1 371.3 21.3
3 149.2 6 6 .0 337.6 19.3
MEAN ± S.D. 156.9 ± 7.4 67.0 ± 1.8 355.2 ± 16.9 19.1 ± 2.4
1 119.0 50.0 442.9 20.9
50 2 1 1 2 .8 45.1 420.0 18.8
3 107.4 50.6 399.7 2 0 .6
MEAN ± S.D. :- 113.1 ± 5.8 48.6 ± 3.0 420.9 ±54.2 2 0 .1 ± 1 . 1
1 72.2 29.9 532.5 18.3
100 2 74.9 30.0 552.4 21.3
3 83.1 38.1 612.5 19.3
MEAN ± S.D. 76.7 ± 5.7 32.6 ± 4.7 565.8 ± 41.6 19.6 ± 1.5
1 47.6 18.4 698.8 12.9
200 2 56.4 25.2 828.8 16.2
3 62.7 28.4 921.4 11.4
MEAN' S.D. 55.5 ± 7.5 24.0 ± 5.1 816.3 ±111.8 13.5 ± 2.4
Table 3.3 Endocytosis of formaldehyde-denatured I-labelled bovine125
serum albumin by the 17.5-day rat yolk sacs incubated in serum-free
medium : effect of added (non-radioactlve) exogenous proteins or peptides.
125The uptake of formaldehyde-denatured X-labelled bovine serum 
albumin {1 yg/ml of medium) in the presence of an added protein or peptide 
(100 yg/ml), was determined as described in Section 3.2.1. Controls (no 
addition of protein or peptide) were performed in parallel and are derived
from Table 3.1.
Non-radioaetive Endocytic Tissue- Duration of
protein/peptide Expt. Index -associated the lag
(present at a No. (yl/h per mg radioactivity period
concentration of yolk-sac (yl/mg yolk- (min)
1 0 0 yg/ml) protein) -sac protein)
None MEAN — S.D. 282.3 ± 31.8 136.2 ± 14.1 22.7 ± 3.4
Tyrosyl-glycyl- 1 295.0 138.9 25.1
-glycine 2 230.2 140.4 23.4
3 245.5 129.3 22.4
MEAN ± S.D. * * 256.9 ± 33.8 136.2 ± 6 .0 23.6 ± 1.4
1 152.3 82.4 22.9
Calcitonin 2 219.3 1 0 0 .2 2 0 .6
3 142.6 74.4 2 2 .1
MEAN + S.D. • v• 171.4 + 41.8 85.7 + 13.2 21.9 ± 1.2
1 64.2 27.3 13.7
Insulin 2 85.9 27.9 25.0
3 79.2 37.2 17.8
MEAN ± S.D. * M• 76.4 ± 1 1 . 1 30.8 ± 5.5 18.8 ± 5.7
1 365.9 161.0 27.2
Ribonucléase 2 318.0 145.8 25.4
3 317.3 141.2 2 2 .1
MEAN ± S.D. 333.7 ± 27.8 149.3 ± 10.4 24.9 ± 2.6
1 310.8 124.1 21.5
Lysozyme 2 321.8 127.4 17.3
3 301.4 127.8 2 0 .6
MEAN ± S.D. 5- 311.3 ± 1 0 .2 126.4 ± 2 .0 19.8 ± 2.2
1 342.0 157.9 18.5Bovine serum 2 274.7 147.9 2 0 .0
albumin 3 314.0 159.9 22.5
MEAN ± S.D. • • 310.2 ± 33.8 155.2 ± 6.4 20.3 ± 2.0
Table 3.4 Endocytosis of I-labelled ribonucléase by 17.5-day rat yolk125
sacs i n c u b a t e d  in serum-free medium : effect of added (non-radioactive)
exogenous proteins or peptides.
125The uptake of I-labelled ribonuclease (1 yg/ml of medium) in the 
presence of an added protein or peptide (30 or 100 pg/ml) was determined as 
described in Section 3.2.1. Controls (no addition of protein or peptide) 
were performed in parallel and are derived from Table 3.2.
Cone11. Expt. 
(pg/ml) No.
Endocytic Tissue- Duration of
Non-radioactive 
protein/peptide
Index
(pl/h per mg 
yolk-sac
-associated 
radioactivity 
(pl/mg yolk-
the lag
period
(min)
protein) -sac protein)
No addition MEAN ± S.D. :- 637.7 ± 68.7 273.8 ± 26.3 20.9 ± 1.0
30 1 635.6 287.7 23.6
Tyrosyl-glycyl-
-glycine
100 1 
2 
3
690.6
508.6 
676.4
293.2
2 2 0 .6
313.6
2 0 .0
23.3
22.7
MEAN ± S.D. 625.2 ± 101.2 275.8 ± 48.9 2 2 .0 ± 1 . 8
30 1 214.3 103.4 24.1
2 239.1 122.9 23.0
Calcitonin 100 1 
2
134.5
115.9
57.7
46.7
17.3
16.5
3 138.3 61.6 22.9
MEAN ± S.D. 129.6 ± 11.9 55.3 ± 7.7 18.9 ± 3.5
30 1 454.5 210.3 17.5
Insulin 100 1 
2
424.5
346.4
192.5
172.4
15.3
25.0
3 345.3 168.2 2 1 .6
MEAN ± S.D. s — 372.0 ± 45.4 177.7 + 12.9 20.6 ± 4.9
30 1 402.4 178.4 20.4
2 461.8 228.3 21.7
Lysozyme 100 1 
2
397.7
398.5
174.7
185.5
19.6
2 0 .0
3 327.0 127.4 21.7
MEAN ± S.D. :- 374.4 ± 41.0 162.5 ± 30.9 20.2 ± 0.7
30 1 570.1 265.4 18.7
2 674.5 286.7 19.9
Bovine
100 1 603.5 256.2 18.0serum
albumin 23
731.2
'543.4
293.0
245.9
21.5
21.3
MEAN ± S.D. :- 626.0 ± 95.9 265.0 ± 24.7 20.3 ± 2.0
100 1 510.7 221.7 23.6HCHO-denatured 2 567.8 252.0 2 1 .2
bovine serum 3 602.2 254.8 2 0 .0
albumin MEAN ± S.D. :- 560.2 ± 46.2 242.8 ± 18.3 2 1 .6 ± 1 .8
Table 3.5 Endocytosis of I-labelled poly(vinylpyrrolidone) by 17.5-dav 
rat yolk sacs incubated in semm-free medium : effect of added proteins or
125
peptides.
125The uptake of I-PVP (2 Pg/ml of medium) was determined as described
in Section 2.2.1 but in the absence of calf serum.
Non-radioactive Endocytic Intercept No. of yolk
protein/peptide Expt. Index Correlation on ordinate sacs per
(present at a No. (pl/h per mg Coefficient (yl/mg yolk- experiment
concentration of yolk-sac -sac protein)
100 ug/ml) protein)
1 2.226 0.941 + 2.226 9
2 3.421 0.975 + 1.134 10
3 4.580 0.964 + 4.730 8Control 4 4.165 0.974 + 3.310 9(no addition) 5 4.949 0.932 + 4.810 10
6 3.956 0.956 + 5.270 8
7 3.985 0.940 + 1.240 9
8 2.965 0.969 + 0.853 10
MEAN ± S.D. :- 3.781 ± 0.881
Tyrosyl-glycyl- 1 3.679 0.956 +2.699 102 3.552 0.961 + 1.709 10-glycine 3 3.383 0.974 + 1.537 10
- 3.538 ± 0.148MEAN ± S.D. s*
1 2.192 0.925 + 1.735 9
Calcitonin 2 1.624 0.968 + 0.824 8
3 2.005 0.967 + 0.983 10
mean ± S.D. :- 1.940 ± 0.289
1 1.640 0.934 + 1.605 10
2 2.303 0.957 + 0.853 10
Insulin 3 1.661 0.940 + 1.735 9
4 1.917 0.953 •H 1.106 13
mean + S.D. :-1.880 ± 0.309
1 3.128 0.975 + 0.419 10
Ribonucléase 2 2.517 0.955 + 0.056 8
3 2.966 0.988 + 0.896 10
mean ± S.D. :- 2.870 ± 0.316
1 2.682 0.981 + 1.698 9
Lysozyme 2
3
3.555
4.302
0.930
0.951
+ 3.294 
+ 2.458
10
9
MEAN + S.D. •- 3.513 ± 0.811
Bovine serum 1
2
3.132
3.018
0.900
0.990
+ 1.941 
+ 0.435
11
12albumin 3 3.945 0.941 + 1.311 9
S.D. *- 3.365 + 0.506MEAN +
Formaldehyde- 1 3.406 0.972 + 1.530 10
-denatured 2 2.165 0.976 + 1.145 9
bovine serum 
albumin +
3 2.682 0.958 + 1.182 8
S.D. :- 2.751 ± 0.623
Table 3.6 Catabolic Indices of various I-labelled protein substrates
125
digested by 17.5-day rat yolk sacs that were incubated in medium 199 
containing 1 0% (v/v) of calf serum.
The Catabolic Index, defined as the mean time taken by the yolk 
sac to digest and release a substrate once it has been captured bv 
endocytosis, is the ratio of the tissue-associated radioactivity (in the 
steady state period) to the Endocytic Index. The Catabolic Index therefore 
has the units of hours. The Catabolic Indices were calculated from data 
presented in Chapter 2 and from data* published by Moore et al (1 9 7 7)
In these experiments yolk sacs were cultured in medium co^aHTing 1 0% (v/v) 
calf serum. * ' ' '
^“labelled substrateTreatment 
(as defined 
in Section 
2.2.3)
*Oroso-
mucoid
*Bovine
serum
albumin
Insulin Lysozyme Ribonucléase 
(Type XA)t(Type XIA)
Fr0 zen 1.50 0.78 0.32 0.85 0.72 1.33
pH 2.5 Acetic Acid - 0 .8 6 0.42 0 .8 6 0.78 1.31
ürea, pH 5.0 1.45 0 .8 8 0.44 0.81 0.72 1.24
Formaldéhyde 3.64 1.53 0.82 0 .6 8 0.84 0.62
Bicarbonate 1 .6 6 0 .8 6 0.62 1.48 0.78
tSee Section 2.2.3(1).
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125Figure 3.2 Endocytosis of I-labelled ribonucléase by 17.5-day rat yolk 
sacs incubated in serum-free medium 199 in the presence of increasing 
concentrations of non-radioactive ribonUClease.
The Endocytic Index ( • ) and the yolk-sac associated radioactivity ( o ) were 
determined as described in Section 3.2.1. Each value shown is the mean 
(± S.D.) of results obtained using yolk sacs from three or four different
animals (see Table 3.2).
Figure 3.3 Hoftsee_plot for the uptake of formaldehyde-denatured bovine 
serum albumin by_ 17.5-day rat yolk sacs incubated in serum-free medinm 199
The curve was plotted according to equation 3.12 (a = FT + CDt 
data from Fig. 3.1. To obtain both the mean value of q and i t-c ^  
deviation (vertical bar), the Endocytic Index, El and its standard d
deviation (horizontal bar) were respectively multinHo^i x !?nd d 
initial substrate concentration (pmoles of radical * ny 016 associated 
substrate) in the culture medium.” radioactive plus non-radioactive
The smaller inset figure shows how q increases with 
(radioactive plus non-radioactive) concentration. increasing substrate
800 800
Endocytic Index, q/c (ylA per mg yolk-sac protein)
Figure 3.4 Hoftsee plot for the uptake of ribonuclease by the 17.5-day rat 
yolk sac incubated in serum-free medium 199.
The curve was plotted according _
data from Fig. 3.2. To obtain both the mean “value of USing
deviation (vertical bar), the Endocytic Index ei ^ ? and lts standard 
deviation (horizontal bar) were respectively
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125Figure 3.5 Endocytosis of formaldehyde-denatured I-labelled bovine serum 
albumin by 17.5-day rat yolk sacs incubated in serum-free medium 199 in the 
presence of various proteins or peptides.
Values of the Endocytic Index (open bar) and the yolk-sac associated 
radioactivity (shaded bar) were determined as described in Section 3.2.1.
Each value shown is the mean and standard deviation (vertical bar) of results 
obtained using yolk sacs from three or five different animals (see Table 3.3).
Abbreviations: fdBSA, formaldehyde-denatured bovine serum albumin; BSA, 
bovine serum albumin; Lys, lysozyme; RNase, ribonuclease; Ins, insulin;
Cal* calcitonin; Tgg, tyrosyl-glycy1-glycine; cont., control (no additional
protein/peptide).
Figure 3.6 Endocytosis of I-labelled ribonuclease by 17.5-day rat yolk 
sacs incubated in serum-free medium 199 in the presence of various proteins 
or peptides.
Values of the Endocytic Index (open bar) and the yolk sac associated radio­
activity (shaded bar) were determined as described in Section 3.2.1. Each 
value shown is the mean and standard deviation (vertical bar) of results 
obtained using yolk sacs from three or four different animals (see Table 3.4).
Abbreviations: fdBSA, formaldehyde-denatured bovine serum albumin; BSA, 
bovine serum albumin; Lys, lysozyme; RNase, Ribonuclease; Ins, insulin;
Tgg, tyrosyl-glycyl-glycine; cont., control (no additional protein/peptide).
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Figure 3.7 Correlation between the quantity of yolk-sac associated radio- 
activity and the Endocytic Index of formaldehyde-denatured i-labelled 
bovine serum albumin for 17.5-day rat yolk sacs incubated in serum-free 
medium 199 in the presence of increasing concentrations of non-radioactive 
formaldehyde-denatured bovine serum albumin or various proteins or peptides.
Data are taken from Tables 3.1 & 3.3. Formaldehyde-denatured 125i-labell^ 
^ItursS^ uT U m n  PreSent “  “  i n i t U 1  « ““ »tration of 1 vg% i  o ?
( n ) Tyrosyl-glycyl-glycine 100
(° ) Calcitonin 100
(A ) Insulin 100
(*) Ribonucléase 100
(• ) Lysozyme 100
(* ) Bovine serum albumin 100
(• ) Non-radioactive formaldehyde- 
-denatured bovine serum albumin
yg/ml
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Figure 3.8 Correlation between the quantity of yolk-sac associated
, 125radioactivity and the Endocytic Index of I-labelled ribonucléase for 
17.5-day rat yolk sacs incubated in serum-free medium 199 in the presence 
of increasing concentrations of non-radioactive ribonucléase or various 
proteins or peptides.
125Data are taken from Tables 3.2 & 3.4. I-Labelled ribonucléase was 
present at an initial concentration of 1 yg/ml of culture medium.
(□ ) Tyrosyl-glycy1-glycine, 30 and 100 yg/ml
(o ) Calcitonin, 30 and 100 yg/ml
(A) Insulin, 30 and 100 yg/ml
(•) Ribonucléase, 0, 10, 30, 50, 100 and 200 yg/ml
(• ) Lysozyme, 30 and 100 yg/ml
( a ) Bovine serum albumin, 30-and 100 yg/ml
(#•) Formaldehyde-denatured bovine serum albumin, 100 yg/ml
62
Much of the foregoing discussion is based on the assumption 
125
that each of the I-labelled protein substrates studied here interact
with the surface of yolk-sac cells in the same manner as the corresponding
unlabelled forms of the same protein. Sherman et al. (1974) have shown
that radio-iodination of proteins by the chloramine-T method of Hunter &
Greenwood (1962) can result in aggregation of monomeric protein molecules.
But such observations were made only when high concentrations of chloramine-T
were used. Sherman et al.(1974) found no evidence for the formation of
macromolecular complexes when human serum albumin was iodinated using
a chloramine-T to albumin concentration ratio of 2:1 (w/w). A much lower
ratio (1:3) was used here. Moreover, gel-filtration studies of preparations
125of both formaldehyde-denatured I-labelled bovine serum albumin (Moore
125
—  — ' ' 1977* ^  of I-labelled ribonucléase (see Chapter 2) exclude 
macromolecular-complex formation as a source of error. However, after 
iodination, some polypeptide hormones have been shown to differ in their 
behaviour compared to the native hormones (Stagg et al., 1970? i220 et al 
1972; Marxetal., 1973; Sutcliffe et al., 1973■; Desbusquois, 1975).
Such differences include changes in the biological activity, membrane- 
-binding properties, proteolytic susceptibility and rate of clearance from 
the bloodstream. The modification of the behaviour became more marked 
on increasing the number of atoms of iodine incorporated per molecule of 
polypeptide hormone (Izzoetal., 1972; Desbusquois, 1975). Usually only 
small differences in the behaviour between monoiodinated and native forms 
of a polypeptide hormone are reported. Thus IZ20 et al. (1 9 7 3) showed 
that after the iodination of insulin by the chloramine-T method, mono- 
-iodoinsulin behaved like native insulin in two different biological 
assay systems. Terris & Steiner (1976) found close similarities in
3.4 DISCUSSION
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the behaviour of various mixtures of native insulin and "^-labelled 
insulin containing 0 .1 -0 .2 atoms of [1 2 5  *i]iodine per molecule ¿f 
insulin. Marx et al. (1973) showed that iodination of salmon calcitonin 
by the chloramine-T method, with an incorporation of 0.9-0.95 atoms of 
iodine per molecule of hormone, had no effect on the hormones biological 
activity. The incorporation of iodine into gastrin was without effect 
on its biological activity (Stagg et al., 1970) but required the presence 
of dimethylsulphoxide to protect the essential methionyl residue from the 
oxidative effects of chloramine-T. Chloramine-T has also been reported 
to destroy the essential methionyl residue in parathyroid hormone 
(Sutcliffe et al., 1973).
Both the formaldehyde-denatured 12 5I-labelled bovine serum 
125albumin and the I-labelled ribonuclease preparations used here
125contain fewer than 1 atom of [ I]iodine per 300 molecules of protein.
It is therefore unlikely that the radioiodinated proteins studied differ
substantially from the corresponding unlabelled proteins unless a methionyl
residue is important in the adsorption of these proteins to internalizing
binding sites on the surface of the yolk sac. Moreover, Davidson (1973)
125has shown that I-labelled ribonuclease preparations, containing
125approximately 10 times more [ I] iodine per mole of ribonuclease than 
the preparation used here, showed an undiminished ribonuclease activity. 
Furthermore, Lloyd (1976) reported that the conformation of native bovine 
serum albumin remains unchanged after its iodination with [1 2 7I]iodine
as judged by optical rotatory dispersion studies. It seems reasonable, 
therefore, to assume a substantial similarity between the properties 
of radiolabelled proteins and the corresponding unlabelled proteins. 
However, since conclusive proof of this is lacking, the interpretation 
of some data may require caution.
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Williams et_al_. (1975b) showed that the Endocytic Index of 
125acid-denatured I-labelled bovine serum albumin, in the rat yolk-sac
system, was independent of the substrate concentration over the range
1-60yg/ml of incubation medium, when the incubation medium contained
10% (v/v) calf serum. This finding did not seem compatible with their
conclusion that the acid-denatured 1 2 5I-labelled bovine serum albumin was
ingested by adsorptive endocytosis, but was easily explained if proteins,
present in the calf-serum, were also able to compete with acid-denatured 
125I-labelled bovine serum albumin for binding sites on the surface of 
the yolk sac. This conflict was resolved by Ibbotson (1978) who 
showed that calf-serum proteins did compete with denatured bovine serum 
albumin for binding sites on the surface of the yolk sac and that the 
Endocytic Index of formaldehyde-denatured 1 2 5I-labelled bovine serum 
albumin in the yolk-sac system is substrate- concentration-dependent when 
yolk sacs are incubated in the absence of calf serum. In the experiments 
described in this chapter the yolk sacs were incubated in medium free 
of calf serum, the method avoids problems of the sort encountered by
Williams etal.(1975b). The Endocytic Index of both formaldehyde-denatured 
125I-labelled bovine serum albumin (Ibbotson, 1978 and Fig. 3.1) and
125I-labelled ribonuclease (Fig. 3.2), were observed to decrease with
increasing concentration of the corresponding unlabelled proteins, if the
radiolabelled and the corresponding unlabelled substrates behave alike,
the shape of the curves in Figs. 3.1 and 3.2 also reflect the dependence
of uptake on the concentration of the albumin and the ribonuclease. These
observations confirm Ibbotson*s findings with formaldehyde-denatured 
125I - l a b e l l e d  b o v in e  se ru m  a lb u m in  a n d  f u r t h e r  d e m o n s t r a t e  t h a t  b o t h  s u b s t r a t e s  a r e  i n g e s t e d  b y  a d s o r p t i v e  e n d o c y t o s i s .
65
Analysis of the uptake data in Figs 3.1 and 3.2 showed, for
both substrates (Figs. 3.3 & 3.4), a non-linear relationship between the
rate of substrate uptake (in ymole/h per mg yolk-sac protein) and the
Endocytic Index (in yl/h per mg yolk-sac protein). The upward concave
shape of the curves in Figs. 3.3 and 3.4 indicates, for each substrate,
that the apparent magnitude of the dissociation constant of the pinocytosing
membrane-substrate complex (negative slope of the curve) increases with
a decreasing Endocytic Index or increasing substrate concentrations. These
data are, therefore, typical of substrate-receptor interactions that show
negative co-operativity (Lewitzi & Koshland, 1960). The uptake of 
125I-labelled low density lipoproteins by human fibroblasts in culture also
displayed negative co-operativity (Bachorik, 1976) . Negative co-operativity
has been found in both specific protein-receptor interactions (Kahn et al.,
1974) and non-specific protein-receptor interactions (Jennissen, 1976), but
not all such interactions show negative co-operativity and some (e.g.
concanavalin A binding to isolated fat-cells in culture) show positive
co-operativity (Ullrich & Wallack, 1976; Prujansky et al., 1978).
Ibbotson (1978) did not observe a co-operative interaction
125between formaldehyde-denatured I-labelled bovine serum albumin
and binding-sites on the surface of the rat yolk sac. It is not easy
to explain this discrepancy. Negative co-operativity in substrate-receptor
interactions is usually ascribed to the presence of either more than one
receptor or more than one substrate species, or both. In the examples
shown in Figs. 3.3 and 3.4 the curvature of each plot might be explained
. 125by differences in the behaviour of the I-labelled substrates and the 
corresponding unlabelled substrates. However, if, as discussed above, 
both forms of the substrates behave alike in their interaction with the
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yolk-sac cell-surface, the curvature might be explained by: 1) interaction 
of the yolk sac cell surface with a number of different recognition sites 
on each substrate molecule; 2) different binding sites existing on the 
surface of the yolk sac (each having different affinities for the substrate 
recognition site) and 3) a combination of both 1 & 2. it is also possible 
that an increasing concentration of substrate in the incubation medium 
results in an increasing rate of pinosome formation. If this is so, it 
would be necessary to postulate only a single type of interaction between 
each substrate and binding sites on the yolk-sac cell-surface. But this 
possibility can be excluded since no increases in the rate of 125i-pvp 
uptake was observed with either formaldehyde-denatured bovine serum albumin 
or ribonuclease when either was present at a concentration of lOOyg/ml of 
incubation medium.
The magnitude of the dissociation constant of the membrane- 
-substrate complex obtained here for ribonuclease was 0.55 - 11.82 x lo”6M 
over the substrate concentration range l-200pg/ml of incubation medium, 
whereas for formaldehyde-denatured bovine serum albumin, over the same 
substrate concentration range, the dissociation was 0.29 - 4.72 x 1 0~6M 
Over a formaldehyde-denatured bovine serum albumin concentration range 
of l-160yg/ml, Ibbotson (1978) obtained an average value, for the apparent 
dissociation constant, of 1.26 x 10-6m . This value falls well within the 
range obtained here. The apparent affinity of the above substrates for 
the internalizing binding-sites is 2-4 orders of magnitude less than that 
for some polypeptide hormone receptor interactions, but compares well 
with some other endocytic systems, and is two orders of magnitude greater 
than the non-specific interactions of phosphorylase b with methyl- 
-Sepharose and myoglobin with phosphocellulose (see Table 3.7 for 
comparisons).
Table 3.7 Affinity constants of proteins for binding sites on the surface of cells, isolated membranes
and synthetic materials.
Bindinq system Substrate Affinity
(yg/ml)
constant 
(Molar cone.)
Reference
17.5-day rat yolk sac 
pinocytic membrane
Ribonucléase 8 - 173 0.55-11.82xl0_6 Section 3.4
Formaldehyde-dena­
tured bovine
20 - 320 0.29- 4.72x10
1 .26xl0~6
Section 3.4
Cultured Kupffer
serum albumin 
Formaldehyde
86 Ibbotson, 1978
cell pinocytic 
membrane
-denatured human 
serum albumin
4 0.06x10 Nilsson & Berg, 1977
Cultured human 
fibroblasts
Low density 
lipoprotein
10 - 15 - Goldstein & Brown, 1974 
Brown & Goldstein, 1974
Cultured fat Concanavalin A 120 - Cuatrecasas, 1973cell-surface Wheatgerm agglutinin 8 -
Cultured human fibroblasts 3-Glucuronidase - 6xl0~9 Kaplan et^  al., 1977a
Isolated rat liver 
plasma membrane
Asialo-orosomucoid - -96x10 Van Lenten & Ashwell, 1972
Isolated liver cell 
plasma membranes (two 
receptors)
Insulin 2 .0 xl0~9
2 . 1  xlO- 8
Kahn et al., 1974
Isolated kidney brush 
border membranes Calcitonin - 1.1 xlO" 10 Marx et al., 1973
Cultured central smooth 
muscle cell-surface Gastrin - 2.0 xlO" 9 Baur & Bacon, 1976
Methyl-Sepharose Phosphorylase b - 4 - 3 9  xlO- 4  
—4 Jennissen, 1976Pho sphoce1lulose Myoglobin - 2 - 9  xlO
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An easy comparison can be made between the kinetic constants of
formaldehyde-denatured bovine serum albumin and ribonuclease in the yolk-
sac system. The dissociation constant of the membrane-substrate complex
(K) and the maximum rate of uptake (SR) were determined for each substrate
-7at a concentration of 10 M, from the slope of each curve (Pigs. 3.3 and
3.4) and the intercept of each curve on the ordinate axis respectively. 
These values together with those of the associated Endocytic Index are 
shown below.
SUBSTRATE ENDOCYTIC INDEX membrane- MAX R A T E  rYE>(yl/h per mg
yolk-sac
protein)
-SUBSTRATE 
DISSOCIATION 
CONSTANT, K
(JJM)
UPTAKE, SR 
(pmoles/h 
per mg yolk- 
-sac protein)
Formaldehyde- 
-denatured bovine 
serian albumin
2 2 0 .1 0.38 105
Ribonuclease 587.1 0.56 400
Although the formaldehyde-denatured bovine serum albumin,
-7at a concentration of 10 M shows an. apparent affinity
for the internalizing binding sites on the yolk-sac surface that is almost 
one and a half times greater than that of ribonuclease at the same 
concentration, the Endocytic Index of ribonuclease is almost three times 
that of formaldehyde-denatured bovine serum albumin. This must result 
from a larger (approx, four times more) number of internalizing meiribrane 
binding sites available for the ribonuclease molecules than for the 
formaldehyde-denatured bovine serum albumin molecules. The large difference 
in the number of internalizing membrane binding sites available to these 
two substrates indicates that formaldehyde-denatured bovine serum albumin 
and ribonuclease adsorb, at least in part, to different binding-sites on
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the plasma membrane from which pinosomes are formed.
The maximum rate of internalization of a substrate-binding-site 
complex is given in equation 3.12 (q =-K.EI + SR) by the term SR where S 
is the rate of internalization of unit area of membrane, and R is 
the number of receptors (binding sites) per unit area of membrane 
internalized. If the value of S is the same for both substrates (e.g. 
the substrates share common pinosomes) the number of binding-sites per 
unit area of plasma membrane internalized (R) must differ for each substrate 
(formaldehyde-denatured bovine serum albumin and ribonuclease). It is 
possible, however, that the value of R is similar for each of the two 
substrates. If this is so, the rate of internalization of unit area of 
the plasma membrane must differ for each substrate i.e. the two substrates 
are taken up into different pinosomes which are being formed at different 
rates. This was considered a possible explanation by Moore et al. (1977), 
for their observed differences between the rates of uptake of different 
1 2 5I-labelled bovine serum albumin preparations. There being no evidence 
to support this supposition it was dismissed by Moore and co-workers as 
being extremely improbable. Nevertheless, specific receptors for IgG are 
thought to exist on the surface of rabbit yolk sacs, and the IgG is 
considered to become internalized and transported within coated micro- 
pinocytic vesicles across the endothelial cell. (Moxon et al., 1976). 
Although coated micropinocytic vesicles have been seen in electron 
micrographs of the rat yolk sac (observations of A.J. Kenny and of C. Wilde, 
unpublished work), they probably do not contribute significantly to the 
uptake of either substrate studied here since electronmicroscopic evidence 
indicates that the number of such vesicles is very small in comparison with 
the abundant smooth micropinocytic vesicles. The different values of SR, 
for formaldehyde-denatured bovine serum albumin and ribonuclease, therefore
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per unit area of the internalizing plasma membrane.
The ability of a number of unlabelled proteins and peptides to
125compete with both formaldehyde-denatured I-labelled bovine serum albumin 
125and I-labelled ribonucléase for binding sites on the surface of the
rat yolk sac further distinguish the two types of binding sites (Fig.
3.5 & 3.6). The competitive studies were complicated by the ability
of both calcitonin and insulin to inhibit significantly the rate of
125pinosome formation as judged by the inhibition of I-PVP uptake (Table
3.5) . Calcitonin and insulin are therefore not ideal competitive substrates
in the rat yolk-sac system, but after correction for their inhibition of
membrane internalization, an estimate is obtained for the inhibition of the 
125adsorption of a i-labelled protein substrate to binding sites at the
yolk-sac cell-surface. Ribonucléase caused no detectable inhibition of
125formaldehyde-denatured I-labelled bovine serum albumin uptake (Fig.
3.5) . The converse was also true i.e. formaldehyde-denatured bovine serum
125albumin did not measurably modify the rate of uptake of I-labelled 
ribonucléase (Fig. 3.6). It is clear that both formaldehyde-denatured 
bovine serum albumin and ribonucléase adsorb to different binding sites 
on the internalizing surface of the rat yolk sac. The question then arises 
as to what characteristic features of a protein molecule are recognised 
by each of the two different binding sites.
The basic protein lysozyme, was without effect on the adsorption 
of formaldehyde-denatured bovine serum albumin, but substantially inhibited 
1 2 5I-labelled ribonucléase adsorption. This supports the supposition that 
the basic characteristic of both ribonucléase (pi = approx. 9.5; Richards 
& Wyckoff, 1970) and lysozyme (pi z approx. 11.2; Imoto e t £ . ,  1972) 
are responsible for their adsorption to the internalizing plasma membrane.
most likely reflect differences in R, the number of bindingrsites available
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After correcting for the effects of non-competitive inhibition (on
pinocytosis), insulin was found to competitively inhibit the uptake of
125formaldehyde-denatured I-labelled bovine serum albumin,but was
125without measurable effect on the uptake of I-labelled ribonuclease.
This further supports the suggestion that both formaldehyde-denatured 
bovine serum albumin and insulin share a similar, if not common mechanism 
responsible for their adsorption to the plasma membrane. A hydrophobic 
interaction between these two proteins and the plasma membrane suggests 
itself. The hydrophobic interior of bovine serum albumin is almost 
certainly displaced to the surface of the protein molecule following its 
denaturation with alkaline formaldehyde (Lloyd, 1976) and approximately
60% of the surface of the insulin monomer contains hydrophobic residues 
(Chothia & Janin, 1975).
The rat yolk-sac plasma membrane is not unique in its ability 
to selectively bind protein substrates. If, using published data found 
in a literature survey, substrates are ranked according to the extent to 
which they adsorb to membranes (see Table 3.8) it can be seen that several 
membranes show a similar degree of specificity. In general, the ranking 
according to the extent of adsorption to plasma membranes is: insulin « 
ribonuclease > formaldehyde-denatured albumin > IgG. Albumin appears to 
adsorb to the membrane only to a small extent and poly(vinylpyrrolidone) 
either does not bind significantly to membranes (e.g. 17.5-day rat yolk 
sac and possibly rat liver cells) or shows only an extremely small extent 
of binding (human placental cell membranes). [A possible exception to 
these observations, however, is the finding of Zalin & Hoffenberg (1977) that 
1 2 5I-labelled poly(vinylpyrrolidone) appears to be accumulated by minced 
thyroid tissue more rapidly than [3H]inulin; this implies that i2 5I-PVP 
might be partly ingested by adsorption to pinocytic membrane.] Ashwell
Table 3.8 Selective adsorption of proteins to natural lipid membranes
Key: Ins, Insulin; RNase, ribonuclease; fdBSA, formaldehyde-denatured bovine serum albumin; IgG^,
2rat immunoglobulin G; IgG , human immunoglobulin G; BSA. bovine serum albumin; HSA, human serum 
albumin; PVP, poly(vinylpyrrolidone).
Binding Site
17.5-Bay rat yolk sac 
pinocytic membrane Ins * RNase > fdBSA > IgG > BSA > PVP
Chapter 1, Moore et al. 
(1977) & Ibbotson (1978)
Kidney proximal
tubule pinocytic Ins - RNase, , - > BSA, - Cortney et al. (1970)
membrane
Liver Kupffer cell 
endocytic membrane fdBSA, - > BSA > PVP
Moore et al. (1977)
Millard, unpublished results
Human placental 
cell-membranes Ins, ,>IgG2 > HSA > PVP Balfour & Jones (1977)
Human erythrocyte 
cell-membranes IgG > HSA, Balfour & Jones (1977)
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& Morell (1974a^b) showed that the adsorption of asialo-glycoproteins 
to rat liver parenchymal cell membranes is mediated through a specific 
receptor protein. Polypeptide hormones are also recognised by specific 
receptor proteins in the plasma membranes of target cells (for reviews 
see Roth, 1973; Posner, 1975). However, it is not necessary to postulate 
the involvement of receptor proteins to account for the selective adsorption 
of proteins by yolk sac pinocytic membrane or plasma membranes from other 
tissues. Proteins are known to adsorb to lipid films and in particular 
lipid bilayers may selectively adsorb proteins (Tyrrell et al., 1976). 
Anionic lipids interacted with the basic proteins lysozyme and ribonuclease. 
Most phospholipids are negatively charged at physiological pH (Bangham,
1972) and those present in the membranes of yolk sac pinosomes might 
bind the basic proteins lysozyme and ribonuclease. Hydrophobic interactions 
might take place between the hydrophic lipid of the pinocytosing yolk-sac 
membrane and hydrophobic regions of exogenous proteins. These suggestions 
are not incompatible with the observed negative co-operativity in the 
interaction of formaldehyde-denatured bovine serum albumin and of ribo­
nuclease with the pinocytosing plasma membranes of the 17.5-day rat 
yolk sac, but would suggest a tenable model for the negative co-operativity 
similar to the "sequential adsorption model” described by Jennissen (1976). 
However, further research is necessary to discover the nature of those 
regions of the pinocytosing plasma to which exogenous proteins bind.
CHAPTER FOUR
SITE OF DIGESTION OF FORMALDEHYDE- 
125-DENATURED I-LABELLED BOVINE SERUM 
ALBUMIN BY RAT YOLK SACS IN VITRO
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4.1 INTRODUCTION
When proteins are exposed to mammalian cells in culture, their 
digestion products are often observed to accumulate in the culture medium 
(Fri¿(handler & Zipper, 1964; Ehrenreich & Cohn, 1967, 1968, 1969;
Gabathuler & Ryser, 1969; Kirsch et al^ ., 1972; Edelson & Cohn, 1974; 
Williams et al_., 1975b; Goldstein et al., 1975; Terris & Steiner, 1975; 
Stein et al., 1976; Tokes & Sorgente, 1976; Tokes & Cspike, 1977; Moore 
et al., 1977; Pratten et al., 1977, Nilsson & Berg, 1977; Tolleshaug et al., 
1977). In the majority of these studies, protein digestion is assumed to 
occur by endocytic capture of the proteins by the cells and their 
subsequent proteolysis within the lysosomal system. While the lysosomes are 
undoubtedly a major site of digestion, a possible contribution from 
extracellular proteolysis cannot be excluded. Indeed, Tokes & Sorgente
(1976) and Tokes & Cspike (1977) claim to have observed the extracellular 
digestion of calsein (bound to plastic beads) in several cell types: 
T-lymphocytes, macrophages, bovine aorta endothelial cells, normal and 
transformed quail fibroblasts and normal and carcinogen-treated liver 
epithelial cells. Moreover, extracellular membrane-bound peptidases 
have been implicated in the digestion of several peptide hormones including 
insulin (Freychet et al., 1972) and glucagon (Pohl et al., 1972);
Desbuquois & Cuatrecasas, 1972; Desbuquois at al., 1974) by liver plasma 
membranes, corticotrophin by crude preparations of adrenal-cortex 
membranes (Saez et al., 1975), calcitonin (Marx et al., 1972, 1973) , 
glucagon and insulin B-chain by kidney plasma membranes (Kerr & Kenny,
1974).
It is not known whether the microvilli of the yolk sac, like 
those of the kidney proximal tubule (see Kenny, 1977), are endowed with 
neutral endopeptidases on their outer surface or whether, if present,
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such endopeptidases can make a significant contribution to the overall 
catabolic activity of the rat yolk sac. Preliminary investigations of pep­
tidase activity of membrane-rich fractions of the rat yolk sac showed 
very low specific activities (A.J. Kenny, unpublished work) in comparison 
with similar fractions from rabbit kidney proximal tubules (Kerr & Kenny, 
1974). Nevertheless, even a small hydrolytic activity in the disrupted 
yolk-sac preparations does not exclude the possibility of a significant 
contribution of such enzymes to the hydrolytic capacity of the rat yolk 
- sac in culture. Possibly the rat yolk sac membrane preparations examined 
by Kenny contained enzymes with very different specificities from those 
enzymes from rabbit kidney tubules so that only low activities were 
shown towards the substrate used in their assays.
When formaldehyde-denatured 125I-labelled bovine serum albumin 
was incubated with 17.5-day rat yolk sacs, it was rapidly hydrolysed 
(Moore et al., 1974, 1977; see also Chapters 2 & 3). Moore et al. (1977) 
briefly discuss circumstantial evidence indicating that lysosomes are 
involved in the digestion process but there is, however, no direct 
evidence to suggest that formaldehyde-denatured 125I-labelled bovine 
serum albumin is digested exclusively intracellularly. This protein has 
been employed by several workers (Moore et al., 1 9 7 4, 1977? Roberts et al., 
1977; Pratten et al., 1978; Ibbotson, 1978; Duncan & Lloyd, 1978; see 
also Chapter 2 and 3) in quantitative studies of pinocytosis in the rat 
yolk-sac culture system devised by Williams et al. (1975a,b). In each 
of the above studies, the quantity of albumin captured by pinocytosis at 
a given time was calculated by summing the quantity of substrate accumulated 
in the yolk-sac tissue and the quantity of substrate digestion products 
accumulated in the incubation medium during the same incubation period.
The calculation of the rate of pinocytic capture of digestible proteins
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in this manner requires the albumin to be digested exclusively
intracellularly, but, to date, conclusive evidence of this has been 
lacking.
^■^^•arns (1971) showed that when acid-denatured
125
bovine serum albumin was injected into pregnant rats it 
accumulated within the lysosomal system of the visceral yolk sac.
These observations led Williams et al. (1975b) to suggest that 125i- 
-labelled albumin was digested intracellularly, within the lysosomal 
system, when it was added to isolated yolk sacs in culture. These 
studies did not, however, exclude the possibility that in culture, 
extracellular proteolysis might also take place. Similarly, Moore et al. 
(1974, 1977) showed that formaldehyde-denatured 125l-labelled bovine 
serum albumin incubated with 17.5-day rat yolk sacs was digested several 
times faster than acid-denatured I-labelled bovine serum albumin (see 
Table 2.3). The higher rate of digestion of the formaldehyde-treated 
protein was attributed to its enhanced rate of uptake into the yolk-sac 
lysosomal system, but equally well could have been explained by an enhanced 
rate of extracellular hydrolysis. The latter explanation could not be 
excluded essentially because, as stated by Moore et al (1977), "a 
decisive experiment to differentiate extracellular from intracellular 
proteolysis has so far proved impossible to devise". Hydrolysis, due 
to the release of enzymes into the incubation medium after introduction 
of a yolk sac is readily identified but it is a more difficult task to 
distinguish between enzymes, active at an intracellular (lysosomal) 
site from enzymes of similar specificity that are active on the tissue- 
-surface.
Pittman & Steinberg (1978) devised an ingenious method to show that 
some proteins . added to human fibroblasts in culture are digested
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exclusively intracellularly. The method requires that the protein to be
studied is dual-labelled both with a marker which, after proteolysis,
will diffuse from the lysosomes into the culture medium and with a
marker which after proteolysis will not diffuse from the lysosomes.
These authors used [ I ] i o d i d e  as the diffusible marker and succinylated
[14C]sucrose as the non-diffusible marker. When lipoproteins and albumin
were dual-labelled by the above method and added to cells in culture the
125rate of accumulation of acid-soluble [ I]-activity in the incubation
14medium was equal to the rate of accumulation of [ C]-activity in the
cells. The equality of the two rates demonstrated that the albumin
molecule was digested entirely intracellularly. However, one minor
criticism of the technique is that the labelling of the protein, with
a marker large enough to be retained within lysosomes may modify either
the rate of pinocytic uptake of the protein or of its rate of intralysosomal
digestion, so that the results cannot be extrapolated to predict the
behaviour of the unlabelled protein. Problems were also encountered in
obtaining a homogeneously dual-labelled protein preparation. Nevertheless,
an analagous principle: equating the rate of uptake of the lysosomally
retained substrate, I-labelled poly(vinylpyrrolidone), and the rate
of appearance of acid-soluble radioactivity in the incubation medium,
125when formaldehyde-denatured I-labelled bovine serum albumin is used
as substrate, has been employed in the work reported in this chapter.
125Unfortunately I-labelled poly(vinylpyrrolidone) is pinocytosed only in 125
125the fluid phase while formaldehyde-denatured I-labelled bovine serum
albumin is most probably ingested mainly by adsorptive pinocytosis
(Moore et al., 1977) thus the absolute value for the rate of capture of
125the protein is far higher than that of i-labelled poly(vinylpyrrolidone).
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rat yolk sacs, the relative changes in the rate of uptake of 125l-PVP
125and the rate of digestion of the I-labelled albumin should be equal if 
digestion is exclusively an intralysosomal event. Duncan & Lloyd (1978) 
recently showed that decreasing the temperature at which yolk sacs are 
incubated lowers the rate of pinocytosis, they also showed an inhibition 
of pinocytosis by metabolic inhibitors. Similarly, Brown & Segal (1977) 
reported glucagon to be an inhibitor of pinocytosis in the rat yolk sac. 
Changes in temperature, the presence of either glucagon or the metabolic 
inhibitor, rotenone were therefore employed in the work reported in this 
chapter to induce changes in pinocytic activity. In addition, the 
kinetics of digestion of formaldehyde-denatured I-labelled bovine 
serum albumin, immediately after its exposure to yolk-sac tissue were 
investigated and additional experiments were designed to discover whether 
lysosomes alone are responsible for the digestion of the I-labelled 
albumin in this system.
However, when changes are induced in the rate of pinosome formation in
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4.2 METHODS
4'2'1 Assay of the uptake and degradation of ^-labelled substrata 
by 17.5-day rat yolk sac incubated in serum-free medium 199.
125The uptake of I-labelled poly(vinylpyrrolidone) was determined
as described in Section 2.2.1. The rates of uptake and of digestion of
125formaldehyde-denatured I-labelled bovine serum albumin (prepared as 
described previously; Section 2.2.3) were determined as described in 
Section 3.2.1 assuming an intracellular site of digestion. Yolk sacs 
were incubated singly in 20ml of serum-free culture medium. When yolk 
sacs were incubated in the presence of either rotenone or glucagon or 
dibutyryl-cyclic AMP (each from Sigma, London), radioactive substrate 
was added to the culture medium 30min after introduction of the yolk sacs 
to medium containing the inhibitor. Rotenone was initially dissolved 
in 95% (v/v) ethanol (lmg/ml); dilutions of the alcoholic rotenone 
solution to the required concentration were then made using medium 1 9 9. 
in the experiments where yolk sacs were incubated at different temperatures, 
the tissue was placed in media at the appropriate temperature and incubated 
for 15min before addition of the radioactive substrate.
Acid-soluble radioactivity in the alkaline yolk-sac solution 
was assayed essentially as described previously [see Section 2.2.1 (3), 
i.e. by the method used to assay acid-soluble radioactivity in the 
incubation medium using an empirical correction factor, see Appendix I, 
of 1.65] but 0.1ml of calf serum was added to 1.0ml of yolk-sac solution, 
followed by 1.0ml of 20% (w/v) trichloroacetic acid to achieve full 
precipitation. The formaldehyde-denatured 125I-iabelled bovine serum 
albumin was found to be slightly unstable in the aq. lM-NaOH used to 
digest yolk sacs; at 37*c an increase in acid-soluble radioactivity of
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<0.3%/h was observed, but at room temperature this fell to <0.1%/h.
The instability of the formaldhyde-denatured 125l-labelled bovine serum 
albumin in the lM-NaOH will result in an overall error of only <2% in 
the values shown for the acid-insoluble and acid-soluble radioactivity 
present in yolk-sac tissues.
4,2,2 Cen-^rifPgal subcellular fractionation of 17.5-dav rat yolk s^s 
that had accumulated formaldehyde-denatured 125i-labelled bovine serum 
albumin in vitro.
Yolk sacs (12) were dissected from a 17.5-day pregnant rat 
and incubated at 37°C in serum-free medium 199 as previously described 
(Section 2.2.1). Formaldehyde-denatured 125i-labelled bovine serum 
albumin was added to the culture medium (10ug/ml) and incubation continued 
for 1.5h. The yolk sacs were removed from the culture medium, washed 
(as described in Section 2.2.1) and homogenised in 2.5M-sucrose (10ml, 
adjusted to pH 7.4 with NaHCO^ by using a Potter-Elvehjem type Teflon-on- 
-glass homogeniser (with an 0.19mm clearance) at a speed of 2 500*pm.
Four up-and-down strokes were made within a period of 30s. The homogenate 
was diluted with 20ml of cold 0.25 M-sucrose, pH 7.4, and fractionated 
by differential centrifugation. The fractionation scheme used (Lloyd 
& Beck, 1969) yields five particulate fractions, isolated with 
successively higher centrifugal forces, and a final supernatant (S). The 
five fractions are designated first nuclear (N^ isolated at 150g x lOrnin), 
second nuclear (N2, lOOOg x lOmin), mitochondrial (m , 3 300g x lOmin), 
lysosomal (L, 16 OOOg x 20min) and microsomal (P, loo OOOg x 30min)
Fraction ^  was obtained using an MSE Mistral 4L centrifuge, fractions 
N2, M and L were obtained using an MSE High-Speed 18 centrifuge and 
fraction P was obtained using an MSE Superspeed 50 centrifuge. Each
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pellet was resuspended in 0.25M-sucrose, pH 7.4 and all fractions were 
immediately assayed for total and acid-soluble radioactivity. After 
freezing (-20°C) each fraction was assayed for protein and acid-proteinase 
activity.
4.2.3 Assay of acid-proteinase activity.
Acid proteinase activity was assayed by the method of Anson 
(1937). An aqueous solution of bovine haemoglobin (Sigma, London) was 
dialysed against running tap-water for 3 days, diluted to 8% (w/v) and 
stored at -20°C until used. When required, the haemoglobin solution was 
thawed and diluted to 2% (w/v) with 0.4M-sodium acetate, pH 3.4 (final pH
3.6). To 1.0ml of 2% (w/v) haemoglobin was added 0.2ml of the cell fraction 
to be assayed. After incubation at 37°C for 1.5h, the protein was 
precipitated with 3.0ml of 5% (w/v) trichloroacetic acid and the incubation 
continued for a further lOmin. When the mixture had cooled to room 
temperature it was centrifuged (500g x 20min, MSE Mistral 4L centrifuge).
To 0.5ml of the supernatant, made alkaline with 2.0ml of aq. lM-NaOH, was 
added 0.5ml of Folin Ciocalteu's Reagent. The extinction was measured at 
750nm after 15-20min.
Blanks, incubated in parallel, contained 2% haemoglobin 
only but 0.2ml of a particular cell fraction was added just before 
the addition of the trichloroacetic acid. A standard curve was prepared 
using L-tyrosine.
4.2.4 Assay of the proteolytic activity (against formaldehyde-denatured 
125I-labelled bovine serum albumin) in a cell-free extract of 17.5-day 
rat yolk sacs.
Yolk sacs (10) were homogenised (as described in Section 4.2.2)
in 10ml of distilled water. The homogenate was diluted with 20ml of
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distilled water then centrifuged (150g x lOmin) to remove intact cells.
The incubation mixture consisted of an appropriate buffer
solution, 130yl, cell-free extract, 50yl (approx. ISOyg protein) and 20yl
125of formaldehyde-denatured I-labelled bovine serum albumin (10yg).
After incubating the mixture at 37°c for Ih the reaction was stopped by 
adding 0.5ml of 20% (v/v) aq. calf serum immediately followed by 0.5ml 
of 20% (w/v) trichloroacetic acid. The precipitate was removed by 
centrifugation and the acid-soluble radioactivity was assayed (see
Section 2.2.1). Blanks, containing appropriately buffered substrate 
were also incubated for lh at 37°C.
Over a 3.0 to 6.5 pH range, O.lM-sodium acetate was used as 
buffer but over the pH range 6.5 to 9.0 this was replaced by O.lM-Tfi* 
[2-amino-2-(hydroxymethyl) propane-1,3-diol].
4*2‘4 5 foalrsAS-pf the hydrolysis products derived from formaldehyrt»- 
125
-denatured--- I-labelled bovine serum albumin Incubated w<f-h 17.5-day
rat yolk sacs.
Analysis of the hydrolysis products derived from formaldehyde- 
125
-denatured I-labelled bovine serum albumin on incubation with 17.5-day 
rat yolk sacs in serum-free medium 199 was performed as described previously 
[Section 2.2.4(3)]. The gel columns were both equilibrated and eluted 
with 0.05- M-sodium acetate (pH 6.5) containing 0.1% (w/v) sodium azide.
When the radioactivity present in the yolk-sac tissue was 
analysed, the yolk sacs (3), loaded with 125I-labelled albumin, were 
homogenised in 5ml of distilled water with a hand-held glass-on-giass 
Potter-Elvehjam type homogeniser. The radioactivity present in a 1.0ml 
sample of the homogenate was assayed (see Section 2.2.1), then the whole 
of the homogenate was applied to a Sephadex g-25 column. The rest of the 
analysis was performed as for the hydrolysis products present in the 
incubation medium [see Section 2.2.4(3)].
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4.3 RESULTS
1254.3.1 Association of formaldehyde-denatured I-labelled bovine 
serum albumin with the yolk-sac tissue and the appearance of acld- 
-soluble digestion products both in the yolk-sac tissue and in the 
serum-free incubation
When yolk sacs were incubated in serum-free medium 199 containing 
125formaldehyde-denatured I-labelled bovine serum albumin, acid-soluble
radioactive digestion products were found associated with the yolk-sac
tissue and also in the incubation medium after a short period of time. If
125the digestion of the I-labelled albumin occurs intracellularly, it is to
be expected that acid-soluble radioactivity will appear inside the yolk-
-sac tissue before it appears in the incubation medium and that both these
125events will occur only after ingestion of the I-labelled albumin by 
the yolk sacs.
This sequence of events was, indeed, observed (Fig. 4.1) in
yolk sacs incubated in medium 199 containing formaldehyde-denatured
I-labelled bovine serum albumin (lpg/ml of incubation medium).. The
quantity of acid-insoluble radioactivity associated with the yolk-sac
tissue increased steadily, from a measurable level at 3min to about
12550ng/mg yolk-sac protein 25min after addition of the I-labelled 
albumin, but then remained virtually constant. By 3min a measurable 
quantity of acid-soluble radioactivity could also be detected within the 
tissue but, although the quantity of acid-soluble radioactivity also 
increased steadily with time this rise occurred at a later time than that 
of the acid-insoluble radioactivity. In contrast, the appearance of 
acid-soluble radioactivity in the incubation medium was only observed 
after a lag-period of 12-15min. After 25min the rate of appearance of
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the acid-soluble radioactivity in the incubation medium reached a maximum
value (4.4ng/min per mg yolk-sac protein), that was virtually identical
to the maximum observed rate of accumulation of acid-insoluble radioactivity
by yolk-sac tissue in the initial 15min (4.3ng/min per mg yolk-sac protein).
These observations suggest a precursor-product relationship
between the radioactive species monitored. Moreover, the close similarity
between the maximum rate of accumulation of acid-insoluble radioactivity
by the tissue and the maximum rate of release of acid-soluble radioactivity
into the incubation medium indicates that the complete digestion of acid-
-insoluble radioactivity (i.e. the ^I-labelled albumin) subsequent to Its
endocytosis can completely account for the observed rate of appearance
of acid-soluble radioactivity in the incubation medium. Furthermore, the
lag-period of 12-15min before the appearance of any acid-soluble radioactivity
in the medium is consistent with an intracellular site of digestion of the 
125I-labelled albumin.
4*3*2 S ^ ^ -U Hi-ar distribution of the radioactivity accumulated within
the 1?.5-dag, rat yolk sac, after incubation in serum-free medium too m i-u
125formaldehyde-_denatured----^labelled bovine serum albumin and th»
of the radiolabelled albumin by a cell-free extract of the votV-sac tissue.
Fig. 4.2 shows the distribution of acid-proteinase activity,
acid-soluble radioactivity and acid-insoluble radioactivity in subcellular
fractions of yolk sacs that had previously ingested formaldehyde-denatured 
125
I-labelled bovine serum albumin, the sum of the acid-soluble radioactivity 
present in all of the fractions was equivalent to 38% of the total radio­
activity; this proportion compares with a value of 40% obtained in the yolk- 
sac homogenate assayed prior to centrifugation. The close similarity of 
these proportions indicates that no detectable digestion of the accumulated
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formaldehyde-denatured i-labelled bovine serum albumin occurred during
the 2.5h period required to prepare the subcellular fractions. Fig. 4 .2 ,
which is presented in the manner described by de Duve et al. (1955), shows
60% of the acid-insoluble radioactivity to be particle-bound. The
distribution of the acid-insoluble radioactivity closely parallels that
of acid-proteinase activity and strongly suggests that the two are
associated with the same organelle. The two patterns differ slightly in
that the distribution of sedimentable acid-insoluble radioactivity is
skewed toward the smaller particles, (a  possible explanation of this
125trend is that some of the I-labelled albumin is present in smaller
pinocytic vesicles that have not fused with lysosomes.)
The sedimentable acid-soluble radioactivity showed a distribution
essentially coincident with the sedimentable acid-proteinase activity. This
125suggests that hydrolysis of the I-labelled albumin occurs in the organelle 
with which the acid proteinase activity is associated. But the largest 
proportion (74%) of the acid-soluble radioactivity was associated with the 
S-fraction. These observations are consistent with the entry of 
125I-labelled albumin into lysosomes, in which digestion takes place, and
from which release of low molecular-weight digestion products occurs by
diffusion into the cytosol throught the lysosomal membrane.
Cell-free extracts of yolk-sac tissue were shown to be capable
of rapidly degrading the formaldehyde-denatured 1251 -labelled bovine
serum albumin to acid-soluble material. The reaction showed a very sharp
optimum at pH 4.0 with no measurable acid-soluble radioactivity produced
above pH 6.0 (Fig. 4.3). This finding of an acid pH-optimum for the
125degradation of the I-labelled albumin by a cell-free extract is consistent 
with the data in Fig. 4.2 which suggest that the observed degradation in 
intact cells (Fig. 4.1) occurs in lysosomes. Moreover, because yolk sacs
125
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were incubated in a medium at pH 7.1, the lack of digestion of the 
125I-labelled albumin by the cell-free extract at this pH suggests that it
is unlikely that extracellular tissue-associated enzymes could be involved
125in the observed digestion of the I-labelled albumin by yolk sacs.
4.3.3 Analysis of the hydrolysis products derived from formaldehvde-
125-denatured I-labelled bovine serum albumin when incubated with 17.5-day 
rat yolk sacs in serum-free medium 199/
Fig. 4.4 shows Sephadex G-25 elution profiles of 125I-labelled 
albumin that had been incubated either for 2h in medium 199 alone or for
1.2.3 or 6h in medium 199 containing yolk sacs (upper); yolk-sac homogenate
125prepared from tissue that had been incubated with I-labelled albumin 
for 2h (middle); and radioactivity released into medium 199 during a 2h 
re-incubation of yolk sacs that had previously Ingested the i25I-labelled
albumin (lower).
125I-Labelled albumin incubated alone showed only a single peak 
that eluted at the void volume of the column. When yolk sacs were present, 
two new peaks of radioactivity (one minor and one major) appeared and the 
amount of radioactivity present in each peak progressively increased with
time. The minor peak of radioactivity eluted at the same position as free 
125I IIiodide and the major peak of radioactivity eluted at the same
125position as [ I]iodo-L-tyrosine, and slightly later than the elution
125position of glycyl-[ I]iodo-L-tyrosine. The amount of radioactivity
contained in the minor peak was equivalent to 4.8, 4.4, 3.8 and 5.0% of
the total radioactivity present in the combined minor and major peak at
1 , 2, 3 and 6h respectively. No radioactivity was ever observed to elute 
125between the I-labelled albumin and the minor peak of radioactivity.
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When yolk-sac associated radioactivity was examined by Sephadex
G-25 chromatography (Fig. 4.4, middle) a major peak of radioactivity
representing 29% of the total (recovered) radioactivity, eluted in the same 
125position as [ I]iodo-L-tyrosine. Again a minor peak of radioactivity
125eluted in the same position as free [ I]iodide; the quantity of radio­
activity in this peak represented 8.1% of that in the combined minor and 
major peaks. However, unlike the elution profiles of the incubation media,
the elution profile of the yolk-sac associated radioactivity showed a
• . 125small amount of radioactive material to elute between the I-labelled
albumin peak and the minor peak; this could represent intermediate
digestion products.
When radioactivity, released on re-incubating washed yolk
sacs that had previously accumulated formaldehyde-denatured 125I-labelled
bovine serum albumin, was examined, virtually none eluted in the position
of i-labelled albumin but the major and minor peaks of radioactivity
eluted in the same positions as [125I]iodo-L-tyrosine and free [125I]-
iodide respectively. The minor peak represented 7.4% of the combined
radioactivity in both the minor and major peaks.
Examination of the radioactivity present in the major peaks
[ A  (3h incubation), B and Cl on a copper-complex of Sephadex G-25 showed
125that each contained approximately 75-90% of [ I]iodo-L-tyrosine
125.
(Table 4.1).
4*3*4 Ef f-e-c-fc-°-f temperature on the rate of uptake of - p i ^ n ^  
polyvinylpyrrolidone), the rate of digestion and nntative rat,, of 
uptake of formaldehyde-denatured 125i-iah>11^  bovine 
the 1 7 .5-day rat yolk sac incubated in serum-free medium.
Lowering the temperature at which yolk sacs are incubated in 
serum-free medium markedly inhibited the rate of accumulation of 
125I-labelled polyvinylpyrrolidone) (Table 4 . 2) ,  the rate of digeation
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and the putative rate of uptake of formaldehyde-denatured 125i-labelled
bovine serum albumin (Table 4.3). A rapid decline in the rate of uptake
125 125of I-PVP and in the rate of digestion of I-labelled albumin occurred
with only a small decrease in incubation temperature. At 15°c the two
processes were fully inhibited. A closely parallel pattern of inhibition
125of the putative rate of uptake of the I-labelled albumin by the yolk
sac was also observed on lowering the temperature. When the data (Tables
4.2 and 4.3) are expressed as a percentage of the rates observed at 37°c,
the parallel nature of these effects can be clearly seen (Table 4.4).
The quantity of radioactivity remaining associated with the
yolk-sac tissue after 3h of incubation with I-labelled albumin showed a
biphasic effect on lowering of the incubation temperature? initially a
small increase was observed, but, below 30°C, a rapid decline occurred.
125If the observed digestion of I-labelled albumin is an intracellular event,
the biphasic effect can be eaqjlained by the data in Fig. 4.5 which show
the time-course of the appearance of acid-soluble radioactivity in the
incubation medium. After an intitial lag-period, the amount of acid-
-soluble radioactivity appearing in the incubation medium increased
linearly with time, at each incubation temperature above 15°C. With
decreasing incubation temperature, the duration of the lag-period increased
(values at 34, 30 and 25°C were 123, 230 and 423% of that observed at
37°C). The duration of the lag-period represents the time taken for the
125yolk sac to digest and release the I-labelled albumin once captured by 
endocytosis. The longer this period the higher will be the quantity of 
radioactivity remaining associated with the tissue. Consequently, lowering 
the incubation temperature will elevate the level of the tissue-associated 
radioactivity until the decrease in rate of uptake of radioactivity (with
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decreasing temperature) begins to have the predominant effect, the 
tissue level of radioactivity will then begin to decline.
Tne close parallels in the decline (on lowering the incubation
temperature) in the rate of uptake of 325I-PVP, the rate of digestion-
and the putative rate of uptake of formaldehyde-denatured 125l-labelled
bovine serum albumin, strongly suggest that all three processes share a
common rate-limiting step, namely pinocytosis. The increase in the
duration of the lag-period and the attendant elevated quantities of tissue-
-associated radioactivity, observed with decreasing incubation temperature,
are both consistent with an intracellular site of digestion of the
125
formaldehyde-denatured I-labelled bovine serum albumin by the yolk-sac 
tissue.
4-3*5 greets:ofrotenone and glucagon on the uptake of l25r-1ahBn ^
polyvinylpyrrolidone) , the rate of digestion and the p u t a t i v e  ^
125uptake _o_f_ formaldehyde-denatured I-labelled bovine «Ann» 
albumin,by_the_17.,5,-day rat yolk sac incubated in serum-free m^nn,
Table 4.5 shows that rotenone is a potent inhibitor of 125IHPVP
uptake and of the rate of digestion and putative rate of uptake of formalde- 
125
hyde-denatured I-labelled bovine serum albumin. The effects observed
were dependent on the concentration of rotenone in the incubation medium.
Little effect was observed with lo'^M-rotenohe, but above this concentration
increasing concentrations progressively inhibited all three processes.
125Fifty percent inhibxtion of i-pvp uptake, of the rate of digestion- 
and of the putative rate of uptake of the 125l-labelled albumin were 
observed at 1 x lo“8*, 3 x l<f 8m  and 5 x icf8m , respectively. Progressive 
inhibition of each of the three processes occurred up to 10~5M-rotenone.
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The quantity of radioactivity remaining associated with the 
yolk-sac tissue after the 3h incubation with 125I-labelled albumin 
remained unchanged at 10 9M-rotenone, a concentration which inhibited both 
125I-PVP uptake and 125I-labelled albumin uptake (assuming that digestion 
occurs intracellularly). As with the temperature effects (see Section
4.3.4) this can be explained by the increase in the duration of the 
lag-period observed before acid-soluble radioactivity appears in the 
incubation medium (Fig. 4.6) when the yolk sacs are incubated in the 
presence of rotenone.
Fig. 4.7 shows that glucagon is also a potent inhibitor of
125 _ loc
I-PVP uptake. Fifty percent inhibition of 125i-pvp uptake by yolk
sac was observed at a glucagon concentration of 2 x 10"®M; at a concentra­
tion of 10"6m  maximum inhibition of 125i-pvp uptake was observed but 
uptake was still linear with incubation time; the uptake of 125i-pvp at 3h 
was equal to 30% of the control value. Table 4.6 shows that lo'Vglucagon
inhibits both the rate of digestion and the putative rate of uptake of
125
formaldehyde-denatured I-labelled bovine serum albumin by about 60%. 
Glucagon is thought to act via the second messenger, cyclic 3'-5* AMP.
Its analogue, dibutyl cyclic 3'-5' AMP was also shown (Table 4.6) to 
inhibit the digestion and putative uptake of the 125I-labelled albumin.
The close similarity in the inhibitory effects, of both rotenone 
and glucagon, on the rates of uptake of 125i-pvp and of both digestion 
and the putative uptake of formaldehyde-denatured 125i-labelled bovine 
serum albumin is further evidence that the rates at which the three 
processes occur are determined by the same rate-limiting step.
Table 4,1 Chromatography of the low molecular weight hydrolysis product«
of formaldehyde-denatured I-labelled bovine serum albumin on thp
complex of Sephadex G-25.
The pooled fractions A, B and c [see Pig. 4.4] were each 
concentrated by freeze-drying and further analysed on the copper-complex of 
Sephadex G-25, as described in Section 2.2.4(3). The distribution of S L  
radioactivity between the fraction eluted by alkali and the fraction eluted 
with acid is reported as a percentage of the recovered radioactivity The 
total recovered radioactivity is expressed as a percentage of the radio­
activity applied to the column. The elution patterns of [1251 iodo-L- 
-tyrosine and glycyl-[1Z5IJiodo-L-tyrosine are taken from Table 2 5*
Radioactivity applied 
to the column
Percentage of 
radioactivity 
eluting with 
borax buffer, 
pH 11
Percentage of 
radioactivity 
eluting with 
0.4M-HC1
Percentage 
recovery of 
radioactivi ty 
from column
125[ I]iodo-L-tyrosine 2.5 97.5 102.0
125Glycyl-[ I]iodo-L-tyrosine 88.4 11.6 88.0
Peak A (Product produced 
from 125I-labelled albumin 
incubated in the presence of 
a yolk sac)
10.7 89.2 79.8
Peak B (Yolk-sac associated 
radioactivity) 24.4 75.6 105.0
Peak C (Product released from 
a yolk sac loaded with 
12*I-albumin)
17.8 82.2 100.4
Table 4.2 Effect of incubation-temperature on the rate of uptake of
125I-labelled poly(vinylpyrrolidone) by 17.5-day rat yolk sacs Incubated In 
serum-free medium 199.
125The rate of ingestion of I-PVP by yolk sacs was determined as 
described in Section 2.2.1. Yolk sacs were incubated for 15 min in 
serum-free medium 199 at the temperature indicated, before the addition of 
125I-PVP (2 Mg/ml of medium), then further incubated for up to 3 h and 
yolk sacs removed at 0.5 h intervals.
Incubation Expt.
Endocytic 
Index (Ml/h Correlation
Intercept on 
the ordinate
No. of yolk 
sacs per
temperature No. per mg yolk- Coefficient (yl/mg yolk- experiment
-sac protein) -sac protein)
1 +3.562 +0.959 +2.038 5
2 +3.914 +0.988 +1.510 537°C 3 +3.481 +0.996 +1.237 6
4 +3.453 +0.960 +2.250 6MEAN S . D . +3.602 ±0.213
1 +3.174 +0.989 +0.777 6
2 +2.933 +0.989 +0.487 634 °C 3 +3.029 +0.997 +1.261 6
4 +3.677 +0.993 +0.800 6
m e a n S . D . : - +3.203 ±0.330
1 +1.981 +0.899 +1.743 6
30°C 2 +1.489 +0.796 +2.128 6
3 +2.094 +0.981 +0.613 6MEAN S . D . +1.854 ±0.3221 +0.2Ì8 +0.293 +1.581 8
25°C 2 +0.947 +0.656 +0.548 8
3 +0.485 +0.666 +1.396 8
MEAN S . D . +0.564 ± 0.365
1 +0.135 +0.250 +0.686 8
2 +0.288 +0.453 +0.260 8
15°C 3 -0.057 -0.124 +0.916 8
4 -0.246 -0.267 +2.583 8
5 +0.002 +0.003 +1.523 8MEAN S . D . : - +0.024 ± 0.201
[Results obtained at 25 and 15°C were provided by Mrs H. Cable].
Table 4.3 Effect of incubation temperature on the rate of digestion and on
125the putative rate of uptake of formaldehyde-denatured I-labelled bovine 
serum albumin by 17.5-day rat yolk sacs incubated In serum-free medium.
The rate of digestion and the rate of uptake of formaldehyde- 
-denatured l25I-labelled bovine serum albumin (calculated assuming that 
digestion occurs intracellularly) were determined as described in 
Section 4.2.1. Yolk sacs were incubated, at the temperature indicated, 
for 15 min before addition of the 125I-labelled albumin (1 yg/ml of culture 
medium) then incubation was continued for a further 3 h. The values 
reported in each individual experiment are the means of pairs of values 
obtained from two yolk sacs incubated separately (see Section 4.2.1).
Quantity of
Incubation Expt. Rate of digestion radioactivity Putative rate
temperature No. (ng/h per mg yolk- associated with of uptake
-sac protein) yolk-sac at 3 h (ng/h per mg yolk-
(ng/mg yolk-sac -sac protein)
protein)
1 +387.9 124.3 391.6
2 +274.1 142.5 299.637°C 3 +352.8 130.2 341.1
4 +366.9 206.3 379.7
MEAN ± S.D. :- +345.4 ± 49.7 150.8 ± 37.7 353.0 ± 41.6
1 +219.9 138.2 245.4
2 +186.7 96.1 197.434°C 3 +318.9 225.7 356.4
4 +279.9 172.7 303.1
MEAN ± S.D. +251.3 ± 59.3 158.1 ± 54.8 275.5 ± 69.0
1 +131.0 155.3 159.2
30 °C 2 +126.8 163.6 154.8
3 +118.3 131.6 137.1
MEAN ± S.D. +125.4 ± 6.4 150.2 ± 16.6 150.4 ± 11.7
1 + 33.7 97.1 58.1
25°C 2 + 43.5 122.5 117.3
3 + 44.1 37.0 43.8
MEAN ± S.D. s- + 40.5 ± 5.8 85.5 ± 43.9 73.1 ± 38.9
1 + 1.0 31.4 10.8
2 + 0.1 11.4 4.6
15 °C 3 - 0.1 17.2 5.8
4 - 0.6 32.8 11.3
5 - 0.9 34.1 14.4
MEAN ± S.D. j- + 0.1 ± 0.7 28.8 ± 7.8 10.6 ± 3.6
[Results obtained at 25 and 15°C were provided by Mrs H. Cable].
125rate of accumulation of I-labelled poly(vinylpyrrolidone), and
on the rate of digestion and the putative rate of uptake of formaldehyde- 
125-denatured i-labelled bovine serum albumin by 17.5-day rat yolk 
sacs incubated in serum-free medium.
Table 4.4 Summary of the effects of incubation-temperature on the
Prom the data in Tables 4.2 and 4.3, the relative rates of 
uptake and digestion were calculated and expressed as a percentage 
(± standard deviation) of the mean value obtained at 37°C.
Incubation
temperature
(°C)
Relative rate 
No. of of accumulation 
expts. of l25I-labelled 
PVP (3.0 h period)
Relative rate 
of digestion of 
125I-labelled 
albumin (3.0 h 
period)
Relative 
putative rate 
of uptake of 
i2^I-labelled 
albumin (3.0 h 
period)
37 4
34 4
30 3
25 3
15 5
100.0 ± 5.9
88.9 ± 9.2
51.4 ± 8.9
15.6 ± 10.1 
0.7 ± 5.8
100.0 ± 14.4
72.7 ± 17.2,
36.3 ± 1.8
11.7 ± 1.7
0.1 ± 0.7
100.0 ± 11 .8
78.0 ± 19.5
42.6 ± 3.3
20.7 ±,11.0
3.0 ± 1.0
Table 4.5 Effects of rotenone on the uptake of I-labelled poly(vinyl-125
-pyrrolidone) and on the rate of digestion and putative rate of uptake of 
125I-labelled formaldehyde-denatured bovine serum albumin by 17.5-day rat
yolk sacs incubated in serum-free medium 199.
125The quantity of I-PVP accumulated during a 3.0 h period of 
incubation was determined as described in Section 2.2.1. The rate of 
digestion and the rate of uptake of formaldehyde-denatured l25I-labelled 
bovine serum albumin (calculated by assuming that digestion occurs intra- 
cellularly) were determined as described in Section 4.2.1. In experiments 
with either substrate, yolk sacs were incubated in the presence of a given 
concentration of rotenone for 30 min before addition of substrate (12*I-PVP 
2 yg/ml of culture medium; or 125I-labelled albumin, 1 yg/ml of medium)..
The results shown for each experiment are derived from data on a single 
yolk-sac. Each experiment was performed with yolk sacs taken from a 
different animal.
Uptake of Rate of Quantity of 
T25I-labelled
Putative
lz5I-PVP at digestion of rate of
Rotenone Expt. 3.0 h (yl/mg 1 2h -labelled albumin uptake of
concentration No. yolk-sac albumin (ng/h accumulated li5I-labelled
(M) protein) per mg yolk- in yolk-sac by albumin (ng/h
-sac protein) 3.0 h (ng/mg per mg yolk-
yolk-sac
protein)
-sac protein)
1 9.49 252.6 125.9 249.70 2 10.08 283.9 150.4 286.7(control) 3 8.12 268.8 159.7 275.6
4 9.92 333.5 171.6 344.0
MEAN ± S.D. • — 9.40 ±0.88 284.7 ±34.9 151.9 ± 19.4 289.0 ± 39.8
1 10.24 234.7 145.6 236.3
10-11
2 8.92 290.5 155.0 302.3
3 9.52 280.0 134.4 285.4
4 8.56 292.1 141.0 293.0
MEAN ± S.D. J- 9.31 ±0.73 274.3 ± 26.9 144.0 ± 8.6 279.2 ± 29.4
1 4.40 200.4 110.2 223.1
2 8.31 224.8 134.2 228.9
io"9 3 7.34 232.2 161.3 257.6
4 4.83 286.0 194.0 280.3
MEAN ± S.D. 6.22 ± 1.90 235.9 ± 36.1 149.9 ±36.0 247.5 ± 26,6
1 2.69 107.4 94.2 110.2
-7 2 1.16 95.6 87.9 98.1. 10 3 3.50 142.6 127.0 166.8
4 1.76 116.0 84.7 125.8
MEAN ± S.D. 2.39 ± 0.88 115.4 ± 19.9 98.4 ± 19.4 125.2 ± 29.9
i 1.71 21.3 43.5 30.1
-5 2 0.96 32.4 54.7 45.310 3 1.24 62.7 88.3 77.3
4 1.02 32.1 48.4 39.5
vra&N ± S.D. :- 1.23 ± 0.34 37.1 ± 17.8 58.7 t 20.2 48.1 t 20.4
Table 4.6 Summary of the effects of rotenone on the uptake of
125I-labelled poly(vinylpyrrolidone) and on both the rate of digestion
125and putative rate of uptake of formaldehyde-denatured I-labelled 
bovine serum albumin by the 17.5-day rat yolk sacs incubated in 
serum-free medium 199.
From the data presented in Table 4.5 the relative rates 
of uptake and digestion were calculated and expressed as a 
percentage (± standard deviation) of the mean value obtained with 
control yolk-sacs.
Rotenone 
ooncen tration 
(M)
No. of 
expts.
Relative uptake 
of 2^^I-labelled 
PVP over a 3.0 h 
period
Relative rate 
of digestion of 
125I-labelled 
albumin (3.0 h 
period)
Relative 
putative 
rate of 
uptake of
lz ^ -labelled 
albumin (3.0 h 
period)
0 4 100.0 ± 9.4 100.0 ± 12.2 100.0 ± 13.8
(control)
10-U 4 99.0 ± 7.7 96.3 ± 9.4 96.6 ± 10.1
icf9 4 66.2 ± 2.0 82.8 ± 12.7 85.6 ± 9.1
10-7 4 25.4 ± 9.4 40.5 ± 6.9 43.3 ± 10.3
10-5 4 13.1 ± 3.6 13.0 ± 6.2 16.6 ± 7.0
125Table 4.7 Effects of glucagon on the uptake of I-labelled poly(vinylpyrrolidone)
and on both the rate of digestion and putative rate of uptake of formaldehyde-
125-denatured I-labelled bovine serum albumin by 17.5i-day rat yolk sacs
incubated in serum-free medium 199.
125The quantity of I-PVP accumulated during a 3.0 h period of incubation 
was determined as described in Section 2.2.1. The rate of digestion and the rate 
of uptake of the 12:>I-labelled albumin (calculated by assuming that digestion 
occurs intracellularly) were determined as described in Section 4.2.1. With 
either substrate, yolk sacs were incubated in the presence of the glucagon (or 
dibutyryl-cAMP) for 30 min before addition of substrate (12:>I-PVP, 2yg/ml of 
culture medium; or 125I-labelled albumin, 1 yg/ml of culture medium). The results 
shown for each experiment are derived from data on a single yolk-sac each taken from 
a different animal.
Effector Expt. 
compound No.
, ^ 125_ Uptake of I—
-PVP at 3.0 h
(yl/mg yolk-sac
protein)
Rate of digestion 
of 125I-labelled 
albumin (ng/h/mg 
yolk-sac protein)
Quantity of 
125I-labelled 
albumin accum­
ulated by the 
yolk sac at 3.0 
h (yg/mg yolk- 
-sac protein)
Putative rate 
of uptake of 
125I-labelled 
albumin (ng/h 
per mg yolk-sac 
protein.
(Control) 1 10.12 216.3 123.7 237.5
2 8.45 196.1 153.3 227.7
3 9.61 233.0 144.0 238.0
MEAN ± S.D. :- 9.39 ± 0.86 215.1 ± 18.4 140.3 ± 15.1 234.4 ± 5.8
(As % of Control: 100.0 ± 9.9 100.0 ± 8.5 100.0 ± 10.7 100.0 ± 2.4)
Glucagon 1 2.45 120.0 72.6 137.4
10”6M 2 3.56 47.1 25.7 42.0
. ..3 . . . 2.99 100.5 58.7 102.1
MEAN ± S.D. 3.00 ± 0.55 89.2 ± 37.7 52.3 ± 24.1 93.8 ± 48.2
(As % of Control: 31.9 ± 5.8 41.1 ± 17.5 37.2 ± 17.2 40.0 ± 20.5)
db-cAMP 1 - 170.3 133.8 187.6
5 x 10"4M 2 - 120.1 59.7 123.2
3 - 130.0 52.1........ 131.8
mean ±S.D. :- - 140.1 ± 26.6 81.8 ± 45.1 147.5 ± 34.9
(As % of Control : 65.1 ± 12.3 58.3 ± 32.1 62.9 ± 14.9)
10 0
Figure 4.1 Time course of the appearance of acid-insoluble and -soluble
radioactivity in the yolk-sac tissue and acid-soluble radioactivity in the
culture medium when 17.5-day yolk sacs were incubated in the presence of
125formaldehyde-denatured I-labelled bovine serum albumin in serum-free 
medium 199.
Yolk sacs were incubated in serum-free medium containing 125i-labelled 
albumin (1 yg/ml of culture medium). At the indicated times, samples were 
taken to measure the quantities of tissue-associated acid-soluble (o ) S  
-insoluble (•) radioactivity and the cruant-it-v of a
U )  in the culture medium. Tte noi^s S  !, ? 16 radioactivity
from single yolk sacs. P°1"tS eaCh tlme ^ ^ r v a l  „ere derived
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Figure 4.2 Distribution of acid-soluble radioactivity, acid-insoluble
radioactivity and acid proteinase activity in subcellular fractions
prepared from yolk sacs that had been previously incubated with formaldehyde- 
125-denatured I-labelled bovine serum albumin in serum-free medium 199,
Graphical presentation as described by deDuve (1955). For experimental 
method see Section 4.2.2.
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Figure 4.3 Effect of incubation pH on the release of acid-soluble radio-
125activity from formaldehyde-denatured I-labelled bovine serum albumin 
by cell-free extracts of yolk sac.
The incubation medium contained cell-free extract (approx. 150 yg yolk-sac 
protein), formaldehyde-denatured 125I-labelled bovine serum albumin (10 yg) 
and buffer solution (O.IM-Na acetate, pH 3.0 to 6.5 and 0.1M-TRIS pH 7.0 
to 9.0). Each point is the mean of four individual determinations using 
a single preparation of cell-free extract. For methods see Section 4.2.4.
Figure 4.4 Sephadex G-25 chromatography of formaldehyde-denatured
125I-labelled bovine serum albumin hydrolysis products.
Upper;
Middle;
Lower;
125I-Labelled albumin incubated in the absence of yolk- 
-sac tissue for 2h and in the presence of yolk-sac tissue 
for 1, 2, 3 & 6h. (The recovery values were; 107, 86, 96,
104 & 106% of the radioactivity applied respectively.)
125I-Activity associated with the yolk-sac tissue after 
incubation of the tissue with 125I-labelled albumin for 
2h. (The recovery value was 90% of the radioactivity applied.)
125I-Activity released during a 2h incubation period from 
the yolk-sac tissue previously loaded with 125I-labelled 
albumin. (The recovery value was 109% of the radioactivity 
applied.)
For experimental details see Section 4.2.5. The elution positions 
of formaldehyde-denatured 125I-labelled bovine serum albumin 
(fdBSA), [12^I]iodide, [125I]iodo-L-tyrosine and glycyl-[125I]iodo-L- 
-tyrosine are indicated by the horizontal bars. The radioactivity 
contained in the fractions under the horizontal bars of peaks A (3h), 
B & C were separately pooled, lyophilized and further analysed on a 
copper-complex of Sephadex G-25.
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Figure 4.5 Effect of incubation temperature on the rate of appearance 
of acid-soluble radioactivity in the culture medium when yolk sacs are
i 2 cincubated in the presence of formaldehyde-denatured i-labelled bovine 
serum albumin in serum-free medium 199.
sacEach plot was obtained from data obtained on incubating a single yolk-aa in serum-free culture medium containing 125I-labelled albumin (1 yg/ml). 
Each plot is a representative member taken from a group of similar plots 
(see Table 4.3) showing the time-course for the digestion of the 125i_ 
-labelled albumin. For methods see Section 4.2.1.
Time (h)
Figure 4‘6 gjfect of rotenone on the rate of appearance of a c i d - s o b ^  
radiqactivity__in_ the culture medium when yolk sacs ere incubated n n ^  
pre,sence_of formaldehyde-denatured 125l-labelled bovine serum n <„
serum-free medium 199.
Each plot was obtained on the incubation of a cinrru .
culture medium containing 12 5I-labelled albumin (1 yg/ml o ^ c u l ^ r e ^ T  
Each plot is a representative member taken from a group of similar oloS * 
(see Table 4.4), showing the time course for the digestion of the 1?5? 
-labelled albumin. Yolk sacs were incubated in the presence of rotencme 
for 30 min before the substrate was added. For methods see Sectio^ 4 2 1
10
Glucagon concentration (M)
Figure 4.7 Effect on tne —  ^  _ ___A"-i-aDeiled poly (vinyls
pygolldsne) by 17..5-day rat T > a  ^ ¿ lagjba^ t .  .e t M .fr„
125Uptake ct I-PVP (2 UgA,l> „as determined as described in SecUon 2 2 ^
2EES£! control, (. ) , lo'Vglucagon ( o ),
lower, uptake (3 h) at differing glucagon concentrations.
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4.4 DISCUSSION
In previous quantitative studies of pinocytosis, using the
yolk-sac culture system, several authors (Moore et al., 1974, 1977;
Roberts et al., 1976; Pratten et al., 1978; Duncan & Lloyd, 1978;
Ibbotson, 1978 and Chapters 2 & 3 of this thesis) have assumed that formalde- 
125hyde-denatured I-labelled bovine serum albumin, added to the incubation 
medium, is digested entirely intracellularly by the yolk-sac tissue.
Except for Moore et al. (1977) who briefly discussed some evidence 
(unpublished work, mainly derived from this thesis), none of the above 
authors gave evidence for the site of the albumin digestion being intra­
cellular. Several lines of evidence presented here show that, when incubated
125with rat yolk-sacs, formaldehyde-denatured I-labelled bovine serum
albumin is, indeed, digested entirely intracellularly within lysosomes.
From an analysis of the distribution of radioactive species
during the course of an incubation experiment with formaldehyde-denatured 
125 .I-labelled albumin, the maximum rate of accumulation of acid-insoluble 
radioactivity (representing macromolecular albumin) in the yolk-sac 
tissue, in the initial stages of the incubation was found to be equal to 
the rate of appearance of acid-soluble radioactivity in the incubation 
medium at a later stage, i.e. when the tissue-associated radioactivity 
had reached a steady-state level (Fig. 4.1). Provided that the rate of 
pinosome formation does not decrease with increasing incubation time 
(there is no evidence to suggest that it does), the rate of appearance of 
acid-soluble radioactivity in the incubation medium can be fully accounted for 
by the complete digestion of that albumin that has been captured by 
pinocytosis. The sequence of events shown in Fig. 4.1 is of the form 
expected if a precursor-product relationship exists between the acid-
90
-insoluble- and acid-soluble radioactive-species in the tissue, and between
the acid-soluble radioactivity in the tissue and that in the incubation
medium. These events are entirely consistent with the formaldehyde- 
125
-denatured I-labelled bovine serum albumin being ingested by pinocytosis, 
its accumulation in the vacuolar system prior to digestion within lysosomes, 
then diffusion of the digestion products from the lysosomes, through the 
cytoplasm to the incubation medium, where they accumulate.
Digestion of formaldehyde-denatured 125I-labelled bovine serum
albumin at an extracellular site could also lead to an initial lag-period,
before products of digestion small enough to be acid-soluble appear in the
incubation medium, but, if this explanation is valid, it would be expected
that detectable amounts of intermediate-sized digestion products would be
present in the medium. Alternatively, the observed lag-period could
represent a delay in secretion of neutral proteinase activity into the
incubation medium. This latter possibility can be dismissed since no
hydrolysis of the formaldehyde-denatured 125I-labelled bovine serum albumin
occurred on its addition to incubation medium in which yolk-sacs had
previously been incubated for 3h. The lag-period observed here (15-20min)
is of the same magnitude as other lag-periods recently reported in the
literature: approx. 20min for the digestion of formaldehyde-denatured 
125
I-labelled human serum albumin by non-parenchymal cells isolated from 
rat liver (Nilsson & Berg, 1977), 30min for the digestion of 125I-labelled 
plasma low density lipoprotein by normal human fibroblasts (Stein et al., 
1976) and 7-8min for the intracellular digestion of l25I-labelled insulin 
by cultured hepatocytes (Terris & Steiner, 1975). Terris & Steiner also 
showed that increasing concentrations of insulin do not shorten the 
lag-period and suggested that this is consistent with an obligatory
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translocation of the insulin from a binding-site to an intramembranous 
or intracellular site of degradation. Increasing the concentration of
formaldehyde-denatured ~ ---JZ bovine serum albumin (0-200yg/ml,
Table 3.1) did not shorten the lag-period in the rat yolk-sac system.
Nilsson & Berg (1977) suggested that the lag-period is indicative of the 
time required for fusion of phagosomes with lysosomes, but evidence 
presented in Chapter 7 of this thesis indicates that it is at least in 
part dependent on the susceptibility of the endocytosed substrate to 
digestion by the lysosomal enzymes subsequent to phagosome-lysosome fusion.
A strong piece of evidence for the site of hydrolysis being 
intracellular comes from the demonstration that the calculated concentration 
of acid-soluble radioactivity in the yolk-sac tissue is several orders of 
magnitude greater than that in the incubation medium. Yolk sacs were found 
to contain approx. HOmg protein (BSA equivalents) per g wet-weight of 
tissue. Assuming the tissue to have an approximate specific gravity of 
1.0, the volume of the tissue was calculated to be 8.85yl/mg yolk-sac 
protein. After 40min of incubation with formaldehyde-denatured 125i- 
-labelled bovine serum albumin <lyg/ml of incubation medium), the quantity 
of acid-soluble radioactivity associated with the yolk-sac tissue was 
43ng/mg yolk-sac protein (Pig. 4.1); this is equivalent to a concentration 
in the yolk-sac tissue of 43/8.85 or 4.85ng/yl. At the same time (40min) 
the concentration of acid-soluble radioactivity in the incubation medium, 
determined from Fig. 4.1, was [lOlng/mg x 5mg yolk-sac protein/20 OOOyl 
of incubation medium] or 0.025ng/yl assuming the incubation had been
performed with an averaged-sized yolk sac containing 5mg of protein. These 
results therefore indicate that the concentration of acid-soluble radio­
activity in the yolk-sac tissue is 4.85/0.25 or 194 times greater than the 
concentration in the medium after 40 min of incubation. [This value must 
be regarded as a conservative estimate of the actual ratio of the
92
concentration, since not all the space within the yolk-sac tissue will be 
available to the acid-soluble radioactivity.J The much higher tissue 
concentration of the radioactive digestion products compared to the 
concentration in the incubation medium suggests that the direction of 
the flow of the digestion products is from within the tissue, out into the 
incubation medium.
The presence of measurable levels of intermediate products of
digestion in the incubation medium (Fig. 4.4) would be expected if
extracellular digestion of the albumin substrate occurred. The Sephadex G—25
profiles of the digestion products that appear in the medium on incubating 
. 125yolk sacs with formaldehyde-denatured I-labelled bovine serum albumin
125shows only peaks corresponding to [ I]iodo-L-tyrosine and oligopeptides
containing this amino acid residue. Similar profiles are also obtained on
analysing the radioactivity released from yolk sacs previously loaded 
125with the I-labelled albumin substrate. This indicates that the products 
of digestion can be accounted for by the radioactivity released from the 
yolk-sac tissue. Moreover, the presence of only small amounts of intermediate 
products of digestion in the yolk-sac homogenate indicates that degradation, 
once begun, proceeds rapidly. This is concordant with the "all or none" 
hypothesis of Huisman et al. (1974) in which they suggest that the initial 
proteolytic cleavage is the rate-limiting step in the digestion of a 
protein intralysosomally. The appearance, in the incubation medium, of 
only end-products of digestion, is in full agreement with a lysosomal site 
of digestion in which the size of the digestion products released into the 
incubation medium is determined by the permeability preperties of the 
lysosomal membrane (see Reijngoud & Tager, 1977, for a discussion of this 
subject).
Further evidence for a lysosomal site of digestion was obtained
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fractions, obtained by differential centrifugation (see Section 4.3.2),
from homogenates of yolk sacs that had been loaded with formaldehyde- 
125-denatured I-labelled bovine serum albumin. The distribution of 
125acid-insoluble I-activity in the various centrifugal fractions closely
paralleled that of acid-proteinase activity. Similar observations
were reported by Williams ejt al. (1971) using acid-denatured 125I-labelled
bovine serum albumin and by Goetze et al. (1976) using formaldehyde- 
125-denatured I-labelled human serum albumin. Moreover, the digestion of
125formaldehyde-denatured I-labelled bovine serum albumin by cell-free
homogenates of 17.5-day rat yolk sacs showed an acid pH optimum, a
finding that is consistent with digestion involving lysosomal cathepsins
(Coffey & de Duve, 1968). No measurable digestion occurred with the
cell-free extract at neutral pH. This result indicates that the tissue
does not contain, intracellularly or extracellularly, neutral proteinases,
with either sufficient activity or with the appropriate specificity to
125digest the formaldehyde-denatured I-labelled bovine serum albumin, and
that such enzymes cannot be involved in the digestion of this protein
when incubated with yolk sacs in medium 199 (pH 7.1).
125The digestion of formaldehyde-denatured I-labelled bovine
serum albumin by yolk sacs was inhibited by decreasing the temperature at
which yolk sacs were incubated, by the presence of the metabolic inhibitor
rotenone, and by the presence of the peptide hormone glucagon. These
conditions were also shown to inhibit the pinocytic uptake of 125i-
125-poly(vinylpyrrolidone) [ I-PVP]. It is difficult to envisage how each 
of the three conditions might also inhibit a possible extracellular 
proteolytic enzyme activity. The pattern of the inhibition of 125I-PVP 
uptake by the yolk sacs on incubation at lower temperatures in serum-free
on examining the distribution of ■‘■‘"'i-radioactivity among subcellular
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yolk sacs incubated in the presence of 10% calf serum. The inhibition of
pinosome formation, in the rat yolk sac, by rotenone has not been previously
“6reported. Here glucagon, present at a concentration of 10 M, maximally
125inhibited the uptake of I-PVP by approximately 70%; half-maximum effect
—8of glucagon was obtained with a concentration of 10 M-glucagon. The 
observations made here with yolk sacs incubated in serum-free medium 
compare well with those of Brown & Segal (1977) who used medium containing 
10% calf serum. These authors observed a 75% inhibition of the uptake of
“ 6 - Qyeast invertase by 10 M-glucagon; half-maximum effect being at 3 x 10 M- 
-glucagon.
The change in the rate of digestiqn of formaldehyde-denatured
l^i-labelled bovine serum albumin paralleled the change in the rate of 
125uptake of I-PVP when either the incubation temperature was progressively
decreased (Table 4.4) or the rotenone concentration progressively increased 
—6(Table 4.6) or 10 M-glucagon was present (Table 4.7). Such parallelism
strongly indicates that the rate of digestion of the formaldehyde-denatured
12i>i_iabelled bovine serum albumin is limited by the rate of pinosome formation
125and that no detectable extracellular digestion of the I-labelled albumin 
occurs.
The data reported in this chapter validate the previous assumption 
125that formaldehyde-denatured I-labelled bovine serum albumin is digested
I
exclusively intracellularly and within lysosomes. Consequently, the
125putative rate of uptake of the I-labelled albumin reported here represents
the actual rate of uptake of this protein into epithelial cells of the
125rat yolk sac. Thus formaldehyde-denatured I-labelled bovine serum 
albumin is a suitable substrate for use in the yolk-sac culture system to 
investigate aspects of pinocytosis and lysosome function.
medium closely parallels that obtained by Duncan & Lloyd (1978) for
CHAPTER FIVE
EFFECTS OF WEAK BASES ON 
PROTEIN CATABOLISM WITHIN
RAT YOLK SACS
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5.1 INTRODUCTION
The weak base chloroquine, an anti-malarial and anti-inflammatory
drug, has been shown to inhibit the digestion of several substances that
gain entry into the lysosomes of intact cells via either autophagy or
heterophagy. Wibo & Poole (1974) used chloroquine to partially inhibit
the digestion of cellular-proteins within rat fibroblasts in culture.
Lie & Schofield (1973) showed that human fibroblasts incorporate (35SJ-
sulphate into mucopolysaccharides and that, in the presence of chloroquine, 
35these cellular S-labelled mucopolysaccharides accumulate within lysosomes, 
so that normal cells exposed to chloroquine were indistinguishable from 
cells with a genetic defect in a lysosomal enzyme responsible for the 
digestion of mucopolysaccharide. When macrophages were allowed to engulf 
[3H]leucine-labelled bacteria (de Duve et al., 1974), complete inhibition 
of the release of acid-soluble radioactivity was achieved by chloroquine 
present in the incubation medium.
The lysosomal digestion of lipoproteins, both in vivo and by 
cells in culture, is also sensitive to inhibition by chloroquine.
Stein et al. (1977) showed that both human- and rat-plasma low density 
lipoproteins are cleared from the circulation of the rat by the liver 
and that recovery of the lipoproteins from the liver was increased by 
pretreating the animals with chloroquine, a result compatible with a 
decreased rate of hydrolysis of the lipoproteins by the liver. Goldstein 
et al. (1975) discovered that chloroquine inhibits the lysosomal 
proteolysis of low density lipoproteins that had been endocytosed by 
human fibroblasts in culture. The lysosomal hydrolysis of the cholesteryl 
ester associated with lipoproteins was also inhibited (Goldstein et al., 
1975; Brown et al^ ., 1975). Moreover, Floren & Nilsson (1977) showed 
an inhibition, by chloroquine, of cholesteryl ester degradation, subsequent
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to the endocytosis of chylomicron remnant particles by rat hepatocyte 
monolayers.
The ability of chloroquine to inhibit the lysosomal breakdown 
of a variety of substrates does not seem to be a property peculiar to 
this drug, but has led to it being regarded as a specific inhibitor of 
lysosome function. Ammonium ions (and methylammonium- and ethylammonium 
ions) are also inhibitors of lysosome function, but have been used less 
extensively for this purpose than has chloroquine. Seglen (1975, 1977) 
and Seglen & Reith (1976) observed that ammonium ions inhibited the autopha­
gic digestion of cellular proteins in hepatocytes in culture. This 
observation was confirmed by Hopgood et al.(1977), who also showed that 
methylammonium- and ethylammonium ions had a similar but more potent 
inhibitory effect. The greater potency was, however, considered by 
these authors to be due to the inability of the hepatocytes to detoxify the 
substituted ammonium ions via the urea cycle. Tolleshaug et al,(1977) 
also showed that the digestion of asialo-fetuin, endocytosed by hepatocytes 
in culture, is sensitive to ammonium ion inhibition (and to inhibition 
by chloroquine). Moreover, Carpenter & Cohen (1976) discovered that 
ammonium ions are potent inhibitors of the degradation of endocytosed
epidermal growth factor by human fibroblasts in culture. Glimelius
35et al. (1977) discovered that human glial cells incorporate [ S]sulphate 
into glycosoaminoglycans and that these labelled macromolecules accumulate 
in the cells when incubated in medium containing ammonium ions; no such 
accumulation was observed when these cells were incubated in the absence 
of ammonium ions.
It is not entirely clear how chloroquine or ammonium ions (and 
other weak bases) exert an inhibitory effect on lysosomal digestion, but 
it is apparent that these substances gain access to the lysosomal interior.
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Several basic (and neutral) substances have been shown to accumulate in 
the lysosomes of mammalian cells (Allison fi Young, 1964). Chloroquine 
is taken up by HeLa cells (Polet, 1970), rat fibroblasts (Wibo & Poole, 
1974), human fibroblasts (Lie & Schofield, 1973; Donato et al., 1976), 
macrophages (Fedorko et al., 1968a,b) and L-cells (Fedorko et al., 1968b) 
and has been shown to accumulate in lysosomes (Fedorko et al., 1968b; 
Allison & Young, 1964; Reijngoud & Tager, 1976). Morphological and 
biochemical evidence suggest that ammonium ions and other weak bases 
accumulate in lysosomes of isolated rat hepatocytes (Seglen & Reith, 1976) 
and that methylammonium ions can accumulate in isolated rat-liver lysosomes 
in vitro (Reijngoud & Tager, 1973 & 1977; Reijngoud et al., 1976;
Henning, 1975; Goldman & Rottenberg, 1973). Morphological studies indicate 
that vacuolation (i.e. an increase in both the size and the number of 
vacuoles found in the cytoplasm) accompanies the uptake of both chloroquine 
(Fedorko et a U , 1968a,b) and ammonium ions (Seglen & Reith, 1976) so 
that morphologically, the cells resemble those from individuals with a 
genetically induced lysosomal storage disease (Hers & Van Hoof, 1973).
Two different routes of entry of the weak bases into the 
lysosomes of intact cells have been suggested. Polet (1970) argued that 
for chloroquine an endocytic route could be involved. He observed 
that the cytoplasm of chloroquine-treated HeLa cells contained chloro- 
quine-rich vacuoles, which he suggested resembled pinocytic vacuoles. But 
de Duve et al. (1974) suggested that the rate of entry of chloroquine into 
cells by this route would be too slow to explain the observations on 
chloroquine induced lysosomal dysfunction but also suggested that the 
alternative route (by permeation of both plasma and lysosomal membranes) 
could be slow, since, at neutral pH, chloroquine is almost entirely
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this problem when they explained that, at physiological pH, chloroquine,
with ionization constants of pKa^ = 10.2 and pKa^ =8.1 (Irvin & Irvin,
1947), is 18% in the monoprotonated form and only a negligible amount is
in the non-protonated form. The monoprotonated form, Homerwood and co-
-workers suggest, is soluble in lipid, consequently this form is capable
of passing through cell membranes (Albert, 1968; see below) hence could
readily enter lysosomes and then be retained within the more acidic
lysosomal environment. This hypothesis was corroborated by the observation 
14that [ C]chloroquine is accumulated by isolated rat liver lysosomes
(Reijngoud & Tager, 1976) a finding which refutes the suggestion that
the only route of entry into the lysosomes is one involving endocytosis.
Reijngoud & Tager (1976), however, assumed that chloroquine enters
isolated lysosomes in the unprotonated form. But Albert (1968) writes
"... a non-penetrating ion can often be made penetrating by the addition
of a lipophilic group; the chloro- and other lipophilic-groups of the
antimalarials mepacrine ('Atebrin') and chloroquine may assist thus
in the necessary penetration [of the membranes) of red blood cells."
A non-endocytic route of entry into lysosomes for ammonium ions
(also méthylammonium- and ethylammonium ions) also seems probable
14since isolated rat-liver lysosomes accumulate [ C]methylamine (for 
review see Reijngoud & Tager, 1977), a process that can be inhibited by 
ammonium ions in the incubation medium (Reijngoud et al., 1976). Hence, 
both ammonium- and méthylammonium ions are able to enter lysosomes by 
permeation of membrane elements, but, unlike chloroquine, which might 
penetrate cell membranes in the monoprotonated form, it seems likely 
that ammonium ions (and probably the substituted ammonium ions) pass 
through the cell membranes in the unprotonated form (Verity & Brown, 1973).
in the protonated form. Homerwood et al. (1972), partially resolved
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There is little doubt that/ once inside a lysosome, weak bases 
become trapped on protonation (de Duve et al.( 1974; Reijngoud & Tager,
1977). It is not known, however, to what extent the protonated weak 
bases become bound to large anions within lysosomes. Glycoproteins in 
lysosomes have, in general, acidic-isoelectric points (Tappel, 1969), and 
Henning et al. (1973) showed the interior side of rat-liver lysosomal 
membranes to contain acidic-glycolipids. Dingle & Barrett (1969) 
extracted from kidney lysosomes an acidic substance, of apparent 
glycolipid nature, with a strong affinity for acridine orange and other 
cations (Acridine orange is a basic dye, that accumulates in lysosomes 
(Robbins & Marcus, 1963) and fluoresces orange at acid pH; it is now 
commonly used as a histological stain for this organelle.] Such 
substances might also contribute to the lysosome's ability to trap and 
accumulate weak bases. Henning et al. (1973) and Reijngoud & Tager
(1977) suggested that such anionic substances are responsible for the 
generation of the acidic interior of the lysosome. Binding of protonated 
weak bases [and other cations which can permeate the lysosomal membrane, 
(Henning et al.', 1975)] could therefore interfere with the ability of 
such anionic substances to maintain an acid environment within lysosomes.
The accumulation of weak bases by lysosomes is associated with 
a rise in the pH of the lysosome interior; this has been observed to 
occur both with methylamine (Reijngoud & Tager, 1973, 1977; Reijngoud et al., 
1976; Henning, 1975) and with chloroquine (Reijngoud & Tager, 1976).
In some of these studies a concomitant decrease in the rate of digestion 
of endocytosed formaldehyde-denatured XZ3I-labelled bovine serum albumin 
was also observed. The proteolytic inhibition was considered to result, 
in part, from an elevation of the intralysosomal pH toward a value at 
which the lysosomal enzymes were less active (Coffey & de Duve, 1968).
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Choroquine also directly inhibits cathepsin B (Wibo & Poole, 1974) 
aryl-sulphatase A (Smith elb al., 1976) and the activities of several 
other poorly-defined hydrolytic enzymes (cowey & Whithouse, 1966).
The above studies illustrate that both chloroquine and 
ammonium ions (and the substituted ammonium ions) can be usefully 
employed to demonstrate, in several cell types, the involvement of 
lysosomes in the digestion of several classes of substrate. However, 
a literature survey indicates that no quantitative studies of the effects 
of the weak bases on lysosome function and on endocytosis have been 
conducted. Many of the investigations of the effects of weak bases on the 
digestion of substrates by intact cells have been unsuitable for the 
quantitative estimation of lysosome function.
The contribution of non-lysosomal digestion to the breakdown 
of cellular proteins is not known so that an investigation of the effects 
of weak bases on the inhibition of total cell-protein breakdown would 
not permit an estimate to be made of the degree of inhibition of lysosomal 
activity. If, however, the degree of lysosomal inactivation were known 
precisely, such studies would permit an estimate to be made of the contribu­
tion of non-lysosomal digestive processes to the total cell-protein 
breakdown. This has been part of the aim of the investigations reported 
in this chapter.
Neufeld and co-workers (Fratantoni et al_., 1968, 1969 ;
Neufeld & Fratantoni, 1970) described a technique to measure the normal
catabolic function of lysosomes in cultured fibroblasts. The technique
takes advantage of the fact that when mammalian cells are cultured in
35the presence of inorganic [ S]sulphate, the only macromolecules to become 
labelled are the mucopolysaccharides. The majority of the newly synthesized
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mucopolysaccharide is rapidly secreted from the cell as proteoglycans,
but a minor portion is transferred to the lysosomes where it must be
digested to small molecules before passing out of the cell. The rate of
35disappearance of the S-labelled mucopolysaccharide in "chased” cells 
was used as an index of lysosome function. This rate, however, must 
also depend on the rate of transfer of the mucopolysaccharide to the 
lysosomes, a quantity that was not measured. Consequently, Neufeld's 
index of lysosome function might not be reliable quantitatively.
Measurement of the inhibition, by weak bases, of the digestion 
of endocytosed exogenous substrates should permit a quantitative estimate 
of the degree of inhibition of lysosomal activity providing any concomitant 
effects of the inhibitors on the uptake of the substrate into the lysosomes 
are taken into account, and that the substrate used for the investigation 
is digested exclusively within the lysosomal system. (Evidence of this is 
not always given in many published studies.)
It has been already established (see chapter 4) that the
125digestion of endocytosed formaldehyde-denatured I-labelled bovine
serum albumin by the 17.5-day rat yolk sac occurs exclusively within
lysosomes. In the work reported below the effects of weak bases on
125the endocytosis and lysosomal digestion of the I-labelled albumin has 
been studied quantitatively. This in turn permit» comparison of the effects 
of the same concentrations of a given weak base on lysosomal inactivation 
and the degree of inhibition (by similar concentrations of weak bases) of 
the rate of degradation of endogenous yolk-sac proteins labelled with
3
[ H]leucine. The latter study was conducted concurrently by Knowles and 
Ballard (CSIRO, Division of Human Nutrition, Adelaide, Australia).
5.2 METHODS
5.2.1 Assay of the uptake and degradation of ''“"’i-labelled substrates 
by 17.5-day rat yolk sacs in serum-free medium 199.
125The uptake of I-labelled poly(vinylpyrrolidone) was determined
as described in Section 2.2.1. Two different methods were used to assay
125the uptake and degradation of formaldehyde-denatured I-labelled bovine 
serum albumin. Each has been described previously (Sections 2.2.1 and
3.2.1). When the rapid method was used (Section 3.2.1) yolk sacs were 
incubated singly and when the method described in Section 2.2.1 was used, 
yolk sacs were again incubated singly but in 20ml of serum-free medium 
199. Sidastrates were prepared as described previously (Sections 2.2.1 and 
2.2.3). When yolk sacs were incubated with inhibitors (ammonium chloride, 
methylamine hydrochloride and chloroquine diphosphate, (each from sigma, 
London) and ethylamine hydrochloride (Cambrian Chemicals, Beddington 
Farm Road, Croydon, U.K.)] the radioactive substrate was added to the 
medium 30min after the introduction of the yolk sacs to medium containing 
the inhibitor.
1255.2.2 Expression of the uptake and degradation data for the I-labelled 
substrate incubated with rat yolk sacs: a quantitative estimation of 
lysosomal activity.
In Chapters 2 & 3 both uptake and degradation data have been
expressed as the volume (yl) of incubation medium whose contained
substrate has been captured by unit quantity of yolk-sac tissue (mg
yolk-sac protein). This form of expression (yl/mg yolk-sac protein) is
125appropriate for substrates (e.g. I-PVP) which are ingested only by 
fluid endocytosis but, for a substrate like formaldehyde'denatured
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I-labelled bovine serum albumin that is ingested mainly by adsorptive 
endocytosis, the rate of uptake is better expressed as the quantity 
(e.g. ng) of substrate captured by unit quantity of yolk-sac tissue (mg 
yolk-sac protein). This avoids the possible inference that a high rate of 
substrate uptake is associated with an increased rate of fluid capture.
When an effector compound substantially modifies the rate of 
uptake of a digestible substrate, the overall rate of digestion of the 
substrate will also be modified; this can mask any possible effects of 
such compounds on the digestion of a substrate once it has been 
endocytosed. To determine the precise action of an effector compound on 
the digestive process it is necessary to correct the overall rate of 
substrate digestion for the modified rate of substrate uptake. This 
can be achieved simply by expressing the overall rate of substrate 
digestion (ng/h per mg yolk-sac protein) as a percentage of the rate of 
uptake (ng/h per mg yolk-sac protein) to give a dimensionless quantity.
When the overall rate of substrate digestion is limited by the rate of 
endocytic uptake (see Section 2.4) a value of 100% should be obtained, 
but when the digestion step is rate limiting, a value <100% should be 
obtained. However, it follows that any effector compound which enhances 
the rate of digestion by stimulating the digestive process will not 
affect this quantity (the rate of digestion cannot exceed the rate of 
substrate uptake).
A similar analysis can be made of the quantity of substrate 
accumulated by the yolk-sac tissue. But, to obtain a dimensionless 
quantity, the average rate of substrate accumulation by the yolk sac 
(ng/h per mg yolk-sac protein) must be expressed as a percentage of the 
rate at which the substrate is endocytosed (ng/h per mg yolk-sac protein). 
This has been done irrespective of whether the time-course of the substrate
125
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accumulation within the tissue is linear or non-linear. When the 
digestive process is completely inhibited, so that no digestion products 
are released back into the medium following the endocytosis of a 
digestible substrate, the value of the average rate of tissue accumulation 
when ejqpressed as a percentage of the rate of uptake should be 100%, In 
the absence of an effector compound this value should be <100% (say x%); 
the precise value will depend on the ease with which an individual substrate 
can be digested within the yolk sac. An effector compound that inhibits 
the digestive process should give a value >x%, whereas an effector compound 
that stimulates the digestion of a substrate once it has been captured (so 
that the digestion products are released back into the culture medium 
more rapidly than would occur under control conditions) should give a value 
<x%.
5.2.3 Release of both radioactivity and enzymes from yolk sacs that have 
125ingested I-labelled substrates in vitro
125A decrease in the quantity of a non-digestible I-labelled 
substrate accumulated within the rat yolk sac, due to the presence of an 
effector compound, can result from either an inhibition of pinocytosis 
or an accelerated rate of release of the pinocytosed substrate from the 
yolk sac. When digestible substrates are being investigated an inhibition 
of the digestion process could leave more intact radiolabelled substrate 
within the tissue to be subsequently exocytosed. It was therefore 
important to investigate the potential effects of the effector compounds 
on the rates of release of the endocytosed substrates.
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1) Assay of the release of radioactivity from yolk sacs that have
125ingested formaldehyde-denatured I-labelled bovine serum albumin 
in vitro. This assay was performed essentially as described in Section 
2.2.4(1) except that yolk sacs were allowed to ingest substrate over 
an incubation period of 3h in serum-free medium 199. When the 
effect of a weak base on the release of substrate from a yolk sac was 
being investigated, the weak base was present in the culture medium 
during the ingestion, washing, and re-incubation phases of the experiment. 
The release of both acid-insoluble and acid-soluble radioactivity 
were monitored as described previously [Section 2.2.4(1)].
(2) Assay of the release of radioactivity from yolk sacs that have
125ingested I-labelled poly(vinylpyrrolidone) in vitro. This assay
12 Swas performed essentially as described in (1) above, but using I- 
-labelled poly(vinylpyrrolidone) at a concentration of 10ug/ml of medium 199, 
instead of the radiolabelled protein substrate; a 3h ingestion period 
was again used.
The yolk sacs were washed for slightly longer periods
125(3 x 5min). Some yolk sacs were allowed to ingest I-labelled 
poly(vinylpyrrolidone) for 2h, in the absence of a weak base, washed 
in medium 199 alone then placed into medium containing a particular 
weak base and the incubation continued. The release of radioactivity 
was monitored as described previously [Section 2.2.4(1)].
(3) Assay of the release of lactate dehydrogenase activity and 
8-N-acetylglucosaminidase activity from yolk sacs that have 
ingested I-labelled poly(vinylpyrrolidone) in vitro. The
release of both lactate dehydrogenase activity and B-N-acetyl-
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-glucosaminidase activity from yolk sacs that had previously ingested 
I-labelled poly(vinylpyrrolidone) were monitored together with the 
release of radioactivity. Yolk sacs were allowed to ingest the radio- 
tracer for 2h, in the absence of a weak base, washed in medium 199 alone 
then re-incubated in the presence of a weak base at concentrations of 
0-200yM as described in (2) above. The release of enzymic activity and 
radioactivity were monitored by taking 1.0ml samples of culture medium 
at 0.5h and 3.Oh after introducing the washed yolk sacs into the 
re-incubation medium. Incubations were terminated at 3h and the medium 
samples were centrifuged at 1500g for 15min to remove cell debris and the 
supernatant assayed for radioactivity as described previously [Section 2.2.1(3)] 
then stored at -20°C before assaying lactate dehydrogenase and B-N-acetyl- 
-glucosaminidase activities. The radioactivity and enzymic activities of
cv-
each sample were used to calculate the total radioactivity and total 
enzymic activities released into the medium over the period 0.5h to 3.Oh 
of incubation. At the end of the incubation, the yolk sacs were homogenized 
at 4°C for 30s in 5ml of 0.01M-K2HPC>4 buffer, pH 7.4, by using a Virtis 
homogenizer (Virtis Research Equipment, Gardiner, N.Y., U.S.A.) set at speed 
2, The homogenates were assayed immediately for lactate dehydrogenase 
activity, g-N-acetylglucosaminidase activity and radioactivity.
(4) Calculation and expression of the quantities of radio- and enzymic
125activities released from yolk sacs that have ingested 1-labelled substrate. 
The amounts of radioactivity and enzymic activities released from the 
yolk sacs were calculated by the method described in Section 2.2.4(2).
The activities released were then expressed as a percentage of that 
activity associated with the yolk sac at the time of transfer to the 
re-incubation medium. As described before [Section 2.2.4(4)], the total
107
amounts of radioactivity and enzymic activities present in the yolk sac 
at the time of transfer to the re-incubation medium were calculated 
by adding the total radioactivity or enzymic activity in the yolk-sac 
homogenate to the total radioactivity or enzymic activity in the culture 
medium at the end of the re-incubation period.
5.2.4 Recovery of pinocytic and digestive activities of rat yolk sacs 
previously exposed to ammonium chloride.
Three yolk sacs from a single 17.5-day pregnant rat were
incubated together for lh at 37.0 ± 0.3°C under 95% 0,: 5% CO in 20ml
of medium 199 containing ammonium chloride at a concentration of either
6.32mM or 20.0mM. The yolk sacs were then washed three times for 2min
in 20ml of warm, gassed medium 199 containing no ammonium chloride and
placed into 19ml of warm, gassed medium 199, containing no ammonium chloride,
and incubation continued. The uptake and degradation of formaldehyde- 
125-denatured I-labelled bovine serum albumin by each yolk sac was assayed 
by the rapid method as described in Section 4.2.1 by adding the radioactive 
substrate (dissolved in 1ml of medium 199) to a flask containing a washed 
yolk sac either at 8, 60 or 120min after the transfer of the yolk sacs 
from the medium containing ammonium chloride to the fresh medium 199.
Control experiments were performed using three yolk sacs from 
the same animal as used above but excluding ammonium chloride during 
the lh incubation prior to washing the yolk sacs. The incubation media 
containing the ammonium chloride to which the yolk sacs had been exposed 
was reutilized to determine the effect of continuous exposure to ammonium 
chloride on the uptake and degradation of formaldehyde-denatured
125 ,
I-labelled bovine serum albumin. This was done by introducing into this 
medium a freshly dissected yolk sac, taken from a second 17.5-day pregnant
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rat. After 30min the uptake and degradation of formaldehyde-denatured
125I-labelled bovine serum albumin was assayed by the rapid method as 
described in Section 4.2.1 by adding radioactive substrate dissolved in 
50jj1 of aq. NaCl (1% w/v) .
5.2.5 Assay of lactate dehydrogenase activity.
Lactate dehydrogenase activity was measured by the method of 
Lowry et al. (1951). A mixture was prepared containing: sodium pyruvate 
(5.5mg in 0.5|nL distilled water), reduced nicotinamide adenine dinucleotide 
(35.5mg in 0.5ml distilled water) and O.lM-Na HPO , pH 7.5 (4.0ml). To 
20yl of this mixture was added lOyl of culture medium or appropriately 
diluted yolk-sac homogenate [Section 4.2.3(3)] and the mixture was 
incubated at 37°c for 15min. The reaction was terminated and the remaining 
reduced nicotinamide dinucleotide destroyed by adding 0.4M-HC1 (4.0ylJ.
After at least 30s, lOM-NaOH (120yl) was added and incubation continued 
at 37°C for 30min. To the reaction mixture was added 2.0ml of distilled 
water and the fluorescence was determined in a Perkin-Elmer 1000 fluorimeter, 
using an excitation wavelength of 365nm and an emission wavelength of 
470nm. Standards containing up to 2ng of nicotinamide adenine dinucleotide 
were incubated and assayed.
5.2.6 Assay of g-N-Acetylglucosaminidase activity.
3-N-Acetylglucosaminidase was assayed by using 2.5m^-4-methyl-
umbelliferyl 2-acetamido-2-deoxy B-D-glucopyranoside (Koch-Light Ltd.,
CoInbrook, Bucks, U.K.) as substrate in 0.1ml of citrate/phosphate buffer
pH 4.3 (O.lM-citric acid adjusted to pH 4.3 with 0.2M-Na HPO ). To ~ = 2 4 *
this was added lOyl of incubation medium (or appropriately diluted yolk-sac 
homogenate [Section 4.2.3(3)] and the mixture was incubated at 37°C for 
15min. The reaction was terminated by addition of 2.5ml of 0.17 ^-glycine/-
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carbonate buffer, pH 10.5. The fluorescence was determined in a Perkin- 
-Elmer 1000 fluorimeter, using an excitation wavelength of 365nm and 
an emission wavelength of 450nm. Standards containing up to Inmole of 
4-methylumbelliferone in glycine/carbonate buffer, pH 10.5, were also 
assayed.
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5.3 RESULTS
. 1255.3.1 Uptake and digestion of formaldehyde-denatured 1-labelled 
bovine serum albumin by 17.5-day rat yolk sacs incubated in serum-free 
medium 199 containing 20mM-ammonium chloride.
A preliminary study showed the presence of ammonium chloride 
(20mM) in the incubation medium to completely inhibit the production of
trichloroacetic acid-soluble radioactivity from formaldehyde-denatured 
125I-labelled bovine serum albumin by 17.5-day rat yolk sacs; a marked
inhibitory effect on the uptake of this substrate was also noted. The
time course of these effects, after a 30min pre-incubation of yolk sacs
in 20mM-ammonium chloride, is shown in Fig. 5.1 together with the
corresponding results for a control experiment. In the control experiment
the level of tissue-associated radioactivity rose during the first hour
but after this period it remained constant, so that the rates of digestion
125and of uptake of the I-labelled albumin became equal. By contrast, 
yolk sacs incubated in the presence of ammonium chloride (20mM) continued■* as=
to accumulate radioactivity at a constant rate throughout the 3h incubation 
but no acid-soluble digestion products were released into the incubation 
medium, so that the rate of tissue accumulation of radioactivity was 
equal to the rate of substrate ingestion. These rates were, however, 
markedly decreased in the presence of ammonium chloride and were equal to 
approximately 10% of the control rate of uptake.
Ammonium chloride therefore appears to have two major effects: 
firstly, inhibition of the endocytic process and secondly, an inhibition 
of the proteolytic process responsible for the digestion of the ingested 
i25I-labelled albumin.
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5.3.2 Effects of ammonium-, methylammonium- and ethylammonium chloride
125on the uptake and digestion of formaldehyde-denatured T-labelled 
bovine serum albumin by 17.5-day rat yolk sacs Incubated in serum-free 
medium 199.
To determine whether inhibition of both substrate uptake and 
proteolysis occurred in the presence of other weak bases, and to determine 
whether proteolysis could be inhibited without any concomitant effect on 
uptake, the effects of methylammonium- and ethylammonium ions on both 
ingestion and digestion were also examined.
Table 1 shows that, at 20mM concentrations, ammonium-, methyl- 
ammonium- and ethylammonium chlorides each inhibited the rate of ingestion
to a similar extent and also almost fully inhibited the proteolysis of the 
125I-labelled albumin. Only a small proportion of that radiolabelled
protein ingested by the yolk sac was hydrolysed, and the average rate of
tissue accumulation of radioactivity became almost equal to the rate of
uptake. Each weak base at a concentration of 5mM inhibited both uptake
and digestion, but to lesser extents than at a concentration of 20mM.
The amount of acid-soluble radioactivity released into the incubation
media containing a weak base at a concentration of 5mM increased linearly
with time after an initial lag-period. No inhibition of proteolysis was
observed without an attendant effect on ingestion also being observed.
These effects did not result from changes in the pH of the incubation
media since all media, at 37°C under an atmosphere of 95% 0 s 5% CO ,2 2
showed a pH of 7.1 whether they contained ammonium-, methylammonium- or 
ethylammonium chloride (20mM) or no weak base at all.
5.3.3 Effect of different concentrations of ammonium chloride on the
125uptake and digestion of formaldehyde-denatured I-labelled bovine
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serum albumin by 17.5-day rat yolk sacs incubated In serum-free medium 199.
The inhibitory effects of ammonium chloride on both uptake 
and digestion are clearly concentration dependent phenomena (Table
5.1)• Fig. 5.2 shows the extent of the same effects over a range of 
ammonium chloride concentrations. The rate of uptake of 125I-labelled 
albumin decreased on increasing the ammonium chloride concentration from 
approx. 0.2mM to 20mM. Similarly, the overall rate of appearance of 
acid-soluble radioactivity progressively decreased over the same ammonium 
chloride concentration range. The.effect on digestion was more pronounced 
than the inhibitory effect on ingestion and reached approx. 100% 
inhibition in 20mM-ammonium chloride; at all other ammonium chloride 
concentrations the rate of appearance of acid-soluble radioactivity was 
measurable and was constant over the remainder of the 3h incubation period 
beyond the initial lag-period. A biphasic effect on the accumulation of 
radiolabelled substrate by the yolk-sac tissue was observed. No measurable 
effect on the tissue-accumulated radioactivity occurred below an ammonium 
chloride concentration of 2mM. At concentrations above 2mM-ammonium chloride 
the amount of tissue-associated radioactivity increased to reach a maximum 
equal to approx. 210% of control (at 6.32mM) then decreased again, but, 
even with 20mM-ammonium chloride, the quantity of tissue-associated 
radioactivity was not measurably lower than that observed for yolk sacs 
incubated in the absence of ammonium chloride. On increasing the ammonium 
chloride concentration,the acid-insoluble radioactivity accumulated by the 
tissue constituted a greater proportion of the total yolk-sac associated 
radioactivity and was found to reach a maximum value, equivalent to approx. 
310% of the level in the control, at an ammonium chloride concentration of 
6.32mM. At 20mM this value was approx. 165% of the control.
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Because ammonium chloride inhibits the uptake of the 125I-labelled 
albumin, it is not easy to distinguish the extent of the effect of 
ammonium chloride on the proteolytic process when the data are presented 
in the format used in Pig. 5.2. However, if the rate of digestion and 
the average rate of tissue accumulation of 125I-labelled albumin are each 
corrected for the modified rate of uptake, as described in Section 5.2.2 
it becomes clear that one effect of ammonium chloride is to inhibit the 
lysosomal proteolytic process (Fig. 5.3). As the corrected rate of 
digestion progressively decreases,with increasing concentrations of 
ammonium chloride, a corresponding rise in the corrected rate of tissue 
accumulation of radioactivity occurs. Pig. 5.3 (lower) shows the 
proportion of the total tissue-accumulated radioactivity that is acid- 
-soluble at each ammonium chloride concentration; this is observed to 
decrease with increasing ammonium chloride concentration.
5-3*4 Eff-ect-s of chloroguine on the uptake and digestion of formaldehyde.
125-denatured I-labelled bovine serum albumin by 17.5-dav rat yolk sacs 
incubated in serum-free medium 199.
Chloroquine, like ammonium-, methylammonium- and ethylammonium
chlorides is a weak base and reports in the literature have indicated that
in some cell types it can inhibit both eridocytosis and lysosomal digestion
of proteins (see de Duve et al., 1974) . It seemed that chloroquine might
have similar properties to ammonium chloride and therefore decrease both
the rate of uptake and the rate of digestion of proteins by the rat yolk
sac. In order to investigate this possibility, the uptake and digestion 
125of the I-labelled albumin by the rat yolk sac was measured in the 
presence of chloroquine phosphate at concentrations which did not modify 
the PH of the incubation medium. Fig. 5 . 4  shows that chloroquine does
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indeed have effects which are qualitatively similar to those already 
described above for ammonium chloride. As with the other weak bases, the 
rate of appearance of acid-soluble radioactivity in each separate 
experiment, at a given chloroquine concentration, was constant after an 
initial lag-period. As the chloroquine concentration was increased a 
progressive decrease occurred both in the rate of uptake and in the rate 
of digestion of the radiolabelled protein. A biphasic effect on the 
accumulated tissue radioactivity was also observed when such results, 
from a number of experiments at different chloroquine concentrations, 
were compared.
After correcting both the overall rate of digestion and the 
average rate of tissue accumulation of radioactivity for the chloroquine- 
-induced decrease in the rate of uptake of the radiolabelled substrate, 
the effects of chloroquine on the lysosomal proteolysis of the radiolabelled 
substrate can be clearly seen (Fig. 5.5) . As with ammonium chloride 
(Fig. 5.3), an increase in chloroquine concentration caused a marked 
decrease in the rate of proteolysis and a corresponding rise in the 
corrected rate of accumulation of tissue-radioactivity. The proportion of 
the tissue-accumulated radioactivity found to be acid-soluble also 
decreased with increasing chloroquine concentration.
The results showed that chloroquine was a more potent inhibitor 
of both the uptake and of the proteolytic processes than was ammonium 
chloride. Fifty percent inhibition of uptake occurred at a concentration 
of approx. 100yM-chloroquine, but the same result was only achieved with 
approx. lOmM-ammonium chloride (i.e. 100 times greater than for chloroquine). 
Similarly, 50% inhibition of the proteolytic process occurred at a 
chloroquine concentration of approx. 75yM, while the concentration of 
ammonium chloride that gave the same result was approximately 9mM (i.e.
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120 times greater than for chloroquine).
5.3.5 Effect of different concentrations of ammonium chloride and of
125chloroquine on the uptake of____I-labelled poly(vinylpyrrolidone) by
17.5-day rat yolk sacs incubated in serum-free medium.
To determine whether ammonium chloride or chloroquine caused
a decreased rate of pinosome formation or whetner the Inhibition of
125formaldehyde-denatured i-labelled bovine serum albumin uptake arose
from an interference with the adsorption of the macromolecule to pinocytos-
ing plasma membrane, it was necessary to determine the effects of these
125compounds on the rate of uptake of fluides measured by I-labelled
125poly(vinylpyrrolidone) l I-PVPJ ingestion. Both ammonium chloride
125(Fig. 5.6) and chloroquine (Fig. 5.7) inhibited the uptake of I-PVP,
125indicating that the observed inhibition of I-labelled albumin uptake,
in the presence of these inhibitors, is a result of a decreased rate of
pinosome formation. Brown & Segal (1977) reported that chloroquine
was without effect on the uptake of invertase by 17.5-day rat yolk sacs.
However, these authors incubated yolk sacs in the presence of calf serum.
It therefore seemed possible that calf serum might quench the effect seen
here with chloroquine. But, when calf serum (10% v/v) was added to the
125incubation media chloroquine still inhibited I-PVP uptake (Fig. 5.7).
5.3.6 Release of radioactivity from yolk sacs that had previously
125accumulated either I-labelled poly(vinylpyrrolidone) or formaldehyde- 
125-denatured I-labelled bovine serum albumin.
The effects of ammonium-, méthylammonium- and ethylammonium
chlorides and chloroquine on the rates of release of radioactivity from
125yolk sacs that had previously accumulated I-labelled substrates were 
determined to establish whether the lower rates of accumulation of substrate
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by the yolk sac in the presence of these weak bases could arise from more 
rapid rates of release of captured substrate.
125When yolk sacs were allowed to accumulate I-PVP in the 
absence of a weak base then transferred to media containing ammonium-, 
methylammonium- or ethylammonium chlorides (20mM), the rate of release 
of radioactive substrate remain essentially the same as that observed in 
control yolk sacs re-incubated in media containing no weak base (Table 5.2). 
In contrast, chloroquine at 200pM caused a rapid rate of release of 
radioactivity (approx. 13%/h; c.f. control rate of 1.1%/h), but even this 
enhanced rate of release was not sufficient to completely account for the 
decreased rate of accumulation.
Similar experiments, in which yolk sacs were allowed to accumulate
125I-PVP in the presence of either ammonium chloride (20mM) or chloroquine 
(200yMJ before monitoring the release of radioactivity on re-incubation in 
the presence of the same weak base,gave similar results (Table 5.2). When 
the latter experiment was repeated with yolk sacs that had accumulated the 
125I-labelled albumin, chloroquine caused a rapid rate of release of 
acid-insoluble radioactivity but ammonium chloride did not (Fig. 5.8). An 
inhibitory effect of these weak bases on the proteolysis of the radiolabelled 
protein was also observed. In control experiments acid-soluble radioactivity 
was rapidly released from the yolk sacs, whereas the rates of release of 
acid-soluble radioactivity in the presence of either ammonium chloride 
(20mM) or chloroquine (200yM) were negligible.
5.3.7 Release of radioactivity, lactate dehydrogenase activity and
8-N-acetylglucosaminidase activity from yolk sacs that had previously 
125accumulated i-labelled poly(vinylpyrrolidone).
To determine whether chloroquine (200ijM) was toxic to the yolk-sac
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cells, or whether it specifically elevated the rate of exocytic
regurgitation of either lysosome or pinosome contents, the rate of 
125release of I-PVP, lactate dehydrogenase activity and 8-N-acetyl- 
glucosaminidase activity from yolk sacs was measured with different 
concentrations of chloroquine in the re-incubation medium.
Fig. 5.9 shows that only small amounts of 125I-PVP, lactate 
dehydrogenase activity and g-N-acetylglucosaminidase activity are 
released in the presence of 0, 10 and lOOyM chloroquine, but above 100UMss
all three markers are rapidly released, indicating that cytolysis occurs 
at the higher concentrations of chloroquine.
5*3*8 Recovery of the endocytic and proteolytic activities of 17.5-day 
rat yolk sacs following exposure to ammonium chloride.
It seemed possible that the ammonium chloride induced inhibitions 
of both pinocytosis and protein digestion by the rat yolk sac could arise 
from general irreversible cytotoxic effects. Results of recovery experiments 
(Table 5.3) indicate that this is not so. After a lh exposure to 6.32mM 
ammonium chloride (sufficient to cause approx. 25% inhibition of pinocytic 
activity and an approx. 50% inhibition of the proteolytic process when 
continuously presentl yolk sacs immediately showed a complete recovery of 
both activities. Following exposure to 2OmM-ammoniurn chloride, a complete 
recovery of pinocytic activity was not achieved but it did rapidly return 
to 85-90% of that observed for control yolk sacs. However, a complete 
recovery of the proteolytic capacity was achieved, even after exposure 
to ammonium chloride at a concentration sufficient to inhibit this process
by 100%.
Table 5.1 Effects of ammonium, méthylammonium and ethylammonium ions on the rates of uptake and digestion of
formaldehyde-denatured 125I-labelled bovine serum albumin by 17.5-day rat yolk sacs incubated in serum-free
medium 199.
125The rates of uptake and digestion of formaldehyde-denatured I-labelled bovine serum albumin were 
determined by the method described in Section 3.2.1. The 125I_^a]-)ei^e(j albumin (1 yg/ml of medium) was added 
30 min after placing the yolk sacs in serum-free medium 199 containing the weak bases at the concentrations 
indicated. Each value reported represents the mean (± S.D.) of 3 - 4 separate determinations each over a 3 h 
uptake period.
Inhibitor
Inhibitor Rate of uptake 
concentration (% of control) 
(bM)
Rate of digestion 
(% rate of uptake)
Average rate of 
tissue accumulation 
over the 3.0h period 
(% rate of uptake)
Proportion of the 
radioactivity in 
the yolk sac (at 3 h) 
that is acid-soluble 
(%)
Control 0 100.0 + 8.9 95.1 + 5.6 16.3 + 2.7 39.2 + 5.3
+NH.4 5 55.2 + 9.8 68.8 + 4.9 48.6
+ 3.6 18.1 + 1.7
MeNH* 5 57.4 + 19.8 67.0 + 13.5 48.6 + 8.0 17.4 + 3.4
EtNH* 5 65.5 ± 12.6 59.0 + 13.8 46.0 + 7.3 14.8 + 2.3
+NH.4 20 10.8
± 2.0 5.3 + 7.2 92.0 + 9.7 7.5 + 1.9
MeNH* 20 9.2 ± 5.2 -2.8 + 9.2 102.0 + 10.0 6.8 + 0.6
EtNH* 20 9.8 ± 2.8 4.5 + 1.4 97.7 + 5.3 6.8 + 1.7
Table 5.2 Release of radioactivity from 17.5-day rat yolk sacs, that had
125accumulated I-labelled poly(vinylpyrrolidone) in vitro, on re-incubating 
the tissue in the presence of ammonium, rnethylammonlum, or ethylammonium 
ions or chloroquine.
Yolk sacs (3) each from a different animal were loaded in vitro 
with 125I-PVP in the presence or absence of a weak base for 2 h, washed to 
remove extracellular substrate as described in Section 5.2.3(2). After 
washing, each yolk sac was re-incubated separately in fresh tracer-free 
medium 199, with or without (control) a weak base, and the release of 
i25I-PVP was monitored as described in Section 5.2.3(2). Each value
of the rate of 
1 - 3 h, from
release is the mean (± S.D.) value, over the period 
3 separate determinations.
Weak base
Loaded in the 
presence (+) 
or absence (-) 
of the weak 
base
Concentration 
of weak base in 
loading and 
re-incubation 
media
Rate of ^I-PVP 
release (% tissue- 
associated radio­
activity released 
per h.)
Control - 0 1.16 ± 0.17
- 0 1.17 ± 0.14
HNH* - 20 jn^ 1.23 ± 0.12•J
+ 20 mM 0.79 ± 1.54
+MeNH^ - 20 mM 2.14 ± 1.15
EtNH* - 20 mM 2.26 ± 1.42
Chloroquine - 200 jjM 13.07 ± 1.90
+ 200 yM 11.84 ± 1.22
Table 5.3 Recovery of the endocytic and proteolytic activities of 17.5-day rat yolk sacs that had previously 
been exposed to ammonium chloride.
Following a 1.0 h exposure of yolk sacs to ammonium chloride, at the concentrations indicated, the 
tissues were washed as described in Section 5.2.4, then placed in fresh, serum-free medium 199 containing no 
ammonium chloride. Uptake and digestion (determined as described in Section 3.2.1) of formaldehyde-denatured 
125j-labelled bovine serum albumin commenced on addition of substrate (lyg/ml of medium) to the flasks 
containing the washed yolk sacs. Such additions were made at 8, 60 or 120 min after removing the yolk sacs 
from medium containing the ammonium chloride.
The inhibitory effects, on endocytic and proteolytic activity, of the continuous presence of 
ammonium ions were also investigated. Freshly dissected yolk sacs were placed in media that had previously 
been used to expose yolk sacs to ammonium chloride and, after a 30 min period, the uptake and degradation of 
125l-lahelled serum albumin studied on adding this substrate.
Continuous presence of NH^-ions in Recovery after 1.0 h exposure to NH*-ions
the culture medium
Concentration of Rate of uptake Rate of digestion Period before Rate of uptake Rate of digestion
NH^-ions in medium (% of control) of ingested protein addition of (% of control) of ingested protein4 (as a percentage of substrate (as a percentage of
the rate of uptake) the rate of uptake)
8 min 119.4 ± 13.3 99.2 ± 1.2
6.32 mM 76.1 ± 2.5 54.4 ± 8.8 60 min 91.2 ± 13.6 100.2 ± 4.0
120 min 98.5 ± 14.7 96.4 ± 2.5
8 min 89.6 ± 17.8 102.9 ± 2.3
20.0 mM 20.0 ± 8.5 -0.04 ±1.18 60 min 84.2 ± 8.5 98.9 ± 2.4
(100% inhibition) 120 min 86.4 ± 14.9 94.9 ± 2.5
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Figure 5.1 Effects of ammonium chloride (20 nq) on the upteire
degradatiorLof^ormaldehyde-denatured 125T-labelled hovlne serum a1h„nWn
by 17.5-day_rat yolk _sacs incubated in serum-free medium 1 9 9.
The uptake and degradation of formaldehyde-denatured 125T-i*v«.n„a u • 
serum albumin were determined as described in Section 2 2 J Slk S  
were incubated with ammonium chloride for 30 min before^tZke commenced 
on adding substrate (1 ng/ml of culture medium). Each experiment was 
performed using yolk sacs from a single animal.
Values of the tissue-associated radioactivity, (o); acid-soluble 
radioactivity released into the culture medium, <»). sum of tissue- 
-associated radioactivity and acid-soluble radioactivity released lntn 
the culture medium ( . ), acid-insoluble radioactivity in yolk-sac t i i L  
(□ ) are shown at each time point for two yolk sacs that have each been 
incubated separately.
In the presence of 20 ^-ammonium chloride the tissue-associated acid- 
-insoluble radioactivity at each time point was equivalent to 94 4 Z 96 5% 
of the total tissue-associated radioactivity. *
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Figure 5.2 Effects of different concentrations of ammonium chloride on
125the rates of uptake and digestion of formaldehyde-denatured I-labelled 
bovine serum albumin by 17.5-day rat yolk sacs incubated in serum-free
medium 199.
“ d 1 . ^ gradation of formaldehyde-denatured
1251-labelled bovine serum albumin were determined as described (n 
Section 3.2.1. Yolk sacs were incubated for 30 min in 
ammonium chloride, at the concentrations indicated, b e f o r e ' ^ p t S e ^ 1^  
started by the addition of substrate (1 yg/ml of culture medico Each 
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Rate of uptake, (•); rate of degradation, (■).
radioactivity, (o), tissue-associated acid-insoluble Ldioactlvltyf (??.
100
0
01
31$ni p k Qt 
P  T>C <W «J O
a <o0 P •h  id p k nJt3 dfi 
n }  — - kO' d<u o-pp >h  nJ
° g01 ea) P p u o (C&
o <V
p
IDflj 0)rH
u •Hp +J
CD 0r-i e •P
%
•H iwrH >1 0o P(0•H dP1 >•o •k•r( Po O
< m
Figure 5.3 Effects of different concentrations of ammonium chloride
125r»n the proteolysis of pinocytosed formaldehyde-denatured I-labelled 
hnvine serum albumin by 17.5-day rat yolk sacs incubated in serum-free 
medium 199.
Upper These data (means ± S.D.) are taken from Fig. 5.2 but differ 
in that the rates of degradation and rates of tissue- 
-accumulation have been corrected for changes in the rate of 
uptake. Rate of degradation, (•); rate of accumulation,
(o ).
Lower Shows the proportion (means ± S.D.) of the tissue-associated 
radioactivity that is acid-soluble.
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Figure 5.4 Effects of different concentrations of chloroquine on the rates
125of uptake and degradation of formaldehyde-denatured I-labelled bovine
serum albumin by 17.5-day rat yolk sacs incubated in serum-free medium 199.
The rates of uptake and the rates of degradation of formaldehyde-denatured 
laSj.iabeiied bovine serum albumin were determined as described in Section 
3 2 1 .  Yolk sacs were incubated for 30 min in medium containing chloroquine, 
at tbe concentrations indicated, before uptake was started by the addition 
of substrate (1 yg/ml of culture medium). Each value is the mean (± S.D.) 
from 4 separate determinations each using a single yolk sac from a different
animal.
Rate of uptake, (•); rate of degradation, (■); total tissue-associated 
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Figure 5.5 Effects of different concentrations of chloroquine on the
125proteolysis of pinocytosed formaldehyde-denatured I-labelled bovine 
serum albumin by 17.5-day rat yolk sacs incubated in serum-free medium 199.
These data (means ± S.D.) are taken from Fig. 5.4 but differ 
in that the rates of degradation and rates of tissue-accumulation 
have been corrected for changes in the rate of uptake. Rate 
of degradation, ( • )j rate of accumulation, (o ),
L o w e r Shows the proportion (means ± S.D.) of the tissue-associated 
radioactivity that is acid-soluble.
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Figure 5 6 Effect of different concentrations of ammonium chloride on 
the ingestion of 125I-labelled poly(vinylpyrrolidone) by 17.5-day rat 
yeti k sacs incubated in serum free medium 199.
The quantity of 125I-PVP ingested by yolk sacs was determined as described 
• Section 2.2.1. Yolk sacs were incubated in medium containing ammonium 
chloride for*30 min before uptake was started by the addition of l25I-PVP 
C(2 ug/ml of culture medium) and incubation continued for a further 3 h. 
Each reported value for uptake is the mean (± S.D.) of 4-5 determinations 
ach with a single yolk sac taken from a different animal. Uptake is 
ex ressed as the volume of medium (ul) whose contained substrate has been 
captured over a 3.0 h period.
Figure 5.7 Effect of different concentrations of chloroquine on the 
125
T-poly(vmylpyrrolidone) hu 17 -- sacsingestion of x*',I oly (vin by .5-day rat yolk 
incubated in serum-free medium 199.
125
I-PVP ingested by yolk sacs was determined as described 
Yolk sacs were incubated for 30 min in medium line, at vKa — J-J
The quantity of —
in Section 2.2.1. ____ --v-o ¿ c
containing chloroquine, at the concentration indicated, before uptake 
was started by the addition of l25I-PVP (2 yg/ml of culture medium) and 
incubation continued for a further 2 h. Each reported value { • ) is the 
mean (± S.D.) of 3 determinations each with a single yolk sac taken 
from a separate animal. (Values (o ) relate to similar experiments in 
which the culture medium contained 10% (v/v) calf serum.)
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Figure 5.8 Effects of ammonium chloride or chloroquine on the release of formaldehyde-denatured I-labelled bovine 
serum albumin from 17.5-day rat yolk sacs.
For experimental details see Section 5.2.3. The released acid-soluble radioactivities (• ) and acid-insoluble radio­
activities (o ) are expressed as a percentage of that radioactivity initially associated with the yolk-sac tissue.
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Figure 5.9 Release of I-labelled poly(vinylpyrrolidone), lactate 
dehydrogenase and g-N-acetylglucosaminidase activities on re-incubating
17.5-day rat yolk sacs in the presence of different concentrations of
TOPchloroquine after the tissue had accumulated I-labelled poly(vinyl­
pyrrolidone) in vitro.
125yolk sacs were loaded in vitro with I-PVP for 2 h as described in 
Section 5*2.3. After washing* each yolk sac was re—incubated separately 
in fresh culture medium containing chloroquine, at one of the concentra­
tions indicated, but initially no 125I-PVP. The quantities of I25I-PVP 
lactate dehydrogenase activity and g-N-acetylglucosaminidase activity ' 
released into the culture media between 0.5 h and 3.0 h were determined 
as described in Section 5.2.3. The values shown are the means (± S.d .) 
of results from 3 yolk sacs, each taken from a separate animal. The 
results are expressed as the proportion of the initial yolk-sac 
activities released between 0.5 h and 3.0 h of reincubation.
125I-PVP, (•); lactate dehydrogenase (.), 8-N-acetyl-glucosaminidase (o)
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5.4 DISCUSSION
The marked inhibitions by ammonium-, methylammonium- and
ethylammonium ions and chloroquine of the digestion of formaldehyde- 
125-denatured I-labelled bovine serum albumin subsequent to its ingestion
125by yolk sacs, and the concomitant accumulation of the I-labelled
albumin in the yolk-sac tissue are in full agreement with the conclusion,
125in Chapter 4, that formaldehyde-denatured I-labelled bovine serum 
albumin is digested by the yolk sacs intracellularly and within lysosomes. 
The highest concentration of each weak base used completely inhibited 
the observed lysosomal digestive activity (Table 5.1 & Figs 5.3 and 5.5).
3
De Duve et al. (1974) showed the digestion of [ H]leucine-labelled bacteria
engulfed by macrophages in culture to be completely inhibited by lOOyM
chloroquine and Floren & Nilsson (1977) showed that 50yM chloroquine
virtually completely inhibited the digestion, by hepatocytes in culture,
of cholesterylester associated with chylomicron remnant particles (formed
by the action of a lipoprotein lipase on chylomicrons).
The results of a literature survey indicate that a complete
inhibition of a lysosomal activity by ammonium- and substituted ammonium
ions has not been previously reported. Reijngoud et al. (1976) measured
the inhibitory effects of ammonium- and methylammonium ions on the digestion
125of endocytosed formaldehyde-denatured I-labelled bovine serum albumin 
contained in isolated rat-liver tritosomes; both weak bases were equally 
inhibitory. Current results (Table 5.1) also show ammonium- and methyl­
ammonium ions to be equally inhibitory of lysosomal digestive activity 
in the intact cell. This is in full agreement with the findings of 
Reijngoud and co-workers in their cell-free system. However, in the cell- 
-free system only 40-50% inhibition of proteolysis occurred at a 20mM
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concentration of each weak base whereas approximately 1 0 0% inhibition 
was observed in yolk-sac tissue when 20mM concentrations of the same weak 
bases were used. Maximum inhibitory effects (60% inhibition) in the 
cell-free system were observed only when the tritosomes were incubated at 
pH 7.5 in the presence of a 50mM concentration of either weak base 
(Reijngoud et al_., 1976). The large discrepancy between the extent of the 
weak-base inhibition in the yolk-sac system and that in isolated tritosomes 
must be a result of inherent differences in the experimental models used 
or the different source of lysosomes or the presence of Triton WR- 1 3 3 9  
within the liver lysosomes. Reijngoud and co-workers measured the rate of 
production of acid-soluble radioactivity over the first lOmin of 
incubation. A short delay (approx. 5min) between uptake of a weak base 
and the inhibition of digestion in the tritosomes would explain the 
discrepancy, but there is however, no evidence to suggest this. (1 4cl- 
Methylammonium ions reach a steady-state level in isolated tritosomes 
within 45s (Reijngoud et al., 1976), therefore incomplete uptake of the 
weak bases by isolated tritosomes would not explain the discrepancy unless 
an additional mechanism, involved in the uptake of the weak bases by the 
lysosomes present in the intact cell, enhances the weak-base inhibition 
of lysosomal proteolysis. Such a mechanism might be energy dependent.
Polet (1970) observed that chloroquine uptake by Hek cells in culture 
occurred by both energy-dependent and independent mechanisms. An alternative 
explanation of the discrepancy (that might be related to Polet's findings) 
can be forwarded; it assumes that the interior of isolated lysosomes is 
less acidic than the interior of the lysosomes within the cytoplasm of 
the intact cell. If this is the case, the control rate of proteolysis 
measured by Reijngoud et al. (1976) in isolated tritosomes would underestimate 
lysosomal activity in the intact cell, also the amount of weak base accumu­
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lated would be less than that which would accumulate in lysosomes 
within the intact cell. The net result of both effects would be that 
the inhibition by each weak base of the proteolytic activity of 
isolated lysosomes would be less than the inhibition of the proteolytic 
activity of lysosomes present in the intact cell. The idea that the pH 
of the interior of isolated lysosomes is greater than that in lysosomes 
present in the intact cell seems feasible if, as discussed by Casey et al.
(1978), an energy-dependent mechanism is involved in the maintenance of an 
acidic intralysosomal pH in the intact cell. Such a mechanism could
I*-operate in addition to the Donnan equilibrium (energy^dependent) mechanism 
discussed by Reijngoud & Tager (1977).
From the experiments performed in this chapter it is not 
possible to establish the mechanism of the lysosomal inhibition by the weak 
bases. It is possible that an inhibition of heterolysosome formation 
could explain the observations made here, but evidence in Chapter 7 indicates 
that such an inhibition does not occur. It is probable that the weak 
bases directly inhibit the lysosomal digestion process due to an elevation 
of the intralysosomal pH (de Duve et al., 1974; Reijngoud & Tager, 1977; 
see also Section 5.1). But it is possible that the weak bases are also 
able to selectively inhibit certain lysosomal proteinases. Chloroquine is 
an inhibitor of cathepsin B (Wibo & Poole, 1974). Should cathepsin B 
contribute to the observed digestion of the formaldehyde-denatured 
125l-labelled bovine serum albumin (see Chapter 6) it is possible that the 
chloroquine would interfere with the lysosomal digestion of the 125i- 
-labelled albumin independently of and in addition to any elevation of the 
intralysosomal pH. However, it does not seem likely that ammonium- and 
substituted ammonium ions could act other than by elevating the intralyso­
somal pH since neither ammonium- nor methylammonium ions inhibited the
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digestion of formaldehyde-denatured I-labelled bovine serum albumin by 
broken lysosomes (Reijngoud et al., 1976).
Knowles & Ballard (unpublished work), again working with the
17.5-day rat yolk sac, discovered that 20mM concentrations of ammonium-,
methylammonium- and ethylammonium chloride each inhibited the normal
3
breakdown of endogenous [ H]leucine-labelled proteins by 47.1% ± 5.3%,
44.6 ± 7.6 and 45.6 ± 3.4 (mean ± S.D.) of the control rates respectively.
The extents of these inhibitions of endogenous protein degradation by each
weak base are approximately equal, as were the weak-base inhibitions of
125the lysosomal proteolysis of the I-labelled albumin in the rat yolk 
sac (Table 5.1) and in isolated lysosomes (Reijngoud et al., 1976).
Knowles & Ballard also showed that chloroquine (500pM)inhibited the 
breakdown of the endogenous proteins of the 17.5-day rat yolk sac by
36.1 ± 9.8% (mean ± S.D.).
These values for the inhibition of endogenous protein breakdown
obtained by Knowles & Ballard contrast with the almost complete inhibition
125of the lysosomal digestion of formaldehyde-denatured I-labelled bovine 
serum albumin (Table 5.1 and Figs. 5.3 & 5.5). One explanation of these 
observations is that more than 50% of the breakdown of the endogenous 
proteins is not intralysosomal, and that the breakdown of cellular 
proteins is evenly divided between a lysosomal and a non-lysosomal site.
An alternative explanation is that all cellular proteins are digested in 
lysosomes but that weak bases selectively inhibit the lysosomal digestion 
of some proteins more than others so that only half of them are susceptible 
to the weak-base inhibition. This possibility is examined in Chapter 7 
of this thesis where the results indicate that not all lysosomal enzymic
activity is inhibited by the weak bases and that selective inhibition of 
proteolysis does indeed occur.
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The inhibitory effects of the weak bases on the rate of pinosome
formation (as judged by an inhibition of both 125i -p v p  and 1'25I-labelled
albumin uptake and by the observation that, except for chloroquine, the
weak bases do not enhance the release of the endocytosed substrates)
are almost as marked as the observed inhibition of lysosomal proteolysis 
125
of the I-labelled albumin. Both inhibition of pinocytic uptake and
125inhibition of lysosomal digestion of the I-labelled albumin occur 
over the same concentration range with a given weak base. Tulkens et al.
(1970) showed that when lysosomal function, in cultured fibroblasts, was 
inhibited by anti-lysosomal antibodies endocytosis was also impaired.
These results might indicate that the two processes are linked in some 
way. It is possible that an inhibition of lysosome function could result 
in a feedback inhibition of pinosome formation. This would have 
advantages for the cell since it would prevent the engorgement of the 
vacuolar system with extracellular material.
Both ammonium ions and chloroquine are vacuolating agents 
(Seglen & Peith, 1976, and Fedorko et al., 1968a,b, respectively) and 
Ballard (personal communication) has recently reported very marked 
vacuolation in yolk-sac tissue exposed to 20mM-NH* ions. However,
Roberts et ad. (1977) showed that after vacuolation was induced (using 
either Triton WR-1339 or sucrose or PVP or Dextran) in rat yolk sacs
in vivo neither atypical pinocytic activity nor atypical proteolytic
125activity against formaldehyde-denatured I-labelled bovine serum albumin 
occurredwhen the vacuolated yolk-sac tissue was investigated in vitro.
The observations of Roberts and co-workers using the non-ionic vacuolating 
agents are in marked contrast to the observations made here using the 
weak bases. The observed inhibitions of pinocytosis and lysosomal 
digestion by the weak bases cannot be attributed to vacuolation, unless
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tissue undergoing vacuolation behaves differently to tissue already 
vacuolated at the start of the experiment (as used by Roberts et al.,
1977) . A criticism of the design of experiments of the type reported 
by Roberts et al. is that any inhibition dependent on the inhibitor being 
present in nascent secondary lysosomes could be missed. Also, if the 
tissue rapidly recovers from the effects of a small diffusible vacuolating 
agent, like the ammonium-and substituted ammonium ions, again any effect 
would be missed.
Feedback-inhibition of pinosome formation might operate through 
stopping membrane re-cycling at a stage after phagolysosome formation. 
Alternatively, plasma membrane replenishment might result from a secretory 
mechnism whereby membrane synthesized in the Golgi region is formed 
into vesicles which fuse with the plasma membrane. Ammonium ions at a 
similar concentration to those used here have been shown to inhibit 
secretion of proteins by hepatocytes (Seglen & Reith, 1977) and might 
also inhibit membrane replenishment by the above mechanism should it operate 
in the rat yolk sac. A more readily tested explanation of the inhibition 
of pinocytosis is, however, an inhibition by the weak bases of energy 
producing processes. Knowles .& Ballard (unpublished work)
showed (see below) that the levels of ATP and of the ATP/ADP ratio in 
yolk-sac tissue were decreased when the tissue was exposed to either 
ammonium- ormethylammonium- or ethylammonium ions.
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Weak Base
ATP content 
(nmole/mg yolk-sac 
protein) ATP/ADP
Control 14.19 ± 0.45 (12) 5.00 ± 0.30 (12)
5mM- ammoni urn 12.75 ± 0.56 ( 6) 4.69 ± 0.24 ( 6)
20mM " 10.84 ± 0.32 (13) 3.19 ± 0.15 (13)
5mM-methylammonium 12.09 ± 0.39 ( 6) 4.28 ± 0.15 ( 6)
20mM " 9.80 ± 0.31 (13) 2.76 ± 0.12 (13)
5mM-ethylammonium 13.74 ± 0.09 ( 3) 5.41 ± 0.33 ( 7)
20mM „ 11.68 ± 0.64 ( 3) 3.65 ± 0.24 ( 3)
Yolk sacs, .from 17.5-day pregnant rats, were incubated in the presence 
of a weak base for 2h before assaying for the adenine nucleotide levels. 
The data show the mean values (± S.E.M.) with the number of individual 
determinations shown in parentheses (Knowles & Ballard, unpublished data).
The metabolic inhibitors rotenone (Copter 4), dinitrophenol and 
iodoacetate (Duncan & Lloyd, 1978) are also known to inhibit pinocytosis 
of substrates by the 17.5-day rat yolk sac. The effect of ammonium ions 
on intermediary metabolism and energy production has been studied in the 
liver (Katunuma et al., 1966) kidney (Vinay, 1976) and brain (Hindfelt, 
1977).
An ammonium-ion load on kidney was shown by Vinay (1976) to 
have very little effect on the energy status of the kidney cells of 
fasted rats. In contrast, ammonium ions markedly decreased the energy 
status of both liver and brain tissues. In the brain, lOmin after 
injection of ammonium ions into rats (that had been made chronically
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hyperammonaemic by portal-systemic shunting 8 weeks previously), creatine 
phosphate levels were found to decrease whereas the level of the hydrolysis 
products, creatine and phosphate, increased. By 60min this effect was more 
pronounced and ATP levels were also diminished as was the ATP/ADP ratio. 
Measurements of the pyridine nucleotide reduction-potential in the 
cytoplasm and mitochondria indicated an increased NAD+/NADH ratio in the 
mitochondria and a decreased NAD+/NADH ratio in the cytoplasm. Hindfelt et 
al. (1977) suggested that the decreased level of ATP resulted from 
inhibition of respiration which occurred secondary to changes in the 
pyridine nucleotide levels. In the brain ammonia-loading decreases the 
tissue-level of asparate [considered by Hindfelt et al., (1977) to be the 
result of a net tramsamination between asparate and pyruvate giving rise 
to alanine and oxaloacetate]. Glutamate levels are also decreased as 
a result of the detoxification of ammonium ions in the brain, a process 
brought about by the synthesis, from glutamate and ammonium ions, of 
glutamine. The fall of both glutamate and aspartate levels, Hindfelt 
and co-workers suggested, inhibits the "malate-aspartate shuttle" which 
normally functions to transfer reduced equivalents of NADH from the cyto­
plasm to the mitochondria. A deficiency of intramitochondrial NADH was 
suggested to inhibit oxidative energy coupling and ultimately lead to a fall 
in ATP levels.
A similar event might also occur in the liver, but in addition, 
Katunuma et_ a2_. (1966) discovered that, following ammonia intoxication, 
the total level of mitochondrial pyridine nucleotides markedly decreased. 
Katanuma and co-workers discovered that ammonia activated a new pathway of 
pyridine nucleotide catabolism. In this pathway NADH and NADPH were 
enzymically converted by a pyrophosphatase enzyme to NMNH that, after
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in the levels of mitochondrial pyridine nucleotide would necessarily bring
about an inhibition of respiration.
The effects of ammonium, methylammonium- and ethylammonium ions
on intermediary metabolism and the levels of pyridine nucleotides in the
yolk sac are not known, but it is possible that the observed decreases in
ATP levels and ATP/ADP ratios could be the result of changes similar to
those described by Hindfelt et al.(1977) and Katunuma et al. (1966).
It is also possible that the inhibition of pinocytosis in the
1 7 .5-day rat yolk sac by chloroquine is due to an interference with the
energy status of the yolk-sac epithelial cells, but data on this is not
available. Chloroquine, however, has been reported to decrease the
cellular level of ATP. (see Goldstein & St. John, 1976, unpublished results).
Morphological studies indicate that chloroquine also inhibits
pinosome formation in macrophages (Fedorko et al. 1968b). Chloroquine
at a concentration of 5yM completely inhibited the uptake of arylsulphatase A
14by human fibroblasts whereas the uptake of [ C]dextran was only inhibited
by about 5-10% (see Fig. 5 of Weismann, 1974). This suggested to Weisman
that chloroquine might mask the cell-surface binding-site for the lysosomal
enzyme. [It is interesting to note however, that chloroquine inhibits
arylsulphatase enzymic activity (Smith et al., 1976) which also suggests
that chloroquine binds to the lysosomal enzyme, possibly masking the
recognition site on the enzyme surface.] Brown & Segal (1977) reported
that chloroquine had no effect on the pinocytic activity of the 17.5-day
rat yolk sac. This is a marked contradiction of the observations made
■ * 125here showing chloroquine to inhibit the uptake of [ i]-labelled substrates 
in both serum-free and serum-containing incubation medium. However, because
oxidation, was further converted to nicotinamide. The consequent decrease
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Brown & Segal (1977) do not present any data on the uptake of substrates 
by the 17.5-day rat yolk sac in the presence of chloroquine and because 
they do not state the concentration of chloroquine used it remains impossible 
to explain this discrepancy. Nevertheless, a lack of effect of chloroquine 
would be surprising since chloroquine is a toxic substance. Chloroquine 
toxicity has been described both in vivo and in vitro. The injection of 
chloroquine into rats at doses higher than 75mg/kg body-weight is usually 
lethal (Stein et al., 1977). Deleterious effects of chloroquine, at 
doses higher than 50yM, were observed on human fibroblasts in culture 
(Lie & Schofield, 1973) and 55yg/ml (approx. lOOyM) concentrations of 
chloroquine in the culture medium produced severe toxic effects with 
macrophages, most of the cells being dead or detached by 2h. Moreover, 
Goldstein & St, John (1976) report that their unpublished data show 
chloroquine to cause the release of endogenous proteins from within cells. 
Concentrations of chloroquine in excess of lOOyM were found to be severely 
toxic to yolk sacs, and resulted in the release of ingested substrates, 
endogenous B-N-acetyl-B-D-glucosaminidase and endogenous lactate 
dehydrogenase.
In contrast to the observed toxicity of chloroquine to intact 
cells, the drug has been shown to stabilize lysosomal membranes (Weismann, 
1965, 1966, 1967; Ignarro & Colombo, 1972). However, a biphasic effect 
of chloroquine on the stability of erythrocyte membranes has been reported 
by Inglot & Wolna (1968). These authors reported that low concentrations 
(approx. 100_^ M) of chloroquine stabilized the membranes but higher concentra­
tions (approx. ImM) labilized them. Cells in culture can accumulate 
chloroquine to produce an intracellular concentration many times that in 
the extracellular medium (Polet, 1970; Wibo & Poole, 1974) and might
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therefore produce intracellular concentrations of chloroquine which are 
sufficiently high to labilize the cytomembranes even though low 
concentrations of chloroquine are present in the incubation medium.
Ammonia is known to be toxic i n vivo causing severe neurological 
side effects (Wergedal et al., 1964, Hindfelt et al., 1977) but in vitro 
ammonia appears to be less toxic. Here ammonium- méthylammonium- and 
ethylammonium ions at effective inhibitory levels did not cause the same 
degree of release of endocytosed substrates as did chloroquine (Table 5.2). 
Moreover, the inhibitory effects of ammonium ions on both endocytic and 
proteolytic activities were found to be reversible (Table 5.3)s complete 
recovery was observed except after exposure to 20mM-ammonium ions for lh 
when the endocytic activity of the exposed rat yolk sacs remained 10-15% lower 
than in control yolk sacs. Seglen (1975) obtained a complete recovery in 
the autophagic digestive activity of hepatocytes in culture after exposure 
to 5mM-ammonium ions and rat hepatocyte monolayers incubated with lOmM- 
-ammonium ions for several days showed an undiminished viability (Seglen,
1977). Knowles & Ballard (unpublished data) showed that after exposure 
of 17.5-day rat yolk sacs to 20mM-ammonium ions for 2h, the yolk sacs, 
after re-incubation in medium free of ammonium ions, fully regained 
their ability to degrade endogenous proteins. Indeed, a higher rate of 
such digestion was observed during re-incubation, an effect which might be 
explained by the accumulation of cellular material within lysosomes 
during the exposure to ammonium ions so that on removal of the ammonium 
ions, more cellular protein was immediately available for digestion.
Knowles & Ballard also showed a recovery in both the ATP levels and the 
ATP/ADP ratios after removal of ammonium ions:
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Recovery period in serum-free medium
Oh lh 2h
ATP
(nmoles/mg control 14.19±0.45 (12) 13.61±0.49 (6) 14.1210.73 (5)
yolk-sac
protein) 20mM-NH^ ions 10.84+0.32 (13) 11.37±0.41 (6) 11.5410.28 (4)
ATP/ADP
control
+
5.00±0.30 (12) 5.1110.23 (6) 5.7310.40 (5)
20mM-NH. ions == 4 3.19+0.15 (12) 4.9210.31 (6) 5.1010.30 (4)
Adenine nucleotide levels in control tissue and rat yolk sac after exposure 
to 20mM-NH+ ions for 2h followed by 0, 1 and 2h recovery in medium free of 
NH+-ion. The mean values (± S.E.M.) of the ATP levels (nmole/mg yolk-sac 
protein) and ATP/ADP ratios are shown together with the number of individual 
determinations shown in parentheses. (Knowles & Ballard, unpublished data).
The ATP/ADP ratio clearly returns to almost normal within lh but 
the recovery of ATP levels is slow and incomplete by 2h. The rapid recovery 
of pinocytic activity (Table 5.3) and the ATP/ADP ratios, but not ATP levels, 
in yolk sacs after exposure to 20mM-ammonium ions suggests that it is the 
ATP/ADP ratio that probably regulates the pinocytic activity of the rat yolk 
sac. ATP levels might, however, limit the pinocytic activity of the yolk- 
-sac and the incomplete recovery of pinocytic activity after exposure to 
ammonium ions might be the result of a slower recovery of ATP levels.
The inhibition of pinocytic activity of the rat yolk sacs 
observed in the presence of ammonium-, methylammonium- and ethylammonium 
ions is a new finding (as indicated by the results of a literature survey) 
and adds to the many effects that ammonium ions are reported to have.
Ammonium ions inhibited the toxic action of diphtheria toxin on mammalian 
cells in culture (Ivins et al., 1975) but the ammonium ions at the protective
130
levels did not alter the uptake of the toxin (Bonventre, 1975). Lectin- 
-induced lymphoblastogenesis was reported to be inhibited in a tissue 
culture medium, and the inhibitor was identified as ammonia, generated 
by deamination of glutamine (Baechtel et al. 1976). Ammonium chloride 
buffers were accidentally discovered to markedly reduce the ability of 
lymphoid cell preparations to function as attacking cells in an antibody- 
dependent cell-mediated cytotoxicity test, but the cells retained their 
ability to adhere to antibody-coated target cells (Yust e_t al^ ., 1976). 
Seglen & Reith (1977) discovered that ammonium ions inhibited protein 
secretion in isolated rat hepatocytes. All these effects might be the 
result of the interference of ammonium ions on energy production. 
Stimulatory effects of ammonium ions have, however, also been reported: 
increased iodide uptake by thyroid cells (Burk & Kowalski, 1971), enhanced 
Ca++-dependent catacholamine secretion from adrenal glands (Sorimachi, 
1968), enhanced aldosterone production by rat adrenal sections (Muller, 
1965) and increased gluconeogenesis in isolated rat hepatocytes (Zahlten 
et al., 1974).
CHAPTER SIX
EFFECTS OF MICROBIAL PROTEINASE 
INHIBITORS ON PROTEIN CATABOLISM
WITHIN RAT YOLK SACS
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6.1 INTRODUCTION
In the previous chapter evidence was forwarded that the 
digestion of endogenous yolk-sac proteins occurs at both a lysosomal 
and a non-lysosomal site. The evidence was gained through the use of 
weak bases that were shown to inhibit both lysosomal proteolysis and 
the breakdown of endogenous proteins. The inhibition of proteolysis 
by the weak bases was not, however, a specific effect? concomitant decreases 
were observed in the tissue-level of ATP, in the ATP/ADP ratio and in 
the rate of pinosome formation. Simpson (1953) as well as Steinberg & 
Vaughan (1956), showed agents that inhibited the generation of ATP to also 
inhibit protein degradation in liver slices. It has now been observed, 
in many cell types, that protein degradation is inhibited by compounds 
that interfere with energy production (Goldberg & St. John, 1976). 
Consequently, the observed inhibition, by weak bases, of endogenous 
yolk-sac protein breakdown may, in addition to any inhibition of intra- 
lysosomal proteolysis, be caused by an inhibition of some non-lysosomal 
energy-requiring process essential to protein breakdown. For example, 
autophagosome formation, which appears to contribute to the breakdown of 
endogenous proteins in other cell types(Dean & Barrett, 1976; Ballard,
1977) might also be inhibited by weak bases in a manner analogous to the 
inhibition of heterophagosome formation observed in the previous chapter.
To further investigate the contribution of lysosomal and 
non-lysosomal enzymes to the breakdown of endogenous yolk-sac proteins and 
to further investigate the hydrolysis of endocytosed protein substrates, 
it was desirable to discover lysosomal enzyme inhibitors free of any 
attendant complications of the type met in studies made with weak bases, and 
which preferably act solely on lysosomal enzymes. It was the aim of the 
work reported in this chapter to discover such inhibitors.
132
A new group of peptide proteinase inhibitors isolated from Strepto- 
mycese culture filtrates (for reviews see Aoyagi & umezawa, 1975 and 
Umezawa & Aoyagi, 1977) have been usefully employed to specifically inhibit 
certain groups of proteolytic enzymes. Six such microbial compounds have 
been utilized in the studies that follow. Pepstatin is a N-acyl-pentapeptide 
of which several distinct chemical forms have been isolated (Aoyagi &
Umezawa, 1975) The structure of pepstatin A is shown in Diagram 6.1; it 
is thought to be a transition state, pseudo-irreversible, competitive 
inhibitor of acid proteinases (Marcinszin et al., 1976). Pepstatin specifically 
inhibits the acid-proteinases pepsin and renin (Aoyagi et al., 1971, 1972) 
and Cathepsins D and E (Barrett & Dingle, 1972; Woessner, 1972). Dean 
(1975b) showed that pepstatin, entrapped in liposomes, was taken up by 
rat liver, where it inhibited endogenous protein digestion.
Hopgood et al_. (1977) showed that, in addition to pepstatin, the 
microbial proteinase inhibitors antipain, bestatin and leupeptin could 
also be used to inhibit endogenous protein breakdown in isolated rat 
hepatocytes. Antipain and leupeptin were also effective inhibitors of 
protein breakdown in Reuber H35 hepatoma cells (Knowles & Ballard, 1976). 
Antipain (Diagrams 6.1) is an inhibitor of papain, trypsin, thrombokinase, 
plasmin, cathepsin A and cathepsin B (Suda et al., 1972; Ikezawa et al.,
1972). Bestatin (Diagrams 6.1) inhibits the enzymes aminopeptidase B and 
leucinaminopeptidase but not aminopeptidase A or endopeptidases (Umezawa 
& Aoyagi, 1977). Leupeptin is the name given to a group of compounds 
comprising acetyl-(or propriony1-)-L-leucy1-L-leucy1-L-arginal and their 
analogues in which leucine is replaced by either isoleucine or valine 
(Rondo et al., 1969; Kawamura et al., 1969). The structure of the 
leupeptin, used in the studies that follow is in Diagram 6.1. Leupeptin 
inhibits (competitively); plasmin, trypsin, kallikrein, thrombokinase,
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Diagram 6.1 Structures of six peptide proteinase inhibitors of microbial origin.
Antipain: [ (S)-l-carboxyl-2-phenylethyl]-carbamoyl-L-arginyl-L-valylargininal (umezawa et al., 1972). Bestatin: (2S,3R)-
-3-amino-2-hydroxy -4-phenylbutanoyl-L-leucine (Umezawa & Aoyagi, 1977) . Chymostatin: N-[(S)-l-carboxy-2-phenylethyl)- 
-carbamoyl-a-N[2-iminohexahydro-4(S)-pyromidyl]-(S)~glycyl-L-leucyl-phenylalaninal (Tatsuta et al., 1973). Elastatinal:
N- [ (S) -1-carboxy-isopentyl] -carbamoyl-a- [2-iminohexahydro -14 (S) -pyrimidylj - (S) -glycyl- (S) -glutaminyl- (S) -alaninal 
(Okura et al., 1975). Leupeptin: acetyl-L-leucyl-L-leucyl-L-argininal (Rondo et al., 1969). Pepstatin: isovaleryl-L- 
-valy 1-L-valy 1-AHMHA-L-alanÿl-AHMHA, where AHMHA is 4-amino-3-hydroxy-6-methylhepatonoic acid (Morishima et al., 1970) .
133
papain and cathepsin B (Aoyagi et al., 1969; Aoyagi & Umezawa, 1975;
Umezawa, 1975; Fritz et al., 1973) and cathepsin L (Kirschke et al., 1977) 
but not cathepsin D (see Kirschke et al., 1977). In addition to the 
above microbial inhibitors, chymostatin, an inhibitor of chymotrypsin 
(Umezawa ejt al., 1970) and elastatinal, a specific inhibitor of elastase 
(Umezawa et al., 1973) might also inhibit lysosomal proteolysis in the 
yolk-sac culture system. Chymostatin is a good inhibitor of cathepsin B 
but poorly inhibits cathepsins A and D (Ikezawa et al., 1971). Riemann 
& Hanson (1978) have recently reported that chymostatin is also an 
inhibitor of cathepsin L.
Two characteristics of the above microbial proteinase inhibitors 
make them suitable for use as potential specific inhibitors of lysosomal 
proteolytic activity in the yolk-sac system. Firstly, they have been 
reported to be non-toxic, umezawa & Aoyagi (1977) indicate that an 
intravenous injection of antipain, 250mg/kg body-weight, and intraperitoneal 
injection of bestatin, 300mgAg body-weight, caused no death in mice.
No toxicity in mice was observed after an intravenous dose of 250mg 
elastatinal per kg body-weight. The quantity of leupeptin (given 
intravenously) and pepstatin (given intraperitoneally) that killed half 
the number of mice was reported as 118mgAg body-weight (125mgAg in rats) 
and 1 090mgAg body-weight, respectively. Secondly, cellular membranes, 
will not normally permit molecules of molecular weight >150 to permeate 
through them (Albert, 1968) and lysosomal membranes are not permeable to 
peptides with a molecular weight exceeding 200-250 (for review see 
Reijngoud & Tager, 1977). It is, therefore, most unlikely that the above 
microbial peptide proteinase inhibitors, each with a molecular weight that 
exceeds 300, will reach intracellular proteinases other than those within
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the lysosomal system. Also this implies that for inhibition of lysosomal 
proteolysis to occur, the inhibitors must be taken up by endocytosis.
Substances, other than microbial proteinase inhibitors, known
to inhibit enzymes of the type that occur in lysosomes include: heavy
metal ions (Huisman et al., 1973; Mego, 1976), iodoacetate (Huisman et al.,
1973, 1974), diazonium compounds (e.g. diazoacetylnorleucine methylester)
2+in the presence of Cu (Sodek & Hofmann, 1968), Tosyl derivatives
(Barrett, 1977), anti-proteinase antibodies (Dingle, 1971; Tulkens et al.,
1970) and protein proteinase inhibitors isolated from either plants and
animals (Kassell, 1970; Loskowski & Sealock, 1971) or microbes (Kakinuma
et al., 1978). The possibility of using protein proteinase inhibitors
was considered to be of little interest here since it is likely they would
be rapidly digested once inside lysosomes. Antilysosomal-enzyme antibodies
were shown to impair pinocytosis in fibroblasts (Tulkens et al., 1970) and
iodoacetate a powerful inhibitor of lysosomal catheptic activity (Huisman
et al^, 1973) was shown to inhibit pinocytosis in the rat yolk-sac
system (Duncan & Lloyd, 1978). The diazonium compounds are slow acting
2+and require the presence of Cu , which like the heavy metal ions, might 
be expected to be generally toxic; like metal ions and iodoacetate, Tosyl 
derivatives might not be expected to limit their antiproteolytic activities 
to the lysosomes. Also, Tosyl derivatives have been shown to inhibit 
protein synthesis at extremely low concentrations(Chou, et al., 1974).
The microbial proteinase inhibitors seem to offer the best 
prospect of a specific inhibition of lysosomal proteolytic activity 
provided that adequate quantities can be taken into the lysosomes by 
endocytosis. Leupeptin is a potent inhibitor of proteolysis in broken 
lysosome preparations (Huisman ejt al/, 1974) and an inhibitor of endogenous 
protein catabolism in intact cells (Hopgood et al., 1977; Neff et al.,
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1977; Libby & Goldberg, 1977). In this chapter the effects of leupeptin 
on endocytosis and lysosomal proteolysis in the 17.5-day rat yolk sac 
were studied in detail; possible effects of antipain, bestatin, chymostatin, 
elastatinal and pepstatin on this system were also investigated. A 
parallel study of the effects of these inhibitors on endogenous protein 
breakdown in the 17.5-day rat yolk sac is, at the time of writing, 
being conducted by Knowles & Ballard.
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6.2 METHODS
All methods used in this chapter were essentially the same as
described in previous chapters. Two different methods (see Section
5.2.1) were used to assay the uptake and degradation of formaldehyde- 
125-denatured 1-labelled bovine serum albumin. [Two different batches
125of formaldehyde-denatured I-labelled bovine serum albumin were used
in the experiments reported in this chapter and are designated batch I 
and batch II. Each was prepared ostensibly by the same method (see 
Section 2.2.3).} When yolk sacs were incubated with inhibitors, the 
radiolabelled substrate was added to the incubation medium 30min after the 
introduction of the yolk sacs to medium already containing the inhibitor. 
Antipain [(l-carboxy-2-phenyl-ethyl) carbamoyl-L-arginyl-L-valyl-L- 
-arginine] and bestatin [3-amino-2-hydroxy-4-phenylbutanoyl-L-leucine] 
were kind gifts from Dr. H. Umezawa, Microbial Chemistry Research 
Foundation, 14-23 Kamiosaki, 3-Chome, Shingana-Ku, Tokyo, Japan. 
Chymostatin [N-(l-carboxy-2-phenylethyl)-carbamoyl)-a-(2-iminohexahydro- 
-4-pyrimidyl)-L-glycyl-L-leucyl-phenylalaninal] and Elastatinal [N-(l- 
-carboxyisopentyl) carbamoyl-a-(2-imino-hexohydro-4-pyrimidyl)-glycyl- 
glutaminyl-alininal] were kind gifts from Dr. W. Troll, Department of 
Environmental Medicine, Obstetrics and Gynaecology, New York University 
Medical Centre, 550 First Avenue, New York 1006, U.S.A. Leupeptin 
[acetyl-L-leucyl-L-leucyl-L-arginal] and pepstatin [isovaleryl-L-valyl-L- 
-valy1-AHMHA-L-alanyl-AHMHA; where AHMHA is 4-amino-3-hydroxy-6-methyl- 
-hepatonoic acid] were purchased from the Peptide Institute Inc., 476 Ina, 
Minoh-shi, Osaka 562, Japan.
Ihe method used to determine the recovery of the yolk-sac 
proteolytic activity after exposure to leupeptin was the same as that
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The effects of proteinase inhibitors on the release of endocytosed
125formaldehyde-denatured I-labelled bovine serum albumin were
determined as described for the effect of the weak bases (see Section
5.2.3(D) except that a 2h incubation period was used to load the yolk 
125sacs with i-labelled albumin.
The proteolytic activity (against formaldehyde-denatured
^^I-labelled bovine serum albumin) of cell-free extracts of 17.5-day
rat yolk sacs was assayed essentially as described in Section 4.2.4.
The incubation mixtures contained the following: buffer solution
[250yl, O.lM-sodium acetate, either pH 4.0 or 5.5]; Triton X-100 [150yl,
0.75% (v/v) dissolved in the appropriate buffer solution]; cell-free
extract [lOOyl, containing lOOyg yolk-sac protein]; inhibitor [llyg in
12550yl of distilled water]; formaldehyde-denatured I-labelled bovine 
serum albumin [lOyg in 50yl of 1% (w/v) aq. NaCl]. When assays were 
performed in the absence of Triton X-100, 150yl of Triton-free buffer 
solution was added in place of the Triton solution.
described for recovery from ammonium chloride exposure (see Section 5.2.4).
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6.3 RESULTS
6.3.1 Uptake and digestion of formaldehyde-denatured I-labelled 
bovine serum albumin by 17.5-day rat yolk sacs incubated in serum-free 
medium 199 containing leupeptin (20vg/ml).
A preliminary study showed that the digestion of formaldehyde- 
125denatured I-labelled bovine serum albumin, when incubated with 17.5-day
rat yolk sacs, was markedly inhibited by leupeptin at a concentration
of 20Pg/ml of serum-free medium 199. No effect on the rate of uptake of
the substrate was observed. The time course of the effect is shown in
Fig. 6.1 together with the corresponding control. In the control (as
described previously. Section 5.3.1) the tissue-associated radioactivity
rose during the first hour but then remained constant, so that the rates
125of digestion and of uptake of the I-labelled albumin became equal. In
contrast, yolk sacs incubated in the presence of 20yg/ml leupeptin
continued to accumulate radioactivity throughout the 3h incubation period!
also the rate of substrate digestion was markedly decreased (by approx.
12550%) but the rate of uptake of the I-labelled albumin was not altered.
125Moreover, the overall quantity of I-labelled albumin endocytosed by 
the yolk sac, the quantity of acid-soluble radioactivity released into 
the incubation medium and the quantity of radioactivity accumulated by 
the yolk-sac tissue each increased linearly with time. Such linearities 
indicate that, if a progressive accumulation of the leupeptin within 
lysosomes occurs during the course of incubation it does not result in a 
progressively greater inhibition of the lysosomal digestive process.
6.3.2 Effects of different concentrations of leupeptin on the uptake and
125digestion of formaldehyde-denatured I-labelled bovine serum albumin by
125
17.5-day rat yolk sac incubated in serum-free medium 199.
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The inhibitory effect of leupeptin on the digestion of 
125formaldehyde-denatured I-labelled bovine serum albumin by yolk sacs 
was shown to be dependent on its concentration in the incubation 
medium. Fig. 6.2 shows the time-course of the appearance of acid-soluble 
radioactivity in the incubation^when yolk sacs were incubated with the 
125I-labelled albumin in the presence of different concentrations of 
leupeptin (0-100yg/ml of incubation medium) . At each leupeptin concentra­
tion the acid-soluble radioactivity appearing in the medium, after an 
initial lag-period, increased essentially linearly with time over the 
remainder of the 3h incubation period. The rate of production of acid- 
-soluble radioactivity did not show any indication that it was progressively 
decreasing throughout the incubation period as might be expected if the 
leupeptin progressively accumulated within the lysosomes of the yolk sacs.
Fig. 6.3 shows the effects of the different concentrations of
125leupeptin on the rates of uptake and of digestion of the I-labelled 
albumin and on its accumulation by yolk sacs. A small (18%) inhibition 
of uptake was observed in the presence of leupeptin at a concentration 
of lOOpg/ml, but this was not statistically significant (P<0.10). As 
the leupeptin concentration was increased, the rate of digestion of the 
*25I_labelled albumin progressively decreased, reaching about 20% of 
the control rate of digestion in the presence of lOOyg/ml of leupeptin.
The decreased rate of digestion resulted in an observed concomitant increase 
in the 3h-level of tissue-associated radioactivity, which, at 40yg/ml of 
leupeptin, reached a maximum equivalent to 413% of that in control yolk 
sacs. The corresponding increase in the acid-insoluble radioactivity 
associated with the yolk sacs was significantly higher, 593%. The 
quantity of acid-soluble radioactivity in the yolk-sac tissue remained 
approximately constant (34-50ng/mg yolk-sac protein) at each leupeptin
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concentration so that the proportion of tissue-associated radioactivity
that was acid-soluble decreased with increasing leupeptin concentration
(Fig. 6.4, lower). The difference was found to be statistically
significant (P<0.02) even at a leupeptin concentration of lyg/ml of
medium. Fig. 6.4 (upper) shows the effects of different concentrations
125of leupeptin on the rate of digestion of the I-labelled albumin and
the average rate of accumulation of radioactivity by the yolk sac, but
after corrections for the observed fluctuations in the rates of uptake.
These data show more accurately the inhibitory effects of leupeptin on
125the digestion of the I-labelled albumin within the lysosomal system ©$ 
yolk-sac tissue.
6.3.3 Recovery of the proteolytic activity of 17.5-day rat yolk sacs 
after exposure to leupeptin.
The lack of a progressive decrease in the rate of digestion of 
125formaldehyde-denatured I-labelled bovine serum albumin, with increasing 
duration of incubation of yolk sacs in the presence of leupeptin (Fig. 6.1 
and 6.2), suggests either that the endocytosed leupeptin is continually 
inactivated or that newly-formed pinosomes containing the I-labelled 
albumin do not fuse with heterolysosomes containing previously endocytosed 
leupeptin. In either case a recovery of the proteolytic activity of 
the yolk sacs following exposure of the tissue to leupeptin would be 
expected. Fig. 6.5 shows that yolk sacs, exposed to concentrations of 
40yg/ml of leupeptin for lh, showed an initial rapid recovery of a 
large proportion of their proteolytic activity on being washed and 
re-incubated m  inhibitor-free medium 199 containing the I-labelled 
albumin (lyg/ml of medium). A slow, progressive recovery of the remainder 
of the proteolytic activity was observed over an 8-120min washing period,
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but complete recovery was never observed even after 2h of incubation in
leupeptin-free medium before re-determining the proteolytic activity of
the tissue. (It is possible, however, that a complete recovery might
have been achieved if a much longer recovery period had been used.) The
results obtained with the control yolk sacs (Fig. 6.5) show them to
maintain a constant proteolytic capacity throughout the duration of the
125experiment; at each time interval the I-labelled albumin endocytosed 
was completely digested so that the level of tissue-associated radioactivity 
remained constant.
0 # 3 . 4  Effects of chymostatin and leupeptin on the release of formaldehyde- 
125-denatured I-labelled bovine serum albumin by 17.5-day rat yolk sacs.
Yolk sacs, incubated in serum-free medium 199, were permitted
125to accumulate formaldehyde-denatured I-labelled bovine serum albumin
in the presence of either chymostatin (an inhibitor of the digestion of
12 5I_labelled albumin by yolk sacs, see Table 6.1) or leupeptin. After
washing the yolk sacs (in medium 199 containing the appropriate inhibitor,
see Section 6.2), they were re-incubated in medium containing the
125appropriate inhibitor but no I-labelled albumin. Fig. 6 .6  shows that,
compared with corresponding control experiments, both chymostatin and
leupeptin inhibited the release of acid-soluble radioactivity into the
incubation medium; leupeptin was more effective than chymostatin. However,
125such inhibition of the digestion of the I-labelled albumin did not 
enhance the proportion of the tissue-associated radioactivity that was 
released into the incubation medium as acid-insoluble radioactivity when 
the tissue was re-incubated. Indeed the proportion (<0.2%/h in the 
presence and absence of the inhibitors) was, if different, less when the 
inhibitors were present.
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6.3.5 Effects of six different microbial proteinase inhibitors on the
125rates of uptake and of digestion of formaldehyde-denatured I-labelled 
bovine serum albumin by 17.5-day rat yolk sacs incubated in serum-free 
medium 199.
The above experiments show that leupeptin is a powerful
125inhibitor of the lysosomal digestion of formaldehyde-denatured I-labelled
bovine serum albumin. Five other microbial proteinases (antipain,
bestatin, chymostatin, elastatinal and pepstatin) were tested to discover
whether they too inhibited proteolysis in the yolk-sac system. Results
of such experiments are shown in Table 6.1. (The inhibitory effects of
leupeptin were again measured so that a more direct comparison of the
inhibitory effects of the various inhibitors could be made. This was
125necessary as the batch of formaldehyde-denatured I-labelled bovine
serum albumin used in the following experiments differed from that used
125previously.) In control experiments, the rate of uptake of the I-labelled 
albumin used here (batch II; 208.8 ± 23.8ng/h per mg yolk-sac protein, 
see Table 6.1) was less than that observed in the previous control 
experiments (batch I; 275.6 ± 32.9ng/h per mg yolk-sac protein, see 
Fig. 6.3).
None of the microbial proteinase inhibitors, present at either
10 or 30pg/ml of incubation medium, modified the rate of uptake of the 
1 2 *5I-labelled albumin (Table 6.1, columns 1 and 2). Leupeptin was found 
to be the most potent inhibitor of digestion, showing a rate of digestion 
equal to 52.4 ± 11.2% (mean ± S.D.) of the rate of uptake (Table 6.1, 
column 4). Antipain and chymostatin also showed substantial inhibitory 
powers; chymostatin appeared to be slightly more effective but this 
difference was not statistically significant (P<0.10). Bestatin and 
elastatinal showed a small inhibitory effect when present at 30yg/ml of
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incubation medium, but this was only statistically significant in the case
125of bestatin (P<0.02). No inhibition of I-labelled albumin digestion 
was observed in the presence of either 10 or 30ug/ml concentrations of 
pepstatin.
125Whenever an inhibition of the digestion of I-labelled 
albumin was observed with any of the microbial inhibitors, a corresponding 
increase in the tissue-associated radioactivity was seen. Thus the 
quantity of tissue-associated radioactivity increased along the series: 
control = pepstatin = elastatinal = bestatin «  antipain = chymostatin 
«leupeptin (Table 6.1, columns 5 and 6). The proportion of the tissue- 
associated radioactivity that was acid-soluble decreased in the same order 
(Table 6.1 column 7).
6.3.6 Effects of the six microbial proteinase inhibitors on the digestion
125of formaldehyde-denatured i-labelled bovine serum albumin by a cell-free 
extract of 17.5-day rat yolk sacs.
The lack of inhibition of the digestion of formaldehyde-
125-denatured I-labelled bovine serum albumin by yolk sacs incubated in the 
presence of some of the above microbial proteinase inhibitors (Section
6.3.4) might be explained in a number of different ways. Either some 
of the microbial compounds have intrinsically low inhibitory papers against 
cathepsins in general or they are active against cathepsins other than 
those involved in the rate-limiting steps of the overall digestion of 
proteins, or their intralysosomal concentration never reaches an effective 
level (either because they are poorly endocytosed or because they are 
rapidly inactivated within lysosomes). A further way in which the microbial 
compounds might inhibit intralysosomal proteolysis of endocytosed protein 
substrate is by preventing lysosome-pinosome fusion. The last of these
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possibilities was tested by determining the effects of the inhibitors on
125the digestion of the I-labelled albumin by a cell-free extract of
17.5-day rat yolk sacs. In this system the membrane barriers that exist
in the yolk sac are disrupted so that the added inhibitors have free
access to the cathepsins. However, the intralysosomal pH within intact
tissue is not known precisely hence cell-free extracts were incubated 
125with I-labelled albumin at two pH's: 4.0 and 5.5 (i.e. an optimal- 
and suboptimal pH, see Fig. 4.3). Also, because a possible binding of 
inhibitors to disrupted membranes might decrease their effective concentra­
tions (especially pepstatin which is very hydrophobic) the determinations 
at both pH's were also made in the presence and absence of 0.2% (v/v)
Triton X-100. Results of such experiments are shown in Table 6.2.
In the presence of Triton X-100 at pH 4.0 the order of the
effectiveness of the inhibitors in preventing the hydrolysis of the 
125I-labelled albumin by the cell-free extract of yolk sacs was: 
leupeptin > chymostatin = antipain > bestatin = elastatinal - pepstatin > 
control. In the presence of Triton x-100 at pH 5.5 the potency of each 
inhibitor was, in general, decreased, except for pepstatin, which 
(unexpectedly) was more inhibitory at pH 5.5 than at pH 4.0. This effect 
was reproducible. A similar decrease in the extent of inhibition by 
pepstatin occurred on increasing the pH of the Triton-free assay medium 
from 4.0 to 5.5. As in the presence of Triton X-100, all the other 
proteinase inhibitors were less effective at the higher pH. These results, 
in general, indicated that leupeptin is the most potent inhibitor, antipain 
and chymostatin were good inhibitors at pH 4.0 whereas pepstatin was a 
good inhibitor at pH 5.5. Elastatinal and bestatin were only poor 
inhibitors. The presence of Triton X-100 did not affect the general 
patterns of inhibition. These results suggest that the differential
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inhibitory effects of the microbial compounds does not reside in a
differential inhibition of lysosome-pinosome fusion but resides in a
direct inhibition of those cathepsins involved in the rate-limiting step
125of the overall proteolysis of the I-labelled albumin after reaching an 
intralysosomal site.
Table 6.1 Effects of microbial proteinase inhibitors on the rates of uptake and of digestion of formaldehyde-denatured 1-labelled
bovine serum albumin by 17.5-day rat yolk sacs incubated in serum-free medium 199.
125 . .The rates of uptake and of digestion of formaldehyde-denatured I-la'oel3ed bovine serum albunun were determined by the 
method described in Section 3.2.1. ii5I-labellec’. albumin (Batch II lpg/ml of incubation medium) was added 30min after placing the 
yolk sacs in incubation medium containing the inhibitor .at the concentrations indicated. Each value reported represents the mean 
(± S.D.) of 3-8 separate determinations each over a 3h uptake period.
125
Inhibitor Cone
Ug/ml
Kate of uptake Rate of digestion
ng/h/mg
yolk-sac
protein
(% of ng/h/mg (% of rate
control) yolk-sac of uptake)
protein
Tissue- Average race
-associated of tissue 
radioactivity accumulation 
(ng/mg) at 3h over 3h period 
(% rate of 
uptake)
Proportion No. of
of the radio- determin 
activity in ations
the yolk sac 
(at 3h) that 
is acid-soluble
Control
Antipain
Bestatin
Chymostatin
Elastatinal
Leupeptin
- 208.8 + 23.8 (100.0) 204.9 + 25.8 ( 97.9 + 1.9) 99.1 + 17.0 15.8 + 2.4, 36.4 ± 3.2 8
(10) 227.2 + 16.0 (108.8) 201.8 ± 11.7 ( 88.9 + 3.7) 149.8 + 13.7 22.0 + 2.1 26.3 ± 3.1 4
(30) 199.8 + 23.2 ( 95.7) 151.6 ± 34.9 ( 75.2 + 10.2) 218.9 + 34.2 .37.1 + 8.5! 15.7 ± 3.2 4
(10) 216.2 ± 26.1 (103.5) 214.2 ± 21.5 ( 99.2 ± 2.5) 107.7 + 16.4 .16.6 + 1.3. 38.4 ± 5.5 3
(30) 196.9 + 25.6 ( 94.5) 185.5 ± 22.2 ( 94.3 + 1.2) 107.0 + 12.9 .18.1 + 0.2; 34.7 ± 2.9 3
(10) 215.1 ± 20.6 (103.0) 180.6 ± 18.3 ( 84.0 + 3.4) 181.1 + 26.5 .28.1 + 3.3. 19.6 + 3.9 4
(30) 208.5 + 28.6 ( 99.8) 173.7 ± 16.2 ( 71.8 + 8.8) 241.3 + 26.2 39.1 + 6.9. 14.8 + 3.6 4
(10) 200.0 + 7.8 ( 95.7) 193.6 ± 2.7 ( 97.0 + 4.9) 90.6 + 12.3 15.0 ± 1.6. 36.7 + 4.4 3
(30) 196.4 + 29.2 ( 94.0) 182.1 ± 26.1 ( 92.9 ± 6.9) 101.4 + 31.2 .16.9 ± 3.3. 30.8 + 4.9 3
(10) 212.2 + 59.5 (101.6) 167.3 ± 45.4 ( 79.0 ± . 5.6) 207.5 + 56.9 32.8 + 3.1 17.7 ± 3.6 4
(30) 214.2 + 33.4 (102.4) 114.8 ± 40.2 ( 52.4 ± 11.2) 314.2 + 54.6 :54.8 ± 8.9 9.6 + 2.3 3
(10) 211.0 + 23.5 (101.0) 207.3 ± 23.0 ( 98.3 ± 2.3) 98.1 + 14.4 15.4 ± 0.9. 36.6 ± 3.2 3
(30) 195.7 + 21.3 ( 93.7) 196.4 ± 16.9 (100.5 ± 3.3) 100.5 ± 18.5 16.9 ± 1.8. 35.2 + 3.0 3
Pepstatin
125of formaldehyde-denatured I-labelled bovine serum albumin by a 
cell-free extract of the 17.5-day rat yolk sac.
The effects'of the six microbial proteinase inhibitors on the 
rate of digestion of formaldehyde-denatured * ^ I-labelled bovine 
serum albumin (Batch II) was determined as described in Section 6.2.1. 
The data show the mean (± S.D.) of four replicate determinations. In 
each case the maximum amount of substrate digested did not exceed 3% 
of that initially present. Each of the inhibitors was present at a 
concentration of 20 yg/ml of incubation mixture.
125Relative rates of digestion of I-labelled albumin
(Control = ]00%)
Presence of Triton X-100 Absence of Triton X-100
Table 6.2 Effects of microbial proteinase inhibitors on the digestion
pH 4.0 pH 5.5 pH 4.0 pH 5.5
Control 100.0 + 5.7 100.0 + 14.3 100.0 ± 7.5 100.0 + 9.9
Antipain 14.6 + 4.3 84.5 + 5.3 18.8 + 7.3 48.9 + 9.3
Bestatin 75.0 + 10.9 98.3 ± 1.8 89.6 ± 8.5 88.4 + 16.1
Chymostatin 11.9 + 6.4 84.7 + 15.7 23.6 ± 4.4 69.0 ± 11.0
Elastatinal 71.8 + 12.9 83.5 + 4.0 57.4 ± 5.2 71.1 ± 9.0
Leupeptin 5.3 + 5.5 49.3 + 6.5 10.0 ± 2.0 25.1 + 10.7
Pepstatin 77.4 + 4.6 63.3 + 14.5 50.8 ± 5.9 19.4 + 6.3
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Figure 6.1 Effect of leupeptin (20 yg/ml) on the uptake and digestion of j
125 ! 
formaldehyde-denatured , I-labelled bovine serum albumin by 17.5-dav rat j
yolk sacs incubated in serum-free medium 199. f
ii
The uptake and digestion of formaldehyde-denatured 125l-labelled bovine I
serum albumin were determined as described in Section 2.2.1. Yolk sacs »
were incubated (in 20 ml medium 199) with leupeptin for 30 min before uptake I 
commenced on adding substrate (Batch I, 1 ug/ml cf incubation medium)
Each experiment was performed using yolk sacs from a single animal The 
control experiment was performed in parallel and is the same as that shown 
m  Fig. 5.1. Values at each time point are from two yolk sacs incubated I
separately. Tissue-associated radioactivity, (o ); acid-soluble 1
radioactivity released into the incubation medium, ( ■ ), sum of tissue- I
-associated radioactivity and acid-soluble radioactivity released into the !
incubation medium (•)? acid-insoluble radioactivity in the yolk-sac tissue,
l D J #
Figure 6.2 Effecteof different concentrations of leupeptin on
of appearance,of_acid-soluble radioactivity in serum-free incubation
medium^whejppolk^acs were incubated in the presence of formaldehvde-
125-denatured I-labelled bovine serum albumin.
Each curve was obtained on incubating a single yolk sac in serum-free medium 
199 containing “ Sl-iabaUed albumin (Batch 1, 1 yg/ml) (for method see 
Section 6.2). Yolk sacs were incubated in serum-free medium 199 
containing leupeptin for 30 min before addition of the * 125I-labelled albumin 
Each curve was selected, from a group of curves, to show a typical rat f o f  
digestion of the 1 5I-labelled albumin. The leupeptin concenSaUoJs 
(yg/ml) were: ( • ) , 0; ( a ) , 1, ( A ) , 20; ( o ) . 40; (■), 100.
FigUre 6'3 *L*?S*» of different concentrations of leupeptin on th* 
uptake andjligestipn of formaldehyde-denatured 125l-laheUed bovin*
albumin by. 17,.5-day rat yolk sacs incubated in semm-fr»» }nn
The rates of uptake and digestion of formaldehyde-denatured 125r , u 
bovine serum albumin were determined as describe s f?d I-labelled 
sacs were incubated for 30 min in medium “ s®ctlon 6-2. Yolk
concentrations indicated, before uptake wa<s «."I *euPePtin, at the 
substrate (Batch I, 1 yjmi of i n S S o n  I d  by * *  a<3diti°n of
(± S.D.) from 4 separate determinations each Eaf 1 yalue is the mean
a different animal. sing a single yolk sac from
Reading from left-hand scale: rate of uptake (m \ a .
Reading from right-hand scale: total tissue-as-Lr-Lf^ ra*? °f di9estion (■) 
tissue-associated acid-iasduM, t a d i o t t i " ^  ,T, ' ° > ™
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Figure 6.4 Effects of different concentrations of leupeptin on the rates
of digestion and of accumulation of pinocytosed formaldehyde-denatured 
^•^I-labelled bovine serum albumin by 17.5-day rat yolk sacs incubated
in serum-free medium 199.
Upper These data (mean ± S.D.) are taken from Fig. 6.2 but differ in 
‘ that the rates of digestion and rates of tissue-accumulation 
have been normalized for experimental variations in the rate of 
uptake. Rate of digestion, (•); rate of accumulation, (o).
Lower Shows the proportion (mean ± S.D.) of the tissue-associated 
radioactivity that is acid-soluble.
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Figure 6.5 Recovery of proteolytic activity by 17.5-day rat yolk sacs 
following their exposure to leupeptin.
Following a 1.0 h exposure of yolk sacs to leupeptin (40 yg/ml of 
incubation medium), the tissues were washed as 'described in Section 5.2.4, 
then placed in fresh incubation medium containing no leupeptin. Uptake 
and proteolysis (determined as described in Section 6.2) of formaldehyde- 
-denatured 2^I-labelled bovine serum albumin commenced on addition of 
substrate (Batch I, 1 yg/ml of medium) to the flasks containing the washed 
yolk sacs. Such additions were made at 8, 60 or 120 min after removing 
the yolk sacs from medium containing the leupeptin.
To determine the degree of inhibition of proteolysis caused by the 
continuous presence of leupeptin, media, that had been previously used to 
expose yolk sacs to leupeptin, were re-utilized. Freshly dissected yolk 
sacs were placed in such media and, after a 30 min period, the uptake and 
proteolysis of 125I-labelled albumin monitored on adding this substrate.
Each value is the mean (± S.D.) of four separate determinations using 
yolk sacs taken from different animals. Data indicated by "CP" on the 
abscissia are those obtained from experiments in the continuous presence 
of leupeptin and of the corresponding controls.
Control yolk sacs that had not been exposed to leupeptin were incubated in 
parallel. Rate of digestion: (o) control; (•) leupeptin (40 yg/ml).
Kate of tissue accumulation: ( n ) control; (■) leupeptin (40 yg/ml).
Figure 6.6 Effects of chymostatin and leupeptin on the release of formalde- 
125hyde-denatured I-labelled bovine serum albumin from 17.5-day rat yolk sacs.
Three yolk sacs, each from a different animal, were loaded with formaldehyde- 
-denatured 125I-labelled bovine serum albumin (Batch I I ,  5 yg/ml) in the 
presence or absence (control) of either chymostatin (40 yg/ml) or leupeptin 
(40 yg/ml). After washing, each yolk sac was re-incubated separately 
in fresh serum-free medium 199 with or without (control) inhibitor but 
initially containing no formaldehyde-denatured 125I-labelled bovine serum 
albumin. The quantities of released acid-soluble- and acid-insoluble 
radioactivity were monitored as described in Section 2.2.4(1) and expressed 
as a percentage of that radioactivity associated with the washed yolk sac 
when transferred to the fresh incubation medium. Values shown are the mean 
(±S.D.) of three determinations. Acid-soluble radioactivities: control, (A); 
chymostatin, (■); leupeptin, (•). Acid-insoluble radioactivities: 
control, ( A ); chymostatin, (o ); leupeptin, (o ).
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6.4 DISCUSSION
An inhibitor of proteolytic enzymes will only inhibit protein 
breakdown at an intracellular site within an intact cell if the inhibitor 
can penetrate the cell to the site of proteolysis and the inhibited 
proteinase is essential to the digestion process (Ballard, 1977). Because 
the microbial peptide proteinase inhibitors used here (see Fig. 6.1) are 
too large to penetrate cell membranes, they are not expected to inhibit 
intracellular proteinases except those confined to the vacuolar system 
(see Section 4.1), namely, the lysosomal cathepsins; their only envisaged 
route of access to the lysosomes is by endocytosis. The endothelial cells 
of the rat yolk sac are actively engaged in pinocytosis (see Chapter 1) 
and might therefore concentrate larger quantities of these inhibitors than 
some of the other cell types used to study endogenous protein breakdown 
(see Goldberg & St. John, 1976). This makes the study of the inhibition 
of the breakdown of endogenous proteins by yolk-sac cells more amenable to 
investigation by the use of microbial peptide proteinase inhibitors.
[Such a study (Knowles & Ballard, unpublished work) has been conducted in 
parallel with the current investigation.]
None of the six microbial proteinase inhibitors had measurable
125effects on the rate of uptake of formaldehyde-denatured I-labelled 
bovine serum albumin by 17.5-day rat yolk sacs. This observation is in 
marked contrast to the observed inhibitions of pinocytosis by the weak bases 
used in Chapter 5; hence the microbial compounds should prove more useful 
as specific inhibitors of lysosomal proteolysis than the weak bases. Moreover, 
an inhibition of intralysosomal proteolysis (see Table 6.1) does not result 
in any feedback-inhibition of pinocytosis of the type discussed in Section 
5.4. Nagai et al. (1978) showed chymostatin to be an inhibitor of phago­
cytosis by guinea pig macrophages, thus demonstrating the participation of
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a chymotrypsin-like enzyme in the phagocytic uptake process. This
observation corroborates the observations of Perlman et al_. (1969) and
Mussen & Becker (1977) that serine proteinase inhibitors are inhibitors of
phagocytosis in both human and rabbit neutrophils. As none of the six
125microbial compounds modified the rate of pinocytosis of the I-labelled
albumins, no proteinases either to which the microbial compounds might
gain access or of the type described by Nagai et al.(1975) are necessary
for continued micropinocytosis in 17.5-day rat yolk sacs.
Although much circumstantial evidence is available that suggests
antipain, leupeptin and chymostatin inhibit intralysosomal proteolysis
when added to cells in culture (see Knowles & Ballard, 1976; Hopgood et al.,
1977; Neff et al., 1977; Libby & Goldberg, 1977; Riemann & Hanson, 1978)
the observations made here (Table 6.1), to my knowledge, give the first
direct evidence. No inhibition of intralysosomal proteolysis was observed
when yolk sacs were incubated in the presence of pepstatin. A lack of
inhibition by pepstatin in the yolk-sac system was also observed by Moore
125(1975) who used both formaldehyde-denatured I-labelled bovine serum 
125albumin and i-labelled fibrinogen as substrates. In marked contrast,
pepstatin was shown here (Table 6.2) to inhibit the digestion of formaldehyde- 
125-denatured I-labelled bovine serum albumin by a cell-free extract of
rat yolk sacs. The reason for this discrepancy is not known. A possible
explanation is that cathepsins D and E, which are specifically inhibited
by pepstatin (Barrett & Dingle, 1972; Woessner, 1972), might not catalyse the
125rate-limiting step in the intralysosomal proteolysis of the I-labelled
albumin. Indeed, cathepsin D might not necessarily contribute to the 
125hydrolysis of I-labelled albumin in intact lysosomes. An alternative 
and equally feasible explanation is that yolk-sac epithelial cells are 
unable to transport pepstatin into their lysosomes. Concordant with this
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suggestion is a report in Turk & Marks (1977),[see Goldberg & St. John,
1976] that pepstatin does not readily enter cells. Also, Dean (1975b) 
reported that pepstatin does not seem to permeate macrophage plasma membranes 
(work of A.J. Barrett & C.G. Knight). Evidence that peptstatin is capable 
of inhibiting intralysosomal proteolysis was provided by Dean (1975b) 
who found that liposomally entrapped pepstatin was endocytosed by rat liver 
and caused up to 50% inhibition of the breakdown of endogenous proteins.
The lack of inhibition of formaldehyde-denatured 125I-labelled 
bovine serum albumin digestion by bestatin and by elastatinal,in the yolk- 
-sac system,correlates with their poor inhibition of the digestion of 
the same substrate in the cell-free system. So, even if these inhibitors 
were endocytosed,no marked inhibition of intralysosomal digestion would be 
expected.
Leupeptin was discovered to be the most potent inhibitor of
lysosomal proteolytic activity in both the intact yolk-sac tissue (up to
80% inhibition, see Table 6.1) and the cell-free system (up to 95% inhibition,
see Table 6.2). Leupeptin is a powerful inhibitor of cathepsin B (Huisman
et al., 1974) and cathepsin L (Kirsche et al., 1977). These are the only
lysosomal cathepsins known to be inhibited by leupeptin. Moreover, both :
enzymes (especially cathepsin l)readily hydrolyse protein substrates. Hence,
either one, or both together are expected to play a major role in the
125digestion of formaldehyde-denatured I-labelled bovine serum albumin 
within yolk-sac lysosomes.
Antipain and chymostatin (Ikezawa et al., 19 72 and 1971, 
respectively) are also inhibitors of cathepsin B but are less potent 
inhibitors of this enzyme than is leupeptin (Aoyagi & Umezawa, 1975). 
Chymostatin is also an inhibitor of cathepsin L (Riemann s Hanson, 1978).
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In the current study, both antipain and chymostatin were found to be less
125active than leupeptin as inhibitors of the I-labelled albumin digestion
in both the yolk-sac system and the cell-free system. [It is important
to note that the comparison of the inhibitory activities of these compounds
is made here on an equal weight basis, and that Aoyagi & Umezawa (1975)
also compared their activities on the same basis.] It seems probable,
therefore, that the inhibitions of digestion observed with antipain and
chymostatin are a consequence of the inhibition of cathepsin B (or
cathepsin L or both). Antipain is also an inhibitor of cathepsin A
(Suda et al., 1972; Ikezawa et al., 1972) and chymostatin is a weak
inhibitor of both cathepsins A and D (Aoyagi & Umezawa, 1975). An inhibition
125of the digestion of the I-labelled albumin as a result of an inter­
ference with cathepsins A and D cannot therefore be ruled out.
Tappel (1969) postulated that during the degradation of 
denatured proteins by lysosomal extracts, the first bonds to be split 
were those hydrolysed by cathepsin D, while the large peptide fragments 
formed were broken down by other proteases and peptidases. Coffey & 
de Duve (1968) also suggested an important role for cathepsin D. However, 
Huisman et al., (1973, 1974) demonstrated that thiol enzymes were important 
in the digestion of several protein substrates and concluded (1974) that, 
for serum albumin, the first peptide bonds to be broken are those cleaved 
by either cathepsin B or another leupeptin-sensitive thiol enzyme. Riemann 
& Hanson (1978) indicate that such thiol-dependent proteinases include 
cathepsin L. The results reported here, especially those obtained using
the cell-free system (see Table 6.2), also indicate this may be true for
125the digestion of formaldehyde-denatured I-labelled albumin by the yolk- 
-sac lysosomal cathepsins.
It is an implicit assumption that, to exert an inhibitory action
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®ft intralysosomal proteolysis, antipain, chyinostatin and leupeptin, are
accumulated within the yolk-sac lysosomes. Evidence that the inhibitions
of intracellular proteolysis of the 3I-labelled albumin is the result
of a direct inhibition of lysosomal cathepsins, rather than an inhibition
of lysosome-pinosome fusion, was gained by showing that, except for pepstatin,
hhe pattern of inhibitions by the microbial compounds could be reproduced
in the cell-free digestive system, if the inhibitors continued to accumulate
in an active form throughout the 3h incubation period employed in these
studies, it might be expected that the rate of digestion of the formaldehyde- 
125denatured I-labelled bovine serum albumin would decrease with increasing
time of incubation. There is, however, no evidence of this; the rate of 
125digestion of the I-labelled albumin was constant (after an initial lag- 
-period) throughout the 3h incubation in the absence and presence of all 
the inhibitors at each of the inhibitor concentrations used, it seems 
likely, therefore, that the intralysosomal concentrations of these three 
microbial-peptide proteinase inhibitors must reach a steady-state level so 
that the yolk-sac lysosomes continue to digest incoming 125I-labelled 
albumin at a constant but lowered rate. This would occur either if the 
microbial peptide proteinase inhibitors were inactivated within the 
lysosomes or if newly-formed pinosomes fuse only with primary lysosomes.
The latter explanation would imply an extremely rapid turnover of lysosomes 
and does not, therefore, seem feasible since Wang & Touster (1975) estimated 
the average half-life of lysosomal constituents to be four days. The 
rapid recovery of proteolytic activity following the exposure of yolk sacs 
to leupeptin (Fig. 6.5) is consistent with the contention that the microbial 
proteinases are inactivated within the lysosomes. Neff et al. (1977) also 
observed a recovery of proteolytic activity in hepatocytes 30min after 
exposure to leupeptin.
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Knowles & Ballard (unpublished work) showed leupeptin, chymostatin
and antipain (at concentrations of 50yg/ml of medium) to be inhibitors of
endogenous yolk-sac protein breakdown; inhibitions of 15-20%, 15-20%, and
15% of total yolk-sac protein breakdown were shown, respectively. They
also showed pepstatin, bestatin and elastatinal (and phosphoramidone)
to have no measurable inhibiting effects on endogenous yolk-sac protein
breakdown. The inhibitions demonstrate a lysosomal site of digestion of
endogenous yolk-sac proteins (since these inhibitors will be restricted
to the lysosomal compartment). However, these inhibitions are not as
.125marked as those for an exogenous protein ( I-labelled albumin). A 
possible interpretation of these findings is that endogenous yolk-sac 
proteins are also digested at an extra-lysosomal site. But such a 
conclusion would be based on the supposition that the exogenous protein 
( I-labelled albumin) has a susceptibility to hydrolysis by lysosomal 
enzymes that is representative of the bulk of endogenous proteins, so that 
the microbial compounds will cause a similar degree of intralysosomal 
inhibition. This could only be expected to arise from a very fortuitous 
choice of exogenous proteins.
When the six microbial inhibitors are ranked according to their
inhibitory powers against both endogenous protein digestion and exogenous
protein digestion the ranking orders are seen to be the same. This indicates
that for those endogenous yolk-sac proteins that are digested intralysosomally,
the rate-limiting step of their intralysosomal catabolism is catalysed by
similar enzymes to those that catalyse the rate-limiting step of the
125intralysosomal digestion of formaldehyde-denatured I-labelled bovine
serum albumin.
CHAPTER SEVEN
125PINOCYTOSIS OF I-LABELLED PROTEINS 
AND PEPTIDES AND THEIR SITES OF 
DIGESTION BY RAT YOLK SACS IN VITRO
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7.1 INTRODUCTION
The ability of several types of mammalian cells in culture
to endocytose and digest various exogenous proteins is well known (see
Chapters 1, 2 & 4) but little is known about the fate of polypeptides in
such systems. Ryser (1970) suggested that polypeptides with a molecular
weight less than 1000 are probably not endocytosed and that large
polypeptides and proteins are endocytosed more rapidly than small ones.
The observations made in Chapter 2, however, are not concordant with
125Ryser's suggestion; I-labelled preparations of lysozyme, ribonuclease
and insulin were shown to be pinocytosed more rapidly by the rat yolk sac
125in vitro than were I-labelled preparations of the larger proteins
orosomucoid and bovine serum albumin (results of Moore et al^ , 1977).
(These observations are more readily explained in terms of the surface
charge and hydrophobicity of the protein preparations, see Section 3.4.]
There may, however, be a "cut-off" point in the size of peptide molecule
below which it can carry no determinant for selective endocytic uptake.
125It was therefore of interest to determine whether I-labelled poly-
125peptides smaller than I-labelled insulin (molecular weight 5 700,
the smallest polypeptide investigated in the yolk-sac system, see Chapter
2) are endocytosed by the rat yolk sac and, if so, at what rates they
125are ingested. The possible uptake of I-labelled preparations of 
calcitonin (molecular weight 4 500), insulin B-chain (3 500) and 
glucagon (3 650) were therefore investigated.
The above substrates were chosen for investigation since they 
are precipitatable with trichloroacetic acid, but, of more physiological 
importance,they also enabled a concomitant study to be made of any 
extracellular digestion by peptidases associated with the cell surface of 
the 17.5-day rat yolk sac. Extracellular digestion of the peptides;
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insulin, calcitonin, insulin B-chain and glucagon has been suggested 
to occur in tissues other than the rat yolk sac (for review see 
Kenny, 1977; see also Section 4.1). For insulin, however, lysosomes are 
suggested as a possible site of digestion (Bohley et^  al., 1971;
Terris & Steiner, 1975; Grisolia & Wallace, 1976; see also Chapter 2).
. 125Direct evidence that formaldehyde-denatured I-labelled
bovine serum albumin is digested exclusively intracellularly is given in
Chapter 4. Firm circumstantial evidence for an intralysosomal site of
125digestion is given in Chapter 2 for the I-labelled substrates:
lysozyme, ribonuclease and insulin, and by Ibbotson (1978) for rat
immunoglobulin G. These digestible substrates were therefore re-examined
. 125here in order to compare results with those for the I-labelled peptides.
The susceptibility of proteins to digestion by proteinases
is of current major interest since this might regulate the rate at which 
#■
cell proteins turnover in vivo (Goldberg & Dice, 1976; Ballard, 1977).
Bohley et al. (1971) discovered that, in general, polypeptide substrates 
were more rapidly degraded by enzymes contained in lysosomal extracts 
than were larger protein substrates. Also, Marco et al. (1978) observed 
a similar increasing resistance to proteinases with increasing size of the 
protein substrate. These observations are contrary to those of Dice 
et al. (1973) and Dice & Goldberg (1975); both publications report the 
converse relationship.
If the peptide substrates investigated here are endocytosed 
by the rat yolk sac and their rates of uptake can be accurately determined, 
it becomes possible to discover whether the observations made by Bohley 
and Marco and their co-workers also hold for digestion within intact 
yolk-sac lysosomes in situ. The susceptibility to proteolysis of the proteins
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and peptides was judged by their Catabolic Indices (see Section 3.3.2).
The principle used here to determine the contribution of intra-
125cellular digestion to the overall digestion observed, when I-labelled
proteins (rat immunoglobulin G, formaldehyde-denatured bovine serum
125albumin, lysozyme and ribonuclease) and I-labelled peptides (insulin, 
calcitonin, insulin B-chain and glucagon) were added to the 17.5-day 
rat yolk sac in culture, is the same as that described in Section 4.1.
Here inhibition of pinocytosis was achieved using decreased incubation 
temperature^, the metabolic inhibitor rotenone and the weak base ammonium 
chloride.
The effect of ammonium chloride, also an inhibitor of lysosomal
proteolysis (see Chapter 5), on the intracellular digestion of each protein
and peptide substrate is of particular interest. Complete inhibition of
125the lysosomal digestion of formaldehyde-denatured I-labelled bovine
serum albumin by yolk sacs can be achieved by including a 20mM concentration
of ammonium chloride in the incubation medium (see Chapter 5). But it is
not known whether this effect is the result of a complete inhibition of all
lysosomal proteolytic activity or whether the result with formaldehyde- 
125-denatured I-labelled bovine serum albumin is atypical. Weak bases
are regarded as specific inhibitors of lysosome function (see Section 5.1).
It is generally assumed that the digestion of all proteins within lysosomes
will be inhibited by weak bases but this remains unproven.
Finally, the early events in the digestion of the 125I-labelled
proteins and peptides have been examined here. It was shown in Chapter 4
(see Fig. 4.1) that degradation products of formaldehyde-denatured
125I-labelled bovine serum albumin, added to 17.5-day rat yolk sacs in
culture, appeared in the incubation medium only after an initial lag-
125-period. Since the lag-period with I-labelled albumin was observed to
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increase with decreased incubation temperature, the possibility that similar 
observations would be made with other substrates was investigated.
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7.2 METHODS
1257.2.1 Preparation of I-labelled protein and peptide substrates.
125The I-labelled proteins formaldehyde-denatured bovine
serum albumin, bovine pancreatic ribonuclease A (type XIA), hen
egg-white lysozyme and bovine insulin were prepared as before [see
Section 2.2.1f3)]. Rat immunoglobulin G (Pentex Fraction II; Miles
Laboratories, Stoke Poges, Bucks.) bovine calcitonin (Calbiochem, San
Diego, California) bovine/porcine glucagon (Sigma, London) and
carboxymethylated insulin B-chain ( a kind gift from Dr. A.J. Kenny,
Department of Biochemistry, University of Leeds) were each iodinated with
[125l]iodide as described in Section 2.2.3(1). When glucagon (lOmg) was
added to tne phosphate buffer (pH 8.0, 4.25ml) it did not completely
dissolve but remained in suspension in which form it was iodinated.
125(Since the i-labelled glucagon remained insoluble it could be dialysed
125[Section 2.2.3(1)1 to remove [ IJiodide). After dialysis, the
125I-labelled glucagon preparation was titrated to pH 3.5 with dilute
acetic acid to solubilize it. Insulin B-chain was soluble in aqueous
125solution but separation of the I-labelled insulin B-chain from free
[125I]iodide and other salts was achieved on a Sephadex G-25 column
(30cm x 1.7cm), equilibrated and eluted with distilled water by the
method described in Section 2.2.4(3). Virtually all of the radioactivity
applied to the column was eluted; 95% being associated with the insulin
B-chain. The iodination efficiency for this peptide was therefore 95%.
Determination, by the acid-precipitation method [see Section 2.2.3(1)]
of the labelling efficiencies of the immunoglobulin G, calcitonin and
glucagon gave values of 60, 35 and 75% respectively. The specific 
125activities of the I-labelled substrates at the time of preparation were 
60, 35, 75 and 95yCi/mg for immunoglobulin G, calcitonin, glucagon and
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insulin B-chain; the corresponding numbers of protein or peptide molecules
125containing one atom of [ I]iodine were 700 - 1 200; 8 000 - 13 000;
3 500 - 6 000 and 2 500 - 4 000, respectively.
1257.2.2 Handling of the yolk-sac tissues in experiments with I-labelled 
peptides.
Yolk sacs, dissected from 17.5-day pregnant rats by the method
described in Section 2.2.1, and placed in serum-free medium 199 were 
125found to digest I-labelled insulin B-chain at a very rapid rate
(approximately 20%/h for a single yolk sac in 20ml of medium 199
125containing 20yg of I-labelled insulin B-chain) . Only half of the
digestive activity was eliminated on removing the yolk sac from the
incubation medium, indicating that degradative enzymes were released
into the incubation medium from the incubated tissue.
A more thorough washing of the freshly dissected yolk sacs, with
medium 199, decreased the quantity of degradative enzymes released.
Deliberately cutting such yolk sacs with scissors or gripping them between
a pair of forceps resulted in the release of large quantities of the
degradative enzymes. Also, a single well-washed amnion (previously
125dissected free of the yolk-sac tissue) digested i-labelled insulin 
B-chain (20yg) at a rate of 1.15%/h when both were incubated together in 
20ml of medium 199. Approximately one third of the digestive activity 
remained associated with the incubation medium on removal of the amnion 
after 3h of incubation.
Because of the extreme ease of release of degradative enzymes from 
the yolk-sac tissue, special care was required when handling it to reduce 
such release to a minimum. Additional procedures were therefore adopted 
when preparing yolk sacs for experiments. Care was taken to ensure that all 
the amnion was dissected away from the yolk-sac tissue (by increasing the
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contrast between the tissues by dissecting over a black background) 
also yolk-sac tissue was handled as little as possible. As an additional 
precaution before their use in digestion studies with peptides, yolk 
sacs completely free of amniotic tissue were washed (3 yolk sacs per 20ml 
of medium 199) for lOmin under the usual incubation conditions; the washing 
was repeated twice more before introducing the tissue into the experimental 
incubation medium. Care was required when transferring the yolk sacs from 
one medium to another. To transfer the yolk sacs, the wash medium and 
yolk sacs were decanted from the incubation flask into a clean Petri dish. 
Each yolk sac was scooped out of the wash medium, on the top of a clean 
pair of curved forceps, and the yolk sac allowed to float off the tip of 
the forceps after submerging both in fresh medium.
1257.2.3 Assay of the uptake and digestion of I-labelled proteins and 
peptides by 17.5-day rat yolk sacs incubated in serum-free medium 199.
125The rates of uptake and digestion of i-labelled proteins and
peptides by 17.5-day rat yolk sacs were each assayed by the rapid method
described in Section 3.2.1. When the acid-soluble radioactivity released
into the incubation medium was monitored over a 0-50min period, either 1
or 3 yolk sacs were incubated in 20.0 or 30.0ml of serum-free medium
125respectively. For the I-labelled substrates immunoglobulin G, 
formaldehyde-denatured bovine serum albumin, ribonuclease, lysozyme, 
glucagon and insulin, three yolk sacs were incubated in 30.0ml of serum- 
-free medium. With ^^I-labelled calcitonin and *^I-labelled insulin 
B-chain, yolk sacs were incubated singly in 20.0ml of serum-free medium. 
[The reason for the two different methods employed is historical; 
initially it was considered that to obtain measurable quantities of 
radioactive digestion products during the first few minutes of incubation,
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the larger quantity of yolk-sac tissue would be required, but this was
not generally the case.] All the yolk sacs were incubated at an
125appropriate temperature for 15min before addition of the I-labelled 
substrate at an intial concentration of 5yg/ml of medium. Medium 
samples (1.0ml) were taken at frequent periods and immediately mixed with 
0.1ml of calf serum quickly followed by the addition of 20% (w/v) 
trichloroacetic acid before the acid-soluble radioactivity was assayed 
as described in Section 2.2.1(3).
When an incubation period of 3h duration was employed, the
yolk sacs were incubated singly in 20.0ml of serum-free medium 199.
125This procedure was adopted for all the i-labelled protein and peptide
substrates used. Substrates, initially present at lyg/ml of incubation
medium, were always added to the incubation medium at least 30min after the
introduction of the yolk sac. Duplicate samples (0.5ml) of medium were
taken at frequent time intervals. Each sample was immediately mixed with
0.5ml of 20% (v/v) aq. calf serum, quickly followed by the addition of
20% (w/v) trichloroacetic acid (0.5ml) to only the second of the duplicate
samples. The second sample was used to assay acid-soluble radioactivity,
the first to assay the total radioactivity. [The immediate addition of
trichloroacetic acid to the second sample was essential to prevent the
125continued digestion of the I-labelled peptides, subsequent to taking 
the sample out of the incubation medium, but was not necessary for the 
sample used to determine the total radioactivity present at each time 
interval.] When the quantity of acid-soluble radioactivity in medium 
containing either 125I-labelled ribonuclease or 125I-labelled lysozyme 
was measured, 0.5ml of phosphotungstic acid [prepared as described in 
Section 2.2.1(3)} was added to the sanple prior to the addition of the 
trichloroacetic acid.
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When the I-labelled substrates, insulin, calcitonin, insulin 
B-chain and glucagon were being investigated the incubation medium was 
incubated for a further 3h after removal of the yolk sac. When either 
ammonium chloride or rotenone was added to the incubation media, the 
addition was made 30min prior to the addition of the substrate (see 
Section 4.2.1 & 5.2.1).
7.2.4 Calculation and expression of the pinocytic uptake and digestion 
data.
125The quantities of the I-labelled proteins (immunoglobulin G, 
formaldehyde-denatured bovine serum albumin, ribonuclease and lysozyme)
ingested and digested were each calculated as described in Section 3.2.1(2).
125For the I-labelled peptide substrates that became digested by degradative 
enzymes released into the incubation medium, additional calculations were 
required to obtain data on that fraction of the total digestion that 
arose from enzymes associated with the yolk-sac tissue.
125Fig. 7.1 shows the time-course of digestion of I-labelled 
insulin B-chain by yolk sacs incubated singly in either the presence or the 
absence of rotenone (an inhibitor of pinocytosis). In both cases the 
rate of digestion decreases after removal of the yolk-sac tissue from the 
incubation medium. For the purpose of calculating the rate of tissue- 
-associated digestion it was assumed that the rate of extracellular 
digestion over the period 3-6h (after removal of the yolk sac) was 
identical to that in the presence of the yolk sac over the period 0-3h.
This assumes that the release of the enzymes from the yolk sac is complete 
before the I-labelled substrate is added to the incubation medium. The 
assumption was not made without experimental support; the quantities of 
enzyme present in incubation medium in which washed yolk sacs had been
125
125Figure 7.1 Digestion of I-labelled insulin B-chain by 17.5-day rat 
yolk sacs incubated in serum-free medium 199.
The data show two typical experiments in which a single yolk sac was 
incubated in 20 ml of serum-free medium 199 containing 1^ 5I-labelled 
insulin B-chain (1 pg/ml of medium) in the presence (o ) or absence 
(•> 10 5M-rotenone, an inhibitor of pinocytosis. For experimental 
details see Section 7.2.3. The rate of yolk-sac associated digestion 
is calculated by subtracting the rate of digestion at 3-6h from the 
rate of digestion at 0-3h and assumes that the rate of digestion in 
the medium itself is constant over the period 0-6h. The quantity of 
acid-soluble radioactivity generated by yolk-sac associated digestion 
during the 0-3h period of incubation is calculated by subtracting the 
quantity of acid-soluble radioactivity generated over 3-6h (a or b) 
from the corresponding quantity of acid-soluble radioactivity present at 
3h.
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previously incubated for either 0.5, 1.0, 1.5 or 2.Oh were found to be
125the same when assayed using i-labelled insulin B-chain as substrate.
Furthermore, in the absence of yolk sacs the rate of degradation of 
125
I-labelled insulin B-chain over a 6h period, by the degradative enzymes 
released from yolk sac, was constant. These observations indicate that 
the above assumption is valid.
The data as presented in the form shown in Fig. 7.1 were derived 
using equations 3.1 & 3.6 in Section 3.2.1(2). (For the purpose of calculating 
the amount of digestion that occurs after removal of the yolk-sac tissue 
(3-6h), P in equation 3.1 was made equal to the quantity of yolk sac protein.] 
The quantity of acid-soluble radioactivity produced by the tissue-associated 
degradation process throughout the 0-3h incubation period (T^ ) is calculated 
according to the equation:
= T, - (T “ V = 2T - T (7.1)
where is as defined above [see also Section 3.2.1(2)J, T;J is the total
amount of acid-soluble radioactivity generated in the 0-3h period of
incubation by both intracellular and extracellular digestive processes and
T6 is the total amount of acid-soluble radioactivity generated in the
period 0-6h by both the tissue-associated degradation process and the
degradative enzymes present in the culture medium. [t - t is the same
6 3
as the quantity indicated by 'a' or 'b' in Fig. 7.1.1 T and T are
3 6
calculated according to equations 3.2 in Section 3.2.1(2):
[T> - Vt . Ci(i.n) + £i=^n 11 C J  where Tn is equal to t3 or Tg when n
is the serial muter of the sample taken at 3.0h or 6.0h respectively. The
32 5
rate of pinocytic uptake of a l-labelled peptide was calculated (assuming 
that the tissue-associated digestion process is intracellular) according to
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equations 3.1 & 3.6 in Section 3.2.1(2) using values of T claculated as 
described above.
125The rate of digestion of a I-labelled peptide by the tissue- 
-associated digestion process is calculated according to the equations
Rl “ R2 “ R3 <7-2>
where Rj_ is the rate of digestion of the I-labelled peptide by the 
tissue-associated digestion process, R2 is the rate of production of 
acid-soluble radioactivity in the presence of the yolk sac (0-3h), and 
R3 is the rate of production of acid-soluble radioactivity in the absence 
of the yolk sac (3-6h).
All uptake and digestion data are expressed as the quantity 
(ng) of substrate ingested or digested per unit quantity of yolk-sac 
tissue (mg yolk-sac protein).
7.2.5 Preparation of rat-liver tritosomes.
Rat—liver tritosomes were isolated by the method of Trouet (1974).
Two male Wistar rats (each weighing approx. 250g) were injected intra- 
peritonealy with 2.5ml of Triton WR-1339 solution [20% (v/v) in 0.9% (w/v) 
aq. NaCl]. Four days later, they were killed after overnight fasting, the 
livers quickly removed then washed in ice-cold 0.25M-sucrose. The washed 
livers were pressed through a wire gauze (1mm mesh-size) and the liver 
pulp homogenized, in ice-cold 0.25M-sucrose (5ml per g of liver), using a 
Potter-Elvehjemtype Teflon-on-glass homogenizer (with an 0.19mm clearance) 
at a speed of 2 500r.p.m. Four up-and-down strokes were made within a 
period of 30s.
The homogenate was centrifuged at 2 200r.p.m. for lOmin (6 500 g-min) 
in a refrigerated MSE High-Speed 18 centrifuge. After removing the supernatant, 
the sediment was again homogenized in 0.25M-sucrose (3ml per g of liver) and
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the suspension centrifuged at 2 OOOr.p.m. for 10min (5 OOOg-min). The 
pooled supernatants were made up to a volume of 10ml per g of liver by 
addition of 0.25M-sucrose then centrifuged at 17 OOOr.p.m. for 10min 
(340 000g-min). The supernatant and the pink fluffy layer which covered 
the light brown pellet were removed, the pellet suspended in 0.25M-sucrose 
(5ml per g of liver) and again centrifuged at 17 OOOr.p.m. for 10min. The 
supernatant and fluffy layer were removed from above the pellet. The 
pellet was carefully suspended in 45% (w/v) sucrose (1ml per g of liver) 
by one up-and-down stroke in the homogeniser. A volume (5-7ml) of 
suspension was placed in a 25ml centrifuge tube and layered successively 
with 10ml of 34.5% (w/v) sucrose and 5ml of 14.3% (w/v) sucrose, by 
gently pipetting one solution on top of the previous one. The sucrose gradient 
was then centrifuged at 17 500r.p.m. for 2h (34 000 g-av.) in a refrigerated 
MSE Superspeed 50 centrifuge. The tritosomes, which congregated at the 
interface between the 34.5% and the 14.3% sucrose layers, were removed and 
kept at -20°C until required. The tritosome preparation and a sample of 
the liver homogenate were each assayed for acid phosphatase activity 
[method of Torriani (1960) and preincubating the fraction for 10min to 
inactivate microsomal phosphatases as described by Neil & Homer (1964)) 
and for protein content (method of Lowry et al., 1951). The relative 
specific activity of the acid phosphatase in the tritosome preparation 
was 33.5, this compares with a value of 32 ± 3.5 (n=22) reported by 
Trouet (1974).
7.2.6 Assay of the digestive activity of disrupted rat-liver tritosomes 
125using various 1-labelled proteins and peptides as substrates.
The method used to assay the digestive activity of 
disrupted tritosomes was essentially the same for each substrate
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investigated,but,when using a substrate for which the tritosomes have a 
low specific activity, it was necessary to increase both the quantity of 
tritosomes utilized and the duration of the incubation period in order 
to obtain measurable quantities of acid-soluble digestion products. The 
digestive activity was also measured at several pH values (4.0, 5.0 & 6.5) 
using 0.lM-sodium acetate and at pH 8.0 using O.lM-TnV [2-amino-2-(hydroxy­
methyl) propane - 1,3-diol].
The incubation mixtures contained buffered 0.32% (v/v) Triton
X-100 (350yl), tritosomes (5-200yl, containing 0.5yg protein per ul),
sufficient distilled water to bring the volume to 550yl and (after a
125lOmin preincubation at 37°C) I-labelled protein or peptide substrate 
(lOyg in 20yl of l.Q% (w/v) aq. N a d ) . The incubations were performed 
in 3ml disposable tubes (LP3, Luckhams Ltd., Burgess Hill, Sussex).
After incubation for an appropriate interval, the reaction was stopped by 
the addition of 20% (v/v) aq. calf serum (0.5ml) immediately followed 
by 20% (w/v) trichloroacetic acid (0.5ml). When 125I-labelled lysozyme 
was used as substrate, phosphotungstic acid [0.5ml, prepared as described 
in Section 2.211(3)] was added prior to the trichloroacetic acid. Substrate 
blanks, that contained distilled water in place of the tritosomes, were 
incubated in parallel. To determine the initial acid-insoluble radioactivity, 
total radioactivity was assayed in un-incubated substrate blanks prior to 
the addition of aq. calf serum, precipitation and assay of acid-insoluble 
radioactivity.
Both total- and acid-soluble radioactivity were assayed using a 
well-type gamma counter. Empirical correction factors, required to 
correct the observed acid-soluble counts for counting geometry (see 
Appendix I), were determined for a sample volume of 0.570ml (the volume
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of the reaction mixture) using I-labelled-L-tyrosine as the acid- 
-soluble radiotracer. The values were 1.67 and, when phosphotungstic 
acid was used to aid precipitation of the protein substrate, 2.17.
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7.3 RESULTS
It is advantageous, for the sake of clarity, to discuss some 
of the results from this chapter at the time of their presentation. A 
more general discussion is given in Section 7.4.
1257.3.1 Stability of I-labelled proteins and peptides under various 
incubation conditions in serum-free medium 199.
Table 7.1 shows the rate of appearance of acid-soluble
125radioactivity derived from various I-labelled proteins and peptides 
incubated under various conditions. The rates of appearance of the acid- 
-soluble radioactivity are each expressed as the percentage of the initial 
acid-soluble radioactivity rendered acid-soluble per h of incubation.
Values below 0.1%/h are considered to be negligible [0.1%/h corresponds 
to a value of 4ng/h per mg yolk-sac protein if the incubation medium
(20ml) contained yolk-sac tissue equivalent to 5mg yolk-sac protein.]
125 125Only I-labelled insulin B-chain and i-labelled glucagon
showed significant rates of production of acid-soluble radioactivity
when present in fresh serum-free medium 199 alone. This indicates that
125the majority of the I-labelled substrates employed are stable under
the usual incubation conditions. When yolk sacs were added to the incubation
. 125medium, significant quantities of each of the I-labelled substrates were
digested. Removal of the yolk sacs from the medium completely halted
125the digestion of the I-labelled protein substrates (immunoglobulin G,
formaldehyde-denatured bovine serum albumin, ribonuclease and lysozyme)
showing that the digestive activity toward these substrates is entirely
125tissue-associated. However, the I-labelled peptide substrates 
(insulin, calcitonin, insulin B-chain and glucagon) continued to be 
digested in the incubation medium in which yolk sacs had been previously
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incubated. The quantities of I-labelled peptide digested in such
conditioned medium were always greater than the corresponding amount
digested in (unconditioned) medium 199 alone. This suggests that
incubating yolk sacs in medium results in the release of significant
125amounts of degradative enzymes. Nevertheless, the amount of I-labelled
peptide digested in the conditioned medium was always significantly less
125than that in the presence of a yolk sac. The I-labelled peptide
substrates therefore appear to be digested mainly by a tissue-associated
process and, to a much lesser extent, by degradative enzymes present in
the incubation medium. Homogenization of the yolk-sac tissue in medium
199 [1 yolk sac was homogenized in 5ml of medium (pH 7.1), using a
Potter-Elvehjem type glass-on-glass homogenizer (0.19mm clearance),
then centrifuged at 300g x 5min to remove intact cells] fully abolished their
125digestive activity toward the I-labelled protein substrates. In
marked contrast, the digestive activity of the yolk-sac tissue toward the
125I-labelled peptide substrates was dramatically increased following
125its homogenization. The lack of digestion of the I-labelled protein
substrates by the yolk-sac homogenate shows that intact cells are required
to maintain protein digestion and, unless they are rapidly inactivated by
homogenization, the yolk sac contains no extracellular, cell-surface
associated enzymes that could be responsible for the observed digestion
in the presence of the intact yolk-sac tissue. The increased ability
125of the yolk-sac tissue to digest the I-labelled peptide substrates on
homogenization suggests that a barrier must separate the bulk of the
125degradative enzymes from the I-labelled peptide substrates in the 
intact yolk-sac tissue. It is probable that the bulk of the degradative 
enzymes is located within some intracellular compartment and is not 
freely accessible to the incubation medium. (The alternative explanation,
125
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that homogenization activates extracellular, cell-surface associated 
enzymes seems implausible.)
The ranking of the relative rates of digestion of the
125I-labelled peptides by the yolk-sac homogenate is the same as the
ranking of the relative rates of digestion in the conditioned medium. In
125each case the most rapidly digested I-labelled substrate is glucagon,
followed by insulin B-chain, calcitonin and lastly insulin. This provides
strong circumstantial evidence to suggest that the digestive activity
present in the conditioned medium is the result of the leakage or transport
of intracellular enzymes into the medium. The proportion of the yolk- 
125-sac I-labelled peptide-degradating activity that must be released into
125the incubation medium to account for the digestion of I-labelled
125 125calcitonin, i-labelled insulin B-chain and I-labelled glucagon in
the conditioned medium was calculated to be 0.16, 0.15 and 0.18%
respectively for a typical yolk sac containing 5mg protein. (The value 
125for I-labelled insulin was 0.06%, but the rates of digestion in the 
conditioned and unconditioned medium were too small to make this determina­
tion accurate.)
The location within the intact yolk sac of the enzymes that 
125digest the I-labelled peptides is not clear. The digestive activity 
of an unfractionated, cell-free, yolk-sac homogenate measured at several 
pH values between 3.0 and 9.0 (essentially by the method described in 
Section 4.2.4) showed the highest activity against I-labelled insulin 
B-chain at pH 3.5 to 5.0. The digestive activity of the homogenate at 
the acid pH values was largely inhibited by a mixture of pepstatin and 
leupeptin (each at 10)jg/ml). The distribution of the 125I-labelled 
peptide-degradating enzymes (measured at neutral pH with I-labelled 
insulin B-chain as substrate) among subcellular fractions obtained by
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centrifugation (for method see Section 4.2.2) suggested a lysosomal
location, except that a large fraction (52%) of the digestive activity
was associated with the cytosol fraction whereas the activities of the
lysosomal markers: acid-proteinase (assayed as described in Section
4.2.3), B-N-acetyl-glucosaminidase (assayed as described in Section 5.3.6)
and acid phosphatase (assayed as indicated in Section 7.2.5) in the cytosol
fraction were 39.5, 10.5 and 24.8% of the total, respectively. Nevertheless,
the digestive activity of the cytosol fraction at several pH values (from
1253.0 to 9.0) against I-labelled insulin B-chain, paralleled that in the 
lysosomal fraction; each peaked at pH 3.5-5.0, this suggested that the 
peptide-degrading enzymes found in the cytosol fraction were derived from 
disrupted lysosomes. Although this data suggests that the digestive 
activity associated with the medium after introduction of a yolk sac 
arises at least in part from a lysosomal location it does not exclude 
a possible contribution from enzymes normally located in the cytosol 
or other organelles.
7*3‘2 Effects gf ammonium chloride and rotenone on the uptake and 
125digestion_of____I-labelled proteins and peptides by 17.5-day rat yolk
sacs incubated in serum-free medium 199.
It was shown above that each of the 125I-labelled proteins and 
peptides was digested mainly, if not entirely by a tissue-associated 
mechanism. Should the site of digestion be lysosomal, inhibitors of 
the endocytic process should also inhibit the observed tissue-associated 
digestive activities, an effect that would not be expected if the under­
lying digestive process was associated with enzymes present on the 
extracellular cell-surfaces of the yolk-sac tissue. Ammonium ions and 
rotenone were each shown (Section 4.3 & 5.3) to be inhibitors of 
pinocytosis in 17.5-day rat yolk sacs.
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The effects of 5mM and 20mM concentrations of ammonium ions 
-5and of 10 M-rotenone on the putative rate of uptake, the rate of
digestion and on the quantity of substrate that becomes tissue-associated
radioactivity (at 3h) for each of eight 125I-labelled proteins and peptides
are shown in Tables 7.2 a,b,c & d. Tables 7 , 2 c i d  also show the rates
125of digestion of the I-labelled peptides in the presence (0-3h) and 
absence <3-6h) of the yolk-sac tissue. A linear increase with time in the 
quantity of acid-soluble radioactivity in the incubation medium was 
observed in all incubations, both in the presence and absence of the 
yolk-sac tissue and in the presence and absence of each of the inhibitors 
(e.g. see Pig. 7.1).
Table 7.3 summarizes the data on the effects of the inhibitors 
on the rates of uptake and digestion of the l25l-labelled substrates and 
includes data on the inhibition of the uptake of 125I-labelled polyvinyl­
pyrrolidone) (data derived from Fig. 5.6 and Table 4.6). Both the rate of
tissue-associated digestion and the putative rate of uptake, for each 
125of the I-labelled proteins and peptides, were decreased by increasing
concentrations of ammonium chloride and by 10“5M-rotenone. Except for 
125I-labelled glucagon, the decreased rates of tissue-associated
digestion and the putative rates of uptake of each 125l-labelled substrate
parallel the decreased rate of uptake of A"l-labelled poly (vinylpyrrolidone)
[12 I-PVP]. A possible exception (in addition to 125I-labelled glucagon)
125is i-labelled calcitonin, which, other than at a 20mM-ammonium ion
concentration, shows a rate of tissue-associated digestion and a putative
rate of uptake that are consistently higher than the rate of uptake of 
125I-PVP. The differences are not, however, statistically significant.
The observed correspondence of parallelisms strongly suggest that, except
171
12 5for glucagon, the tissue-associated digestion of each of the I-labelled 
proteins and peptides occurs mainly, if not exclusively, intracellularly.
“The data on the inhibition of I-labelled glucagon uptake and digestion 
by ammonium ions is difficult to interpret» glucagon is itself an inhibitor 
of pinocytosis in 17.5-day rat yolk sacs (see Section 4.3) and the 
combined effects of glucagon and ammonium ions on the uptake and digestion 
processes cure not known. In general;the rate of tissue-associated 
digestion could not exceed, and indeed would be expected to be less than, 
the putative rate of uptake when the yolk sacs cure incubated in the presence 
of the inhibitors because each inhibitor is also an inhibitor of intra- 
cellular proteolysis. This effect was more pronounced for the I-labelled 
proteins them for the peptides (see Section 7.3.4).
7.3.3 Time-course of the appearance of acid-soluble digestion products 
125derived from I-labelled proteins and peptides when incubated with 17.5-day 
rat yolk sacs in serum-free medium 199.
It is expected that, following addition to the incubation medium
of a substrate that is digested intracellularly by the yolk sac, there
will be a lag in the appearance of acid-soluble digestion products in the
medium. The duration of the lag-period will depend on the time taken for
the tissue to internalize, digest and release the radioactive hydrolysis
products of the substrate. Such a lag was previously shown for the substrate
125formaldehyde-denatured I-labelled bovine serum albumin (see Fig. 4.1).
Except for glucagon. Fig. 7.2 shows such a lag to occur for each 125I-labelled
protein and peptide investigated. Moreover, the duration of the lag-period
was shown to have characteristically different value for each of the 
1 25I-labelled substrates examined.
The effects of decreasing the incubation temperature on the
125length of the lag-period for each I-labelled peptide (i.e. glucagon,
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insulin B-chain, calcitonin and insulin) are shown in Figs 7.3a & b.
Decreasing the temperature at which the yolk sacs were incubated
increased the duration of the lag-period; at temperatures of 34°C, and
less, even ^^I-labelled glucagon showed a lag-period. With ^^I-labelled
calcitonin, an unusual effect was observed at each incubation temperature.
After an initial lag-period, the quantity of acid-soluble radioactivity in
the incubation medium increased linearly with time but, after several
minutes, the rate of appearance of the acid-soluble radioactivity suddenly
125increased. This suggests either that the I-labelled calcitonin
preparation is heterogenous and contains at least two radioactive species,
each with a significantly different lag-period, or that a single species
125of substrate molecule exists but the [I]iodo-L-tyrosyl-residues are
attacked at very different rates by the enzymes of the yolk-sac tissue.
On decreasing the temperature at which the yolk sacs are 
125incubated with each I-labelled peptide, the rate of appearance of
acid-soluble radioactivity in the incubation medium, after the initial
125lag-period, was decreased. Fig. 7.4 shows that, for each I-labelled
peptide, the rate decreases essentially in parallel with the decrease in
125the rate of uptake of I-PVP (data derived from Table 4.4) and also 
parallels the decrease in the rate of digestion of formaldehyde-denatured 
125!»labelled bovine serum albumin (data derived from Table 4.4). The high 
degree of scatter in the results is possibly the result of the variation 
in the small contribution of digestive activity associated with the 
incubation medium.
125These results further indicate that the I-labelled peptides
are digested intracellularly and also suggest an intracellular digestion 
125site for I-labelled glucagon.
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7.3.4 Effects of ammonium chloride and of rotenone on the Intracellular 
125proteolysis of I-labelled proteins and peptides.
Table 7.4 shows a summary of the data on the effects of ammonium
125ions and of rotenone on the intracellular proteolysis of I-labelled 
protein and peptide substrates. The data assume, as suggested by the 
earlier observations, that the tissue-associated digestion of each substrate 
is intracellular. For each substrate, most of the ingested radioactivity
is subsequently released back into the incubation medium in an acid-soluble
. 125form. In control experiments the rates of digestion of I-labelled
X25 125immunoglobulin G, I-labelled lysozyme, I-labelled calcitonin and
*2^I-labelled glucagon each fell slightly below the corresponding value of
the rate of uptake, indicating that some of the yolk-sac associated
substrate is either not readily made available for intracellular digestion
or that some digestion products accumulate within the tissue. Rotenone
(10-5M) inhibited the intracellular proteolysis of each endocytosed
^■^I-labelled substrate investigated (^^I-labelled glucagon was not
investigated). With ammonium ion (20mM) inhibition of intracellular
proteolysis was not invariably observed, but where ammonium ion
inhibition occurred, it was concentration dependent.
125The I-labelled proteins and peptides can be grouped according
to their susceptibility to inhibition of proteolysis by ammonium ions (20mM)
^■^I-labelled immunoglobulin G and formaldehyde-denatured ^^I-labelled
125bovine serum albumin each showed almost complete inhibition, I-labelled 
125ribonuclease and I-labelled lysozyme each showed more than 50% inhibition
12 5125I-labelled insulin and I-labelled calcitonin each showed less than 
50% inhibition and 125I-labelled insulin B-chain and 125I-labelled glucagon 
each showed no inhibition. Where inhibition of intracellular proteolysis 
occurred, the relative rate of accumulation of the I-labelled substrate
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label in the tissue was increased (Table 7.2 a,b,c & d).
1257.3.5 Digestion of I-labelled proteins and peptides by disrupted 
rat-liver tritosomes.
If the inhibition of intracellular proteolysis by ammonium
ions results from an elevation of the intralysosomal pH (see Sections
5.1 & 5.4), it seemed possible that the enzymes that are rate-limiting for
125the digestion of the I-labelled proteins might be more sensitive to
increases in pH than those that are rate-limiting for the digestion of
*2^I-labelled peptides. (Thus explaining the selective inhibition of
125the intracellular proteolysis of I-labelled proteins by the ammonium
ions.) This possibility was tested using disrupted rat-liver tritosomes
incubated at pH values between 4.0 and 8.0 and measuring their digestive
125activity against the various I-labelled proteins and peptides. [Rat 
liver tritosomes were used in preference to rat yolk-sac tritosomes 
because the purity of the latter after isolation is not yet known and 
because the former can be isolated in larger quantities.]
The effects of increasing the pH of incubation on the rate of 
125digestion of I-labelled protein and peptide substrates by rat-liver
tritosomes are shown in Table 7.5. Increasing pH caused similar decreases
in the relative hydrolytic activity of the tritosomes towards protein and
peptide substrates. However, the specific activities of the tritosome
preparation, at each pH, were several orders of magnitude higher for the 
i^c 125x'iJI-labelled peptide substrates than for the I-labelled protein 
substrates.
1257.3.6 Calculation of the Catabolic Index for each I-labelled protein 
and peptide digested by 17.5-day rat yolk sacs incubated in serum-free 
medium 199.
The Catabolic Index of a digestible substrate is defined as the
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mean time taken for the substrate to be digested and released from a 
cell once it has been captured by endocytosis. [it is the ratio of the 
steady-state level of the tissue-associated substrate label to the rate 
of uptake of the substrate by the endocytic cell, and has the dimension of
time (see Section 3.2.2).] Table 7.6 shows the rate of uptake of each 
125I-labelled protein and peptide investigated in this chapter, and the 
corresponding quantity of substrate associated with the tissue at 3h.
(The rate of uptake and the level of tissue-associated substrate label 
125at 3h for I-labelled glucagon are also shown. These values have been 
corrected to give those values that would have been observed if the 
glucagon was not an inhibitor of pinocytosis.)
In general, Table 7.6 shows the 125i-labelled peptides are 
ingested more rapidly than the 125I-labelled proteins (125I-labelled 
ribonuclease, however, contradicts this general trend) but generally 
the levels of the tissue-associated radioactivity for the 125I-labelled 
proteins are greater than the corresponding levels for the 125I-labelled 
peptides. This would not be expected if each l25I-labelled protein and 
peptide was digested in the yolk-sac tissue with the same efficiency 
before the acid-soluble digestion products were returned to the incubation 
medium. The Catabolic Indices for the eight digestible substrates 
investigated are shown in Table 7.6. In general, the smaller the size of 
the substrate the smaller the Catabolic Index. This suggests that the 
smaller substrates are digested more efficiently once inside the yolk-sac 
epithelial cells.
Table 7.1 Stability of I-labellecL proteins and peptides under various incubation conditions in serum- 
free medium 199.
125The rates of appearance of acid-soluble radioactivity in medium 199 containing 1-labelled protein 
or peptide (lyg/ml of medium) were measured over a 3h incubation period tinder the following culture conditions: 
(A) medium 199 [20ml] alone; (B) medium 199 [20ml] containing a single 17.5-day rat yolk sac; (C) uncentrifuged- 
and (D) centrifuged (300g x 5min) medium 199 [20ml] in which a single 17.5-day rat yolk sac had been previously 
incubated for 3h; (E) medium 199 [20ml] containing a cell-free, yolk-sac homogenate [approx, lmg yolk-sac 
protein].
125
Each value shown is the mean rate [± standard deviation) of 3 separate determinations and is expressed 
as the % of the initial acid-soluble radioactivity hydrolysed per h. Data marked t are initial rates measured 
over the period 0-20min.
125x I-Labelled (A) (B) (C) (D) (E)
protein/peptide 199 alone 199 + yolk sac Conditioned 199 Conditioned 199 199 + yolk-sac
(%/h) (%/h) uncentri fuged 
(%/h)
centrifuged
(%/h)
homogenate
(%/h)
Rat IgG -0.08 + 0.05
Formaldehyde- 
-denatured BSA -0.05
+ 0.05
Ribonucléase +0.08 + 0.35
Lysozyme +0.04 + 0.12
Insulin +0.05 + 0.02
Calcitonin +0.00 + 0.10
Insulin B—Chain +0.28 + 0.34
Glucagon +0.42 + 0.49
+1.44 + 0.02 —
+7.05 + 0.79 +0.05 ± 0.16
+16.79 + 2.62 -0.06 ± 0.25
+6.78 + 0.29 +0.07 ± 0.19
+10.61 + 0.47 +0.12 ± 0.08
+13.10 + 0.61 +0.34 ± 0.01
+10.50 + 0.62 +0.97 ± 0.41
+4.26 + 0.51 +1.48 ± 0.53
+0.08 ± 0.08 +0.01 + 0.01
+0.06 ± 0.02 -0.02 + 0.04
+0.09 ± 0.03 +0.09 + 0.01
+0.15 ± 0.06 +0.08 + 0.03
+0.09 ± 0.02 f25.6 ± 3.3
- +42.1 ± 1.5
- +90.2 ± 4.2
_ +116.3 ± 2.5
Table 7.2a Effects of ammonium ions and of rotenone on the uptake and digestion of I-labelled rat immunoglobulin
125G and of formaldehyde-denatured 1-labelled bovine serum albumin by 17.5-day rat yolk sacs incubated in serum-free 
medium 199.
125
For experimental details see Section 7.2.3. Each value reported represents the mean (± S.D.) of 3-4 
separate determinations with yolk sacs from different animals. The data for the albumin are summarized from 
Tables 4.5 & 5.1. Values marked t show data for which the rate of uptake was too small to calculate accurate values.
125I-labelled
protein
Rate of Uptake
_____________ A.______
Rate of Digestion
_____ A________
Quantity of 
radioactivity 
associated 
with tissue 
at 3h (ng/mg 
y.s.protein)
Mean rate 
of tissue 
accumulation 
over 3h 
period (% 
rate of 
uptake)
Inhibitor ng/h per mg 
yolk sac 
protein
% of 
control
ng/h per mg
yolk-sac
protein
----------->
% of rate 
of uptake
Control 66.0 ± 2.9 100.0 ± 4.4 57.6 ± 0.9 87.4 ± 2.4 74.8 ± 1.8 37.7 ± 1.2
Rat immuno- NH*,5mM 4 ==
NHt,20mM 4 =
18.2 ± 8.4 27.8 ± 13.7 10.7 ± 6.6 57.7 ± 18.7 35.5 ± 10.4 68.1 ± 11.4
globulin G
3.2 ± 0.9 4.9 ± 1.3 -0.8 ± 0.7 approx.0+ 12.7 ± 3.2
•fapprox.100
Rotenone,
io"5m 8.8 ± 1.7 13.2
± 2.8 4.3 ± 1.2 48.3 ± 5.9 16.5 ± 2.6 62.6 ± 3.6
Control 257.3 ± 23.1 100.0 ± 8.9 244.2 ± 16.0 95.1 ± 5.6 131.7 ± 28.4 16.5 ± 2.8
Formalde­
hyde NIit,5mM 141.6 ± 24.2 55.2 ± 9.8 98.2 ± 23.2 68.8 ± 4.9 206.1 ± 40.2 48.5 ± 3.8
denatured
bovine
4 —  
NH^,20mM 32.7 ± 6.7 10.8 ± 2.0 1.6 ± 1.9 5.3 ± 7.2 75.8 ± 8.5 91.9 ± 9.7
serum
albumin Control 289.0 ± 39.8 100.0 ± 13.8 284.7 ± 34.9 98.6 ± 1.9 151.9 ± 19.4 17.5 ± 1.2
Rotenone,
iO-SM 48.1 ± 20.4
13.2 ± 6.9 37.1 ± 17.8 76.1 ± 5.8 58.7 ± 20.2 41.8 ± 4.4
I-labelled ribonucléaseTable 7.2b Effects of ammonium ions and of rotenone on the uptake and digestion of 
125and of i-labelled lysozyme by 17.5-day rat yolk sacs incubated in serum-free medium 199.
For experimental details see Section 7.2.3. Each value reported represents the mean (± S.D.) of 
3 separate determinations with yolk sacs from different animals. The rates of uptake were calculated 
assuming that the observed digestion occurred intracellularly.
125I-labelled
protein Inhibitor
Rate of Uptake
l A 1
ng/h per mg % of
yolk-sac control 
protein
Control 682.2 + 88.7 100.0 + 13.0
NH*,5mM 195.1 + 44.2 29.7 + 10.3
Ribonucléase
NH.,20mM 26.5 + 8.5 3.8 + 7.54 ==
Rotenone, 
io" 5M 78.4 + 17.4 11.5 + 1.7
Control 302.8 + 5.7 100.0 + 1.2
NH*,5mM 140.5 + 21.6 46.3 + 6.2
Lysozyme
NH*,20mM 43.4 ± 4.6 14.3 + 1.3
Rotenone, 
io"5m 72.4 ± 5.2 23.9
+ 1.8
Rate of digestion
_______________________ A______________________
Quantity of 
radioactivity 
associated 
with tissue 
at 3h (ng/mg 
y.s.protein)
Mean rate 
of tissue 
accumulation 
over 3h 
period (% 
rate of 
uptake)
t------------
ng/h per mg
yolk-sac
protein
% of rate 
of uptake
671.6 ± 105.7 98.3 ± 2.9 245.5 ± 10.3 12.1 ± 1.6
147.7 ± 38.3 75.3 ± 3.3 185.2 ± 36.8 31.8 ± 1.8
6.6 ± 3.2 27.0 ± 14.0 62.9 ± 28.5 77.4 ± 11.6
59.2 ± 11.8 75.0 ± 5.2 88.2 ± 20.6 36.9 ± 0.5
271.2 ± 11.8 89.5 ± 2.9 249.9 ± 11.1 27.4 ± 0.8
86.3 ± 20.6 61.0 ± 9.5 179.1 ± 23.7 42.6 ± 2.8
20.8 ± 5.9 47.5 ± 9.7 77.9 ± 6.6 61.8 ± 10.7
37.7 ± 2.8 51.9 ± 0.2 113.6 ± 8.4 52.6 ± 0.7
. 125
I-labelled calcitonin by 17.5-day rat yolk sacs incubated in serum-free medium 199.
For experimental details see Section 7.2.3. Each value reported represents the mean (+S.D.) of 3 separate 
determinations with yolk sacs from different animals. The rates of uptake were calculated assuming that the yolk-sac 
associated digestion occurred intracellularly.
Table 7.2c Effects of ammonium ions and of rotenone on the uptake and digestion of I-labelled insulin and of
125
125I-Labelled
Rate of uptake
_______________ A_____________
Rates of digestion 
>___________
Quantity of Mean rate 
radioactivitv of tissue
peptide Inhibitor ng/h per mg
yolk-sac
protein
% of 
control
with without yolk-sac 
yolk sac yolk sac
(ng/h per mg yolk-sac protein)
associated 
(% of rate 
of uptake)
associated 
with tissue 
at 3h (ng/mg 
y.s.protein)
accumulation 
over 3h 
period (% 
rate of 
uptake)
Control 411.4118.4 100.01 4.5 424.6±18.9 8.913.9 415.6±15.7 (102.1± 0.5) 113.1115.6 9.1± 0.8
NH*,5mM 88.8 ±8.7 21.51 1.5 82.21 9.6 4.811.0 77.3 1 8.6 (87.0 11.8) 88.4 ±3.7 20.4 ± 1.0
Insulin NH*,20mM 4 — 11.3 ±1.3 2.7 1 0.4 10.8 1 1.9 3.711.3 7.4 ± 1.3 (66.9±18.2) 18.8 ± 0.4 56.0 ± 5.5
Potenone
io"5m 43.4115.6 10.61 4.2 39.9116.9 1.911.5 38.0118.2 (77.2 ± 5.2) 38.8 ±3.8 31.9 ±9.3
Control 450.4±16.6 100.0 ± 3.7 438.4120.2 11.610.4 426.8119.2 (94.6 1 1.6) 177.9±16.9 13.1± 1.4
+
NH„,5mM 197.2142.1 43.9110.7 181.8151.9 10.714.8 171.1±49.6 (85.6 ± 7.6) 121.0±15.7 21.4± 7.0
Calcitonin 4 —
NH^,20mM 68.7 ± 3.6 15.2 1 1.0 40.01 5.3 1.511.6 38.61 4.5 (56.41 9.0) 100.0±21.3 50.1± 7.8
Rotenone,
io"5m 129.6120.2 27.01 5.3 93.4124.8 12.912.4
80.4127.0 (64.1111.4) 140.3127.2 38.9113.7
I-labelled glucagon by 17,5-day rat yolk sacs incubated in serum-free medium 199.
For experimental details see Section 7.2.3. Each value reported represents the mean (± S.D.) of 3 separate 
determinations with yolk sacs from different animals. The rates of uptake were calculated assuming that the yolk-sac 
associated digestion occurred intracellularly.
125Table 7.2d Effects of ammonium ions and of rotenone on the uptake and digestion Of I-labelled insulin B-chain arid of
125
125 X w nI-Labelled
peptide
Rate of uptake 
•
Rates of digestion Quantity of 
radioactivity 
associated 
with tissue 
at 3h (ng/mg 
y.s.protein)
Mean rate 
of tissue
Inhibitor ng/h per mg
yolk-sac
protein
% of 
control
i----------------------
with without yolk-sac 
yolk sac yolk sac
(ng/h per mg yolk-sac protein)
. iassociated 
(% of rate 
of uptake)
accumulation 
over 3h 
period (% 
rate of 
uptake)
Control 374.1±37.4 100.0110.0 420.2124.5 44.4126.0 375.8136.4 (100.410.9) 61.0115.4 8.213.9
Insulin
B-chain
NH*,5mM 120.4±20.4 32.0± 2.5 168.7117.4 46.114.2 122.6120.5 (101.710.2) 16.51 3.3 4.510.1
NH*,20mM 40.2± 5.3 10.71 1.6 65.81 7.7 25.81 2.6 40.11 6.1 (99.611.8) 7.81 1.1 6.611.9
Rotenone,
io'5m 33.7± 7.3 9.0± 2.0 66.8114.4 36.5112.8
30.21 7.6 (88.913.9) 16.21 0.9 16.513.6
Control 170.2±20.3 100.0111.9 240.6179.2 77.1165.6 163.5120.9 (94.311.3) 38.21 5.0 7.511.5
Glucagon NH*,5mM 132.2±39.4 75.1115.9 193.4142.6 67.31 7.0 129.1135.6 (95.811.9) 33.11 2.7 9.113.7
NH*,20mM 86.3±23.9 50.5115.4 151.7144.6 69.2121.5 82.4123.9 (95.111.4) 15.91 1.6 6.311.5
I-labelled substrates by 17.5-day rat yolk sacs incubated in serum-free medium 199.
Data are summarized from Tables 7.2a,b,c & d [protein substrates] and Table 4.6 and Fig. 5.6 [poly­
vinylpyrrolidone) ]. The rates of uptake were calculated assuming that the yolk-sac associated digestion 
occurred intracellularly. N.D.: not determined.
Table 7.3 Summary of the effects of ammonium ions and of rotenone on the rates of uptake and digestion of
125
125, Rates of uptake (% of control) Rates of digestion (% of control)
substrate
r
NH*,5raM 4 == NH+ , 20mM
-5Rotenone,10 M
t
, 5mM ,20mM
_l
Rotenone,10
PVP 30.4 ± 10.8 15.9 + 2.9 13.1 ± 3.6 - - -
Rat IgG 27.8 ± 13.7 4.9 + 1.3 13.2 ± 2.8 18.5 ± 11.4 -1.4 ± 2.0 7.4 ± 2.1
Formaldehyde- 
-denatured albumin 55.2 ± 9.8 10.8 ï 2.0 13.2 ± 6.9 40.2 ± 9.5 0.6
+ 2.1 13.0 ± 6.2
Ribonucléase 29.7 ± 10.3 3.8 + 7.5 11.5 ± 1.7 21.9 ± 5.7 0.9 ± 0.5 8.8 ± 1.7
Lysozyme 46.3 ± 6.2 14.3 + 1.3 23.9 ± 1.8 31.8 ± 7.5 7.6 ± 2.1 13.7 ± 1.0
Insulin 21.5 ± 1.5 2.7 + 0.4 10.6 ± 4.2 18.6 ± 2.0 1.8 ± 0.3 9.1 ± 4.3
Calcitonin 43.9 ± 10.7 15.2 + 1.0 27.0 ± 5.3 40.0 ± 11.6 9.0 ± 1.0 18.8 ± 6.3
Insulin
B-chain 32.0 ± 2.5 10.7
+ 1.6 9.0 ± 2.0 43.5 ± 5.4 10.6 ± 1.6 8.0 ± 2.0
Glucagon 75.1 ± 15.9 50.5 + 15.4 N.D. 78.9 ± 21.8 50.4 ± 14.6 N.D.
Table 7.4 Summary of the effects of ammonium ions and of rotenone on the intracellular proteolysis of
125I-labelled proteins and peptides ingested by 17.5-day rat yolk sacs incubated in serum-free medium 199.
The data cure summarized from Tables 7.2a,b,c & d. The data were calculated assuming that the yolk- 
-sac associated digestion occurred intracellularly. N.D.: not determined.
Rates of digestion (% rate of uptake)
125I-labelled
f
X
A ---- -  ■ -- >
-5substrate Control n h4»55Î? NH4*20mM Rotenone,10 M
Rat IgG 87.4 + 2.4 57.7 ± 18.7 approx. 0 48.3 ± 5.9
Formaldehyde- 95.1 + 5.6 (Batch I) 68.8 ± 4.9 5.3 ± 7.2 -
-denatured albumin 98.6 ± 1.9 (Batch II) • 76.1 ± 5.8
Ribonucléase 98.3 + 2.9 75.5 ± 3.3 27.0 ± 5.2 75.0 ± 5.2
Lysozyme 89.5 + 2.2 61.0 ± 9.5 47.5 ± 9.7 51.9 ± 0.2
Insulin 102.2 + 0.5 87.0 ± 1.8 66.9 ±18.2 77.2 ± 5.2
Calcitonin 94.6 + 1.6 85.6 ± 7.6 56.4 ± 9.0 64.1 ± 11.4
Insulin B-chain 100.4 + 0.9 101.7 ± 0.2 99.6 ± 1.8 88.9 ± 3.9
Glucagon 94.3 + 1.3 95.8 ± 1.9 95.1 ± 1.4 N.D.
Table 7.5 Rates of digestion of I-labelled proteins and peptides by disrupted rat-liver tritosomes and 
the effects of incubation pH on the relative rates of digestion.
125The increase in acid-soluble radioactivity, on incubating each of the I-labelled proteins or 
peptides (10yg in buffered 0.2% (v/v) Triton X-100) with rat-liver tritosomes (2.5-100yg tritosome protein) 
for the duration and at the pH shown, was determined as described in Section 7.2.6. The data show, for each 
substrate, the mean specific activity of the tritosome preparation (when incubated at pH 4.0) and the mean value 
(± standard deviation, from 3 or 4 separate determinations; using a single tritosome preparation) of the 
increase in acid-soluble radioactivity at pH 4-8, expressed as a percentage of that observed at pH 4.0. 
Incubation conditions were such that the maximum increase in acid-soluble radioactivity did not exceed 25% of 
the initial acid-insoluble radioactivity. The specific activities are expressed as the quantity of protein or 
peptide (pg) hydrolysed per Mg of tritosome protein per h of incubation.
125
125I-labelled
substrate
Quantity of 
tritosomes
Duration of 
incubation
Specific 
activity at
Incubation pH
_____A __________
added
(pg protein)
at 37°C pH 4.0 4.0 5.0 6.5 8.0
Rat IgG 100.0 24h 9.3 x 102 100.0 ± 4.8 62.5 ± 6.5 0.9 ± 0.9 -0.3 ± 1.7
Formaldehyde-
-denatured
albumin
100.0 24h 5.3 x 102 100.0 ± 10.4 102.3 ± 9.8 3.3 ± 0.8 -0.8 ± 0.3
Lysozyme 100.0 24h 4.9 x 102 100.0 ± 12.6 119.3 ± 3.2 0.2 ± 4.8 -2.7 ± 2.5
Insulin 10.0 lh 1.2 x 105 100.0 ± 5.9 62.1 ± 6.0 0.9 ± 0.5 0.3 ± 0.5
Calcitonin 10.0 15min 6.7 x 105 100.0 ± 8.2 82.1 ± 8.4 20.6 ± 2.7 1.0 ± 1.1
Insulin
B-chain 2.5 lOmin 5.5 x 106
100.0 ± 14.1 72.5 ± 8.5 1.3 ± 5.1 0.6 ± 0.1
5.0 15min 1.2 x 106 100.0 ± 12.6 70.3 ± 2.6 1.7 ± 4.5 1.1 ± 2.7Glucagon
125Table 7.6 Summary of the rates of endocytic uptake of I-labelled 
proteins and peptides by 17.5-day rat yolk sacs incubated in serum- 
-free medium 199 and their associated Catabolic Indices.
The rates of endocytic uptake are derived from Tables 7.2a,b,c 
& d. For formaldehyde-denatured 12SI-labelled bovine serum albumin 
(denatured BSA) data are included from Tables 3.1, 4.3, 4.5, 4.7, 6.1 
& 5.1 and Figs. 5.1, 5.2, 5.4 & 6.3. Two groups of data are presented 
for glucagon; the second group is corrected to give the rate of uptake 
that would have been observed if the glucagon was not an inhibitor of 
endocytosis in the rat yolk sac (10_6M glucagon inhibits 125I-labelled 
poly(vinylpyrrolidone) uptake by 68.1%, see Table 4.7). The Catabolic 
Index (the mean time taken to digest and release a substrate once it 
has been endocytosed) is calculated from the ratio of the yolk-sac 
associated radioactivity (at its steady-state level) to the rate of 
uptake. The rates of uptake shown are numerically equivalent to the 
Endocytic Index (yl/h per mg yolk-sac protein).
125I-labelled
protein/peptide
No. of 
expts
Rate of uptake 
(ng/h per mg 
yolk-sac 
protein)
Yolk-sac 
associated 
radioactivity 
(tlg/mg yolk- 
-sac protein)
Catabolic
Index
(h)
Rat IgG 3 66.0 ± 2.9 74.8 ± 1.8 1.132 ± 0.035
Denatured BSA 37 272.8 ± 45.5 133.7 ± 25.6 0.493 ± 0.076
Ribonucléase 3 682.0 ± 88.7 247.5 ± 10.3 0.364 ± 0.049
Lysozyme 3 302.8 ± 5.7 249.9 ± 11.1 0.822 ± 0.024
Insulin 3 411.4 ± 18.4 113.1 ± 15.6 0.273 ± 0.025
Calcitonin 3 450.4 ± 16.6 177.9 ± 16.9 0.393 ± 0.042
Insulin B-chain 3 374.1 ± 37.4 61.0 ± 15.4 0.246 ± 0.117
Glucagon 3 170.2 ± 20.3 38.2 ± 5.0 0.223 ± 0.046
Glucagon
corrected 533.5 ± 63.6 119.7 ± 15.7
Time (min)
Figure 7.2 Appearance of acid-soluble radioactivity in the incubation 
125medium_whe_n____I-labelled proteins and peptides were incubated with
17.5-day rat yolk sacs in serum-free medium 199.
125Each I-labelled substrate was present at 5 yg/ml of incubation 
medium. For experimental details see Section 7.2.3. The 125I-labelled 
substrates were: glucagon, (A); insulin B-chain, (©); calcitonin (a), 
insulin, (■); ribonucléase, (A); formaldehyde-denatured bovine se^um 
albumin, (a ) ; lysozyme, ( • ); rat immunoglobulin G (o ).
Figure 7.3a Effect of incubation temperature on the time of first appearance
of acid-soluble radioactivity in the incubation medium when either ^^i-
125-labelled glucagon (A) or I-labelled insulin B-chain (B) were incubated 
with 1 7 .5-day rat yolk sacs in serum-free medium 1 9 9.
For experimental details see Section 7.2.3. Tbe incubation temperatures 
(°C) were: 37, (•); 34, (o); 30, (■); 20, (o).
Figure 7.3b Effect of incubation temperature on the time of ,rr. , » „ -
of acid-soluble radioactivity in the incubation medic „hen either 125r . , ,
125 " ‘
calcitonin (A). or----^labelled insulin (B) was Incubated with 17,5-dau rat
yolk sacs in serum-free medium 199.
For experimental details see Section 7 5 -j mu„ 1 .-i/i , *°n ™ e  incubation temperatures
were: 37, (•); 34, (o); 30, ( ■ ) ; 20 (o) f=iatures l CJ
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Figure 7.4 Effects of incubation temperature on the rates of digestion of 
125I-labelled proteins and peptides by the 17.5-day rat yolk sacs incubated 
in serum-free medium 199.
For experimental details see Section 7.2.3. The data for formaldehyde- 
-denatured 125I-labelled bovine serum albumin and 125I-labelled poly-' 
(vinylpyrrolidone) are derived from Table 4.4.
125The vertical bars represent from left to right the I-labelled substrates: 
insulin B-chain, glucagon, calcitonin, insulin, formaldehyde-denatured 
bovine serum albumin, and PVP.
An indication of the size of the standard deviation in each set of data, 
relating to a given incubation temperature, is given by a horizontal bar 
representing the value of the mean rate of uptake of PVP plus its standard 
deviation (mean + S.D.).
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7.4 DISCUSSION
For each of the I-labelled proteins and peptides investigated,
the above results on the inhibition of pinocytosis by ammonium ions,
rotenone and decreased temperature (as judged by the decreased putative
rates of uptake and decreased levels of tissue-associated substrates),
are in agreement with the findings in Chapters 4 & 5. The rates of yolk-
-sac associated digestion of each I-labelled protein and peptide
(immunoglobulin G, formaldehyde-denatured bovine serum albumin, ribonuclease,
lysozyme, insulin, calcitonin, insulin B-chain and glucagon) were also
decreased by the inhibitors of pinocytosis. The inhibitions (up to 90%),
125except for i-labelled glucagon, paralleled the inhibition of uptake of 
125I-labelled poly(vinylpyrrolidone) and formaldehyde-denatured 125i- 
-labelled bovine serum albumin, a substrate known to be digested exclusively 
intracellularly by the 17.5-day rat yolk sac (see Chapter 4). These results 
would not be expected if a significant proportion of the protein or 
peptide substrates was digested by extracellular, plasma-membrane associated 
enzymes.
The lack of extracellular, yolk-sac associated proteolytic 
125activity against the I-labelled proteins was not unexpected. Firm
circumstantial evidence (see Chapter 2) indicated an intracellular site
125of hydrolysis of the I-labelled proteins: ribonuclease, lysozyme and 
insulin. Also, Ibbotson (1978) indicated that rat immunoglobulin G was 
digested intracellularly by the 17.5-day rat yolk sac. The results 
presented in this chapter, however, give direct evidence of an intra­
cellular site of digestion of these substrates, unless the unlikely 
explanation is advanced that extracellular yolk-sac associated enzymes 
are inhibited to precisely the same extent as pinocytosis.
125
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The lack of evidence for an extracellular site of yolk-sac 
125associated digestion of the I-labelled peptide substrates is
compatible with the results of preliminary studies by a .J. Kenny
(unpublished results), who investigated the peptidase activity in
plasma membrane-rich fractions of rat yolk-sac and discovered only very
low specific activities in comparison with similar fractions the
rabbit kidney proximal tubule. such findings, however, do not exclude
the possibility that extracellular, yolk-sac associated peptidases exist,
but, either they make very little contribution to the overall catabolic
activity of the rat yolk sac (too little to be detected by the experiments
performed here), or only have specificities for substrates other than those
used in this study. (In the latter case, the putative enzymes must have
an exceptionally narrow range of specificity.)
It is not possible to explain adequately the fate of 125i-
-labelled glucagon added to rat yolk sacs in culture, but evidence suggests
it is digested, at least in part, intracellularly. Possibly l25I-labelled
glucagon is digested entirely intracellularly, as are other 125I-labelled
proteins and peptides, but further evidence is necessary to support such
a conclusion. The inhibitory effects of ammonium ions on 125I-labelled
glucagon digestion are difficult to interpret. Both ammonium ions and
glucagon are inhibitors of pinocytosis in the rat yolk sac (see Chapters
4 & 5). An understanding of the combined inhibitory effects of these
pinocytosis inhibitors would help interpretation of the inhibitory 
. . 125effects of ammonium ions on I-labelled glucagon digestion. However,
125in support of the notion that I-labelled glucagon is digested by yolk
sacs mostly, if not entirely, at an intracellular site, is the observed
125 ->
complete inhibition of I-labelled glucagon digestion at 15-20°C, 
temperatures at which pinocytosis is also’completely inhibited in the rat
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yolk sac in the absence of calf serum (see Pig. 7.4). Moreover, the
increase in the lag-period (Fig. 7.3a) on decreasing the incubation
temperature suggests an intracellular site of digestion. Furthermore,
. . 125an examination of the digestion products of I-labelled glucagon 
after its incubation (2h) with well-washed yolk sacs (results not shown)
showed that all the radioactivity rendered acid-soluble eluted coincidentally
1-25 3.25with the marker substances ( I]iodo-L-tyrosine and glycyl-[ I]iodo-
-L-tyrosine, an observation that is concordant with hydrolysis occurring
at a lysosomal site in which the permeability properties of the lysosomal
membrane limit the size of the digestion products released into the
incubation medium (Reijngoud & Tager, 1977).
The duration of the lag-period observed at 37°c is a character- 
125istic of the particular I-labelled protein or peptide incubated with the
yolk sacs. In general, the larger the size of the substrate the longer
is the duration of the lag-period. The duration of the lag-periods for the
125I-labelled peptides (see Fig. 7.2) correlate well with the initial
rate of digestion of the substrates by cell-free extracts of the rat yolk
125sac (see Table 7.1, column E). Thus, I-labelled glucagon has the
125shortest lag-period, followed by insulin B-chain and I-labelled 125
125calcitonin then I-labelled insulin; this is also the order of suscept­
ibility to digestion by disrupted rat-liver tritosomes (see Table 7.5).
125Fig. 7.3b shows that I-labelled calcitonin has two lag-periods: an 
initial lag-period in which no acid-soluble radioactive digestion products 
are released into the incubation medium, followed by a second period in 
which the rate of appearance of the acid-soluble radioactivity is 
slower than the final rate of appearance. This was observed at each 
temperature investigated (except at 20°C, at which temperature all
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digestion had ceased). This probably relates to the occurrence of
two sites at which the radioiodide attaches to calcitonin the label at
one site being more easily released than that at the other. In support
125of this notion, the digestion of I-labelled calcitonin (but not 
125I-labelled insulin, insulin B-chain and glucagon) by the cell-free
extracts of the rat yolk sac was also biphasic. More than 90% digestion 
125of i-labelled peptides was generally achieved with the cell-free
125extract during a 3h incubation, whereas the digestion of I-labelled
calcitonin was initially rapid but after 18% of the substrate had been
digested, very little further digestion occurred. The idea that the
duration of the lag-period relates to the susceptibility of the substrate
label to proteolytic release from the substrate is also supported by the
observations that those substrates with a short lag-period are more
readily digested by disrupted rat-liver tritosomes (Table 7.5). The
125correlation is not perfect in so much that I-labelled insulin B-chain 
was found to be a better substrate for the tritosomal enzymes than was 
125I-labelled glucagon. [Bohley (1971), using a lysosomal fraction of 
rat liver found the reverse to be the case, however, this author used 
oxidized insulin B-chain whereas the reduced form was used here]. The 
discrepancy in these results may arise from differences in the complement 
of enzymes found in liver lysosomes and yolk-sac lysosomes, since, for the 
peptide substrates, a better correlation between lag-period and 
susceptibility to proteolysis was obtained when a cell-free extract of 
yolk sacs was used in place of tritosomes as a source of proteolytic 
enzymes (Table 7.1, column E).
It is conceivable that factors other than proteolytic 
susceptibility might also contribute to the observed differences in 
lag-periods. The duration of the lag-period must be the sum of the time
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taken for each of the following processes to occur:
a) adsorption of the substrate to the internalizing plasma membrane,
b) pinosome formation,
c) intracellular movement of the newly formed pinosomes to the 
lysosomes (including pinosome-pinosome fusion),
d) fusion of pinosomes with lysosomes,
e) proteolytic cleavage of the substrate-label from the substrate, 
(including desorption of the substrate from the interior side 
of the heterolysosomal membranes if the latter is necessary for 
digestion),
f) diffusion of the digestion products from the lysosomes into the 
cytoplasm and subsequently into the incubation medium.
It was suggested above that factor e) is an important determinant 
of the duration of the lag-period for a particular substrate but it is 
not known whether the time taken for the substrate to desorb from the 
interior side of heterolysosomes would make a significant contribution 
to the lag-period of any of the substrates. It has generally been 
regarded that a) is an instantaneous event; this is not without experi­
mental support. Fig. 4.1 shows the uptake of formaldehyde-denatured 
125I-labelled bovine serum albumin into the yolk sac tissue to occur, 
in effect, immediately the substrate is added to the yolk sac. The time 
taken for f) to occur must be similar for each of the 1-labelled 
substrates (IgG, lysozyme, ribonuclease, insulin, formaldehyde-denatured 
bovine serum albumin and probably glucagon) since, in each case, the 
radioactive digestion product is essentially the same (approx. 90%
[1 2 5 I Ii o d o - L - tyrosine, see Chapter 2,4 & 7 and Ibbotson, 1978).
Thus the lag-period most likely represents the time taken to translocate 
substrate to the lysosomes [i.e. b), c) and d) above] plus the time
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taken to digest the substrate intralysosomally [e) above].
Since more than 98% of uptake of each substrate appears to
take place by adsorptive endocytosis, it is possible that such adsorption
of substrate modifies the properties of the pinosome membrane, hence
modifies factors b), c) and d), above. However, experimental evidence
suggests that this is not the case. The durations of the lag-periods
125for both formaldehyde-denatured 1-labelled bovine serum albumin and
125I-labelled ribonuclease were each independent of the concentrations of
the corresponding non-labelled substrate (Tables 3.1 & 3.2) and of the
presence of different concentrations of (non-labelled) proteins or
peptides in the incubation medium (Tables 3.3 & 3.4). These findings
suggest that factors b), c) and d) are not affected by substrate
adsorption hence these factors probably make a constant contribution to the
lag-periods at 37°C. However, the time taken for these three processes
to occur must be less than the shortest total lag-period observed. Thus, 
125if i-labelled glucagon is, as suggested earlier, digested mostly
intracellularly, this time must be less than 3min, and, unless each of the
eight substrates is taken up into a different class of vesicle, the major
contribution made to the observed lag-periods of the other substrates
must be the time taken to digest the substrate within lysosomes. The
above considerations, and the observed correlation between the duration of
the lag-period (Fig. 7.2) and the susceptibility of these substrates
to digestion by cell-free extracts of the yolk-sac (Table 7.1, column E)
or disrupted tritosomes (Table 7.5), indicate that the duration of the
lag-period observed for a particular substrate when the yolk sacs are
incubated at 37°C is dependent mostly on the time taken to digest the
substrate once it is within the lysosomes.
«
Determination of the lag-period for a particular substrate is
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therefore one way in which one can assess the susceptibility of a 
substrate to digestion by lysosomal enzymes within the intact cell.
An alternative method, which was suggested in Chapter 3, is the calcula­
tion of the Catabolic Index, that is, the ratio of the tissue-associated 
substrate label, at a steady-state level, to the Endocytic Index. The 
Catabolic Index for each of the eight digestible substrates is shown 
in Table 7.6. The values obtained are all larger than the corresponding 
value for the initial lag-period as shown in Fig. 7.2. This presumably is 
because the lag-period represents the most rapid time in which a substrate 
can be digested and returned to the incubation medium, whereas the 
Catabolic Index represents the mean time taken for this process to occur.
As expected, however, the ranking of substrates according to Catabolic
Index is the same as that according to the lag-period provided that, when
125ranking the lag-periods, I-labelled calcitonin takes the position dictated
by the end of its second lag-period (see Fig. 7.3b). Table 3.6 shows
125the Catabolic Index (Cl ) of several I-labelled protein substrates when
incubated with 17.5-day rat yolk sacs in the presence of 10% calf serum.
125The native substrate least susceptible to digestion is I-labelled
125orosomucoid (Cl = 1.5h), the value for native I-labelled bovine serum 
albumin is 0.78h. and the value for the most susceptible substrate, 
*^I-labelled insulin is 0.32h. Treatment of these substrates with 
formaldehyde (pH 10), a procedure that generally makes proteins more 
resistant to proteolytic attack through their chemical modification 
(Feeney et al., 1975) also made the above substrates less susceptible to 
proteolysis by enzymes within yolk-sac lysosomes. The Catabolic Indices 
for the above substrates were doubled giving values of 3.64, 1.53 and 
0.82h respectively. This effect was not observed, however, for 125i-
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-labelled lysozyme and I-labelled ribonuclease. It will be
noticed that the Catabolic Index for a protein substrate digested by
the 17.5-day rat yolk sac in the presence of 10% calf serum (see Table
3 .1) is always greater than the corresponding value for the same
protein digested by yolk sacs incubated in serum-free medium (see Table
7.6). This suggests that 10% calf serum, in addition to inhibiting
pinocytosis by up to 50% [Ibbotson, 1978; also compare value for the rate 
125of uptake of I-poly(vinylpyrrolidone) in Tables 2.1 and 3.5] also
inhibits the proteolysis of a substrate once it has been endocytosed.
The underlying mechanisms for these inhibitions are not known. However,
any explanation must also take into account the fact that the presence of
1 0% calf serum does not modify the initial lag-period for formaldehyde- 
125denatured I-labelled bovine serum albumin (results not shown). 125
125The times taken for the yolk sac to dispose of the I-labelled substrates 
discussed above compare well with those observed by other research workers, 
who, more generally have calculated the half-lives of endocytosed proteins.
Davidson et al, (1971) reported a half-life of 14min for the disposal of 
125I-labelled ribonuclease A by mouse-kidney lysosomes. Mego & McQueen
(1965) showed the half-life of denatured serum albumin digested by liver
cells to be approx. 0.75h. Cohen (1975) graphically illustrated the
disappearance of endocytosed proteins digested by mouse macrophages in
culture; for serum albumin, haemoglobin, horseradish peroxidase and
lysozyme. The half-lives were 5, 20, 30 and 35h, respectively. In
comparison to the 17.5-day rat yolk sac, macrophages seem to clear
endocytosed proteins at a very slow rate. For cells in culture, lag-
-periods of 7-8, 20 and 30min have been reported for I-labelled
125insulin, formaldehyde-denatured I-labelled human serum albumin and
125
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125and 1-labelled plasma low-density lipoproteins (see Section 4.4).
The pattern of ammonium ion inhibition of the digestion of 
125endocytosed I-labelled proteins and peptides also correlates with 
the substrate's susceptibility to attack by lysosomal enzymes (see 
Table 7.5). The mechanism of the lysosomal inhibition by ammonium ions 
is uncertain, but an elevation of the intralysosomal pH is inferred, 
thus inhibiting the action of all lysosomal enzymes with an acid pH 
optimum rather than the inhibition of particular enzymes (see Chapter 5). 
The following scheme offers a possible explanation of how in the yolk- 
-sac system ammonium ions might inhibit the lysosomal digestion of the 
protein substrates but not the peptide substrates. If, for the protein 
substrates, the digestive capacity of the lysosomal enzymes is only a 
little greater than the endocytic capacity of the yolk-sac epithelial 
cells, normally all the endocytosed proteins will be digested. But if 
lysosomal enzymes are inhibited by ammonium ions the endocytosed proteins 
will accumulate in the lysosomes in an undigested form, because the 
digestive capacity will now be substantially less than the endocytic 
capacity. However, if the peptide substrates are endocytosed at a rate 
similar to that of protein substrates but are much more susceptible to 
attack by lysosomal enzymes, the lysosomal capacity for digestion even 
after strong inhibition by ammonium ions, will still remain far greater 
than the endocytic capacity; consequently, there will be no apparent 
inhibition of the digestion of the endocytosed peptides.
It was suggested in Chapter 5, that a possible explanation for
the complete inhibition, by 20mM-ammonium ions, of formaldehyde-denatured 
125I-labelled bovine serum albumin digestion by cultured rat yolk sacs 
might be an inhibition of pinosome-lysosome fusion. Clearly the evidence 
here rules out this possibility. Such an inhibition would result in a
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decreased digestion of the protein and peptide substrate alike.
Finally, the possibility that the adsorptive pinocytosis of the
125I-labelled peptides by the rat yolk sac might occur at a low rate, or
not at all, as suggested by the findings of Ryser (1970) was not the case.
125Table 7.6 shows that, in general (with I-labelled ribonucléase being 
a remarkable exception), the smaller the substrate the greater is its 
rate of uptake by adsorptive pinocytosis.
CHAPTER EIGHT
GENERAL DISCUSSION
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GENERAL DISCUSSION.
After a general introduction to the concepts of endocytosis, 
lysosomal protein digestion and the vacuolar system of animal cells and a 
description of some morphological and biochemical studies of endocytosis 
in the rat visceral yolk sac, reports have been presented of investigations 
of various aspects of endocytosis, lysosomal protein catabolism and (in 
collaboration with S. Knowles s F.J. Ballard, cSIr o, Division of Human 
Nutrition, Adelaide, Australia) the role of lysosomes in endogenous 
yolk-sac protein breakdown. Individual chapters of this thesis generally 
contain substantial introductions, and the investigations reported have 
been discussed at length at the end of each chapter. Therefore, in order 
to avoid overlap with the material presented previously,
only particular aspects of the work that merit further discussion in a 
broader context will be discussed below along with areas of work that 
need further research.
8.1 Selective pinocytic uptake of proteins and peptides by 17.5-day rat 
yolk sacs.
Adsorptive pinocytosis is concluded to be the dominant mechanism
of uptake by 17.5-day rat yolk-sacs of all the proteins and peptides invest- 
125igated. The I-labelled forms of insulin, ribonuclease and lysozyme
(Chapter 2) are captured virtually entirely by an adsorptive mechanism;
these results extend the findings of Moore et al. (1974, 1977) and
125
Ibbotson (1978) that I-labelled rat immunoglobulin G and several denatured 
125
forms of I-labelled bovine serum albumin are captured by the 17.5-day
rat yolk sac by adsorptive endocytosis. it can also be reasoned that the 
125I -labelled peptides: calcitonin, insulin B-chain and glucagon are 
captured almost entirely in the same manner. Although direct experiments
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were not performed to determine whether these peptides, at the concentrations 
used in pinocytosis experiments, stimulate pinocytosis, results (in 
Chapters 3 £ 4 respectively) show that calcitonin (lOOyg/ml) and glucagon 
(several concentrations) are in fact inhibitors, and not stimulators of 
rate of pinosome formation. The effect of insulin B-chain is unknown, but 
there is no reason to suppose that it stimulates pinosome formation.
(Glucagon might have an important role to play in controlling 
yolk-sac pinocytic activity, thus regulating some, as yet unidentified 
but important, process necessary to the normal reproductive physiology of 
the rat (and possibly other animals, e.g. rabbits). A clue to the possible 
importance of glucagon in reproductive physiology is the observed rise in 
serum glucagon in rats during late pregnancy (Girard et al., 1974»
Metzger et al., 1974; Seudek, 1975).]
The widely differing rates of uptake of the various 1 2 5l-labelled 
proteins and peptides can thus be explained solely by the differential 
extents of their adsorption to pinocytosing plasma membrane (Section 2.4).
The specificity of the selective adsorption process was examined in 
Chapters 2, 3 & 7. Hydrophobic and basic regions (Chapter 3) of substrates 
seem to be recognised (c.f. formaldehyde-denatured bovine serum albumin 
and ribonuclease see Section 3.4) and seem to adsorb to different regions 
of the pinocytosing plasma membrane. Chapman-Andresen (1977) commented 
on the nature of the pinocytosing plasma membrane of the 17.5-day rat yolk 
sac. She inferred that the adsorptive uptake of denatured 1 2 5I-labelled 
albumin (that is expected to be negatively charged at neutral pH)
"indicates a net positive charge on the surface of the (yolk-sac) tissue". 
Clearly for this inference to be correct it denies that more than one 
type of interaction (namely electrostatic) can occur between a substrate 
protein and pinocytosing plasma membrane. If (as indicated in Chapter 3)
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hydrophobic and basic regions of substrate are both recognised by the 
pinocytosing plasma membrane, using the same argument presented by 
Chapman - Andresen (1977), it can be inferred that the extracellular 
surface of this membrane is both hydrophobic and negatively charged 
(and not positively charged). The possibility that yolk-sac pinocytic- 
-membrane recognition of regions of molecules depends neither on 
hydrophobic nor basic characteristics has yet to be investigated. 
Trifluoroacetylated bovine serum albumin is rapidly endocytosed by the 
rat yolk sac (P. Agarwal & A.T. Moore, unpublished results). This 
molecule is highly polar and negatively charged, but, it is not yet 
fully characterised so that it may either have regions that are hydro- 
phobic, or the highly polar trifluoroacetyl groups may bind cations thus 
acquiring an overall net positive charge at the surface of the molecule.
In Section 2.1 examples of several glycoprotein-substrate receptor 
recognition systems were described. The well-characterized asialo­
glycoprotein recognition system that binds these proteins to mammalian liver 
parenchymal cells (Ashwell & Morell, 1974<i,b) was in fact shown not 
to be present in the yolk-sac tissue (Moore et al., 1977). This system 
is, indeed, peculiar to the liver parenchymal cells. Nevertheless, it is 
not known whether the rat yolk sac can selectively endocytose lipoproteins, 
lysosomal enzymes and certain types of naturally occurring or semi­
synthetic glycoproteins of the types indicated in Section 2.1.
There appears to be, perhaps superimposed upon the recognition 
of hydrophobic, basic and possibly other characters, a preferential uptake 
of peptide substrates over the larger proteins (Chapter 7). In agreement 
with this generalization, is the demonstrated lower rate of uptake of 
lysozyme aggregates compared with lysozyme monomers (Chapter 2).
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Possible reasons for this latter phenomenon have been discussed in 
Section 2.4. In addition, it is possible that preferential uptake of 
smaller macromolecules occurs because they present a larger surface 
area per unit weight of substrate than do the larger macromolecules. 
Alternatively, the latter may be sterically hindered from interacting with 
the surface of the pinocytosing plasma membrane. Such steric hindrance of 
large macromolecules might occur if they are unable to filter through
C«b>
the dense regions of the cell-surface glyccj£.yx that are observed to line 
the cavities from which pinosomes are formed (Jollie & Triche, 1971).
The above observations contrast with those of Ryser (1970) and 
Gabathuler & Ryser (1975) who investigated the endocytosis of peptides and 
proteins in Sarcoma S180 cells in culture. These authors presented evidence 
indicating that large macromolecules are taken up more rapidly than 
small ones. Also ferritin aggregates are endocytosed more rapidly than 
ferritin monomers. The latter phenomenon was attributed to enhanced 
phagocytic activity (Gabathuler & Ryser, 1975) and is in agreement with 
the higher rates of uptake of protein aggregates, compared with the 
monomeric forms of the corresponding proteins, by the phagocytic 
Kupffer cells, examples of which are cited in Section 2.4. The earlier 
observation of Ryser (1970) might also be attributed to enhanced uptake 
of the larger substrates by phagocytosis. Morphological (Jollie & Triche, 
1971? see also Section 1.7) and biochemical evidence (Goetze et al., 1976) 
indicate that endocytic uptake in the rat visceral yolk sac is by micro- 
pinocytosis alone. The above differences between selective uptake in a 
phagocytic system and the selective uptake in the micropinocytically 
active rat yolk sac suggest an hypothesis that is readily amenable to 
investigation. That is, micropinocytosis selectively captures soluble 
substrates and shows a preference for macromolecules of a small size
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whereas phagocytosis selectively captures substrates with a preference for 
materials of larger size. A mechanistic basis for such a difference has 
not been established but, all else being equal, adsorption to endocytic 
membranes may show a preference for small macromolecules, but, in 
micropinocytosis, no induction of uptake is required whereas in phago­
cytosis uptake needs to be induced (Stossel, 1973» Silverstein et al.,
1977) and this is only achieved by the larger macromolecules.
The hypothesis purposely does not include phenomena that might 
be associated with macropinocytosis. It is envisaged that the mechanism 
underlying macropinosome formation in some instances may resemble phago­
cytosis and in other micropinocytosis.
8.2 Proteolytic activities of the 17.5-day rat yolk sac.
Knowledge of the proteolytic enzymology of the rat yolk sac is
poor. It is now clear, however, from the studies described herein and
those of others (Williams et al., 1971; Goetze et al., 1976) that the
rat yolk sac has a highly active proteolytic system, namely the lysosomal
system. As with many other cells and tissues the existence of particular
cathepsins within lysosomes of yolk sacs can be only inferred. The
inhibitions in intact yolk-sac tissue of the digestion of formaldehyde-
-denatured i-labelled bovine serum albumin caused by leupeptin,
chymostatin and antipain (see Chapter 6) and the inhibitions caused by
these inhibitors and pepstatin of the digestion of this substrate by a
c e l l - free extract of yolk sacs, strongly suggest the presence of enzymes
resembling cathepsin D or cathepsin L, or both, and of cathepsin D or
cathepsin E, or both. Before any particular enzymes can be held responsible
125for the digestion of the endocytosed I-labelled albumin further 
investigations are required.
The presence of proteolytic enzymes associated with the extra-
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cellular cell-surface of the rat yolk sac is possible [c.f. those present
on the surface of kidney brush border membranes (Kenny, 1977)]. But if
such enzymes do exist, they have negligible digestive activity toward 
125several I-labelled substrates: rat immunoglobulin G, formaldehyde-
denatured bovine serum albumin, lysozyme, ribonuclease, insulin, calcitonin
and insulin B-chain. Each of these substrates is rapidly digested by
cultured rat yolk sacs but at an intracellular site (see Chapters 2,4 & 7).
The only mechanism envisaged for the translocation of each of the above
substrates from the extracellular medium to an intracellular site is
pinocytosis; fusion of the pinocytic vesicles with lysosomes resulting in
the observed proteolytic activity. A lysosomal site of digestion was
125confirmed for formaldehyde-denatured I-labelled bovine serum albumin 
digestion (Chapter 4). The intracellular site of the digestion of the 
remainder of the above protein and peptide substrates can safely be 
considered to be lysosomal as discussed in Chapters 2 & 7.
It has been suggested that in hepatocytes, and other insulin 
target cells, the peptide hormone insulin might gain access to the 
cytoplasm and there be degraded by either an insulin specific proteinase 
(Brush, 1971) or a glutathione-insulin transhydrogenase (Thomas, 1973), 
or both. It is not known whether similar enzymes exist in the rat yolk 
sac, but if they do, it is difficult to conceive of a mechanism that 
might translocate insulin into the cytoplasm of cells either within the 
yolk-sac tissue or the liver thus permitting such enzymes to play an 
active role in insulin catabolism. Grisolia & Wallace (1976), however, 
have postulated a model for a role of lysosomes in peptide hormone 
degradation, and suggest that insulin can be partially degraded in 
hepatic lysosomes by a lysosomal glutathione-insulin transhydrogenase.
The occurrence of such an enzyme in yolk-sac lysosomes is unknown but
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its existence might explain how the disulphide linkages of insulin (and 
possibly other proteins) are cleaved.
It is possible that a lysosomal site of digestion of insulin
within hepatocytes could be demonstrated using the microbial proteinase
inhibitors that were shown in Chapter 6 to be inhibitors Of intralysosomal
proteolysis. A possible complication, however, is that insulin is
easily and rapidly digested by lysosomal enzymes in comparison to some
other proteins (see Chapter 7) so that substantial inhibition of lysosomal
catheptic activity might be necessary to prevent intralysosomal insulin
digestion. This is apparent from the observations in Chapter 7 that the
intralysosomal digestion of insulin is very much less sensitive to weak-
-base inhibition than is the intralysosomal digestion of protein substrates
125The digestion of I-labelled peptides (insulin, calcitonin,
insulin B-chain and glucagon) by disrupted rat-liver lysosomes, isolated
by the method of Trouet (1974), is several orders of magnitude more
125rapid than the digestion of I-labelled proteins (rat immunoglobulin G, 
denatured bovine serum albumin, and lysozyme). This observation (Chapter 
7 ) is in full agreement with the "all-or-none" hypothesis of Huisman (1974) 
that was forwarded to explain the apparent absence of intermediate sized 
digestion products derived from proteins hydrolysed intralysosomally. it 
is envisaged that after initial proteolytic attacks by the cathepsins on 
proteins to yield peptide fragments, the fragments are digested extremely 
rapidly and completely so that only very small quantities of intermediate 
sized digestion products are present in the lysosomes at any one time. 
However, the observed differences in the lag-periods (shown in Chapter 7) 
for the various protein and peptide substrates during their digestion by 
cultured rat yolk sacs, indicates that for some proteins (e.g. formaldehyde 
-denatured bovine serum albumin), once they have reached an intralysosomal
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site, a considerable period of time elapses before the protein is 
completely digested. Consequently, this period must represent the time 
taken for the initial rate-limiting cleavages to occur which result in 
the formation of the rapidly degradable peptide fragments. The difference 
in the duration of the lag-periods between the peptide and protein substrates 
suggest that more than one^and prcbably several,initial degradative attacks 
must occur before the rapidly digestible fragments are produced. It is 
possible that the initial intralysosomal degradative attacks on the above 
protein substrates are not peptide-bond cleavages but disulphide bond 
reductions. If this is the case, the durations of the lag-period for 
different sized proteins that contain no disulphide bonds should be 
similar and this should be short in comparison to lag-periods for proteins 
containing disulphide bonds. Further research is required to discover 
whether disulphide reductions constitute an initial, rate-limiting attack 
on disulphide containing proteins or whether the initial attacks are indeed 
a series of peptide-bond cleavages that result in the formation of proteins 
that remain relatively intact before the "last" of such initial attacks 
result in the formation of the rapidly digestible peptide fragments.
If the latter of the above occurs, it is possible that substrates 
that have undergone limited proteolysis cam be isolated. Analysis of 
these fragments to determine the site of cleavage would give valuable 
information that could be compared with the specificity of the known 
lysosomal cathepsins, thus enabling the identification of those cathepsins 
that are responsible for the initial rate-limiting attacks on proteins.
The lysosomal enzymes g-N-acetylglucosaminidase and 0-galacto- 
sidase are released from 17.5-day rat yolk sacs incubated in medium 199 
containing 10% calf serum (Roberts et al., 1977). The rate of release 
was found to be approx. 1% of the tissue-associated enzyme activity per h.
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If the lysosomal cathepsins are also released at this rate then 
substantial extracellular digestion of peptide substrates would be 
expected to occur when they are added to yolk sacs incubated in medium 
containing 10% calf serum. The value of 1%/h is approx. 15 times 
greater than would be predicted from results presented in Chapter 7 
(on the digestion of peptides by enzymes present in the incubation medium). 
After incubating yolk sacs in serum-free medium 199 for 3h, less than 
0 .2% of the catheptic activity of the tissue was present in the incubation 
medium. From the above observations it can be inferred either that 
cathepsins are not released at the same high rate as the glycosidases 
(thus possibly explaining the apparent lack of lysosomal storage disease 
associated with protein catabolism c.f. mucolipidoses, Neufeld et al.,
1977) or that the presence of calf-serum promotes the exocytic release of 
lysosomal hydrolases. Further research is necessary to determine whether 
either of these inferences is correct. It was shown (see Fig. 5.9) 
however, that B-N-acetylglucosaminidase is released at a rate of 0 .3%/h 
when incubated in serum-free medium thus suggesting the latter explanation 
might be incorrect. This, however, is not consistent with the hypothesis 
of Lloyd (1978) that lysosomal enzymes are exocytosed into the extracellular 
medium consequent on recycling of pinocytic membrane since the extent 
of the latter would be expected to decrease secondarily to the approximately 
two-fold decrease in rate of pinosome formation in yolk sacs incubated in 
the presence of 10% calf serum.
It is interesting to note here, that whereas glucagon can 
inhibit exogenous protein catabolism through inhibition of pinocytosis, 
once a protein is captured within pinosomes its lysosomal catabolism 
progresses at the normal rate. This is also true when dibutyryl cyclic 
AMP is used in place of glucagon. Both these compounds had no effect on the
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rate of digestion of formaldehyde-denatured 1 2 5i-labelled bovine 
serum albumin when this was expressed as a proportion of rate of uptake 
of the substrate (values taken from Table 4.7, were: control, 97.5% ±
12.8%; 10 6M-glucagon, 100.5 ± 13.1; 5 x lo“4M-db-cAMP, 100.9 ± 4.7.
Similar values for the average rates of tissue accumulation, expressed as 
a percentage of the rate of substrate uptake were; control, 2 1.9% ± 5 .7%;
“6 410 M-glucagon, 19.5 ± 1.8; 5 x 10 M-db-cAMP, 22.6 ± 4.7). These results 
indicate that the glucagon and the db-cAMP (present at concentrations 
that are sufficient to inhibit the rate of pinosome formation by 58.9% + 
17.5% and 34.1 ± 12.3 respectively) controls neither pinosome fusion 
with lysosomes nor intralysosomal proteolysis. Moreover, although glucagon 
is a stimulator of endogenous protein breakdown in perfused liver (Woodside 
et al., 1974) and in isolated hepatocytes (Hopgood et al., 1 9 7 7) it is 
without effect on the rate of digestion of endogenous yolk-sac proteins 
(Knowles & Ballard, unpublished work). Nutritional step-down , 
achieved by removing calf serum from medium in which yolk sacs are 
incubated, enhanced the rate of pinosome formation, but no effect is 
observed on the rate of endogenous yolk-sac protein breakdown (Knowles 
& Ballard, unpublished work). Furthermore, insulin, an inhibitor of 
hepatic protein breakdown (Mortimore & Mondon, 1970; Knowles & Ballard, 
1976), is without effect on yolk-sac protein breakdown (Knowles &
Ballard, unpublished work). Clearly endogenous yolk-sac protein 
catabolism is under very different controls to that found in the liver. 
[This is probably a marked reflection on the very different metabolic roles 
of the two tissues.] Also, whereas exogenous protein catabolism in the 
rat yolk sac may be under external controls that of endogenous protein 
catabolism does not seem to be.
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8.3 Role of lysosomes in the catabolism of endogenous yolk-sac proteins.
An attempt has been made to identify inhibitors of intralysosomal
catheptic activity. The digestion}by yolk sacs,of formaldehyde-denatured 
125I-labelled bovine serum albumin was employed to monitor this activity 
since it was shown (chapter 4) that it is hydrolysed exclusively within 
lysosomes. The weak bases (Chapter 5): ammonium-, methylammonium- and 
ethylammonium chlorides and chloroquine and the microbial proteinase 
inhibitors (Chapter 6): leupeptin, chymostatin and antipain (but not: 
pepstatin, elastatinal and bestatin) were shown to inhibit intralysosomal 
catheptic activity within intact yolk-sac tissues. Knowles & Ballard 
(unpublished work) showed that each of the above weak bases and each of 
the above inhibitory microbial compounds also inhibited the breakdown of 
endogenous yolk-sac proteins previously labelled in vitro with [3H]leucine.
Wibo & Poole (1974) and Hopgood et al. (1977) suggested that 
results of the types discussed above for weak bases and microbial 
proteinase inhibitors, indicate that lysosomes are involved in endogenous 
protein digestion. However, the weak bases were shown to inhibit energy 
production (Knowles & Ballard, unpublished results and Goldberg & St. John, 
1976 report of unpublished results; see Section 5.4). Since endogenous 
cell-protein breakdown is energy dependent (Ballard, 1977) and the nature 
of the energy requirement is unknown, it is not possible to conclude 
with confidence that the inhibition by weak bases of endogenous cell- 
-protein breakdown in intact cells is a result of lysosomal inactivation. 
Thus, results of the type presented by Wibo & Poole (1974) and in 
Chapter 5 of this thesis can not be argued to be evidence for a 
lysosomal role in endogenous cell-protein turnover without also having shown 
either one or a combination of: (a) accumulation of cell-protein within 
lysosomes, (b) a lack of inhibition of cell-protein breakdown under
197
conditions in which energy production is inhibited or (c) that the 
energy requirement of endogenous cell-protein breakdown is solely 
necessary for either autophago-lysosome formation or the maintenance 
of a normal lysosomal hydrolytic capacity (e.g. maintenance of an acid 
intralysosomal pH). None of these conditions were met either by Wibo 
& Poole (1974) or in Chapter 5 of this thesis.
It is concluded, however, that since antipain, chymostatin and
leupeptin are inhibitors of endogenous, yolk-sac protein breakdown
(up to 20% when present at 50ug/ml of incubation medium) lysosomes are
indeed involved in endogenous yolk-sac protein breakdown. It is possible
that lysosmes are involved in very much more than 20% of such breakdown
since further inhibition of lysosomal proteolysis of the exogenous
protein is obtained with higher concentrations of leupeptin (Chapter 6).
Moreover, endogenous yolk-sac protein hydrolysis in lysosomes may well
be less susceptible to inhibition by the microbial compounds than is
125formaldehyde-denatured I-labelled bovine serum albumin.
It was hoped that monitoring the digestion of formaldehyde- 
125-denatured I-labelled bovine serum albumin by yolk sacs would enable 
a quantitative estimation to be made of lysosomal activity in the 
presence of the various proteolytic inhibitors. It was further hoped 
that a comparison of the extent of lysosomal inactivation, measured by the 
observed impaired digestion of the exogenous protein could be compared 
with the extent of. the inhibition of endogenous cell-protein breakdown 
under identical culture conditions. It was shown (Chapter 7) however, 
that the extent of the observed lysosomal inactivation by the weak base 
ammonium chloride (20mM) was dependent on the exogenous substrate used 
to monitor lysosomal digestive activity. Values were obtained indicating
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that the lysosomal inactivation by 20mM-ammonium chloride ranged from 
0% to 100%: Although lysomal inactivation does indeed occur in the 
presence of the 2OmM-ammonium chloride, the lysosomal capacity for the 
digestion of some substrates (the peptide substrates) remained far 
greater than the endocytic capacity of the yolk-sac tissue (see Section
7.4). The results clearly showed that a comparison of the extent of 
inhibition by the weak bases, between exogenous substrate digestion and 
endogenous substrate digestion yields no meaningful information from 
which the extent of lysosomal participation in cell protein breakdown 
can be estimated. It remains to be investigated whether a selective 
inhibition of the intralysosomal digestion of various exogenous protein 
and peptide substrates occurs when the microbial compounds (Chapter 6) 
are used in place of the weak bases. If similar extents of inhibitions 
are achieved it is then possible to quantitate the lysosomal catheptic 
activity and thus obtain some estimates of the extent to which lysosomal 
and non-lysosomal digestive activities are involved in endogenous 
cell-protein breakdown. If a pattern of inhibition occurs similar to 
that obtained with 20mM-ammonium ions, then only when the exogenous 
substrate and the endogenous substrate are the same can the results of 
such studies be interpreted with confidence.
iAPPENDIX I
Determination of empirical correction factors for the acid-soluble 
radioactivity assays.
When measuring the acid-soluble radioactivity present in culture 
medium as described in Section 2.2.1(3), the supernatant obtained 
following the trichloroacetic acid precipitation and centrifugation 
procedure contains only a part of that present in the original 1 .0ml of 
culture medium (due to some of the acid-soluble radioactivity becoming 
occluded within the pellet of precipitated protein). The acid-soluble 
radioactivity present in the supernatant is also contained in a larger 
volume of solution (due to the addition of acid precipitant). Both the 
loss of acid-soluble radioactivity and the increase in the volume of the 
solution counted in the Packard Selektronic gamma spectrometer will 
decrease the observed count for the acid-soluble radioactivity. In 
order to obtain accurate values for the quantity of acid-soluble 
radioactivity and to standardize the counting geometry to 1 .0ml it was 
necessary to correct the observed count to that which would have been 
observed if all the acid-soluble radioactivity had been present in 1 .0ml 
of culture medium. This was achieved by multiplying the observed count 
for the supernatant (corrected for background) by an empirical correction 
factor, E.
Empirical correction factors were obtained using acid-soluble
radiotracers. Either sodium [^^1]iodide, [^ 2^I]iodo-L-tyrosine or 
125glycyl-[ I]iodo-L-tyrosine was added to culture medium 199 containing
3
10% (v/v) calf serum to give 50-150 x 10 c.p.m. per millilitre. When
[1 2 5I]iodide was used, solid KI was added to 1% (w/v) to prevent excessive 
125binding of the [ I]iodide to the assay tubes. Portions (1.0ml) of the
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culture medium were pipetted into 3ml disposable polystyrene tubes and the 
radioactivity counted (total acid-soluble radioactivity). The protein 
present in each 1 .0ml of culture medium was then precipitated using either 
trichloroacetic acid (0.5ml) or phosphotungstic acid (0.5ml) followed 
by trichloroacetic acid (0.5ml) as described in Section 2.1.1(3). The 
supernatant obtained after the centrifugation procedure was decanted into 
a new 3ml polystyrene tube and the radioactivity counted as before 
(observed acid-soluble radioactivity). The empirical correction factor,
E, can be simply calculated by dividing the total acid-soluble radio­
activity, A (c.p.m. in 1.0ml of culture medium, corrected for background) 
by the observed acid-soluble radioactivity, B (c.p.m. in the supernatant, 
corrected for background) according to the equation: E » B/A.
When the acid-soluble radioactivity was present in culture medium 
deficient in calf serum, 0 .1ml of calf serum was added to the 1 .0ml of 
culture medium just before the addition of acid. This procedure resulted 
in a further dilution of the acid-soluble radioactivity, consequently 
a different set of empirical correction factors needed to be calculated.
Table A. 1 shows the empirical correction factors determined for
both the trichloroacetic acid and the phosphotungstic acid-trichloroacetic
acid protein precipitation methods, using the three different acid-soluble
radiotracers present in the culture medium, both with and without added
125calf serum. In general, [ I]iodo-L-tyrosine and glycyl- [l25IJiodo-L- 
-tyrosine gave similar empirical correction factors, whereas [125I]iodide 
consistently gave smaller values. Because, [l25l]iodo-L-tyrosine was 
always found to be the major hydrolysis product when using l25i-labelled 
protein substrates in the yolk-sac culture system, the empirical correction 
factors obtained for this acid-soluble radiotracer were used in experiments.
Table A.l Empirical correction factors determined for the acid-soluble radioactivity assay.
The empirical correction factors were determined as described in the text. Values are given as 
the mean - standard deviations of six determinations.
Percentage of calf 
serum present in 
the original culture 
medium
Acid-soluble
radiotracer
Precipitation method
Trichloroacetic acid (TCA) Phosphotungstic acid + TCA
[^^1 ] iodide 1.259 ± 0.025 1.480 ± 0.095
1 0% [^^1 ] iodo-L-tyrosine 1.274 ± 0.011 1.514 ± 0.14
125glycyl-[ I]iodo-L- 
-tyrosine 1.291 ± 0.014 1.559 ± 0.034
125[ I ] iodide 1.294 ± 0.016 1.546 ± 0.017
0% 125[ I]iodo-L-tyrosine 1.330 ± 0.022 1.624 ± 0.021
125glycyl-[ IIiodo-L- 
-tyrosine 1.328 ± 0.056 1.617 ± 0.025
iii
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APPENDIX II
Expression of pinocytic uptake data for experiments described in Section
2.2.1
As described before (see Section 2.2.2), the method used to 
calculate and express pinocytic uptake data was that of Williams et al.
1975afb). For reasons discussed in Section 2.2.2, pinocytic uptake is 
expressed as the volume of incubation medium whose contained substrate is 
captured by unit quantity of the yolk-sac tissue. This volume (whose units 
are microlitres of incubation medium per mg of yolk-sac protein) is 
given by the expression
V = Y/(M.P) (A.1)
where Y is the total radioactivity (in c.p.m., corrected for background) in
the whole yolk sac, M is the radioactivity (in c.p.m., corrected for
b a c k g r o u n d )  per microlitres of incubation medium and P is the protein content
(in milligrams) of the yolk-sac tissue. Thus a value of uptake is obtained
for each yolk sac at each time interval in the experiment. The rate of uptake
125[l25i]labelled poly(vinylpyrrolidone) [ I-PVP] is derived from a plot
of uptake against the duration of the respective incubation, (see e.g.
Fig. 2.1). The slope of the plot gives the rate of uptake, and is called
the "Endocytic Index" or "El"; its units are microlitres per milligram
of yolk-sac protein per hour of incubation.
In all the experiments reported in this thesis, uptake of
125I_PVP by the yolk sac resulted in a detectable fall in the 1 2 5I-PVP
concentration in the incubation medium but the rate of fall was never
greater than approximately 0 .1%/h in medium plus 10% calf serum or 0 .2%/h
125in serum-free medium. Thus the concentration of I-PVP in the incubation 
medium is effectively constant for the duration of the incubation,
Vtherefore the measured value of the radioactivity in the medium at the
end of an incubation period can be used for M in equation A.l.
125In experiments where I-labelled protein substrates were used 
a large proportion of the ingested radio-label was not retained within 
the yolk-sac tissue, but was released back into the medium as "acid- 
soluble" digestion products. It is appropriate therefore to modify the 
numerator in the uptake equation A.l, to give:
_ Y + lp(S-F)
M-.P {A‘2)
where 10(S-F) is the total quantity of "acid-soluble" radioactivity 
released into the incubation medium (1 0 .0ml) during the incubation period. 
Y is the total radioactivity in the whole yolk-sac (c.p.m., corrected 
for background), S is the acid-soluble radioactivity in the Incubation 
medium at the end of an incubation period (c.p.m. per ml of incubation 
medium, corrected for background). P, a correction term, is the sum 
of the acid-soluble radioactivity present at the start of an incubation 
and that radioactivity which may be lost from the protein during the 
incubation period by processes not associated with the yolk sac. f was 
determined by assaying the percentage acid-soluble radioactivity in the 
incubation medium in the control flask at the end of each experiment 
(i.e. the incubated flask which contained medium and dissolved substrate 
but no yolk sac). The correction term f in equation A.2 can be derived 
from equation A.3:
where M" is the total radioactivity present in 1.0ml of incubation 
medium from the control flask (c.p.m., corrected for background). Q is
vi
[Q = E.C./C , where C is the mean acid-soluble radioactivity (c.p.m.1 2  1
per ml, corrected for background) and is the mean total radioactivity 
of the incubation medium (c.p.m. per ml, corrected for background). E 
is an empirical correction factor (see Appendix I) that corrects for both 
the loss of acid-soluble radioactivity and a change in counting geometry 
when assaying the incubation medium for acid-soluble radioactivity.]
In all the experiments with a labelled protein as substrate, it
125was found that the rate of uptake was much greater than for I-PVP.
Hence there was significant depletion of the substrate in the incubation 
medium over the period of incubation [almost 1 0% per hour when culturing a 
yolk sac, containing 7mg protein, in the presence of a substrate with 
an Endocytic Index of 150yl/h per mg yolk-sac protein]. It was therefore 
no longer accurate to use the total medium radioactivity M, as in equation 
A.l but to use M', the mean concentration of radiolabelled substrate 
over the particular incubation period (c.p.m. per nl of incubation 
medium, corrected for background), M 1 is calculated from equation A.4:
M’ = M - [ (S-F) /2 x 103] (A.4)
where S and F are as defined in equation A.2.
The uptake, V, in equation A.2, again has the units of microlitres 
of incubation medium per milligram yolk-sac protein. A plot of the 
values of uptake against time (see e.g. Fig. 2.2) should be linear 
over the incubation period used. The slope of the plot gives the value 
of the Endocytic Index.
[The term F in equation A.2, A.3 and A.4, in the experiments 
described in this thesis, represents, almost exclusively, the acid-soluble 
radioactivity present in the incubation medium at the start of the incubation.
the fraction of radioactivity in the control medium that is acid-soluble.
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Evidence that this is so comes from the observations that: firstly, 
no increase in acid-soluble radioactivity was observed in control 
experiments where radiolabelled substrate was incubated without yolk sac, 
and second, incubation medium, removed at intervals (up to 6h) from 
flasks containing yolk sacs and incubation medium without added substrate, 
contained no significant hydrolytic activity when re-incubated under 
the usual incubation conditions with added substrate.]
Calculation of pinocytic uptake d a t a .
Computer programs (BASIC) were written for the calculation of
data for both the uptake of the non-digestible substrate I-labelled
125poly(vinylpyrrolidone) and the digestible I-labelled protein substrates, 
and are shown below. Since uptake was obviously linear with time, a 
best straight line was fitted to each set of points for uptake against time 
by linear regression analysis. Values of the slope and the intercept of 
these lines were obtained from a standard computer program along with 
the value of the association Correlation Coefficients. The calculations 
and the linear regression analysis were made with an ICL 4130 computer.
(1) Program for uptake of an indigestible substrate [e.q. 3-25I-labelled 
poly(vinylpyrrolidone)]
"Input" data are as defined in the program but the assay 
data were collected as follows:
H(X) Duration of the yolk sac incubation period (h).
I(X) Mean observed radioactivity count for 1.0ml of incubation medium.
K(X) Mean observed radioactivity count for 1.0ml of alkaline yolk-sac
solution.
L(X) Total protein content of the incubated yolk sac (mg).
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10 DIM H(15),1(15),K(15),L(15),R(15)
12 IF W=1 THEN 84
13 LET W=1
16 PRINT "NON-DIGESTIBLE PROG. ENTERED"
17 PRINT "EXPT. NO. (DIGITS ONLY)=;
18 INPUT Z
19 PRINT "BACKGROUND IN CPM=";
20 INPUT A
35 PRINT "COUNTING TIME FOR EACH ML OF MEDIUM,SECS=";
40 INPUT C
45 PRINT "COUNTING TIME FOR EACH ML OF YS SOLUTION,SECS 
50 INPUT D
75 PRINT "NO. OF POINTS IN PLOT="f 
80 INPUT G 
82 STOP 
84 LET W=0 
95 FOR X=1 TO G '
98 IMPUT H(X),1(X),K(X),L(X)
99 NEXT X
100 FOR X=1 TO G
101 LET M=(I(X) * 6 0 / 0 -A
135 LET Q=((K(X)*60/D)-A*5
136 LET N=M+Q/20
140 LET R(X)=(Q*1000)/(N*L(X))
145 PRINT FPE(5);H(X),FRE(6);R(X)
150 NEXT X
152 PRINT FRE(5);*1,FRE(6) ;Z
IX
155 DRSPEC TO OWN
157 PRINT " "
158 PRINT " "
160 PRINT "INCUBATION TIME (HOURS)" /'PROTEIN IN YS"," UPTAKE"
165 PRINT
190 FOR X=1 TO G
195 PRINT " ",FRE(5);H(X),FRE(6);L(X),FRE(6),R(X)
200 NEXT X
I
205 STOP
(2) Program for uptake of a digestible substrate [e,g, 1 2 5I-labelled 
proteins]
"Input" data are as defined in the computer program but the assay 
data were collected as follows:
H(X) Duration of the yolk sac incubation period (h).
I(X) Mean observed radioactivity count for 1.0ml of incubation medium.
J(X) Mean observed "acid-soluble" radioactivity count for 1.0ml of
incubation medium after the precipitation and centrifugation procedure. 
K(X) Mean radioactivity count for 1.0ml of the alkaline yolk-sac solution.
L(X) Total protein content of the incubated yolk sac (mg).
10 DIM E (12),H(12),1(12),J(12),K(12),L(12),S(12)
12 IF W=1 THEN 84
13 LET W=1
14 PRINT "PROTEIN PROGRAM ENTERED"
15 PRINT "EXPT. NO. (DIGITS ONLY)=;
16 INPUT V
19 PRINT "BACKGROUND IN CPM=";
20 INPUT A
25 PRINT "PERCENT SOLUBLES IN PREP=";
X30 INPUT B
35 PRINT "COUNTING TIME MEDIUM TOTALS,SECS»";
40 INPUT C
41 PRINT "COUNTING TIME MEDIUM SOLUBLES,SECS=",
42 INPUT Z
45 PRINT "YS COUNTING TIME,SECS-";
50 INPUT D
60 PRINT "CORRECTION FACTOR FOR MEDIUM TOTALS»";
65 INPUT Y
67 PRINT "CORRECTION FACTOR FOR MEDIUM SOLUBLES»";
68 INPUT R
75 PRINT "NO. OF POINTS IN PLOT»";
80 INPUT G 
82 STOP 
84 LET W=0 
95 FOR X=1 TO G
98 INPUT H(X),I(X),J(X),K(X),L(X)
99 NEXT X
100 FOR X=1 TO G
101 LET M=(I(X)*60/C-A)*Y
102 LET N=(J(X)*60/Z-A)*R 
105 LET 0=N-(M*B/100)
135 LET Q=((K(X)*60/D)-A)*5
136 LET P=(M-N)+0/2
137 LET F=((10*0)+Q)*1000
138 LET E(X)=(Q*1000)/(L(X)*P)
139 LET (S(X)=F/(L(X)*P)
140 PRINT FRE (5);H(X),FRE(6);S(X)
xi
150 NEXT X
151 PRINT FRE(5);-l,FRE(6);V
152 DRSPEC TO OWN
153 PRINT " "
154 PRINT " "
155 PRINT " INCUBATION "/'PROTEIN","MICROLITRES"," UPTAKE" 
160 PRINT "TIME (HOURS)"," IN YS PER MG YS "
190 FOR X=1 TO G
195 PRINT FRE(5);H(X),FRE(6);L(X),FRE(6);E(X),FRE(6)>S(X)
200 NEXT X
205 STOP
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